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Abstract 
Exoribonucleases have many important functions in the cell including RNA 
processing, turnover and quality control. One of the key 3’-5’ exonucleases is the 
exosome, a multiprotein complex that has been extensively characterised in yeast. 
Many substrates that undergo maturation and/or degradation involving the yeast 
exosome have been identified and these include tRNAs, mRNAs, snRNAs, snoRNAs 
and rRNAs. By comparison, the human exosome is poorly understood and it is not 
clear whether functions of the yeast exosome are conserved in higher eukaryotes.  
We show that the human exosome has degradation functions including the 
turnover, but not the processing, of snoRNAs and the recycling of excised pre-rRNA 
fragments. We and others have shown that the human exosome also participates in 
pre-rRNA processing to form the mature 3’ end of 5.8S rRNA. Here we identify a novel 
role for the exosome in the processing of the pre-rRNA internal transcribed spacer 1 
(ITS1). The small (18S) and large (5.8S and 28S) subunit rRNAs are co-transcribed as 
a single precursor. Processing of ITS1 is a key step in ribosome biogenesis as it 
separates 18S from the large subunit rRNAs and in higher eukaryotes it involves an 
additional processing step compared to yeast.  
We define alternative ITS1 processing pathways in human cells. In the major 
pathway, following an endonucleolytic cleavage to separate the small and large subunit 
rRNAs, the exosome, which is not involved in ITS1 processing in yeast, processes to 
within 25 nucleotides of the 3’ end of 18S. Our data highlight significant differences 
between the nucleases involved in ITS1 processing in yeast and humans. However, it 
appears that the roles of several yeast biogenesis factors are conserved in higher 
eukaryotes. Further, we have investigated mechanisms by which exonucleolytic 
processing of ITS1 may be regulated and suggest how this could be coordinated with 
the final maturation steps of the pre-40S complex. 
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Chapter One 
Introduction 
1.1 Ribosomes 
Ribosomes are highly conserved RNA-protein complexes that are responsible 
for translating the information encoded in mRNAs into proteins. Eukaryotic ribosomes 
have a sedimentation coefficient of 80S and are composed of two subunits, a large 60S 
subunit and a small 40S subunit. The large subunit (LSU) contains the sites of peptidyl 
transferase activity while the decoding function of the ribosome is carried out in the 
small subunit (SSU) (Lafontaine & Tollervey, 2001). The LSU of eukaryotic ribosomes 
contains three ribosomal RNA (rRNA) species, 28S (25S in yeast), 5.8S and 5S, along 
with approximately 46 ribosomal proteins (r-proteins) while the SSU is composed of a 
single rRNA, 18S, and 32 r-proteins. Crystal structures of eukaryotic ribosomes and 
subunits have recently been published showing the spatial organisation of rRNAs and 
r-proteins (Ben-Shem et al, 2011; Ben-Shem et al, 2010; Klinge et al, 2011; Rabl et al, 
2010). Ribosome biogenesis is a complex process and involves the coordinated 
actions of more than 200 trans-acting protein factors including nucleases, chaperones, 
helicases, methyltransferases and transport factors (Henras et al, 2008). Ribosome 
biogenesis requires a great deal of the cells’ energy with approximately 70 % of all 
transcription being directed for ribosome production (Warner, 1999).  
The number and production rate of ribosomes determines the protein synthesis 
capacity of a cell, thereby coupling ribosome biogenesis and cellular growth rate. As a 
result of this, ribosome biogenesis is down-regulated during cellular differentiation and 
the levels of many ribosome biogenesis factors are also decreased following 
differentiation (Bowman & Emerson, 1977; Knox et al, 2011). In contrast, ribosome 
biogenesis is up-regulated in most cancer cells and several proto-oncogenes and 
tumour suppressor genes are able to directly regulate ribosome biogenesis (Oskarsson 
& Trumpp, 2005; Ruggero & Pandolfi, 2003). p53 has also been shown to be activated 
by ribosome dysfunction and cellular stress (Holzel et al, 2010). Inhibiting ribosome 
production increases the pool of free ribosomal proteins, such as RPL11, which then 
interact with HDM2, a key regulator of p53 (Sasaki et al, 2011). More specifically, the 
ribosome biogenesis factors, BOP1 and ENP, are upregulated in hepatocellular 
carcinoma and BOP1 also in colorectal carcinoma (Chung et al, 2011; Killian et al, 
2006; Wang et al, 2009). 
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Defects in ribosome biogenesis also occur in several genetic diseases (Narla & 
Ebert, 2010). Germline mutations in various proteins found in the mature ribosome 
have been described in diseases characterised by erythroid deficiency including 
Diamond Blackfan anaemia (DBA) and 5-q syndrome, which are particularly associated 
with mutations in RPS19, RPS10, RPS24, RPS26 and RPS14 (Ebert et al, 2008). It 
has been shown that haploinsufficiency of ribosomal protein genes leads to specific 
p53 activation in erythroid progenitors and cell cycle arrest (Dutt et al, 2011). Mutations 
in other ribosome biogenesis factor genes have also been implicated in rare congenital 
syndromes including dyskeratosis congenita and Schwachman-Diamond syndrome 
(Burwick et al, 2011; Gupta & Kumar, 2010). The craniofacial disorder, Treacher Colins 
syndrome, is caused by mutations in the TCOF1 gene or mutations in the genes 
encoding subunits of RNA polymerase I or III (Dauwerse et al, 2011; Dixon et al, 2007; 
Valdez et al, 2004). The TCOF1 gene product, Treacle, is required both for 
transcription of the ribosomal DNA (rDNA) and modification of the rRNAs which are 
important for ribosome function. Other proteins which play important roles in the 
maturation of the RNA components of ribosomes have also been linked to genetic 
diseases. The RNA-protein enzyme, RNase MRP, which is important for rRNA 
processing in yeast, has been linked to CHH syndrome (cartilage-hair hypoplasia) 
(Mattijssen et al, 2010b; Ridanpaa et al, 2001) and a similar syndrome; ANE (alopecia, 
neurological defects and endocrinopathy), is caused by mutation of RBM28, the human 
homologue of a yeast ribosome biogenesis factor (Nousbeck et al, 2008; Spiegel et al, 
2010).  
 
1.2 rRNA organisation, transcription and processing 
In eukaryotes, the 18S, 5.8S and 28S (25S in yeast) ribosomal RNAs are co-
transcribed as a single precursor by RNA polymerase I while 5S is independently 
transcribed by RNA polymerase III (Nazar, 2004). In yeast, ~150 rDNA genes 
containing the co-transcribed rRNAs are found in tandem repeats on chromosome 12 
whereas in human cells approximately 400 tandem rDNA repeats have been found on 
the short arms of acrocentric chromosomes (Kobayashi et al, 1998; Prieto & McStay, 
2005). In yeast, 5S sequences are found immediately downstream of rDNA repeats 
while in higher eukaryotes, 5S genes are often found clustered in separate regions of 
the genome (Douet & Tourmente, 2007). Pre-rRNA transcription occurs within the 
nucleolus, a sub-compartment of the nucleus formed around nucleolar organiser 
regions (NORs) containing the rDNA repeats. Following rDNA transcription, the early 
steps of pre-rRNA processing and ribosome assembly also occur in the nucleoli 
(Hernandez-Verdun et al, 2010).  
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All of the rRNAs are synthesised as precursors and undergo processing to form 
the mature rRNAs. The precursor transcript containing 18S, 5.8S and 28 (25S in yeast) 
is 13kb or 47S long (35S in yeast). In addition to the mature rRNAs this transcript 
contains 5’ and 3’ external transcribed spacer regions (5’ETS and 3’ETS) as well as 
two internal transcribed spacers (ITS1 and ITS2). These spacer regions are removed 
by an ordered series of endonucleolytic cleavages and exonucleolytic processing steps 
to release the mature rRNAs. In yeast, 5S rRNA has been shown to undergo 
processing at both the 5’ and 3’ ends by exonucleases (van Hoof et al, 2000). 
 
1.2.1 Pre-rRNA processing in Saccharomyces cerevisiae 
 The pathway of pre-rRNA processing has been studied most extensively in the 
yeast, Saccharomyces. cerevisiae (S. cerevisiae) (Granneman & Baserga, 2004; 
Henras et al, 2008) (Figure 1.1). Processing of the initial 35S precursor begins as the 
transcript is being produced in the nucleolus and the first steps that occur are 
endonucleolytic cleavages at the B0 site in the 3’ETS, which is carried out by Rnt1 
(Kufel et al, 1999), and at the A0 site in the 5’ETS by an unknown endonuclease. This 
is followed by a cleavage at the 5’ end of 18S (A1) to remove the remaining 5’ETS and 
generate the 32S intermediate. Cleavages at sites A2 and A3 in ITS1 separate the large 
subunit (LSU) and small subunit (SSU) pre-rRNAs producing 27SA2/27SA3 and 20S 
pre-rRNAs, respectively. 20S is transported to the cytoplasm where a final 
endonucleolytic cleavage at site D, carried out by Nob1, generates the mature 3’ end of 
18S (Lamanna & Karbstein, 2009; Pertschy et al, 2009).The A2 cleavage site is an AC-
rich sequence to the 5’ side of a conserved stem-loop structure approximately 217 
nucleotides away from the 3’ end of 18S and cleavage at this site has recently been 
proposed to be carried out by Rcl1 (Horn et al, 2011). In addition to A2 cleavage, the 
majority (approximately 85%) of the pre-rRNA is cleaved at a second site in ITS1, A3, 
by RNase MRP (Lygerou et al, 1996; Schmitt & Clayton, 1993). The A3 cleavage site is 
also an AC-rich sequence to the 3’ side of a stem-loop structure and is located 
approximately 60 nucleotides upstream of the A2 cleavage site. A3 cleavage is followed 
by exonucleolytic processing by the 5’-3’ exonucleases, Rat1 and Rrp17, to the B1S site 
which represents the mature 5’ end of 5.8SS rRNA (Henry et al, 1994; Oeffinger et al, 
2009). The remaining pre-rRNA, which is cleaved at A2 but not A3, is processed to 
produce an alternative form of 5.8S, 5.8SL, probably through an additional 
endonucleolytic cleavage at the B1L site. The 3’ ends of both 5.8SS and 5.8SL are 
produced by a common pathway. An endonucleolytic cleavage in ITS2 at site C2, which 
occurs in the nucleus, produces 7S and 27SBS/27SBL (Michot et al, 1999) This is 
followed by further exonucleolytic processing  
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in the 5’-3’ direction by Rat1 and Rrp17 to generate the mature 5’ end of 25S 
(Geerlings et al, 2000; Oeffinger et al, 2009). The 5.8S containing precursor generated 
by cleavage at site C2 is processed by a 3’-5’ multiprotein exonuclease complex called 
the exosome to produce a form of 5.8S with a 30 nucleotide 3’ extension (5.8S+30). 
Exonucleolytic processing in both directions following C2 cleavage has recently been 
shown to require Las1 (Schillewaert et al, 2011). 5.8S+30 is then converted to 6S by 
Rrp6, the RNase D-like subunit of the exosome, and the mature 3’ ends of 5.8SS and 
5.8SL are formed in the cytoplasm by the exonucleases Rex1, Rex2 and Ngl2 (Faber et 
al, 2002; Thomson & Tollervey, 2010). The mature 3’ end of 25S is also produced by 
 
Figure 1.1 pre-rRNA processing 
pathways in S. cerevisiae A) pre-rRNA 
processing pathway in S. cerevisiae is 
shown with numbers corresponding to the 
intermediates shown in (B) and arrows 
showing the direction of processing. The 
major pathway for 5.8SS production is 
shown in black and the minor pathway for 
production of 5.8SL is shown in grey. 
Endonucleases and exonucleases identified 
as participating in particular steps are 
shown in red. B) Schematic representation 
of the initial pre-rRNA transcript containing 
the mature rRNAs (18S, 5.8S and 28S) and 
both internal (ITS1, ITS2) and external 
(5’ETS, 3’ETS) transcribed spacer regions. 
The major processing sites marked and the 
intermediates generated through processing 
are shown below the full length transcript.  
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exonucleolytic processing following Rnt1 cleavage (Oeffinger et al, 2009). In addition to 
their roles in the formation of the mature 5’ and 3’ ends of several rRNAs, 
exonucleases also function to degrade the spacer fragments released by serial 
endonucleolytic cleavages.  
 
1.2.2 pre-rRNA processing in Xenopus laevis 
 Pre-rRNA processing has been studied in other eukaryotes, more complex 
than yeast and the processing pathway in the vertebrate, Xenopus laevis (X. laevis), is 
well characterised (Savino & Gerbi, 1990). As in yeast, the 18S, 5.8S and 28S rRNAs, 
flanked by internal and external transcribed spacer regions are co-transcribed as a 
single precursor transcript (40S). Compared to yeast, an additional cleavage in the 
5’ETS at a site called A’ has been observed and cleavage at this site generates a 40S 
intermediate (Borovjagin & Gerbi, 2005). Removal of the internal transcribed spacers is 
proposed to occur by endonucleolytic cleavages at the mature 3’ and 5’ ends of 18S, 
5.8S and 28S but the order of these cleavages is variable and two alternative pre-rRNA 
processing pathways have been shown to co-exist in a single oocyte (Figure 1.2) 
(Borovjagin & Gerbi, 2001).  
 
 
Figure 1.2 pre-rRNA processing 
pathways in X. laevis A) Alternative pre-
rRNA processing pathways in X. laevis are 
shown in black and grey with numbers 
corresponding to the intermediates shown 
in (B) and arrows showing the direction of 
processing. B) Schematic representation of 
the initial pre-rRNA transcript containing the 
mature rRNAs (18S, 5.8S and 28S) and 
both internal (ITS1, ITS2) and external 
(5’ETS, 3’ETS) transcribed spacer regions. 
The major endonuclease cleavage sites are 
marked and the processing intermediates 
are shown. 
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Some Xenopus oocytes use only a single pathway in which cleavage at site 3 at the 5’ 
end of 5.8S precedes cleavage at sites 1 and 2, which produce the mature ends of 
18S, and cleavages 4 and 5 which release 5.8S and 28S from the 32S precursor. 
Alternatively, cleavages at sites 1 and 2 can occur prior to site 3 cleavage and this 
directly generates 18S and a different LSU precursor, 36S. Cleavages at sites 3, 4 and 
5 then produce the mature 5.8S and 28S rRNAs.  
 
1.2.3 Pre-rRNA processing in mammals 
 Less is known about pre-rRNA processing in mammals than in yeast. Early 
experimental data indicated a processing pathway broadly similar to that used in yeast 
and Xenopus (Hadjiolova et al, 1984) (Figure 1.3) but most of the cleavage sites in 
human pre-rRNA have not been accurately mapped nor have the enzymes required for 
specific steps been identified. In higher eukaryotes, two cleavage steps occur in the 
5’ETS of the primary 47S transcript; A’ and A0 (Hadjiolova et al, 1993). A’ cleavage is 
the only processing event thought to happen co-transcriptionally and this generates 
45S. Following A’ processing, cleavage at site 2 in ITS1 separates the SSU and LSU 
rRNAs producing the 30S and 32S pre-rRNAs, respectively. The 5’ETS is then 
removed from 30S to generate 21S either directly through simultaneous cleavages at 
sites A0 and A1, or, if A0 precedes A1, via a 26S intermediate. The order of these 
processing steps is variable and cleavages to remove the 5’ETS can occur prior to 
ITS1 cleavage, generating 41S which is then cleaved at site 2 to produce 21S and 32S. 
It is thought that two cleavage events occur in ITS2 (C1, C2) generating two precursors 
of 5.8S, 12S and 8S (Michot et al, 1999). As in yeast, the mature 3’ end of 5.8S is 
generated by exonucleolytic processing involving the exosome. Similarly, 
exonucleolytic processing is thought to be required for formation of the 5’ and 3’ ends 
of 28S in higher eukaryotes (Wang & Pestov, 2011).  
 Production of 18S in mammals involves an additional processing step 
compared to yeast. An 18S precursor, 18SE, which has an extension beyond the 3’ 
end of 18S of approximately 25 nt to site 2a, has been identified (Rouquette et al, 
2005) (Figure 1.3B). However, it is unclear how this precursor is generated and 
different mechanisms have been postulated. In human cells, depletion of a late-acting 
SSU component, ENP1 (bystin), causes accumulation of an intermediate called 21SC, 
just smaller than 21S (Carron et al, 2011). A similar intermediate has also been 
observed upon depletion of the ribosomal protein, RPS19 (Idol et al, 2007). 21SC is 
also seen at very low levels in normal cells suggesting that it is a natural processing 
intermediate that is significantly accumulated in the absence of ENP1 or RPS19. The 3’ 
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end of 21SC is very heterogeneous implying that it and possibly 18SE are generated 
by exonucleolytic processing (Carron et al, 2011). However, it has also been suggested 
that 18SE is produced directly by an endonucleolytic cleavage. Depletion of XRN2 from 
mouse cells caused a significant accumulation of 36S, an intermediate generated by an 
endonucleolytic cleavage at site 2a before site 2. Also observed when XRN2 was 
depleted was a released fragment of ITS1 generated by sequential cleavages at sites 2 
and 2a (Wang & Pestov, 2011). It is unclear, therefore, how ITS1 is processed and 
18SE is formed. Cleavage at site 2 appears to be the initial cleavage in ITS1 that 
separates the SSU and LSU rRNAs and early data using RNase protection mapping of 
pre-rRNA from rat liver cells located this cleavage to a poly(T) tract approximately 160 
nucleotides from the 5’ end of 5.8S (Hadjiolova et al, 1984) but this sequence is not 
conserved in human pre-rRNA. In human cells, depletion of Dicer, the endonuclease 
linked to miRNA and siRNA production, influenced cleavages in this region but the 
effects observed were minor so it seems unlikely that Dicer is the endonuclease 
responsible for site 2 cleavage (Liang & Crooke, 2011). 
 
 
 
Figure 1.3 pre-rRNA processing pathways 
in mammals A) Alternative pre-rRNA 
processing pathways in mammalian cells are 
shown with the numbers corresponding to 
the intermediates shown in (B) and arrows 
indicating the direction of processing. The 
major pathway is shown in black and minor 
pathways are shown in grey. B) Schematic 
representations of the initial pre-rRNA 
transcript containing the  mature rRNAs, 18S 
(blue), 5.8S (orange) and 28S (yellow) and 
the internal transcribed spacer regions (ITS1 
and ITS2) and the external transcribed 
spacers (5’ETS and 3’ETS). The major 
cleavage sites are marked above the 
transcript.  
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1.2.4 ITS1 processing 
 In all eukaryotes, cleavages in ITS1 are particularly important in ribosome 
biogenesis as they separate the small subunit rRNA, 18S, from the large subunit 
rRNAs, 5.8S and 28S (25S in yeast). After cleavage in ITS1, biogenesis of the small 
and large subunits follows separate pathways until the mature 40S and 60S subunits 
become associated in the cytoplasm to form the ribosome. Preliminary data suggest 
that processing of ITS1 in higher eukaryotes may be significantly different from yeast 
and how separation of the LSU and SSU rRNAs is achieved may represent a key 
change in pre-rRNA processing through evolution. 
 
1.3 rRNA modifications and snoRNPs 
 In addition to processing from precursors, rRNAs undergo extensive covalent 
modification both co-transcriptionally and post-transcriptionally (Kos & Tollervey, 2010; 
Terns & Terns, 2002). In excess of 200 nucleotides in 18S and 25S (28S in humans) 
have been shown to undergo modification. Such modifications involve either 2’-O-
methylation of specific nucleotides or conversion of uridine residues to pseudouridine 
(Figure 1.4A). Methylation can stabilize base-pairing interactions within the ribosome 
and is important for mediating RNA folding while pseudouridinylation has been shown 
to help maintain RNA secondary structures and aid interactions between the rRNA and 
particular ribosomal proteins (Decatur & Fournier, 2002; Decatur & Fournier, 2003; 
Helm, 2006). Individual modifications increase the cell’s sensitivity to certain antibiotics 
and stress; particular groups of modifications have been shown to be important for cell 
growth (Baudin-Baillieu et al, 2009; Baxter-Roshek et al, 2007; Esguerra et al, 2008; 
Piekna-Przybylska et al, 2008). Modification sites are generally highly conserved. They 
are found in functionally important domains of the mature rRNAs such as the peptidyl 
transferase domain and the interfaces between the large and small subunits, 
underlining the key regulatory role they can play (Baudin-Baillieu et al, 2009; Decatur & 
Fournier, 2002; Liang et al, 2007). In the absence of these modifications, non-
functional ribosomes are produced. 
rRNA modifications are guided by a number of small nucleolar 
ribonucleoprotein complexes (snoRNPs) (Watkins & Bohnsack, 2011). snoRNPs are 
basically comprised of four core proteins and a small RNA component which guides 
interactions with the pre-rRNA by base-pairing with the target sites to direct the 
modification (Henras et al, 2004; Kiss-Laszlo et al, 1998; Terns & Terns, 2002). The 
core snoRNP proteins provide a scaffold for snoRNA folding and the catalytic activities 
are responsible for carrying out the modification. Most snoRNPs can be divided into 
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one of two classes depending on the type of modification carried out. Box C/D 
snoRNPs direct 2’-O-methylation and box H/ACA snoRNPs catalyse 
pseudouridinylation (Figure 1.4B, C) (Reichow et al, 2007). Instead of catalysing such 
nucleotide modifications, several snoRNPs are also required for particular pre-rRNA 
processing steps (Section 1.3.5) (Henras et al, 2008). It has recently been proposed 
that snoRNPs may also have roles in other cellular processes such as regulating gene 
expression and mediating stress responses (Bratkovic & Rogelj, 2010). 
 
 
 
Figure 1.4 rRNA modifications and snoRNP structures A) Conversion of uridine to 
pseudouridine and 2’-O-methylation are shown. Only the sugar moiety of the ribose is shown 
without the associated phosphates at the 3’ and 5’ carbons. Figure based on previous work 
(Henras et al., 2008). B) Schematic representation of the eukaryotic box H/ACA snoRNP 
which forms a double stem-loop structure. The snoRNA and rRNA are represented by black 
and red lines respectively, with the nucleotide converted to pseudouridine indicated (Rψ). The 
H and ACA motifs are shown and the relative binding sites of the core snoRNP proteins are 
given. C) Schematic representation of the eukaryotic box C/D snoRNP which forms stem-loop 
structure. The snoRNA and rRNA are represented by black and red lines respectively, with 
the methylated nucleotide indicated. The C, D, C’ and D’ motifs are shown and the relative 
binding sites of the core snoRNP proteins are given. Adapted from Watkins and Bohnsack, 
2011. 
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 1.3.1 Box H/ACA snoRNPs 
 Box H/ACA snoRNPs are composed of the snoRNA and four common core 
proteins, NHP2, GAR1, NOP10 and Dyskerin (Cbf5 in yeast) (Figure 1.4B) (Henras et 
al, 1998; Lafontaine et al, 1998a). Dyskerin is the active component responsible for 
catalysing the isomerisation of the targeted uridine residue (Lafontaine et al, 1998a). 
Box H/ACA snoRNAs are identified by the presence of two conserved sequence 
elements which form a distinctive double hairpin structure. Box H contains the motif, 
ANANNA (with N representing any nucleotide) and is found in a single stranded region 
between the two stem-loops. The ACA motif is found downstream of the second 
hairpin, 3 nucleotides from the 3’ end of the mature snoRNA (Figure 1.4B). Box H/ACA 
snoRNAs target modifications by base-pairing of sequences within either or both of the 
stem-loops to the pre-rRNA. This exposes the target uridine, enabling Dyskerin to carry 
out isomerisation (Reichow et al, 2007). The four core proteins can be associated with 
either or both of the stem-loops enabling box H/ACA snoRNPs to catalyse one or two 
modifications approximately 14-16 nucleotides upstream of either the H and/or the ACA 
boxes (Ganot et al, 1997; Ni et al, 1997). 
 
1.3.2 Box C/D snoRNP structure 
 Box C/D snoRNAs also associate with four core proteins to form snoRNP 
complexes; 15.5K (Snu13 in yeast), NOP56, NOP58 and fibrillarin (Nop1 in yeast) 
(Figure 1.4C) (Baserga et al, 1991; Lafontaine & Tollervey, 1999; Lafontaine & 
Tollervey, 2000; Lyman et al, 1999; Tyc & Steitz, 1989; Watkins et al, 2000). Fibrillarin 
is the methyltransferase responsible for transferring a methyl group from the snoRNP 
cofactor, S-adenosyl-L-methionine (AdoMet), to the 2’ hydroxyl of the targeted RNA 
nucleotide (Galardi et al, 2002). Box C/D snoRNAs are identified by conserved 
sequence motifs; the C box (RUGAUGA) which is found at the 5’ end, the D box 
(CUGA) at the 3’ end and the related but less well conserved C’ and D’ boxes. An 
overall stem-loop structure is normally formed as the 5’ and 3’ ends of the snoRNA 
base-pair to bring the C and D boxes into close proximity (Figure 1.4C). Upstream of 
the D box is a sequence capable of base-pairing with the target RNA to direct 
methylation of the nucleotide bound 5 bases upstream of the D box (Kiss-Laszlo et al, 
1996; Kiss-Laszlo et al, 1998). Additional conserved sequences have also been 
identified in both yeast and human snoRNAs that are complementary to regions 
adjacent to rRNA modification sites and this extra-base pairing has been shown to 
support methylation (van Nues et al, 2011).  
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The C, D, C’ and D’ motifs are binding sites for the core snoRNP proteins which 
assemble asymmetrically on the snoRNA backbone. 15.5K is a part of the L7Ae protein 
family of which the box H/ACA core protein, NHP2 is also a member. 15.5K is the first 
core protein associated with the snoRNA and its binding to the box C/D and possibly 
C’/D’ regions is thought to bring about a conformational change that generates binding 
sites for the other core snoRNP proteins (Watkins et al, 2002). Specific interaction 
between 15.5K and the box C/D of a typical snoRNA has been demonstrated in vitro 
(Szewczak et al, 2002; Watkins et al, 2000). NOP56 and NOP58 contain NOP domains 
which have been proposed to be important for RNP association (Gautier et al, 1997). 
Using site-specific cross-linking in Xenopus, NOP56 has been shown to associate with 
the C box and NOP58 with the C’ box leading to a model in which these two proteins 
form a bridge between the box C/D and box C’/D’ motifs (Cahill et al, 2002). snoRNP 
complexes are well conserved and several crystal structures of archaeal snoRNP 
complexes have been recently been published giving insight into the likely structure of 
eukaryotic snoRNPs. Different models have been proposed but the structure that fits 
most experimental data depicts a monomeric complex containing a single sRNA, two 
molecules of fibrillarin and 15.5K and a single copy of NOP56 and NOP58 (Bleichert et 
al, 2009; Lin et al, 2011; Xue et al, 2010; Ye et al, 2009). In addition to these core 
proteins, the eukaryotic box C/D snoRNA, U3 is also associated with another protein, 
hU3-55K. This has been shown to interact with a U3-specific box B/C motif and is 
required for recruiting the U3 snoRNP for its role in pre-rRNA processing (Granneman 
et al, 2004; Knox et al, 2011). 
 
1.3.3 snoRNA maturation 
 snoRNA genes are found throughout the genome and are transcribed in a 
variety of different ways (Dieci et al, 2009). snoRNAs can be transcribed independently 
from a designated promoter either individually or as clusters of multiple snoRNAs. 
Alternatively, snoRNA genes are found within the introns of protein coding genes that 
are transcribed by RNA Polymerase II and the pre-snoRNAs are released during 
splicing. In yeast, the majority of snoRNA genes are independently transcribed, which 
is consistent with the lack of intronic DNA in lower eukaryotes and most are 
monocistronic with only a few polycistronic clusters having been identified. In 
mammals, however, approximately 90% of snoRNAs are intronic, although some, 
particularly those required for pre-rRNA processing rather than modification, are 
independently transcribed. 
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 snoRNAs encoded within the introns of protein coding genes are processed 
from pre-mRNAs in the nucleus by either a splicing dependent or splicing independent 
pathway. In the splicing-dependent pathway, the snoRNA is released as an intron-lariat 
excised by the splicesome bringing the two exon-intron junctions together. 
Endonucleolytic cleavages in the intronic regions can also release the snoRNAs 
independently of splicing. The released intron fragment then undergoes further 
processing at both the 5’ and 3’ ends to produce the mature snoRNA. In yeast, this 
processing is mediated by exonucleases including Rat1 (XRN2) and the exosome 
(Allmang et al, 1999a) but it is not yet clear if this is also the case in human cells. 
 Independently transcribed snoRNAs contain a co-transcriptionally added 7-
methylguanosine (m7G) cap at the 5’ end. During the maturation of many snoRNAs, 
including U3 and U8, this cap is hypermethylated by the methyltransferase, Tgs1, to 
form a tri-methylguanosine (m3G) cap (Verheggen et al, 2002). In yeast, some pre-
snoRNAs are, however, decapped and undergo 5’ processing by exonucleases 
including Rat1 and Xrn1 (Petfalski et al, 1998). Both mono- and polycistronic yeast 
snoRNAs are cleaved by the endonuclease, Rnt1, leaving short 3’ precursor 
extensions (Chanfreau et al, 1998b; Kufel et al, 1999). These often contain poly(U) 
tracts which are stabilised by Lhp1 (yeast homologue of the human La protein) and the 
LSm complex (Kufel et al, 2003). When these proteins dissociate, the 3’ end is 
processed by the exosome to form the mature 3’ end of the snoRNA (Allmang et al, 
1999a). The mature snoRNA accumulates in the nucleolus (Boulon et al, 2004). It is 
also not clear if this pathway of snoRNA maturation is conserved from yeast to 
humans. 
 In human cells, it has been demonstrated that the methyltransferase, Tgs1, the 
La protein, the LSm complex and the exosome are stably associated with the U3 and 
U8 pre-snoRNPs in HeLa cells (Watkins et al, 2004; Watkins et al, 2007). La was found 
to associate with early pre-snoRNP complexes whereas the LSm complex and the 
exosome subunit, RRP46, were found to interact with later pre-snoRNAs suggesting 
that La binds first, stabilising the 3’ end and is then replaced by the LSm complex. The 
exosome is then recruited presumably to carry out processing of the 3’ extended 
sequence (Watkins et al, 2004).  
 
1.3.4 snoRNP biogenesis  
 Concurrent with snoRNA processing, snoRNP biogenesis involves recruitment 
of the core proteins and nucleolar localisation. This involves dynamic association and 
dissociation of a number of protein factors which are not found in the mature snoRNP. 
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In addition to the RNA processing factors discussed above, this biogenesis complex 
includes proteins required for snoRNP assembly (TIP48, TIP49, NUFIP, NOP17, TAF9 
and BCD1) and chaperones (HSP90 and HSC70) (Boulon et al, 2008; McKeegan et al, 
2007; McKeegan et al, 2009; Watkins et al, 2004; Watkins et al, 2007). These 
assembly factors have been shown to form a scaffold for core protein assembly, with 
NUFIP regulating TIP48 and TIP49 bridging the interaction between the NOP proteins 
and 15.5K (McKeegan et al, 2007; McKeegan et al, 2009). Formation of the pre-
snoRNP complex begins at the site of transcription in the nucleus and many factors 
become associated in the Cajal bodies before the snoRNP is localised to the nucleolus. 
This requires the involvement of many transport factors and PHAX, CRM1, RAN, 
NOPP140 and Snurportin1 have been shown to be required for snoRNP biogenesis 
(Boulon et al, 2004; Watkins et al, 2004). 
 
1.3.5 snoRNPs in pre-rRNA processing 
Instead of a role in mediating base modifications, some snoRNPs are required 
for specific pre-rRNA processing events. Unlike snoRNPs required for post-
transcriptional modifications, most snoRNPs required for processing are essential.  
 U3 snoRNP is the most abundant snoRNP and is important for 18S production 
as it is required for cleavage steps in the 5’ETS (A0 and A1) and ITS1 (A2) in yeast 
(Borovjagin & Gerbi, 2001; Granneman et al, 2004; Kass et al, 1990; Savino & Gerbi, 
1990; Sharma & Tollervey, 1999). In human cells, the U3 snoRNP is also required for 
the additional 5’ETS cleavage at A’ (Prieto & McStay, 2005). U3 snoRNA is classified 
as a box C/D snoRNA but instead of the usual secondary C’/D’ box, it contains a 
unique B/C box which provides binding sites for a U3-specific protein, hU3-55K 
(Granneman et al, 2002; Lubben et al, 1993; Pluk et al, 1998; Tyc & Steitz, 1989; 
Venema et al, 2000). Due to a poorly conserved C’ box (equivalent to the C box of 
other snoRNAs), the levels of U3 are regulated by association with hU3-55K (Knox et 
al, 2011). The 5’ end of U3 snoRNA also contains an A’/A motif which mediates base-
pairing with sequences in 18S rRNA. Additional interactions between U3 and the pre-
rRNA are made between the 3’ and 5’ U3 hinges and sequences near the A’ and A0 
pre-rRNA cleavages sites, respectively. It is suggested that these interactions may be 
required to keep the pre-rRNA in a conformation exposing cleavage sites to the action 
of endonucleases (Borovjagin & Gerbi, 2001). Further, base-pairing of U3 brings the 
pre-rRNA into a conformation in which the 5’ and 3’ ends of 18S are in close proximity 
which may be essential in co-ordinating their processing. U3-18S base pairing also 
provides a level of regulation by preventing premature formation of key structural folds 
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such as the central pseudo-knot found in the mature rRNA (Borovjagin & Gerbi, 2001; 
Gerbi et al, 2003; Hughes, 1996; Sharma et al, 1999). 
 The box C/D snoRNP, U14, is highly conserved across eukaryotes. In yeast, 
U14 has been shown to base-pair with 18S and is required for cleavage steps either 
side of 18S (A1 and A2) (Lempicki et al, 1990; Li et al, 1990). Similarly, the box H/ACA 
snoRNP, U17 (snR30 in yeast, E1 in X. laevis) has been shown to be required for 
processing in the 5’ETS and ITS1 (A0, A1 and A2) (Enright et al, 1996; Lemay et al, 
2011). Another box H/ACA snoRNA which is required for these cleavages is snR10. 
Although this snoRNA is not essential, deletion of this gene is synthetically lethal with 
mutations in Rrp5 or Rok1 implying its function is important (Morrissey & Tollervey, 
1993). 
Other snoRNPs which have roles in pre-rRNA processing specifically in higher 
eukaryotes are U8 and U22. In X. laevis U8 has been shown to be essential for 5.8S 
and 28S production. U8 is proposed to base pair with pre-rRNA both in 28S and at the 
5.8S-ITS2 junction (Michot et al, 1999) and depletion of U8 leads to defects in removal 
of the 3’ETS (Peculis, 1997; Peculis & Steitz, 1993; Peculis & Steitz, 1994). The 
helicase, DDX51 is responsible for the dissociation of U8 from the pre-rRNA enabling 
formation of interactions between 5.8S and 28S that are found in the mature ribosome 
(Srivastava et al, 2010). Also in X. laevis, U22 has been shown to be required for 
processing events at both the 5’ and 3’ ends of 18S (Tycowski et al, 1994; Tycowski et 
al, 1996). Two further snoRNPs specific to higher eukaryotes, E2 and E3 in X. laevis, 
are implicated in the processing of ITS1  
Most of the snoRNPs involved in pre-rRNA processing are devoid of any 
modification activity although U14 is thought to have maintained both functions (Atzorn 
et al, 2004; Torchet & Hermann-Le Denmat, 2002). In addition, RNase MRP is an 
unusual snoRNP complex that is also required for pre-rRNA processing rather than 
modification and is discussed in greater detail in section 1.9.2. 
 
1.4 Assembly of ribosomal subunits 
 In the nucleolus, the pre-rRNA transcript becomes associated with a subset of 
ribosomal proteins and many trans-acting factors not found in the mature ribosome to 
form a 90S pre-ribosomal particle (Bernstein et al, 2004; Dragon et al, 2002; Grandi et 
al, 2002). Many of these trans-acting factors, including proteins and snoRNPs are 
recruited as part of a large complex called the SSU processome, which associates with 
the pre-rRNA concurrent with its transcription by RNA polymerase I. Compaction of the 
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5’ end of the transcript and association of these early processing factors with the 
nascent pre-rRNA transcript can be visualised by electron microscopy of chromatin 
spreads as terminal balls (Miller & Beatty, 1969; Mougey et al, 1993; Osheim et al, 
2004). Approximately 30% of pre-rRNAs are fully transcribed with cleavage in the 
3’ETS bringing about their release; alternatively, cleavages in the ITS1 can occur co-
transcriptionally releasing a pre-40S complex (Kos & Tollervey, 2010; Osheim et al, 
2004). Consistent with the majority of pre-rRNAs being cleaved co-transcriptionally, 
most of the processing factors associated with initial 90S particles are involved in the 
biogenesis of the small subunit. Many of the factors required for formation of the large 
subunit via the pre-60S complex are only assembled onto the pre-rRNA after cleavage 
at site A2 in ITS1 (Grandi et al, 2002; Schafer et al, 2003; Tschochner & Hurt, 2003). 
Following cleavage in ITS1, the pre-40S and pre-60S complexes follow separate 
biogenesis pathways, with numerous factors associating and dissociating as the 
complexes are translocated through the nucleolus, the nucleoplasm and into the 
cytoplasm. The final maturation steps of both subunits occur in the cytoplasm before 
the subunits interact to form the mature ribosome. 
 
1.4.1 Formation of the 90S particle and the SSU processome 
 The SSU processome is a dynamic complex of more than 40 proteins that is 
assembled onto the pre-rRNA as it is transcribed forming the 90S complex. The yeast 
SSU processome is required for cleavages on either side of 18S in both the 5’ETS and 
ITS1 yielding the pre-40S complex that matures into the small ribosomal subunit. The 
SSU processome from S. cerevisiae has been purified and key complexes identified 
but more recently, large scale proteomic studies have revealed the protein composition 
(Bernstein et al, 2004; Dragon et al, 2002; Grandi et al, 2002; Schafer et al, 2003). The 
proteins comprising the SSU processome in human cells are less well characterised 
although many of the factors involved appear to be conserved (Gerus et al, 2010; 
Granneman et al, 2003; Granneman et al, 2002; Rouquette et al, 2005; Turner et al, 
2009; Turner et al, 2012).  
In both yeast and higher eukaryotes, the SSU processome is composed of 
several major sub-complexes; t-UTP (transcriptional associated U three protein) 
complex, b-UTP complex, c-UTP complex, U3 snoRNP and the MPP10 (M phase 
phosphoprotein 10) complex. These are each independently assembled prior to 
hierarchal association with the pre-rRNA transcript (Figure 1.5). The first of these sub-
complexes to become associated with the nascent transcript is the t-UTP complex 
containing five to seven proteins: UTP10, UTP4, UTP5, UTP15 and UTP17 with UTP8 
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and UTP9 additionally found in the yeast complex (Gallagher et al, 2004; Krogan et al, 
2004; Prieto & McStay, 2007). The t-UTP complex is associated with the rDNA and this 
is required for efficient transcription of the pre-rRNA (Prieto & McStay, 2007). In HeLa 
cells, depletion of t-UTP proteins, UTP4 or UTP10, leads to formation of a novel 
processome intermediate, 50S, which is also observed when rRNA transcription is 
blocked by treating cells with actinomycin D supporting the role of the t-UTP complex in 
enabling transcription (Turner et al, 2009). Binding of the t-UTP complex to the pre-
rRNA in yeast is a pre-requisite for the recruitment of other complexes which follow two 
independent assembly branches (Perez-Fernandez et al, 2011; Perez-Fernandez et al, 
2007).  
In one branch, the b-UTP complex, composed of PWP2, UTP6, UTP12, UTP13, 
UTP18 and UTP21 proteins, becomes associated with the pre-rRNA (Dosil & Bustelo, 
2004; Perez-Fernandez et al, 2007). It is proposed that the b-UTP complex may be 
primarily a structural component of the SSU processome since many of its proteins 
contain common protein-protein interaction domains (WD or TPR) (Dosil & Bustelo, 
2004). Following association of the b-UTP complex, the U3 snoRNP is recruited to the 
pre-ribosomal complex. Base pairing between the U3 snoRNA and the pre-rRNA is not 
required for this incorporation but instead hU3-55K is proposed to play an important 
role in recruitment (Granneman & Baserga, 2004). As mentioned in section 1.3.5, base 
pairing between the 5’ end of 18S and the U3 snoRNA prevents premature formation of 
the central 18S pseudoknot and the MPP10 complex is proposed to enhance this base 
pairing (Borovjagin & Gerbi, 2001; Gerczei & Correll, 2004; Gerczei et al, 2009; 
Granneman et al, 2003; Hughes, 1996; Lafontaine & Tollervey, 2001). In both yeast 
and humans, MPP10 has been shown to associate with IMP3 and IMP4 (Granneman & 
Baserga, 2003; Lee & Baserga, 1999). This heterotrimeric complex is able to bind 
directly to the U3 snoRNA and in vitro this has been shown to alter the structure of the 
U3 snoRNA such that specific base pairing interactions with the pre-rRNA are 
enhanced (Gerczei & Correll, 2004; Gerczei et al, 2009). Recruitment of the MPP10 
complex, but not of the U3 snoRNP, to the pre-ribosome is dependent on the presence 
of the GTPase, Bms1 (Perez-Fernandez et al, 2011). Bms1 associates with the 90S 
particle downstream of the U3 snoRNP and the b-UTP complex and the incorporation 
of Bms1 has been shown to stabilise the interaction of the b-UTP complex with the pre-
rRNA. Bms1 is proposed to form a stable sub-complex with the endonuclease, Rcl1, 
and together they are able to interact with the U3 snoRNP (Karbstein & Doudna, 2006; 
Karbstein et al, 2005; Wegierski et al, 2001). Rcl1 has recently been proposed as the 
endonuclease responsible for A2 cleavage in ITS1 and is discussed in more detail in 
Section 1.9.3 (Horn et al, 2011). A mechanism by which these proteins are recruited to 
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the early pre-ribosome is proposed: GTP-bound Bms1 interacts with Rcl1 and they are 
recruited to the pre-rRNA through interactions with U3, which in turn alters the 
conformation of Bms1 causing GTP hydrolysis, enabling Bms1 to dissociate, leaving 
Rcl1 deposited on the pre-rRNA (Karbstein & Doudna, 2006; Karbstein et al, 2005; 
Wegierski et al, 2001). The presence of Bms1 has also recently been shown to be 
required for the association of a number of other proteins including Utp20, Kre33 and 
Enp2 (Perez-Fernandez et al, 2011).  
 
The second branch of factors assembled following incorporation of the t-UTP 
complex into the pre-ribosomal particle is initiated by the association of Rrp5 which 
facilitates the incorporation of the c-UTP complex. The c-UTP complex consists of 
Rrp7, Utp22 and the casein kinase II subunits, Cka1, Cka2, Ckb1 and Ckb2 (Krogan et 
al, 2004). The role of these CKII subunits in ribosome biogenesis is not yet understood 
but in a yeast, T. cutaneum, CKII has been shown to phosphorylate ribosomal proteins 
 
Figure 1.5 pre-rRNA transcription and SSU processome assembly Schematic model of 
transcription of the pre-rRNA transcript by RNA polymerase I (white circle and grey line) and 
early steps in the assembly of the 90S pre-ribosomal particle in S. cerevisiae. The t-UTP 
complex is associated first and then assembly occurs in two branches; the first involves 
association of the b-UTP complex followed by U3 snoRNP, Bms1-Rcl1 and finally the Mpp10 
complex while in the second branch Rrp5 is recruited followed by the c-UTP complex. In 
addition to these sub-complexes a number of other proteins, mostly required for formation of 
the SSU, become associated and these include Pno1, Mrd1, Dbp8, Utp2, Utp11, Utp19, 
Utp23, Dim1, Krr1, Emg1, Has1, Utp3, Utp14, Utp20, Utp24, Rio1, Rio2, Nob1, Esf2, Sof1, 
Utp7, Utp16, Utp22, Dhr1 and Nsr1 (nucleolin). These proteins form the 90S complex which 
undergoes compaction to form terminal balls visible by electron microscopy. Based on data 
from references within sections 1.4 and 1.4.1.  
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(Wojda et al, 2002). Rrp5 is also required for recruitment of the Rok1 helicase to the 
90S complex (Vos et al, 2004). 
 
1.4.2 RRP5 
 Recruitment of Rrp5 to the pre-ribosome following t-UTP incorporation is 
important for the subsequent association of several proteins required for formation of 
the SSU processome. Rrp5 has also been shown to associate with the Noc1/Noc2 
protein complex (Merl et al, 2010). This complex is incorporated into the 90S particle 
but plays an important role in the nuclear transit of pre-LSU complexes (Milkereit et al, 
2001; Milkereit et al, 2003). Consistent with this dual association with pre-SSU and pre-
LSU complexes, Rrp5 has been shown to be required for formation of both 18S and 
5.8SS rRNAs and in yeast is important for cleavages at A0, A1, A2 and A3 (Venema & 
Tollervey, 1996). Rrp5 is one of only a small set of proteins which are required for both 
ITS1 cleavages at A2 and A3. Rrp5 contains 12 S1 RNA binding domains at the N-
terminus and binds to the pre-rRNA between the A2 and A3 cleavage sites (Young & 
Karbstein, 2011). These S1 domains are required for the functions of Rrp5 in A2 and A3 
cleavage but not for the cleavages in the 5’ETS which are dependent on the seven 
tetratricopeptide (TPR) repeats found at the C-terminus of the protein (Eppens et al, 
2002; Vos et al, 2004). Mutation of particular S1 domains of Rrp5 blocks A3 cleavage 
and causes ITS1 cleavage at a novel site between A2 and A3 with a concomitant 
increase in 5.8SL formation relative to that of 5.8SS. Interestingly, these processing 
defects can be rescued by deletion of the exonuclease, Rex4, in these cells, although 
this leads to the synthesis of defective ribosomes and is, therefore, lethal (Eppens et al, 
2002). Rrp5 is also suggested to be important in exonucleolytic processing to generate 
the 5’ end of 5.8S following A3 cleavage. A homologue of Rrp5 was identified in human 
cells through its ability to interact with the transcription factor, NF-kB (p50) (Sweet et al, 
2003). It is suggested that RRP5 is required for multiple pre-rRNA processing steps in 
the 5’ETS and ITS1 in human cells (Sweet et al, 2008). In human cells, RRP5 is also 
found associated with a 50S SSU processome complex that accumulates when early 
assembly steps are inhibited (Turner et al, 2009) 
 
1.4.3 A3-cluster proteins 
 The 90S particle is divided into a pre-40S complex and a pre-60S complex by 
cleavages at A2 and A3 in ITS1. In a similar way to the recruitment of sub-complexes of 
the SSU processome to the 90S particle, some trans-acting factors required for 
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formation of the large subunit rRNAs are recruited to the pre-ribosome prior to 
cleavage in ITS1. A group of proteins called the A3-cluster proteins have been defined 
as they are all required for A3 cleavage or the processing downstream of this cleavage 
to convert 27SA3 into 27SB1S. The A3-cluster proteins include Erb1, Nop7, Ytm1, Rlp7, 
Nop15, Cic1, Rrp1 and Nop12 (Fatica et al, 2003b; Granneman et al, 2011; Miles et al, 
2005; Oeffinger et al, 2002; Oeffinger & Tollervey, 2003; Pestov et al, 2001a; 
Sahasranaman et al, 2011; Wu et al, 2001). The recruitment of most of these factors to 
the pre-rRNA is interdependent. Erb1, Nop7 and Ytm1 form a stable trimeric complex 
that is proposed to form a scaffold onto which other A3-cluster proteins, exonucleases 
and ribosomal proteins assemble (Miles et al, 2005; Sahasranaman et al, 2011; Tang 
et al, 2008). The A3-cluster proteins have been shown to cross-link to a variety of 
different sites spanning 5.8S, ITS2 and 25S (Granneman et al, 2011).The major 
binding site for the Erb1/Nop7/Ytm1 complex is at the 5’ end of 25S near the ITS2-25S 
junction. Nop15 and Cic1 cross-link to sequences at the 5’ end of ITS2 in vivo although 
Cic1 was also observed to cross-link to sequences in 25S. During maturation of the 
60S complex, ITS2 undergoes major structural rearrangements with the 5’ end of 25S 
and the 3’ end of 5.8S forming contacts in the mature ribosome, which are not present 
in early pre-60S complexes. The presence of both Cic1 and Nop15 in these early 
complexes is proposed to be important for preventing premature formation of these 
base pairing interactions (Granneman et al, 2011). Similarly, Nop4, another protein 
associated with the A3-cluster (see section 1.4.4), was found to cross-link to many sites 
in domains I and II of 25S and also to the 5’ end of 5.8S. These rRNA regions are close 
proximity in the mature ribosome suggesting a role for Nop4 in long-range base pairing 
interactions (Granneman et al, 2011). Four ribosomal proteins (rpL17, rpL26, rpL35 
and rpL37) are recruited to the pre-ribosome by the A3-cluster proteins and bind to this 
region of the mature ribosome. It is, therefore, suggested that the long-range 
interactions formed by Nop4 in the pre-ribosome are maintained by these r-proteins in 
the mature ribosome (Granneman et al, 2011; Sahasranaman et al, 2011).  
The A3-cluster proteins also play important roles in pre-rRNA processing and 
quality control. The Erb1/Ytm1/Nop7 complex is required for processing from 27SA2 to 
27SA3 and Ytm1 is also important for mediating nucleolar export of pre-66S complexes 
in a reaction driven by the ATPase, Rea1 (Bassler et al, 2010; Miles et al, 2005; Pestov 
et al, 2001a). Incorporation of the core A3-cluster proteins is also required for 
recruitment of the exonuclease, Rrp17, but interestingly not Rat1, although both of 
these proteins carry out processing to form the mature end of 5.8SS rRNA (Granneman 
et al, 2011). The secondary structures of 5.8S, ITS2 and 25S formed by the A3-cluster 
proteins are also proposed to regulate the timing of Rat1 processing of the 5’ end of 
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5.8S. In the absence of A3-factors, short Rat1-dependant RNAs are accumulated 
suggesting that in addition to processing, the Rat1 exonuclease degrades aberrant pre-
rRNAs formed if ribosome assembly is aborted at this stage (Granneman et al, 2011). It 
is suggested that the exonucleolytic processing to the mature 5’ end of 5.8S may 
normally be arrested by the presence of the A3-cluster proteins bound near the 5’ end 
of 5.8S but if these proteins are not recruited, then exonucleolytic processing turns into 
degradation of the aberrant complex. 
Homologues of some of these A3-cluster proteins have been identified in higher 
eukaryotes. Erb1, Nop7 and Ytm1 homologues BOP1, PES1 and WDR12, 
respectively, have been characterised in both mouse and human cells and also form a 
stable trimeric complex, PeBoW (Holzel et al, 2005; Lapik et al, 2004). BOP1 (Erb1) 
was first identified in mouse as a nucleolar protein that is essential for the production of 
both 28S and 5.8S rRNAs (Strezoska et al, 2000). In vitro reconstitution of the PeBoW 
complex and in vivo protein studies in mouse show that the integrity and stability of the 
complex is largely dependent on BOP1 levels (Rohrmoser et al, 2007). BOP1 is critical 
for recruitment of PES1 to the pre-ribosome (Lapik et al, 2004) but interestingly, PES1 
is required for transport of BOP1 into the nucleolus following translation (Rohrmoser et 
al, 2007). In mouse, BOP1 is proposed to be required for four different cleavage steps 
in both internal transcribed spacers and in the 3’ETS (Strezoska et al, 2002). First, 3’ 
extended forms of 36S, 32S and 41S were observed to accumulate after BOP1 
depletion confirming a role for BOP1 in efficient removal of the 3’ETS. Second, 
depletion of BOP1 revealed an accumulation of 32S and a decrease in 12S suggesting 
BOP1 is necessary for ITS2 processing that separates the 5.8S precursors from pre-
28S. Third, BOP1 has an additional role in ITS2 removal as it is required for processing 
of 12S to produce 5.8S (Strezoska et al, 2002). Finally, an increase in the levels of 
36S, an intermediate of an alternative ITS1 processing pathway, suggests that BOP1 is 
also required for late ITS1 processing steps. Mutation or depletion of members of the 
PeBoW complex lead to cell cycle arrest (Strezoska et al, 2002) and expression of 
these proteins is up-regulated by the proto-oncogene, c-Myc, suggesting that this 
complex provides a link between ribosome biogenesis and cell proliferation (Holzel et 
al, 2005).  
By homology searches, we have identified the human homologues of other A3-
cluster proteins and of particular interest may be Mki67 (Nop15). This protein interacts 
with the Ki67 antigen which is localised in the dense fibrillar compartment (DFC) of the 
nucleolus and has been suggested to play an important role in coordinating ribosome 
biogenesis with mitosis and cell cycle progression (MacCallum & Hall, 2000). 
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1.4.4 RBM28 (Nop4) 
Nop4 (also known as Nop77) is absolutely required for cleavage at A3 by 
RNase MRP but is also thought to be important for cleavage at A2 and processing from 
A3 to B1L (Berges et al, 1994; Granneman et al, 2011; Sun & Woolford, 1994; Sun & 
Woolford, 1997). A second function of Nop4 in mediating post-transcriptional 
methylation of the pre-rRNA has been described by one group (Berges et al, 1994) but 
was not observed in another study (Sun & Woolford, 1994). The human homologue of 
Nop4 is RBM28 and although this protein has been linked to ribosome biogenesis, little 
is known about its role in human pre-rRNA processing (Nousbeck et al, 2008). ANE 
syndrome, which is characterised by alopecia, neurological defects and endocrine 
deficiency, is caused by a point mutation in the gene coding for RBM28 which alters 
the protein structure and stability leading to decreased expression levels (Nousbeck et 
al, 2008; Spiegel et al, 2010). The homologue of RBM28 in C. elegans is involved in 
regulating the expression of the miRNA, lin4, which has important functions in 
coordinating the timing of development in this organism (Bracht et al, 2010). 
 
1.4.5 Formation of the pre-60S complex 
 Following cleavage in ITS1, the 90S pre-ribosomal complex is separated into 
the pre-40S and pre-60S complexes. In addition to exonucleases involved in pre-rRNA 
processing to produce mature 5.8S and 25S (28S) rRNAs and recruitment of the A3 
cluster proteins, a number of other trans-acting protein factors required for biogenesis 
of the large subunit are also recruited. In yeast, these include a number of helicases 
(Mak5, Dbp2, Dbp3, Dbp6, Dbp7, Dbp9, Dbp10, Mtr4, Dsr1, Spb4, Has1 and Prp43), 
ATPases (Rix7 and Rea1), GTPases (Nug1, Nog1 and Nog2) and methyltransferases 
(Spb1 and Nop2). The precise roles of many of these proteins have not yet been 
defined. Association and dissociation of members of a group of proteins, Noc1, Noc2 
and Noc3, are proposed to mediate movement of the pre-60S from the nucleolus and 
across the nucleoplasm prior to export into the cytoplasm (Milkereit et al, 2001). The 
ATPase, Rea1, is thought to function at multiple steps during pre-60S maturation 
causing the dissociation of various proteins including the Erb1-Ytm1-Nop7 complex 
and Rsa4 causing structural rearrangements which enable export both from the 
nucleolus and the nucleoplasm (Bassler et al, 2010; Galani et al, 2004). The 5S rRNA 
is independently transcribed by RNA polymerase III in the nucleus and through its 
interaction with the ribosomal protein, RPL5, is re-located into the nucleolus where it is 
incorporated into the early pre-60S complex (Zhang et al, 2007). In the mature 
ribosome, 5S is situated at the interface between the LSU and SSU. The incorporation 
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of 5S into the ribosome is required for processing of the LSU rRNAs and potentially 
regulates the stoichometry of the rRNAs in the ribosome (Dechampesme et al, 1999). 
Export of the pre-60S complex into the cytoplasm will be discussed in more detail in 
section 1.6 but several non-ribosomal proteins are co-exported into the cytoplasm 
where the final maturation occurs. The pre-60S complex and the co-exported factors, 
Alb1, Arx1, Nog1 and Tif6, are joined by cytoplasmic biogenesis factors including Lsg1, 
Sqt1, Drg1, Efl1, Jjj1 and Rei1. Together these factors release the co-exported 
biogenesis factors, provide quality control checkpoints, cause conformational 
rearrangements and promote incorporation of the final ribosomal proteins including 
RPL24.  
 
1.5 Ribosomal proteins 
 The organisation of the ribosomal proteins in the mature ribosome has recently 
been defined through crystal structures of eukaryotic ribosomes (Ben-Shem et al, 
2011; Ben-Shem et al, 2010). The ribosomal proteins of the eukaryotic small subunit 
have been classified into two groups based on their roles in pre-rRNA processing. First, 
initiation-RPS (iRPS), RPS3a, RPS4, RPS5, RPS6, RPS7, RPS8, RPS9, RPS11, 
RPS13, RPS14, RPS16, RPS15a, RPS23, RPS24, RPS28 and RPS27, are associated 
with early 90S complexes. Second, progression-RPS (p-RPS), RPS19, RPS18, RPSA, 
RPS21 RPS2, RPS3, RPS17, RPS20, RPS27a, RPS29 RPS10, RPS12, RPS15, 
RPS26, and RPS25, associate later and are required for downstream processing 
events (O'Donohue et al, 2010). Depletion of i-RPS causes accumulation of 45S and 
30S with no downstream pre-rRNAs being produced indicating a complete block in the 
pathway following the primary cleavages in the 5’ETS and ITS1. It is thought that 
binding of the i-RPS to the pre-ribosome is important for RNA folding to generate a 
stable conformation in which processing can be initiated (O'Donohue et al, 2010). 
Depletion of p-RPS leads to various different phenotypes involving either partial or 
complete removal of the 5’ETS and inhibition of ITS1 processing (O'Donohue et al, 
2010). The class can be subdivided into those proteins which affect 21S-18SE 
processing preventing formation of 18SE (RPS17, RPS18, RPS19, RPS21 and RPSA) 
and those which alter the levels of either 21S or 18SE without affecting the conversion 
process. Of particular interest is the observation of a novel processing intermediate 
previously called 20S (later referred to as 21SC) between 21S and 18SE upon 
depletion of RPS19 and weakly following depletion of RPS17, indicating that these 
proteins are important for the later steps of ITS1 processing (Idol et al, 2007; Robledo 
et al, 2008). Depletion of many of the p-RPS uncouples the 5’ETS cleavages at A0 and 
A1 suggesting that their association into pre-ribosomes may normally be important for 
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coordinating these steps. Further, p-RPS, RPS15 and RPS17 are required for nuclear 
export of pre-40S complexes (Leger-Silvestre et al, 2004) while the presence of many 
other p-RPS is essential for the final cytoplasmic cleavage at site 3 (O'Donohue et al, 
2010). In yeast, however, it has been shown that some RPS such as RPS5 and RPS17 
play roles in both early and late processing steps. The role of ribosomal proteins of the 
large subunit (RPLs) is less well studied but of particular note is the observation that 
depletion of RPL26 (and to a lesser extent RPL35a) leads to defects in both the 5.8S 
precursor (12S) and also 18S precursors (21S and 30S) resulting in less mature 40S 
subunits. This indicates that these LSU proteins are required for processing steps 
following separation of the SSU and LSU precursors (Robledo et al, 2008). 
 
1.6 Nuclear export and cytoplasmic maturation 
 Following nucleolar assembly and nuclear maturation of the pre-40S and pre-
60S complexes, these pre-ribosomal subunits are separately exported into the 
cytoplasm where they undergo final maturation steps before they rejoin to form the 
mature ribosome (Panse & Johnson, 2010; Rouquette et al, 2005; Zemp & Kutay, 
2007). Export of both subunits is a dynamic process involving the exportin, 
Xpo1/CRM1, the RanGTPase system and various nuclear pore components. Each pre-
ribosomal subunit contains one or more adaptors which contain leucine-rich nuclear 
export sequences (NES) through which they interact with CRM1 (Fukuda et al, 1997; 
Zemp & Kutay, 2007). Until recently, the criteria for defining and identifying NES 
sequences was based on four key hydrophobic residues (Φ) following the consensus 
Φ1-(x)2-3-Φ
2-(x)2-3-Φ
3-x-Φ4, with “x” denoting small polar amino acids. This has been 
extended to include a fifth hydrophobic residue and recent structures of CRM1 bound 
to classic NES cargos highlight other structural features which are recognised by 
CRM1 and define a pocket in CRM1 into which the NESs must fit (Guttler & Gorlich, 
2011; Guttler et al, 2010; Mattaj & Muller, 2010; Monecke et al, 2009). CRM1 binds to 
RanGTP and its cargo protein(s) in the nucleus and translocates through a nuclear 
pore complex to the cytoplasm. Here, hydrolysis of RanGTP to RanGDP causes the 
complex to dissociate releasing the pre-ribosomal complexes into the cytoplasm 
(Figure 1.6) (Guttler & Gorlich, 2011; Zemp & Kutay, 2007). It is thought that additional 
factors chaperone the subunits through the nuclear pore complex. For example, the 
HEAT repeat-containing protein, Rrp12, contributes to the nuclear export of both the 
pre-40S and pre-60S complexes (Oeffinger et al, 2004) and could coordinate their 
interactions with the transport receptors. 
 Export of the pre-60S complex into the cytoplasm in both yeast and humans is 
mediated by the NES-containing adaptor protein, Nmd3 (Ho et al, 2000). This protein 
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participates in nonsense mediated decay (NMD) of mRNAs in the cytoplasm but also 
shuttles between the cytoplasm and nucleus to export pre-60S complexes. In yeast, 
export of pre-60S complexes involves additional factors that interact directly with the 
nuclear pore complex and these include the mRNA export factor, Mtr2/Mex67 and the 
shuttling trans-acting factors Arx1 and Ecm1 (Bradatsch et al, 2007; Hung et al, 2008; 
Yao et al, 2007; Yao et al, 2010). Once in the cytoplasm factors such as Lsg1 and Sqt1 
participate in the recycling of Nmd3 into the nucleus. In higher eukaryotes, export of 
pre-60S complexes has also been shown to be achieved by a CRM1-independent 
pathway involving Exportin 5 (Exp5), an export factor previously associated with 
translocation of miRNA precursors (Bohnsack et al, 2004; Lund et al, 2004; Wild et al, 
2010). Depletion of this protein causes strong defects in 60S biogenesis and Exp5 has 
been shown to interact specifically with pre-60S complexes in a RanGTP dependant 
manner clarifying its role as an export adaptor (Wild et al, 2010). 
 
 The export and cytoplasmic stages of pre-40S complex maturation involve a 
small number of proteins because many of the trans-acting factors required for earlier 
steps dissociate in the nucleus. The composition of late cytoplasmic pre-40S 
complexes in yeast has been determined by affinity purification and mass 
spectrometry. These identified key proteins which are required for late processing 
steps in yeast: Dim1, Pno1 (Dim2), Enp1, Ltv1, Hrr25, Nob1, Rio2, Rio1 and Tsr1. 
While Nmd3 is the only known export adaptor of yeast pre-60S complexes, Ltv1 and 
Pno1 both function as adaptors for export of pre-40S complexes (Seiser et al, 2006; 
Vanrobays et al, 2008). Ltv1 is a non-essential ribosome biogenesis factor suggesting 
redundancy between export proteins (Seiser et al, 2006). In human cells, RIO2 has 
been shown to interact with CRM1 in vitro in a RanGTP dependant manner through a 
conserved NES (Zemp et al, 2009). Disruption of this NES inhibits nuclear export of 
 
Figure 1.6 Export of pre-ribosomal 
complexes into the cytoplasm 
Schematic overview of the nuclear export 
cycle. Pre-ribosomal complexes contain 
nuclear export adaptor proteins which 
interact with CRM1 in a RAN dependant 
manner. These complexes are recruited 
to the nuclear pores and following exit 
into the cytoplasm, the RAN associated 
GTP is hydrolysed causing a 
conformational change which releases 
the pre-ribosomal complexes into the 
cytoplasm. CRM1 is then recycled back 
into the nucleus. Adapted from Guttler 
and Gorlich, 2011.  
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pre-40S complexes identifying RIO2 as a nuclear export adaptor for the small subunit 
(Zemp et al, 2009). It is not clear whether PNO1 is also an export adaptor of pre-40S 
complexes in human cells as, although this protein interacts with CRM1 in vitro and a 
putative NES has been identified, mutation of this sequence did not affect CRM1 
binding (Zemp et al, 2009). In human cells, TSR1 has been shown to be involved in 
nuclear export of pre-40S complexes but does not contain a leucine-rich NES and is, 
therefore, not proposed to be a CRM1 adaptor protein. TSR1 depletion does, however, 
cause nuclear retention of pre-40S complexes although TSR1 is not required for pre-
rRNA processing, suggesting the role of TSR1 must be in assembly of an export-
competent complex (Carron et al, 2011).  
To investigate nuclear export, an inhibitor of CRM1, leptomycin B (LMB), is 
often used. LMB covalently binds to a cysteine residue (528) in a conserved pocket of 
CRM1 preventing interaction with the export sequences of cargo proteins. It is 
important to note that CRM1 has functions other than mediating nuclear export which 
include coordinating the nucleolar localisation of snoRNPs including U3 (Boulon et al, 
2004). Treatment of HeLa cells with LMB prevents the shuttling of the pre-40S adaptor, 
RIO2 and other co-exported proteins such as NOB1 between the nucleus and 
cytoplasm causing them to accumulate in the nucleus (Zemp et al, 2009) and Watkins 
lab unpublished data). It has also been reported that treating HeLa cells with LMB 
affects early pre-rRNA processing steps causing a significant accumulation of 26S, a 
pre-rRNA processing intermediate extending from the A0 cleavage site in the 5’ETS to 
site 2 in ITS1. It is, therefore, suggested that inhibiting CRM1 uncouples the normally 
simultaneous cleavages at A0 and A1 in the 5’ETS (Rouquette et al, 2005). 
 
 1.7 Late steps in pre-40S maturation 
 Cytoplasmic maturation of the pre-40S complex in yeast involves two major 
events; structural rearrangements of the complex and pre-rRNA processing to produce 
mature 18S rRNA (Fromont-Racine et al, 2003; Henras et al, 2008). In yeast, pre-rRNA 
processing in the cytoplasm only involves cleavage of 20S at site D by the 
endonuclease Nob1 (Fatica et al, 2003a; Fatica et al, 2004). Other proteins found in 
late cytoplasmic complexes including Pno1, Rio2 and Prp43 are required for this 
cleavage step. In higher eukaryotes, pre-rRNA processing to form the mature 3’ end of 
18S involves an additional processing step (Rouquette et al, 2005) implying that the 
functions of some of the protein factors involved in late maturation steps may not be 
conserved from yeast. Binding sites in 18S pre-rRNA for most of the proteins found in 
yeast late pre-40S complexes (except Rio1 and Pno1) have been defined by in vivo 
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cross-linking (CRAC) enabling a greater understanding of their functions in ribosome 
assembly (Granneman et al, 2010). Based on the crystal structure of the mature 
eukaryotic small subunit, a model of the relative positions of these yeast late acting 
biogenesis factors was developed using cryo-electron microscopy (Rabl et al, 2010; 
Strunk et al, 2011). 
 
1.7.1 Structural reorganisation of pre-40S complexes 
 Mature 40S particles contain a structural feature called the “beak”, which 
consists of a protrusion of 18S rRNA helix 33 and the ribosomal protein Rps3. This 
structure is lacking in pre-40S complexes indicating that a large-scale reorganisation of 
this region is an important maturation step. However, premature formation of this beak 
structure impairs nuclear export of the pre-40S complex indicating that regulating 
timing of this event is important (Schafer et al, 2006; Seiser et al, 2006). It has been 
shown that Rps3 is weakly associated with the pre-40S complex in the nucleus but 
phosphorylation of this protein and the SSU biogenesis factors, Enp1 and Ltv1 by the 
casin kinase I isoform, Hrr25, causes their dissociation from the complex (Schafer et al, 
2006). Rps3 is subsequently dephosphorylated and reforms a more rigid association 
with the pre-rRNA to form the beak in the cytoplasm (Schafer et al, 2006). Consistent 
with this model, Enp1 was found to cross-link directly to helix 33 of 18S and Ltv1 was 
also bound to the beak region (Granneman et al, 2010).  
 
1.7.2 ENP1 
 In yeast, Enp1 is found associated with both early and late pre-40S complexes 
suggesting it may play multiple roles in small subunit assembly. The early role of ENP1 
involves the phosphorylation of Enp1 by Hrr25 and its subsequent dissociation from 
pre-40S complexes described above but following dephosphorylation in the cytoplasm, 
Enp1 is re-associated with late pre-40S complexes to perform its later functions 
(Schafer et al, 2006). Enp1 is required for efficient production of 20S in yeast and is 
associated with the U3 and U14 snoRNPs (Chen et al, 2003). A human homologue of 
Enp1 has been identified and is also known as bystin or BYSL (Fukuda et al, 2008; 
Miyoshi et al, 2007). Depletion of ENP1 from human cells causes accumulation of 
21SC, an intermediate between 21S and 18SE which is thought to be generated by 
exonucleolytic processing due to its heterogeneous 3’ end (Carron et al, 2011). This 
implicates ENP1 in a step of human ribosome biogenesis which is not conserved from 
yeast. In higher eukaryotes, ENP1 has been shown to interact with throphinin, and 
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through this plays an important role in embryo implantation (Suzuki et al, 1998). It has 
also been shown that ENP1 is essential for early embryonic stem cell survival (Aoki et 
al, 2006). More recently, it was reported that ENP1 is over-expressed in hepatocellular 
carcinomas (Wang et al, 2009). These authors also suggested that ENP1 is a target of 
c-Myc possibly indicating a role for ENP1 in coupling ribosome biogenesis and cell 
growth rate or tumour development. 
 
1.7.3 NOB1 and PNO1 
 In yeast, Nob1 is the endonuclease responsible for cleavage at site D to form 
the mature 3’ end of 18S. The nuclease activity of this protein and its regulation will be 
discussed in more detail in section 1.9.1. A cofactor protein that binds to Nob1 is Pno1 
(Partner of Nob1, also known as Dim2). Pno1 has functions both in early pre-rRNA 
processing steps in the nucleolus and also in late steps in the cytoplasm. In yeast, 
Pno1 is associated with the nascent transcript and is essential for early cleavages at A1 
and A2. Further, an aberrant intermediate extending from A0 to A3 (22S) is seen to 
accumulate when the G207 residue in the KH domain of Pno1 is modified (Vanrobays 
et al, 2004). This conserved KH domain of Pno1 has been shown to bind to the 5’ end 
of ITS1 (Vanrobays et al, 2008). In yeast, Pno1 has been shown to shuttle between the 
nucleus and cytoplasm as part of the pre-40S complex. Pno1 contains a leucine-rich 
NES which is required for efficient export of pre-ribosomal complexes into the 
cytoplasm indicating that Pno1 is an export adaptor for pre-40S complexes (Vanrobays 
et al, 2008) but it is not clear if this is also the case for the human protein. The 
localisation of Pno1 has also been shown to be regulated by the mTOR pathway 
potentially coupling external nutritional state to the rate of ribosome biogenesis 
(Vanrobays et al, 2008). Pno1 has been shown to interact with Nob1 both in yeast two 
hybrid studies and also in vitro and more specifically, the KH domain of Pno1 is also 
proposed to mediate this interaction (Tone & Toh, 2002; Woolls et al, 2011). This 
interaction increases the affinity of Nob1 for the pre-rRNA and is important for enabling 
Nob1 to cleave at the 3’ end of 18S rRNA (Woolls et al, 2011).The interactions of Nob1 
with the pre-rRNA and its activity will be discussed in more detail in section 1.9.1. 
 
1.7.4 DIM1 
 In yeast, an important step in the maturation of the small subunit is methylation 
of two conserved adenosine residues (A1179 and A1780) at the 3’ end of 18S pre-
rRNA. This modification is carried out by the dimethyltransferase, Dim1, which is an 
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essential component of the SSU processome (Lafontaine et al, 1995). It has been 
demonstrated that in yeast, dimethylation occurs following export of the pre-40S 
complex into the cytoplasm although Dim1 is associated with early pre-ribosome 
complexes (Brand et al, 1977; Lafontaine et al, 1995; Lafontaine et al, 1998b; Schafer 
et al, 2003). Consistent with these observations, yeast Dim1 is localised predominantly 
in the nucleolus but can also be detected in the cytoplasm. Dim1 is essential for 
cleavages at A1, A2 and D in yeast but these steps are not dependant on dimethyl 
modification of 18S (Lafontaine et al, 1995; Lafontaine et al, 1998b). This suggests that 
the presence of Dim1 and therefore, the ability to methylate is a pre-requisite for early 
pre-rRNA processing thereby preventing formation of aberrant, unmethylated 40S 
subunits. Ribosomes which do not contain these modifications have been shown to be 
inactive in in vitro translation assays underlining the importance of such control 
mechanisms (Lafontaine et al, 1998b).  
  
1.7.5 PRP43 
 RNA helicases are proposed to have several different functions in ribosome 
biogenesis including, unwinding RNA secondary structure enabling it to be degraded, 
RNA remodelling to facilitate pre-rRNA processing steps and the recruitment and/or 
dissociation of the snoRNP complexes involved in both pre-rRNA processing and 
modification. There are 19 helicases that have been identified as playing important 
roles in ribosome biogenesis and most have been shown to be required specifically for 
either large or small subunit synthesis. Yeast Prp43, however, has been demonstrated 
to be involved in both SSU and LSU production (Bohnsack et al, 2009; Combs et al, 
2006; Granneman et al, 2006; Lebaron et al, 2005; Pertschy et al, 2009). Consistent 
with this, using in vivo cross-linking, Prp43 has been shown to associate with sites both 
at the 3’ end of 18S rRNA and also at multiple sites throughout 25S rRNA (Bohnsack et 
al, 2009). Prp43 is thought to have distinct functions in the biogenesis of each subunit. 
Prp43 is implicated in the association and dissociation of a number of different 
snoRNPs which modify 25S rRNA (Bohnsack et al, 2009). In contrast, in SSU 
formation, Prp43 is involved in the final processing step which converts 20S into 18S. 
This step was also shown to require a cofactor of Prp43, Pfa1 and another late 
processing factor, Ltv1 (Lebaron et al, 2009; Pertschy et al, 2009). It is suggested that 
the helicase activity of Prp43 may be required to re-structure the pre-rRNA around site 
D to expose the cleavage site to Nob1. In addition to its role in ribosome biogenesis, 
Prp43 is also a pre-mRNA splicing factor involved in the release of the intron lariat from 
the spliceosome (Arenas & Abelson, 1997)   
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1.7.6 RIO2 
RIO2 is a member of a family of atypical serine kinases that are conserved from 
archaea to mammals (LaRonde-LeBlanc & Wlodawer, 2005a; LaRonde-LeBlanc & 
Wlodawer, 2005b). Compared to other typical protein kinases (ePKs), the kinase 
domains of RIO proteins contain conserved catalytic amino acids but many of the 
sequences and structures normally involved in substrate binding and recognition are 
missing (LaRonde-LeBlanc & Wlodawer, 2005a). In archaea and lower eukaryotes two 
Rio kinases are found, Rio1 and Rio2 whereas in higher eukaryotes, three RIO kinases 
have been identified, RIO1, RIO2 and RIO3. Compared to RIO1, both RIO2 and RIO3 
have an additional N terminal domain, the function of which is not known. In yeast, 
Rio1 and Rio2 have been shown to be capable of serine phosphorylation in vitro 
(Angermayr & Bandlow, 2002; Geerlings et al, 2003; Vanrobays et al, 2003; Vanrobays 
et al, 2001). It has also been demonstrated that Rio1 from Archeoglobus fulgidus is 
able to autophosphorylate serine 108 in a flexible loop region (LaRonde-LeBlanc et al, 
2005). No substrates of the kinase activity of Rio2 have been identified in yeast or 
higher eukaryotes. The binding site of yeast Rio2 in 18S has led to the suggestion that 
ribosomal proteins Rps16 and Rps18 may be potential targets for Rio2 phosphorylation 
but there is no direct evidence for this (Granneman et al, 2010). 
Both RIO1 and RIO2 are required for 18S production in both yeast and human 
cells (Vanrobays et al, 2003; Zemp et al, 2009). Depletion of either protein inhibits the 
final maturation step of 18S and in yeast causes accumulation of 20S (Geerlings et al, 
2003). However, only RIO2 has been found to be stably associated with pre-40S 
complexes (Schafer et al, 2003). It is currently not clear what the role of RIO1 in 
ribosome biogenesis is although recent data show that the kinase activity of RIO1 is 
required for 18S production in higher eukaryotes (Widmann et al, 2011). In human cells 
RIO2 has been shown to be an export adaptor for transport of pre-40S complexes into 
the cytoplasm but this function does not appear to rely on the kinase activity of the 
protein (Zemp et al, 2009). However, the kinase activity of human RIO2 is necessary 
for the conversion of 18SE into 18S but it is not clear how this kinase activity enables 
site 3 cleavage. The kinase activity of both RIO2 and RIO1 is necessary for release of 
LTV1, PNO1 and NOB1 but not ENP1 from pre-40S complexes (Widmann et al, 2011; 
Zemp et al, 2009).  
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1.8 Quality control of ribosome biogenesis 
 Ribosome assembly is tightly regulated to prevent the formation of defective 
ribosomes. In yeast, deletion or mutation of ribosomal proteins can cause pre-rRNA 
processing to stall (Moritz et al, 1990; Moritz et al, 1991; Rotenberg et al, 1988). 
However, mutations in several ribosomal proteins in human cells have been linked to 
genetic diseases such as Diamond Blackfan anaemia (Ellis & Gleizes, 2011). The 
assembly of active biogenesis factors onto the pre-rRNA much earlier in the processing 
pathway than they are required could provide a quality control system. As described 
earlier, Dim1 is recruited to early pre-ribosomal complexes and its presence rather than 
its methylation activity is required for cleavages at A0 and A1 (Lafontaine et al, 1998b). 
Similarly, mutation of factors involved in pre-60S maturation such as Dbp4, Rok1 and 
Rrp3 has been shown to affect early pre-rRNA cleavages (Kressler et al, 1999). 
However, when ribosome biogenesis is disrupted, pre-rRNAs are not accumulated very 
significantly implying they are unstable and that they are rapidly targeted for 
degradation (Houseley & Tollervey, 2009). These abortive pre-rRNAs are degraded by 
the exosome. Defective pre-rRNAs are identified by the TRAMP complex which adds 
short polyadenylated tails which recruits the exosome to these substrates (this will be 
discussed in more detail in section 1.10.3.4.3). Quality control mechanisms also 
function once mature ribosomes have been formed in the cytoplasm. Ribosomes 
containing mutations in functionally important sites such as the peptidyltransferase 
centre or the decoding site are much less stable than functional ribosomes and are 
turned over in a non-functional rRNA decay (NRD) pathway (LaRiviere et al, 2006).  
 
1.9 Endonucleases in pre rRNA processing 
  Although many cleavage steps in pre-rRNA processing in S. cerevisiae have 
been identified and some of the cleavage sites have been mapped, the majority of the 
endonucleases responsible for these cleavages remain elusive. Other proteins that 
have been identified as playing important roles in pre-rRNA processing have been 
putatively suggested to be endonucleases based on protein homology to known 
endonucleases. Although cleavages comparable to those identified in yeast are 
thought to occur in human cells, no endonucleases have thus far been shown to be 
responsible for mediating these cleavages. However, all the endonucleases identified 
in yeast as important for ribosome biogenesis have homologues in higher eukaryotes 
making it possible that these functions are conserved.  
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1.9.1 NOB1 
 NOB1 is a highly conserved protein that is essential for production of the small 
subunit. NOB1 is a component of late pre-40S complexes in both yeast (Schafer et al, 
2003) and human cells (Rouquette et al, 2005; Zemp et al, 2009) and in yeast is 
associated with 20S pre-rRNA. Nob1 has been identified as the endonuclease 
responsible for cleavage at site D at the 3’ end of 18S in yeast (Fatica et al, 2003a; 
Fatica et al, 2004; Lamanna & Karbstein, 2009; Pertschy et al, 2009). It remains 
unclear if this function is conserved in human NOB1. 
NOB1 contains a PIN (PilT N-terminus) domain which has been shown to 
confer endonuclease activity on a number of proteins. PIN domains are motifs of 
approximately 100 amino acids containing up to four highly conserved acidic amino 
acid residues. The spatial arrangement of the four acidic residues is consistent with 
chelation of divalent metal cations, which are often required for ribonuclease activity. 
Other PIN domain proteins, such as Rrp44 and Smg6, have been shown to require 
Mn2+ and Mg2+, respectively, for their activities (Huntzinger et al, 2008; Schneider et al, 
2009). Structural studies of PIN domain proteins from archaea show that PIN domain 
proteins have a similar fold to 5’-3’ exonucleases, T4 phage RNase H and flap 
endonucleases (Arcus et al, 2004; Veith et al, 2011). PIN domain proteins, including 
recombinant yeast Nob1, have been shown to assemble as tetrameric complexes 
creating a central pore through which only single stranded nucleotides are able to pass 
and be cleaved (Lamanna & Karbstein, 2009).  
The PIN domain of yeast Nob1 has been shown to be required for cleavage at 
site D both in vivo (Fatica et al, 2004) and in vitro (Pertschy et al, 2009). Nob1 has 
been shown to be associated with pre-40S particles in the nucleus and is exported to 
the cytoplasm as part of the complex where it performs site D endonucleolytic cleavage 
(Fatica et al, 2003a). This suggests that the activity of Nob1 is suppressed until export 
to the cytoplasm. Different models have been proposed for how this regulation is 
achieved and the first suggests that ITS1 sequences base pair to highly conserved 
sequences near the 3’ end of 18S and block the cleavage site (Lamanna & Karbstein, 
2011). The second model, based on in vivo cross-linking data showing that the primary 
binding site of Nob1 is in the 3’ major domain of 18S RNA and distinct from the 
cleavage site, proposes that structural changes as processing occurs bring Nob1 into 
the proximity of its cleavage site (Granneman et al, 2010). The region around site D 
has been shown to be highly flexible (Granneman et al, 2010) and major structural 
rearrangement of the pre-40S complex once it is exported to the cytoplasm has been 
demonstrated giving credence to this model (Schafer et al, 2006). An NMR structure of 
archaeal Nob1 has recently been published and this identifies key amino acid residues 
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within the PIN domain which are essential for Nob1 interaction with site D while a zinc 
ribbon domain mediates the interaction of Nob1 with its primary binding site on helix 40 
of 18S rRNA (Veith et al, 2011). 
 
1.9.2 RNase MRP 
 RNase MRP is an RNA-protein complex that is conserved from prokaryotes 
through to higher eukaryotes and in yeast both the RNA and protein components have 
been shown to be essential (Chang & Clayton, 1987; Schmitt & Clayton, 1992). The 
RNA component of human RNase MRP is 267 nucleotides long and highly structured 
forming a scaffold for interaction with at least seven proteins: POP1, POP5, RPP20, 
RPP25, RPP30, RPP38 and RPP40 (Figure 1.7) (Pluk et al, 1999; Welting et al, 2006; 
Welting et al, 2004). Biogenesis of RNase MRP, like that of other snoRNPs, is an 
ordered process and at least two of these proteins, RPP20 and RPP25, preassemble 
into a complex before they are able to interact with the P3 domain of the RNA 
component of RNase MRP (Hands-Taylor et al, 2010). It is further thought that RPP20 
and RPP25 may be only transiently associated with the RNase MRP complex and as 
they bind near the catalytic centre (P4 and nucleotides 68-71) their dissociation may be 
required for endonucleolytic cleavage of pre-rRNA (Hands-Taylor et al, 2010; Welting 
et al, 2007). As well as these seven core proteins, three additional proteins associate 
with a subset of RNase MRP complexes: POP4, RPP21 and RPP14 (Welting et al, 
2006). These proteins have been shown to bind RNase P preferentially and are 
thought to dissociate from RNase MRP when it interacts with pre-rRNA. RNase MRP is 
found to co-sediment in two peaks of 12S and 60-80S in both HeLa and Hep2 cells, 
similar to the profile of U3 snoRNP complexes. The 12S peak corresponds to the free-
complex while the 60-80S peak indicates that RNase MRP is associated with pre-
ribosomal complexes. In yeast, two RNase MRP-specific proteins have been identified, 
Snm1 and Rmp1 (Salinas et al, 2005; Schmitt & Clayton, 1994).  
RNase MRP is localised to both mitochondria and the nucleolus and contains 
localisation signals for both these compartments in the central region and the Th/To 
domain, respectively (Jacobson et al, 1995; Li et al, 1994). RNase MRP was first 
identified as an endonuclease in mitochondria where it cleaves mitochondrial RNA 
required for mitochondrial DNA replication (Chang & Clayton, 1987). Localisation of 
RNase MRP in the nucleolus suggested a role in ribosome biogenesis and in S. 
cerevisiae deletion of the RNA component of MRP leads to a change in the ratio in 
which the long and short forms of 5.8S rRNA accumulate (Schmitt & Clayton, 1993). In 
normal cells, 85% of 5.8S is a short form (5.8SS) and only 15% contains an extended 5’ 
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end (5.8SL) but after RNase MRP depletion, the levels of the short form significantly 
decrease while the long form accumulates. RNase MRP was, therefore, identified as 
the endonuclease responsible for carrying out cleavage at site A3 in yeast ITS1 which 
generates the precursors of 5.8SS (Lygerou et al, 1996). Mutation of various residues 
within the key subunit of the RNase MRP complex, Pop1, blocks A3 cleavage without 
affecting the overall levels of the RNase MRP complex (Xiao et al, 2006). More 
recently, it has been suggested that RNase MRP has an additional role in mediating 
entry of early pre-rRNA transcripts into the canonical processing pathway. Pre-rRNA 
transcription was found to be unaffected by mutations in the RNA component of RNase 
MRP, but accumulation of long precursors (35S/33S/32S) was severely reduced. This 
suggests that early cleavage steps (A0, A1, A2 and A3) are inhibited by these 
mutations and this prevents pre-rRNAs from entering the normal processing pathway 
(Lindahl et al, 2009).  
 
 
RNase MRP is also present in human cells although it is not clear whether the 
role in ribosomal RNA processing is conserved. siRNA mediated depletion of the 
RNase MRP/RNase P subunit, RPP38, causes defects in tRNAi
Met processing, which 
are likely to result from RNase P inhibition. However, the ratio of the long and short 
forms of 5.8S was unaffected, suggesting that RNase MRP may not be responsible for 
a cleavage analogous to A3 in human cells (Cohen et al, 2003). RNase protection 
assay data, however, indicate that cleavage of sequences at the 3’ end of ITS1 is 
 
Figure 1.7 Structure of RNase MRP 
Schematic model of the human RNase 
MRP complex with the RNA shown in 
black and particular structural 
elements number according to Welting 
et al., 2004. Core proteins are shown 
in shades of grey. Adapted from 
Welting et al., 2004. 
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aberrant in cells over-expressing RPP38 potentially indicating a subtle or alternative 
role for RNase MRP in ITS1 processing in human cells (Cohen et al, 2003). 
Although RNase MRP RNA and proteins are essential in yeast, A3 is not an 
essential step in pre-rRNA processing suggesting that the mitochondrial activity of 
RNase MRP is vital or that RNase MRP has other critical roles within the cell. 
Additional roles for human RNase MRP in cell cycle regulation and disease have also 
been identified. Cleavage of CLB2 (cyclin B2) mRNA by RNase MRP provides an entry 
point for the exonuclease, XRN1, which degrades this mRNA causing down-regulation 
of cyclin B2 and exit from mitosis (Gill et al, 2004). Further, depletion of RNase MRP 
subunits, POP1 and RPP40, causes accumulation of the anti-viral protein, viperin 
(Mattijssen et al, 2011). This suggests a role for RNase MRP in regulating the levels of 
a protein required for the immune response. Finally, the RNA component of RNase 
MRP forms a complex with telomerase-associated reverse transcriptase (TERT) 
leading to the formation of a double stranded MRP-RNA. This double stranded RNA is 
then processed by the RISC pathway (Dicer) to generate siRNAs which down-regulate 
expression of RNase MRP RNA. This provides a mechanism by which MRP levels can 
be regulated or controlled within the cell (Maida et al, 2009).  
 
1.9.3 RCL1 
 Rcl1 is a nucleolar protein that has general sequence homology to 3’-terminal 
phosphate cyclases. The recombinant yeast protein has been shown not to possess 
this activity and the lack of critical amino acid residues in the active site of the 
eukaryotic protein lead to the suggestion that Rcl1 has an alternative catalytic activity 
as an endonuclease (Billy et al, 2000). More recently, it has been demonstrated that 
recombinant yeast Rcl1 can act as an endonuclease in vitro (Horn et al, 2011). A 
crystal structure of Rcl1 identified a catalytic pocket of residues likely to coordinate the 
divalent cations that would be expected to be important for this activity. However, 
mutation of these was not found to affect Rcl1 activity in vivo (Tanaka et al). RCL1 in 
both yeast and humans associates with the U3 snoRNP-containing SSU processome 
(Billy et al, 2000; Turner et al, 2012). Rcl1 forms a sub-complex with the GTPase, 
Bms1, and this interaction is required for its association with U3 (Karbstein & Doudna, 
2006; Karbstein et al, 2005; Wegierski et al, 2001). A model of how Rcl1 is recruited to 
the pre-rRNA has been proposed in which GTP bound Bms1 interacts with Rcl1 and 
this complex associates with the pre-ribosome. This then induces a conformational 
change which hydrolyses the GTP and releases Bms1, leaving Rcl1 in situ on the pre-
rRNA (Karbstein & Doudna, 2006; Karbstein et al, 2005). In yeast, Rcl1 is required for 
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pre-rRNA processing at the A0, A1 and A2 sites (Billy et al, 2000). A0 cleavage is less 
dependent on Rcl1 than A1 and A2 are and it is currently proposed that Rcl1 is the 
endonuclease responsible for carrying out cleavage at the A2 site. Recombinant Rcl1 
has been shown to cleave pre-rRNA transcripts containing A2 sequences in a 
concentration dependant manner and RNA mutations that have been shown to affect in 
vivo processing at A2, impair this (Horn et al, 2011). 
 
1.9.4 UTP24 and UTP23 
Like Rcl1, Utp23 and Utp24 are components of the small subunit (SSU) 
processome in yeast and are proposed to be endonucleases as they contain PIN 
domains. Both proteins are essential in yeast and are required for the A0, A1 and A2 
cleavages needed to produce 18S RNA (Bleichert et al, 2006; Rempola et al, 2006). 
The PIN domain of Utp24, but not Utp23, is essential for the A1 and A2 cleavages 
suggesting that Utp24 may be the nuclease responsible for carrying out either or both 
of these steps in yeast. The activity of neither Utp24 or Utp23 is required for A0 
cleavage indicating that these proteins may be part of a processing complex required 
for the first 5’ETS cleavage (Bleichert et al, 2006). The PIN domain of yeast Utp23 
contains only two of the four conserved acidic amino acid residues. Thus, Utp23 may 
only be a cofactor of Utp24 and enhance the activity of Utp24 by forming hetero-
tetrameric complexes as other PIN domain proteins do (Bleichert et al, 2006). 
Interestingly, three of the four conserved amino acid residues of the PIN domain are 
found in the human UTP23 protein. 
 
1.9.5 RNT1 
Rnt1 is a double strand-specific endonuclease with homology to bacterial 
RNase III (Elela et al, 1996). Many different substrates of yeast Rnt1 have been 
identified and Rnt1 plays important roles in releasing pre-snoRNAs from introns or 
snoRNA clusters and in the formation of the 3’ ends of splicosomal snRNAs 
(Chanfreau, 2003; Chanfreau et al, 1998a; Chanfreau et al, 1998b). Early pre-rRNA 
processing steps are inhibited in yeast strains expressing mutant Rnt1 and 
recombinant Rnt1 was found to cleave stem-loop RNAs containing both 5’ and 3’ETS 
sequences in vitro indicating a role for Rnt1 in rRNA processing (Elela et al, 1996). 
Deletion of Rnt1 in S. cerevisiae was subsequently shown to cause slowed kinetics of 
early processing steps in the 5’ETS and ITS1 (A0, A1 and A2) but was not essential for 
any of them (Kufel et al, 1999). However, cleavage in the 3’ETS is completely blocked 
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in the absence of Rnt1 and the 3’ extended pre-25S intermediates normally generated 
by this cleavage are not observed. Rnt1 was shown to cleave twice in the 3’ETS on 
either side of a predicted stem-loop structure which is consistent with the consensus 
target site of Rnt1 (Kufel et al, 1999). This cleavage site is now called B1 and 
endonucleolytic cleavage by Rnt1 provides a substrate end for exonucleolytic 
processing by Rex1 to generate the mature 3’ end of 25S. In plant cells, the homologue 
of Rnt1, AtRTL2, also cleaves in the 3’ETS (Comella et al, 2008). 
 
1.10 Exonucleases  
1.10.1 5’-3’ exonucleases 
 Several different conserved 5’-3’ exonucleases have been identified and two of 
the major proteins are XRN2 (Rat1 in yeast) which is found in the nucleus and XRN1, a 
closely homologous protein which is localised to the cytoplasm. Another key and 
conserved 5’-3’ exonuclease is NOL12 (Rrp17 in yeast). These and other 5’-3’ 
exonucleases have important functions in a range of RNA degradation and processing 
pathways including pre-rRNA, snRNA and snoRNA maturation, turnover of RNA 
fragments and RNA surveillance mechanisms.  
The exonuclease activity of Rat1 is stimulated by a cofactor, Rai1 (Xue et al, 
2000). A crystal structure of these two proteins in complex from Schizosaccharomyces 
pombe has been published and the key residues which mediate this interaction were 
identified (Xiang et al, 2009). Although a homologue of Rai1, DOM3Z, is found in 
human cells, the amino acids which mediate the Rat1-Rai1 interaction are not 
conserved in XRN2 raising questions about whether DOM3Z interacts with and 
stimulates the activity of XRN2 in higher eukaryotes (Xiang et al, 2009). Interestingly, 
the crystal structure of Rai1 showed a separate, highly conserved pocket capable of 
coordinating a divalent cation. This region was then shown to endow Rai1 with 
pyrophosphohydrolase activity (Xiang et al, 2009). This activity converts the 5’ 
triphosphate group of RNA substrates to monophosphates which can be degraded by 
Rat1 (Poole & Stevens, 1997; Xiang et al, 2009). Further, Rai1 possesses 
endonuclease activity which is used in the decapping of mRNAs. This activity is 
preferentially targeted towards unmethylated caps implying that Rai1 and Rat1 play an 
important role in degradation of mRNAs with aberrant or absent 5’ caps (Jiao et al, 
2010). 
In yeast, both Xrn1 and Rat1 can function in pre-rRNA processing that 
produces the mature 5’ end of 5.8SS rRNA although Rat1 is normally responsible for 
37 
 
this (Henry et al, 1994). Another 5’-3’ exonuclease, Rrp17, was identified in proteomic 
analysis of late pre-60S complexes and also participtes in 5.8SS processing (Oeffinger 
et al, 2009). The catalytic domain of Rrp17 does not share any sequence homology to 
other known exonucleases but this protein is conserved and homologues have been 
identified in many species including a homologue, NOL12 (also called NOP25), in 
human cells (Fujiwara et al, 2006; Suzuki et al, 2007). NOL12 is able to functionally 
compensate for Rrp17 depletion suggesting that the roles of Rrp17 are conserved 
(Oeffinger et al, 2009). There is functional redundancy between the exonucleases 
involved in the 5’ processing of 5.8SS and deletion of any individual nuclease does not 
lead to detectable defects (Oeffinger et al, 2009). Due to its cytoplasmic localisation, 
Xrn1 does not, however, normally participate in 5.8SS formation but can compensate 
for the absence of Rat1 in this process (El Hage et al, 2008; Henry et al, 1994) 
probably because processing is delayed until the complex reaches the cytoplasm. The 
activities of Rat1 and Rrp17 are probably coordinated during 5.8SS processing as 
different regions of the ITS1 sequence are preferentially degraded by each of the 
exonucleases (Oeffinger et al, 2009). Rrp17 but not Rat1 is recruited to the pre-rRNA 
by the presence of proteins involved in A3 cleavage (section 1.4.3) and which are 
required for the downstream exonuclease processing (Granneman et al, 2011). 
Rat1 is also responsible for the degradation of fragments of pre-rRNA spacer 
regions which are released by consecutive endonucleolytic cleavages such as the A0-
A1 and A2-A3 fragments (Petfalski et al, 1998). The interaction between Rat1 and pre-
rRNA transcripts has recently been investigated using in vivo cross-linking. Consistent 
with its degradation and processing functions, Rat1 was found to cross-link robustly to 
the 3’ end of the 5’ETS, upstream of the A1 site, and to the region immediately 5’ of the 
A3 site but neither Rrp17 nor Rai1 could be cross-linked to pre-rRNA (Granneman et al, 
2011).  
The function of the Rat1 homologue, XRN2, in degradation of fragments of the 
5’ETS is conserved in mouse cells (Wang & Pestov, 2011). Compared to yeast, the 
5’ETS in higher eukaryotes contains an additional cleavage site, A’, and as well as the 
A0-A1 fragment, mouse XRN2 is responsible for degradation of the released 5’ end 
fragment generated by A’ cleavage. Interestingly, in both mouse and plant cells, XRN2 
is also required for A’ cleavage (Wang & Pestov, 2011; Zakrzewska-Placzek et al, 
2010). In mouse cells, this defect in A’ cleavage is suggested to arise because other 
proteins required for this cleavage are not recycled from the 5’-A’ fragment when XRN2 
is not present to degrade it. In contrast, in plant cells, XRN2 is proposed to degrade the 
5’ end of the pre-rRNA, exposing the A’ site enabling the endonucleolytic cleavage to 
occur (Zakrzewska-Placzek et al, 2010). In mouse cells, depletion of XRN2 also 
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causes the accumulation of a fragment of ITS1 extending between the 2a and 2 sites. 
Depletion of XRN2 alters the balance of ITS1 cleavages leading to an increased 
proportion of pre-rRNA cleaved at 2a (Wang & Pestov, 2011). Like Rat1 in yeast, 
XRN2 in mouse cells is required for exonucleolytic processing to form the mature 5’ 
end of 28S rRNA (Wang & Pestov, 2011).  
Both Rat1 and XRN2, in yeast and mammals respectively, have important 
functions in RNA surveillance and quality control of pre-rRNA transcripts. The presence 
of A3-cluster proteins arrests Rat1 processing at the 5’ end of 5.8S rRNA and in their 
absence, pre-rRNAs are completely degraded (Granneman et al, 2011). In mouse 
cells, XRN2 contributes to the degradation of truncated RNA polymerase I transcripts. 
These abortive transcripts are also targeted for 3’-5’ degradation by the exosome 
(Wang & Pestov, 2011). 
 Another function of Rat1 in yeast is the 5’ processing of small non-coding RNAs 
such as snRNAs and snoRNAs. Rat1 (XRN2) also participates in transcription 
termination of mRNAs produced by RNA polymerase II by a mechanism known as 
“torpedo” (Tollervey, 2004). Poly(A) sequences or gene-specific co-transcriptional 
cleavage sites trigger the release of transcribed mRNAs from the RNA polymerase. 
Rat1 (XRN2) is recruited to the carboxy-terminal domain (CTD) of the polymerase (Kim 
et al, 2004; West et al, 2004). Following release of the mRNA, the RNA still being 
transcribed by the polymerase is degraded by Rat1 (XRN2) until the exonuclease 
catches up with the polymerase and terminates transcription by “torpedoing” the 
polymerase off the template. 
 
1.10.2 REX proteins 
The REX proteins represent a poorly characterised family of 3’-5’ exonucleases 
that were identified based on their sequence homology to other 3’-5’ exonucleases 
including RNase D and RNase T (Moser et al, 1997). In yeast, four Rex proteins have 
been described: Rex1, Rex2, Rex3 and Rex4. These proteins appear to be well 
conserved with homologues of the yeast proteins REX1, REX2 and REX4 identified in 
Xenopus and humans. Xenopus REX4 (XPMC2) has a role in cell cycle progression 
(Su & Maller, 1995) but no RNA processing defects were detected in yeast upon 
deletion of the Rex4 gene (van Hoof et al, 2000). PMC2 (Rex4) in human cells has 
recently been shown to have 3’-5’ exonuclease activity in vitro and this catalytic activity 
is required for the repair of estrogen-induced DNA damage (Krishnamurthy et al, 2011). 
Rex1, 2 and 3 have both specific and overlapping functions in RNA processing in 
yeast. Rex1 alone is required for the formation of the proper 3’ ends of 5S rRNA and 
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tRNA–Arg3 while Rex2 has a specific function in the fine trimming of the 3’ end of U4 
snRNA (van Hoof et al, 2000). Defects in the formation of the 3’ end of RNase MRP 
RNA are detected upon deletion of the Rex3 gene while redundancy is observed 
between Rex1, Rex2 and Rex3 in the formation of the 3’ end of the related RNase P 
RNA (van Hoof et al, 2000). Rex1 and Rex2 have also been shown to be functionally 
redundant in the maturation of 5.8S rRNA with co-deletion of these two genes causing 
accumulation of 3’ extended precursors (van Hoof et al, 2000). Interestingly, this 
implicates the Rex proteins in RNA processing events also attributed to the exosome, 
suggesting there may be functional redundancy between multiple exonucleases 
performing the same 3’ processing events. This redundancy is supported by the 
observation that yeast strains lacking both Rrp6 and Rex1 (van Hoof et al, 2000) or 
Rrp47 and Rex1 (Costello et al, 2011) are not viable. However, deletion of specific 
exonucleases gives rise to subtle variations in the accumulation of aberrant precursors 
suggesting that different exonucleases may be required for particular steps within the 
processing or degradation pathways of a single precursor.  
 
1.10.3 The exosome 
 The exosome is a multi-protein complex that functions as a 3’-5’ exonuclease 
and is highly conserved from archaea to humans (Hartung & Hopfner, 2009; Mitchell et 
al, 1997). The exosome was first discovered in S. cerevisiae as an enzyme required for 
formation of the mature 3’ end of 5.8S rRNA (Mitchell et al, 1996). Many of the proteins 
of the human exosome complex were first identified as autoantigens that give rise to 
the autoimmune disorders of polymyositis, scleroderma (Scl) and the PM/Scl overlap 
syndrome (Brouwer et al, 2001; Gelpi et al, 1990). Since then, the exosome has been 
shown to be responsible for the processing and/or degradation of a range of other RNA 
substrates both in the nucleus and cytoplasm (Figure 1.8) (Houseley et al, 2006; Kiss & 
Andrulis, 2011; Lykke-Andersen et al, 2009; Schmid & Jensen, 2008b; Tomecki et al, 
2010a; Vanacova & Stefl, 2007). The exosome is involved in the 3’ processing of pre-
sno/snRNAs, pre-tRNA as well as pre-rRNA (5.8S) in the nucleus (Allmang et al, 
1999a). In the nucleus the exosome also participates in the recycling of the by-products 
of RNA processing such as the fragments of pre-rRNA released by serial 
endonucleolytic cleavages. The exosome plays an important role in RNA surveillance 
and defective sn/snoRNAs, pre-rRNAs, tRNAs or mRNAs which are not correctly 
processed, spliced or assembled into RNP complexes are targeted for degradation by 
the exosome. Other RNA polymerase II transcripts such as cryptic unstable transcripts  
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(CUTs), which regulate gene expression in yeast, and promoter upstream transcripts 
(PROMPTs) which are found in human cells are turned over by the exosome in the 
nucleus (Chekanova et al, 2007; Milligan et al, 2008; Neil et al, 2009; Preker et al, 
2008). In the cytoplasm the exosome also has a quality control function in preventing 
the translation of defective mature mRNAs and as such is involved in the nonsense 
mediated decay (NMD) pathway which eliminates transcripts containing a premature 
stop codon, the nonstop decay (NSD) pathway which removes mRNAs lacking a stop 
codon and the no-go decay (NGD) pathway which degrades mRNAs that could not be 
translated by the ribosome (Isken & Maquat, 2007). The cytoplasmic exosome is 
involved in more specific degradation pathways including the degradation of transcripts 
containing AU-rich elements (AREs) to which the exosome is directy recruited, the 
turnover of viral RNAs containing zinc-finger protein response elements (ZREs) and 
that of mRNA byproducts produced by the RNA interference pathway (Chen et al, 
2001; Gherzi et al, 2004; Guo et al, 2007; Mukherjee et al, 2002; Orban & Izaurralde, 
2005). The cytoplasmic exosome is important for maintaining the levels of histone 
mRNAs and TUTases are proposed to add oligouridine tails to these mRNAs which 
recruits both LSm proteins and the exosome bringing about their subsequent 
degradation (Mullen & Marzluff, 2008). It is still not clear how the exosome is recruited 
 
Figure 1.8 The yeast exosome participates in various pathways of RNA metabolism The 
core exosome (blue/purple ovals) is associated with Rrp44 (yellow) and Rrp6 (red) in the 
nucleus. Various substrates of the nuclear and cytoplasmic exosomes are shown in black. 
Cofactors identified as participating in each pathway are shown along the arrow.  
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specifically to each of its substrates or how the activity of the exosome is regulated to 
perform the different functions of processing and degradation.  
 
1.10.3.1 Core exosome structure 
 The overall structural organisation of eukaryotic exosomes is conserved from 
prokaryotic polynucleotide phosphorylases (PNPases) which are part of the bacterial 
machinery for RNA degradation (Figure 1.9) (Buttner et al, 2005; Liu et al, 2006; 
Lorentzen et al, 2005). PNPases form a six membered homotrimeric ring composed of 
proteins which are homologous to RNase PH. Each protein contains two PH domains 
and only one molecule in each dimer has ribonuclease activity (Figure 1.9) (Carpousis, 
2002; Symmons et al, 2000). 
 
 
 
Figure 1.9 RNA degradation complexes are structurally conserved from bacteria to 
eukaryotes Schematic representations of RNase PH and PNPase from bacteria, the archaeal 
exosome and the eukaryotic exosome. Dark blue and mid-blue ovals represent PH domain 
proteins homologous to archaeal RRP41 and RRP42, respectively. Pale blue circles 
correspond to the trimeric cap formed by the RNA-binding domain proteins containing KH and 
S1 domains. Red and pink stars represent the active sites of the core proteins in bacteria and 
archaea (pink stars indicate that the active site is on the opposite face of the hexameric ring). 
Eukaryotic core exosomes are inactive and associate with RNase D-like RRP6, shown in red, 
which probably interacts in the proximity of the trimeric cap and the exo-/endonuclease, DIS3 
(yellow) which is anchored to the lower face of the core exosome via its PIN domain (small 
yellow shape). 
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 Similarly, the archaeal exosome is a hexameric ring composed of three dimers 
of RNase PH homologues, Rrp41 and Rrp42. Only the Rrp41 subunits have retained 
catalytic activity and as such, three active sites are present in archaeal exosomes 
which are directed towards a central core channel (Figure 1.9) (Lorentzen et al, 2005). 
This channel is only compatible with single stranded substrates and is thought to direct 
RNA substrates toward the active sites of the complex. In archaeal exosomes, 
additional proteins, Rrp4 and Csl4, bind to the Rrp42 subunits of the core exosome. 
Rrp4 and Csl4 proteins contain KH and S1 domains which function in RNA binding and 
therefore, probably substrate recruitment (Hartung & Hopfner, 2009). These domains 
are also found in the bacterial PNPase proteins. 
 Eukaryotic exosomes also consist of nine core proteins which share homology 
with their archaeal and bacterial counterparts and are organised structurally into a 
hexameric ring and cap (Figure 1.9). Crystal structures of both the yeast and human 
exosomes have been published (Liu et al, 2006). Similar to archaeal RRP41 are the 
eukaryotic subunits, RRP41, RRP46 and MTR3 and related to RRP42 from the 
archaeal complex are the eukaryotic proteins, RRP42, RRP43 (OIP2 in humans) and 
RRP45 (PM/Scl75 in humans). These are arranged in RRP41-RRP42-like dimers 
consisting of RRP41-RRP45, RRP42-MTR3 and RRP43-RRP46, which assemble to 
form the doughnut ring shape. Eukaryotic exosomes contain three KH/S1 domain 
proteins, RRP4, RRP40 and CSL4 which in higher eukaryotes are required for the 
stability of the hexameric ring as well as for RNA binding and substrate recognition. 
Crystal structures of the exosome show that these proteins are clustered at the 
entrance to the channel on one side of the ring enabling substrates to be targeted 
through the central pore (Liu et al, 2006). 
 The catalytic amino acid residues of the archaeal PH domain proteins are not 
conserved in five out of the six eukaryotic PH domain proteins and both yeast and 
human core exosomes have lost nuclease activity (Dziembowski et al, 2007; Liu et al, 
2006; Schneider et al, 2007) which instead is derived by association with exonuclease 
subunits, RRP6 and DIS3/DIS3L (Rrp44 in yeast). 
 
1.10.3.2 DIS3/DIS3L (Rrp44) 
 In yeast, Rrp44 is considered a tenth core exosome subunit as it is 
constitutively associated with exosome complexes in both the nucleus and cytoplasm 
and is essential for cell viability (Allmang et al, 1999b; Dziembowski et al, 2007; Liu et 
al, 2006; Mitchell et al, 1997). Rrp44 is homologous to E. coli RNase R, a member of 
the RNase II family of hydrolytic 3’-5’ exonucleases (Vincent & Deutscher, 2006). Like 
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RNase R, Rrp44 contains a cold shock RNA binding domain (CDS), an RNase II 
catalytic domain (RNB) and a C-terminal S1 RNA binding domain. The RNB domain 
contains four highly conserved acidic residues responsible for chelating a divalent 
metal ion (Mg2+) required for nuclease activity. Rrp44 is a highly processive enzyme 
and is able to degrade both structured and unstructured RNA substrates although its 
activity has been shown to be significantly decreased by its association with the core 
exosome (Lorentzen et al, 2008). Rrp44 requires 3’ single stranded overhangs of 
approximately 14 nucleotides to initiate degradation of a duplex substrate (Lorentzen et 
al, 2008). Rrp44 additionally contains a PIN domain at its N terminus (Lebreton et al, 
2008; Schaeffer et al, 2009; Schneider et al, 2007). It was recently shown by three 
different groups that this PIN domain endows Rrp44 with in vitro endonuclease activity 
in addition to its well characterised 3’-5’ exonuclease activity (Lebreton et al, 2008; 
Schaeffer et al, 2009; Schneider et al, 2009). It is not yet clear what the specific 
functions of the endonuclease activity are but Rrp44 mutants deficient in either exo- or 
both exo- and endonuclease activity show different pre-rRNA processing defects 
particularly in the degradation of cleaved 5’ETS fragments accumulating after A0 
cleavage (Lebreton et al, 2008; Schaeffer et al, 2009; Schneider et al, 2009). As well 
as this catalytic role, the PIN domain of Rrp44 is essential for tethering Rrp44 to the 
core exosome (Schneider et al, 2009). Rrp44 associates with the lower face of the core 
exosome, opposite to the trimeric cap (Figure 1.9). A model of RNA processing is 
proposed in which single stranded substrates pass though the central pore of the 
hexameric ring and are directed towards the active site of the exonuclease domain 
(Bonneau et al, 2009). Structured RNA substrates are excluded from the core exosome 
and are thought to be targeted directly to the PIN domain where they are cleaved into 
fragments which can be degraded exonucleolytically. 
While only one form of Rrp44 is present in yeast, three different human 
homologues have been identified: DIS3, DIS3L1 and DIS3L2. Of these, only DIS3 and 
DIS3L are associated with the exosome (Staals et al, 2010; Tomecki et al, 2010b). 
Both these proteins were found to be less stably associated with the core exosome 
than yeast Rrp44 is (Tomecki et al, 2010b). The PIN domain of DIS3L2 is poorly 
conserved and as this PIN domain is required for interaction with the exosome this is 
likely to explain why DIS3L2 is not found in purified exosome complexes (Tomecki et 
al, 2010b). Distinct subcellular localisation of these proteins was observed with DIS3 
being found predominantly in the nucleus but excluded from nucleoli, whereas DIS3L 
was found exclusively in the cytoplasm (Tomecki et al, 2010b). While both DIS3 and 
DIS3L have 3’-5’ exonuclease activity in vitro, only DIS3 was found to have 
endonuclease activity like its yeast counterpart (Tomecki et al, 2010b). Exosome 
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associated RNA processing activities of both DIS3 and DIS3L have been demonstrated 
in vivo and RNAi mediated depletion of DIS3 but not DIS3L leads to the stabilisation of 
PROMPTS in the nucleus and accumulation of extended 3’ precursors of 5.8S rRNA 
(Tomecki et al, 2010b). In the cytoplasm, depletion of DIS3L causes significant 
stabilisation of cMyc and cFos mRNAs (Tomecki et al, 2010b) and the accumulation of 
polyadenylated 28S rRNA fragments (Staals et al, 2010) which are both normally 
degraded by the exosome.  
 
1.10.3.3 RRP6 
 The other exoribonuclease associated with the exosome is RRP6 (also called 
PM/Scl100 in humans). RRP6 shows homology to E. coli RNase D and, as such, is a 
member of the DEDD superfamily of 3’-5’ ribonucleases and deoxyribonucleases 
(Midtgaard et al, 2006; Steitz & Steitz, 1993). In addition to the exonuclease (RNB) 
domain which contains the four conserved catalytic amino acid resides that constitute 
the DEDD box motif, RRP6 also contains a single HRDC domain. The precise function 
of this domain is unknown but it may be important for regulating substrate binding by 
guiding substrates to the catalytic site (Liu et al, 2006; Midtgaard et al, 2006). Other 
important regions of Rrp6 include the PMC2NT domain which mediates interactions 
with the cofactor, Rrp47 and a region to the C-terminal side of the HRDC domain which 
is important for interactions with the core exosome (Callahan & Butler, 2008). Rrp6 also 
contains a putative nuclear localisation signal (NLS) (Phillips & Butler, 2003). A recent 
crystal structure of human RRP6 shows that these domains are conserved in the 
human protein (Januszyk et al, 2011). It is not clear how Rrp6 interacts with the core 
exosome and different models are proposed. A cryo-EM structure from Leishmania 
tarentole reports Rrp6 binding to the trimeric cap of the core exosome (Cristodero et al, 
2008). This places Rrp6 at the mouth of the central pore and close to the RNA binding 
proteins of the core exosome. Alternatively, yeast two hybrid data suggest that human 
RRP6 interacts on the opposite face, in direct contact with the hexameric ring (Lehner 
& Sanderson, 2004). Rrp6 is also able to act independently of the core exosome. Rrp6 
lacking the C-terminal region which tethers it to the core exosome, is still able to 
participate in 5.8S rRNA processing and snoRNA maturation in yeast although other 
functions, such as degradation of long polyadenylated substrates, are inhibited 
(Callahan & Butler, 2008). Both yeast and human RRP6 have processive 
exonucleolytic activity and in yeast, Rrp6 is only capable of degrading unstructured 
RNA substrates. In contrast, human RRP6 is able to degrade structured substrates, 
probably due to a more open conformation of the catalytic site in the human protein 
(Januszyk et al, 2011). While both yeast and human RRP6 are localised in the nucleus, 
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a key difference is that the human protein is concentrated in the nucleoli and can also 
be detected in the cytoplasm (Tomecki et al, 2010b). 
 
1.10.3.4 Cofactors 
1.10.3.4.1 C1D (Rrp47) 
 Rrp47 (or Lrp1 in yeast and C1D in humans) is a nuclear protein that in yeast 
co-purifies with exosome complexes containing Rrp6 (Mitchell et al, 2003; Schilders et 
al, 2007). Deletion of Rrp47 causes RNA processing defects similar to those caused by 
the lack of Rrp6 and indeed Rrp47 has been shown to interact with the PMC2NT 
domain of Rrp6 (Mitchell et al, 2003; Stead et al, 2007). Rrp47 (C1D) is known to 
participate in 3’ processing of 5.8S in both yeast and human cells and is required for 
maturation of both snoRNAs and snRNAs in yeast (Costello et al, 2011; Schilders et al, 
2007). Yeast Rrp47 is an RNA binding protein that in vitro can exist as a hexameric 
complex and binds preferentially to structured RNA substrates (Stead et al, 2007). 
Rrp47 is able to bind concurrently to both Rrp6 and to nucleotides suggesting that it 
may function as an adapter recruiting the Rrp6-exosome to its substrates. This model 
is further supported by evidence of helical or double stranded regions at the 3’ ends of 
known exosome substrates, such as pre-5.8S and CUTs. Rrp47 contains an unusual 
RNA binding domain called a Sas10/C1D domain which is also found in pre-rRNA 
binding factors, UTP3 and Lcp5 (Costello et al, 2011). As well as its role in RNA 
binding, the C-terminal domain of Rrp47 mediates important protein-protein interactions 
during snoRNP biogenesis. Recombinant Rrp47 interacts with core snoRNP proteins 
Nop56 and Nop58. A model is proposed in which mis-assembly of snoRNP particles 
inhibits recruitment of Rrp47, which in turn promotes oligoadenylation of the snoRNA 
targeting it for degradation by the exosome. In this way, Rrp47 is thought to function in 
snoRNP quality control (Costello et al, 2011).  
 
1.10.3.4.2 MPP6 
 Another protein which co-purifies with nuclear exosome complexes is the M-
phase phosphoprotein 6, MPP6 (Milligan et al, 2008). MPP6 is an RNA binding protein 
that interacts most strongly with pyrimidine-rich sequences and localises predominantly 
to the nucleoli of human cells (Schilders et al, 2005). MPP6 is required for 3’ 
processing of 5.8S rRNA in both yeast and human cells (Milligan et al, 2008; Schilders 
et al, 2005). In yeast, Mpp6 is also involved in exosome degradation of unstable non-
coding RNAs produced by RNA polymerase II (Milligan et al, 2008). 
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1.10.3.4.3 TRAMP complex 
 A cofactor of the nuclear exosome that has been well characterised in yeast is 
the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) complex (LaCava et al, 2005; 
Vanacova et al, 2005). TRAMP recruits the exosome to its RNA substrates by adding 
short poly (A) tails and stimulating exonucleolytic degradation by the exosome, thereby 
playing a key role in RNA surveillance and quality control. The TRAMP complex in 
S.cerevisiae is composed of a non-canonical poly(A) polymerase (either Trf4 or Trf5), 
an RNA binding protein (either Air1 or Air2) and the RNA helicase, Mtr4 (LaCava et al, 
2005; Vanacova et al, 2005). Two different TRAMP complexes have been identified; 
the first containing Trf4-Air1/2-Mtr4 and the second comprised of Trf5-Air1-Mtr4 
(LaCava et al, 2005; Vanacova et al, 2005).  
 Trf4/5 are distributive polymerases that are only able to add short poly(A) tails 
to RNA substrates in the context of the TRAMP complex but are inactive by 
themselves. The polyadenylation activity of Trf4/5 is regulated by the associated 
helicase, Mtr4, which modulates the relative kinetics of adenylation and TRAMP 
dissociation to restrict the number of adenosines added to approximately four to five 
(Jia et al, 2011; Wlotzka et al, 2011). Trf4 and Trf5 are highly similar (48% identical) 
and are functionally redundant although Trf5 activity is restricted to the nucleolus while 
Trf4 only functions in the nucleus. Interestingly, evidence has been presented that 
suggests that Trf4 is able to target aberrant RNAs for exosome degradation 
independently of its polymerase activity (Rougemaille et al, 2007; San Paolo et al, 
2009; Wyers et al, 2005). Similarly, the two Air proteins found in TRAMP complexes 
are highly related (45% identical) and functionally redundant, with only deletion of both 
genes leading to a growth defect. The Air proteins contain five zinc knuckle motifs 
proposed to function in RNA binding making it likely that the Air proteins are critical for 
substrate specificity of the TRAMP complex. A recent crystal structure of a partial 
TRAMP complex and mutational studies showed that ZnK4 and ZnK5 are, however, 
responsible for mediating protein-protein interactions between the Air protein and the 
central domain of Trf4 (Fasken et al, 2011; Hamill et al, 2010).  
Mtr4 (also known as Dob1) is an ATP-dependant RNA helicase which belongs 
to the DExH/D superfamily of RNA helicases which also includes the cytoplasmic 
exosome cofactor, Ski2 and Brr2, an essential splicing factor. In vitro Mtr4 is able to 
unwind RNA duplexes with 3’ to 5’ polarity (Wang et al, 2008). The interaction of Mtr4 
with the TRAMP complex proteins, Trf4-Air2, is mediated by the central DExH/D core 
(Weir et al, 2010).  
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 In addition to recruitment of the exosome to substrates targeted for degradation 
by the addition of polyadenylated tails, the TRAMP complex acts as an exosome 
cofactor by directly stimulating its exonuclease activity. In yeast, TRAMP has been 
shown to stimulate specifically the activity of Rrp6 in vitro but it does not increase the 
activity of the core exosome containing Rrp44 (Callahan & Butler, 2010). However, an 
alternative report shows that degradation of tRNAi
Met by Rrp44 without the core 
exosome is enhanced in the presence of the TRAMP complex in vitro (Schneider et al, 
2007). This stimulation does not require ATP implying that the polyadenylation 
activities of Trf4/5 do not participate in this (Callahan & Butler, 2010). 
 It is thought that the TRAMP complex is conserved in higher eukaryotes. The 
human homologue of the helicase, Mtr4, has been characterised as a nuclear protein 
that is strongly concentrated in nucleoli. Putative homologues of the Trf4/5 and Air1/2 
proteins have so far been identified. ZCCHC7 is a strictly nucleolar protein that 
contains zinc knuckles and an IWRxY motif found in yeast Air proteins and, as such, is 
proposed as a human homologue (Fasken et al, 2011; Lubas et al, 2011). Based on 
sequence homology, a human counterpart of yTrf4 is proposed, hTRF4-2/PAPD5. 
ZCCHC7 and hTRF4-2 interact directly and have been shown to be precipitated by 
both MTR4 and RRP6 showing that they are associated with the exosome (Fasken et 
al, 2011; Lubas et al, 2011). RNAi depletion of either ZCCHC7 or hTRF4-2 leads to a 
decrease in the accumulation of polyadenylated 5’ETS pre-rRNA fragments normally 
turned over by the nuclear exosome confirming that these proteins are functional 
cofactors of the human exosome (Lubas et al, 2011). Analogous to the different 
TRAMP complexes found in the nucleus and nucleolus of yeast, another protein 
complex has been identified in the nucleus of human cells called the nuclear exosome 
targeting (NEXT) complex. In addition to MTR4, this complex also contains ZCCHC8 
and RBM7 and is involved in the degradation of PROMPTs but does not appear to 
participate in 3’ processing of 5.8S rRNA (Lubas et al, 2011). 
 
1.10.3.4.4 MTR4 and the exosome 
 Mtr4 has distinct functions not only as part of the TRAMP complex but also as a 
cofactor of the nuclear exosome. The TRAMP complex stimulates the exonuclease 
activity of Rrp6 in vitro and recruits the exosome to its substrates but the helicase 
activity of Mtr4 is also proposed to unwind RNA secondary structures and displace 
RNA-associated proteins ahead of exonucleolytic processing by the exosome. Crystal 
structure models of S. cerevisiae Mtr4 show a helicase domain which is highly similar 
to that of other DExH/D helicases, such as Prp43. Interestingly, the most conserved 
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feature of Mtr4 (and the related exosome cofactor, Ski2) forms an interface below the 
helicase core, at the putative RNA exit site which appears to mediate the interaction 
with the exosome (Jackson et al, 2010; Weir et al, 2010). A model is proposed in which 
the ATPase activity of Mtr4 drives RNA substrates through the helicase domain, 
analogous to the mechanism used by the proteosome, and as these RNAs exit they 
are directly channelled towards Rrp6 and the core exosome for processing (Jackson et 
al, 2010). The crystal structure also revealed a novel arch domain that is not found in 
canonical helicases. This arch structure is essential for the function of Mtr4 in the 3’ 
end processing of 5.8S and disruption of this arch causes accumulation of 3’ extended 
RNA fragments similar to those seen following deletion of Rrp6. In addition to its 
functions in RNA surveillance as part of the TRAMP complex, MTR4 has been shown 
to be an independent exosome cofactor in the processing of the 3’ end of 5.8S rRNA in 
yeast, plants and human cells (de la Cruz et al, 1998; Lange et al, 2011; Schilders et 
al, 2007).  
 
1.10.3.4.5 Nrd1/Nab3 complex 
 In yeast, the Nrd1/Nab3 complex coordinates the termination of RNA 
polymerase II transcription of snRNAs and snoRNAs with initiation of precursor 
processing by the exosome and TRAMP complexes. This complex consists of the RNA 
binding proteins, Nrd1 and Nab3 and the helicase, Sen1. First, this complex recognises 
specific RNA sequences and triggers transcription termination. The exosome is then 
recruited to the nascent 3’ ends of the RNAs enabling processing to form mature 
snRNA and snoRNAs. The exosome is also recruited to the newly formed 3’ end of 
other RNA polymerase II transcripts such as CUTs by the Nrd1-Nab3 complex, but in 
these cases the exosome completely degrades the substrate rather than performing 
limited precursor processing (Arigo et al, 2006; Thiebaut et al, 2006). The proteins of 
the Nrd1-Nab3 complex have homologues in higher eukaryotes although it is not clear 
whether the function of this complex is conserved. Alternative transcription termination 
mechanisms for snRNA genes have been identified (Baillat et al, 2005) and the 
majority of human snoRNAs are not produced by transcription as they are in yeast but 
are instead released from spliced introns (Kiss et al, 2006) possibly negating a role for 
this complex in higher eukaryotes.  
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1.10.3.4.6 Other exosome cofactors 
 The Ski2 helicase is an essential cofactor of the cytoplasmic exosome. This 
helicase, which is related to Mtr4 is part of the SKI complex which also contains Ski3, 
Ski8 and Ski7 which is homologous to the GTP-binding translation elongation factor 
eF1A. Ski7 interacts with both the SKI complex and the exosome and as part of the 
NGD pathway is thought to bind to stalled ribosomes at their A site, thereby recruiting 
the exosome to initiate degradation of the aberrant mRNAs which have caused the 
ribosome to arrest. The NMD and NSD pathways which degrade mRNAs that contain 
either premature or no stop codons, respectively, involve 5’-3’ exonucleolytic 
processing by Xrn1, but also the 3’-5’ exosome is recruited to these transcripts by the 
SKI complex and significantly contributes to their turnover. Homologues of Ski proteins 
are found only in yeasts but a SKI-like complex has also been identified in human cells. 
It is suggested that the human SKI complex may have additional functions as it is found 
in the nucleus as well as the cytoplasm and more particularly at the site of actively 
transcribed genes (Zhu et al, 2005). 
Another multiprotein complex which has been identified as a cofactor of the 
yeast nuclear exosome is the Ccr4-Not complex. This complex was initially 
characterised for its roles in mRNA degradation in the cytoplasm and for regulation of 
transcription by RNA polymerase II in the nucleus. Mutations in certain subunits of this 
complex cause the accumulation of polyadenylated snRNA and snoRNAs similar to 
that observed in mutants of the nuclear exosome. Synthetic growth defects occur when 
mutations in Ccr4-Not subunits are combined with deletion of exosome factors 
suggesting that these complexes are functionally linked (Azzouz et al, 2009). The Ccr4-
Not complex physically interacts with several subunits of the exosome and with the 
TRAMP helicase, Mtr4. It is suggested the Ccr4-Not complex protein Caf4 is necessary 
for the association of Mtr4 with Rrp6 (Azzouz et al, 2009). It is not clear whether this 
complex simply provides a scaffold through which the exosome and TRAMP 
complexes interact or whether the deadenylation and transcriptional regulation 
functions of the Ccr4-Not complex are also linked to exosome function. It is interesting 
to note that a nuclease involved in 3’ processing of 5.8S rRNA, Ngl2, is closely related 
to the deadenylase, Ccr4, and both contain a magnesium-dependant endonuclease 
motif (Faber et al, 2002).  
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1.11 Aims and Objectives 
 The exosome was first discovered in the yeast, S. cerevisiae, and has been 
extensively characterised in this organism. The catalytic activities of Rrp44 and Rrp6 
and the specific roles of a number of cofactors which regulate the activity of the 
exosome have been investigated. Many different RNA substrates of the yeast exosome 
have been identified and models of RNA processing by the exosome outlined. 
However, it has become clear that there are key differences between the yeast and 
human exosomes. Three ribonucleases, DIS3, DIS3L and RRP6, are associated with 
distinct exosome complexes in particular compartments of human cells whereas the 
yeast DIS3 counterpart, Rrp44, which is constitutively associated with all exosome 
complexes throughout the cell. This suggests that different subunits and cofactors may 
be involved in processing particular exosome substrates in human cells and possibly 
implies that RRP6 may play a more prominent role in human cells. Some of the 
functions of the exosome identified in yeast have been shown to be conserved in 
human cells including the role of the exosome and its cofactors in processing the 3’ 
end of 5.8S rRNA. In yeast, other functions of the exosome in pre-rRNA processing, 
including the degradation of excised spacer fragments have been identified. In higher 
eukaryotes, removal of the 5’ETS involves an additional processing step, A’ cleavage, 
and in mouse cells, exonucleases have been shown to recycle the cleaved fragments 
and also participate in A’ cleavage. It is not known whether this is also the case in 
human cells.  
In yeast, one of the functions of the exosome is the processing of precursor 
snoRNAs into their mature form and this involves two cofactors of the nuclear 
exosome, Rrp47 and the TRAMP complex. As described in section 1.3.3, the human 
exosome has been shown to be stably associated with two snoRNP complexes, pre-U3 
and pre-U8. Since this is the only example of the human exosome directly interacting 
with a likely substrate, pre-snoRNA processing and snoRNP biogenesis provide a good 
model by which exosome function in human cells can be studied. 
It is likely that the human exosome has additional functions in higher eukaryotes 
due to the increased complexity of RNA processing. It is suggested that exonucleases 
may be responsible for a key step in pre-rRNA processing of ITS1. Compared to yeast, 
processing to form the 3’ end of 18S in human cells includes an additional step not 
found in yeast but currently two different models are proposed for how this is achieved. 
The first directly involves exonucleolytic processing following cleavage to separate the 
large and small subunit rRNAs (Carron et al, 2011) and if this is the case then the 
exosome is a likely candidate to be involved. The alternative pathway involves serial 
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endonucleolytic cleavages in ITS1 and, in mouse cells, it is suggested that the 
exonuclease, XRN2, may regulate this pathway (Wang & Pestov, 2011). 
The objectives of this study were to characterise the human nuclear exosome 
and to investigate whether some of the roles of the yeast exosome are conserved in 
human cells. A major aim was to identify novel roles for the human exosome in RNA 
processing with particular focus on a potential function in ITS1 pre-rRNA processing. 
This study therefore aimed to; 
 Characterise the structure and activity of the human nuclear exosome and 
cofactors 
 Evaluate the roles of the exosome in pre-snoRNA processing and investigate 
how this is coordinated with snoRNP biogenesis  
 Determine if exonucleases are required for turnover of byproducts of pre-rRNA 
processing in human cells 
 Clarify the pre-rRNA processing pathways used to remove ITS1 in human cells 
and investigate the potential roles of exonucleases in mediating this step.  
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Chapter Two 
Materials and Methods 
2.1 PCR and cloning 
2.1.1. PCR 
Polymerase chain reactions (PCRs) were used to amplify target sequences 
from cDNA or plasmid templates using different polymerases depending on the length 
of the region to be amplified. For genes ≤ 1kb, reactions were carried out using HotStar 
Taq polymerase (Qiagen) and for templates > 1kb Phusion Polymerase (Finnzymes) 
was used. Reactions were set up as detailed in Table 2.1A and thermal cycling carried 
out according to programmes as shown in Table 2.1B. 
 
 
2.1.2 Agarose gel electrophoresis 
6 x DNA Loading Buffer (0.4 % orange G, 0.03 % bromophenol blue, 0.03 % 
xylene cyanol FF, 15 % Ficoll400, 10 mM Tris-HCl pH 7.5, 50 mM EDTA pH 8.0) was 
added to DNA samples to a final 1 x concentration. Samples were analysed on a 1 % 
(> 500 bp) or 2 % (≤ 500 bp) agarose-TBE gel containing 1 x SYBERSafe (Invitrogen) 
which was run in 1 x TBE (90 mM Tris-HCl, 90 mM boric acid, 2 mM EDTA pH 8.0) at 
Table 2.1 PCR reaction mixtures and cycling conditions 
A  
 
 
 
 
 
 
B 
 
HotStar Taq Phusion 
Component 
Final 
Concentration Component 
Final 
Concentration 
10x Qiagen PCR Buffer 1 x 5 x HF Buffer 1 x 
dNTP (10mM of each) 200 µM dNTP (10 mM of each) 200 µM 
Forward primer 1 µM Forward primer 0.5 µM 
Reverse Primer 1 µM Reverse Primer 0.5 µM 
Hot Start Taq 2.5 U Phusion Polymerase 0.02 U 
Template DNA ≈100 ng Template DNA 10 ng 
Water to 100 µl Water To 50 µl 
 Hot Star Taq  Phusion  
 Temp 
(
o
C) 
Duration 
(min) 
Cycles Temp 
(
o
C) 
Duration 
(s) 
Cycles 
Initial activation 95 15 x 1 98 30 x 1 
Denaturation 94 1  
x 35  
98 10  
x 35 Annealing Tm-5
o
C 1 Tm+3
o
C 30 
Extension 72 1 min/kb 72 30 sec/kb 
Final Extension 72 10 x 1 72 300 x 1 
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120 V for 30-60 min. DNA in the gel was visualised using a Syngene ultraviolet 
transilluminator. 
 
2.1.3 DNA extraction from agarose gels and purification 
DNA bands were excised from agarose gels and purified using a Spin Column 
Gel Extraction Kit (NBS Biologicals) according to the manufacturer’s instructions. 
 
2.1.4 Restriction digest 
Digests of 0.5-2 µg DNA were carried out using 10 U of restriction enzyme(s) 
(Promega), 1 x Enzyme Buffer (as recommended by manufacturer) in a final volume of 
20 µl at 37 oC for 2-4 h.  
 
2.1.5 Ligation reactions  
PCR products and vectors were digested with restriction enzymes as required 
and reactions set up to contain insert and vector in a 5:1 molar ratio respectively, 0.3 U 
T4 DNA Ligase (Promega) and 1 x T4 DNA Ligase Buffer (Promega) in a total volume 
of 10 µl. Reactions were incubated at 10 oC for 16-24 h. 
When cloning using the pGEM-T Easy cloning system (Promega), ligation 
reactions were set up using 1 x Rapid Ligation Buffer, 50 ng pGEM-T Easy Vector, 5-
10 ng PCR product (with A overhangs) and 0.3 U T4 DNA Ligase in a total volume of 
10 µl. Reactions were incubated at room temperature for at least 1 h.  
 
2.1.6 Transformation of chemically competent E. coli 
Chemically competent TOP10 Escherichia coli (E. coli) were used during 
cloning ligation reactions and amplification of existing constructs. 50 µl of cells were 
thawed on ice and ligation reactions (section 2.1.5) or 5 ng plasmid DNA was added 
before incubation on ice for 30 min. Cells were heat shocked at 42 oC for 60 seconds 
and placed back on ice before addition of 500 µl Luria Broth (LB) and shaking at 37 oC 
for 1 h. Successful transformants were grown on selective plates containing relevant 
antibiotics overnight at 37 oC. Single colonies were used to inoculate 2.5 ml LB cultures 
which were grown overnight at 37 oC with agitation. DNA was extracted from the cells 
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in these cultures using the Spin Column Plasmid Miniprep Kit (NBS Biologicals) 
following the manufacturer’s instructions. 
 
2.1.7 DNA Sequencing 
Sequencing of PCR products or plasmids was carried out by GATC Biotech. 
Sequencing primers annealing to vector sequences upstream and downstream of the 
cloned gene were generally used and in the case of RRP6 primers annealing to 
internal gene sequences were used to enable complete sequencing coverage of the 
open reading frame (Table 2.2). 
 
2.1.8 Site directed mutagenesis 
Mutagenesis of single or multiple bases within various constructs was carried 
out using the QuikChange Site Directed Mutagenesis Kit (Stratagene). Clean DNA 
preparations of the plasmid with the target mutagenesis site and primers encoding the 
required modifications were used in PCR reactions. Individual PCR reactions were set 
up containing 50 ng, 20 ng and 5 ng of template DNA with 125 ng of forward and 
reverse primers, 0.4 mM dNTPs, 1 x Pfu Reaction Buffer and 1.25 U PfuUltra in a total 
volume of 50 µl. Reactions were heated to 95 oC for 30 s and then thermocycled 
through 95 oC for 30 s, 55 oC for 60 s and 68 oC for 1 min per kilobase of plasmid for 18 
cycles. Reactions were cooled on ice and incubated at 37 oC for 2 h with 10 U DpnI to 
degrade the methylated DNA template. PCR reactions were then pooled and ethanol 
precipitated by addition of NaCl to a concentration of 250 mM and three reaction 
volumes of ethanol. Reaction samples were stored at -20 oC for 2-16 h before 
centrifugation at 13,000 rpm in a benchtop centrifuge to pellet the DNA. The pellet was 
washed in 70 % ethanol to remove contaminating salt and dried. DNA was 
resuspended in 5 µl water and transformed into 40 µl XL1-Blue Super Competent Cells 
(Stratagene) which are able to repair the nicked circular DNA generated by the earlier 
PCR. DNA was extracted from colonies produced and sequenced to confirm the 
presence of the desired mutation. 
 
Table 2.2 RRP6 sequencing primers 
Primer Direction Sequence 
RRP6 seq1 Forward GTACACCGCTTGTTAATGGCAGCC 
RRP6 seq2 Forward CTTGAACTCTATAGGAAGCAGAAG 
RRP6 seq3 Forward CCTCACTGGGACACCGTGCTCCCG 
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2.1.9 Exonuclease constructs 
Plasmids for the expression of the nine core human exosome proteins, RRP4, 
RRP40, CSL4, RRP42, MTR3, RRP43, RRP46, RRP41 and RRP45, as N-terminal-
His-tagged recombinant proteins in bacteria were kindly provided by Dr Christopher 
Lima (Liu et al, 2006). These constructs are based on the pRSFDuet vector (Novagen). 
Clones of human C1D (yeast Rrp47) and MPP6 in the pGEX4T3 vector for expression 
of human GST-C1D and GST-MPP6 proteins were kindly provided by Dr Ger Prujin 
(Schilders et al, 2005; Schilders et al, 2007). RRP6 was amplified from a plasmid 
template and cloned into the pGEX6P3 vector using the primers and restriction sites in 
Table 2.3 to enable expression of human RRP6 with an N-terminal GST-tag. A clone 
for the expression of yeast RRP6 with an N-terminal GST- tag using the vectors 
pGEX2T, was kindly provided by Dr Phil Mitchell (Stead et al, 2007).  
 Recombinant human RRP6 was used in exonuclease assays and it was 
therefore necessary to generate mutant proteins in which the exonuclease activity was 
inhibited, to demonstrate that any RNA degradation observed in such assays is being 
carried out by the exonuclease. In yeast, a mutation targeting a conserved aspartic 
acid residue of the DEDD motif of RNase D nucleases, D303A has been shown to 
abolish the exonuclease activity of RRP6 (Burkard & Butler, 2000). RRP6 is highly 
conserved and the corresponding amino acid in the human sequence is aspartic acid 
313. The coding sequence in the RRP6-pGEX6P3 clone was modified by site directed 
mutagenesis to convert this amino acid to alanine using the primers shown in Table 
2.3, to enable expression of inactive hRRP6.  
To generate constructs for inducible, stable RNAi resistant expression of FLAG-
tagged RRP6 from HEK293 cells, the gene coding for RRP6 was cloned into the 
pcDNA5-FLAG vector. This vector encodes a His-tag, a PreScission Protease site and 
a FLAG-tag upstream of the genes of interest in frame with a tetracycline inducible 
promoter. PCR reactions were carried out using the primers shown in Table 2.3 and 
the RRP6-pGEX6P3 plasmid as a template. The restriction sites detailed in Table 2.3 
were used for cloning of the genes into the pcDNA5 vector. From these basic 
constructs, mutations were introduced that enable RNAi resistant expression of either 
wild-type or inactive RRP6.  Depletion of RRP6 by RNAi is achieved by treatment with 
three siRNAs which all target the open reading frame (ORF) of RRP6. Site directed 
mutagenesis was carried out to introduce five sequence modifications within the target 
site of each of these three siRNAs while not affecting the amino acid sequence of the 
expressed protein. This mutagenesis was carried out serially in three rounds using the 
RRP6-pcDNA5 plasmid as a template and the primers shown in Table 2.3. At each 
stage presence of the mutations and fidelity of the remaining sequence was confirmed 
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by sequencing. Once this construct had been generated a further mutagenesis step 
was carried out to introduce the RRP6 D313A mutation that abolishes the exonuclease 
activity of RRP6 into the RNAi resistant plasmid.  
 
 
 
 
 
 
 
 
 
 
 
 
2.1.9 SSU biogenesis factor constructs 
Constructs containing the gene sequences for human DIM1, NOB1 and PNO1 
in the pcDNA5 vector were kindly provided by Dr Andrew Knox (Watkins lab) and these 
were used as templates for PCR amplification of each of these genes using the primer 
shown in Table 2.4. cDNA clones containing the full length human RIO2 and ENP1 
sequences in the pCMV-SPORT6 vector were purchased from imaGENES 
(IRATp970E122D and IRATp970B1277D, respectively). These were used as PCR 
templates with the primers detailed in Table 2.4. The PCR products generated were cut 
using the restriction enzymes shown and cloned into the pGEX6P1 vector to generate 
constructs from which these genes can be expressed as N-terminal, GST-tagged 
recombinant proteins in E. coli. 
  RIO2 has been shown to be a protein kinase in both yeast and humans. Two 
combined amino acid changes in RIO2 have been identified in the kinase active site 
that decrease this kinase activity (Zemp et al, 2009). Site directed mutagenesis of the 
RIO2-pGEX6P1 plasmid using the primers given in Table 2.4 in two sequential rounds 
Table 2.3 Primers used for generating RRP6 expression constructs 
 
Construct 
Primer 
direction 
Restriction 
site 
Primer Sequence 
GST-RRP6-
pGEX6P3 
Forward BamHI 
GCGCGGATCCATGGCGCCACCCAGTACCCGG
GAG 
Reverse SalI 
GCGCGTCGACTCATCTCTGTGGCCAGTTGTAC
CTGAA 
RRP6D313A 
(exo) 
Forward 
Mutagenesis 
GAATTGTCAGGAATTTGCAGTTAACTTGGAGCA
CCACTCTTACAGG 
Reverse 
CCTGTAAGAGTGGTGCTCCAAGTTAACTGCAAA
TTCTGACAATTC 
RRP6-
pcDNA5 
Forward 
BglII/BamHI 
NotI 
CGCGAGATCTATGGCGCCACCCAGTACCCGGG 
Reverse 
CGCGGCGGCCGCTCTCTGTGGCCAGTTCTACC
TGAAGCCC 
RRP6 
RNAi_1 
Forward 
Mutagenesis 
GCTGTCAAGAAGAAAGCGGCGGAACAGGCTGC
CCGGGAACAGGCAAAGGAGG 
Reverse 
CGGGCAGCCTGTTCCGCCGCTTTCTTCTTGACA
GCTTCTTTAGAGTCTTTTTG 
RRP6 
RNAi_2 
Forward 
Mutagenesis 
GTGCATGAGTCGAGTGATGCAAATCATGGGTG
TCGCAGCAACATTAAGG 
Reverse 
CCATGATATTGCATCACTCGACTCATGCACTGA
AGCAACCTGTCTCCCTG 
RRP6 
RNAi_3 
Forward 
Mutagenesis 
GCAGGGAAGACGAGAGCTATGGCTATGTACTG
CCAAACCACATGATGCTG 
Reverse 
GCAGTACATAGCCATAGCTCTCGTCTTCCCTGC
GAGCTGTTTTATCCCTCCAGG 
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was used to generate a construct for expression of GST-tagged RIO2 K123AD246A 
(RIO2kd). 
Further, to produce a construct for the inducible expression of FLAG-tagged 
RIO2 protein in HEK293 cells, the RIO2 gene was sub-cloned from RIO2-pGEX6P1 
into the pcDNA5 vector by restriction digest using BamHI and XhoI and re-ligation with 
the new vector. 
 
 
 
 
 
 
 
 
 
 
 
2.1.10 snoRNP protein and biogenesis factors constructs 
 Constructs enabling expression of various GST- and His-tagged snoRNP 
proteins were kindly provided by Dr Kenneth McKeegan (Watkins lab) (McKeegan et al, 
2007). GST-tagged fibrillarin, NOP58, 15.5K, TIP48, TIP49, NUFIP, BCD1 (residues 1-
360) and NOP17 were expressed using clones of these genes in the pGEX6P1 vector. 
Further, plasmids for the expression of His-tagged proteins; fibrillarinΔRGG (residues 
82-321) expressed from pET200a vector and 15.5K, TIP48 and TIP49 expressed from 
pETDuet were provided. Expression of N-terminally thioredoxin-tagged, C-terminally 
His-tagged NOP56 (residues 1-458) and NOP58 (1-435) was carried out using 
constructs in the pBAD/Thio-TOPO vector. It is not possible to express full length 
NOP56 and NOP58 but proteins lacking these C-terminal regions have been shown to 
function normally with respect to snoRNP formation in S. cerevisiae (Gautier et al, 
1997; Lafontaine & Tollervey, 2000). 
Table 2.4 Primers used in cloning SSU biogenesis factor genes for protein expression 
Gene 
Primer 
direction 
Restriction 
site 
Primer Sequence 
DIM1 
Forward BamHI CACCGGATCCATGCCGAAGGTCAAGTCGGGGGC 
Reverse XhoI CGCGCTCGAGCTAGGAAAAATGAATACCTTCTGC 
NOB1 
Forward BamHI 
CAC CGG ATC 
CATGGCTCCAGTGGAGCACGTTGTGG 
Reverse XhoI 
CGCGCTCGAGTCACCTTTTCTTTCACAAACTTCTTTC
TGGAAGC 
PNO1 
Forward BamHI CACCGGATCCATGGAATCCGAAATGGAAACG 
Reverse XhoI 
CGCGCTCGAGTCAGAATCGATCTGCTGATCTGCTA
GC 
RIO2 
Forward BamHI CGCGGGATCCATGGGAAAGTGAATGTGGCC 
Reverse XhoI CGCGCTCGAGTCATTCTCCCCAAAAGCTGGCTGC 
ENP1 
Forward BglII GCGCAGATCTATGCCCAAATTCAAGGCGGCCCCG 
Reverse SalI GCGCGTCGACCTCCACGGTGATGGGAACATCTTCC 
RIO2 
K123A 
Forward 
Mutagenesis 
GAAGGACAACAATTTGCATTAAAGCTTCACAGACTA
GGAAGAACC 
Reverse 
GGTTCTTCCTAGTCTGTGAAGCTTTAATGCAAATTGT
TGTCCTTC 
RIO2 
D246A 
Forward 
Mutagenesis 
GTGACCATATCACCATGATTGATTTTCCACAGATGG
TTTCAAC 
Reverse 
GTTGAAACCATCTGTGGAAAATCAATCATGGTGATA
TGGTCAC 
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2.2 Protein over-expression and purification 
2.2.1 GST-tagged proteins 
Plasmids for the expression of GST-tagged proteins were transformed into 
BL21 Codon Plus E. coli cells which were then grown on selective LB agar plates 
containing the appropriate antibiotics (100 µg/ml ampicillin, 12.5 µg/ml chloramphenicol 
or 25 µg/ml kanamycin). Overnight cultures were then set up by inoculating a single 
colony into LB Broth (10 ml/L of expression culture) and grown, shaking at 37 oC for 
16 h. These cultures were then used to inoculate 1 L (or multiple 1 L cultures) of 2 x YT 
broth containing the appropriate antibiotic which were then grown at 37 oC, shaking 
until an O.D.600 ≈ 0.3-0.4 was reached. Cultures were then cooled to 18 
oC, induced by 
adding isopropyl-beta-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM 
and grown for a further 16 h. To check for protein over-expression 1 ml samples were 
taken pre- and post-induction and analysed using SDS-PAGE. Cells were harvested by 
centrifugation at 4000 rpm at 4 oC in a Beckman J6-HC centrifuge for 30 min. The 
supernatants were discarded and the pellets resuspended in either 20 ml Exosome 
Buffer (50 mM Tris-HCl pH 8.0, 10 % glycerol, 300 mM NaCl, 5 mM MgCl2, 0.1 % 
Tween20) or 20 ml Purification Buffer (20 mM Tris-HCl pH 8.0, 10 % glycerol, 300 mM 
KCl, 5 mM MgCl2, 0.1 % Tween20). Exonuclease proteins and cofactors were purified 
in Exosome Buffer and SSU biogenesis factors and snoRNP associated proteins were 
purified in Purification Buffer. A Complete EDTA Protease Inhibitor Cocktail Tablet 
(Roche) and Tris(hydroxypropyl)phosphine (THP) to a final concentration of 0.5 mM 
was added. Samples were sonicated on ice for 3 min, 0.5 cycle time, 90 % power to 
lyse the cells. Cell debris was then pelleted by centrifugation at 18,500 rpm at 4 oC for 
45 min in a JA20 rotor and the clarified lysate used for protein purification. 1 ml 
Glutathione Sepharose Fast Flow beads suspended in 50 % ethanol were washed by 
precipitating by centrifugation at 3000 rpm and resuspension in 1 ml Exosome 
Buffer/Purification Buffer three times. The sepharose beads was then added to the 
clarified E.coli lysate and rotated slowly on a wheel at 4 oC for 2 h. The beads with 
bound protein were then sedimented by centrifugation at 4000 rpm for 3 min in a Fisher 
accuSpin R1 centrifuge and resuspended in 50 ml Exosome Buffer/Purification Buffer. 
This wash step was repeated and then the beads resuspended in 2ml of 
Exosome/Purification Buffer + 50 mM Glutathione pH8.0. The sample was rotated 
slowly at 4 oC for a further 1 h before pelletting the beads as previously and collecting 
the supernatant as the purified protein sample. Protein purification was confirmed by 
analysis of the sample by SDS-PAGE. 
 
59 
 
2.2.2 Purification of His-tagged proteins  
Proteins were expressed from the plasmids described above in BL21 Codon 
Plus cells as for GST-tagged proteins and cells harvested, sonicated and a clarified 
lysate derived as described above. Tagged proteins were purified by immobilised metal 
(Ni2+) affinity chromatography using 1 ml HiTrap Ni Sepharose columns (GE 
Healthcare) and the ÄKTA purification system (GE Healthcare). The 1ml HiTrap Ni 
Sepharose column was equilibrated with approximately 10ml Exosome/Purification 
Buffer using a peristaltic pump. The cleared lysate was loaded onto this column using 
the peristaltic pump. The column was then attached to the ÄKTA and washed with 
10 ml 50 mM immidazole in Exosome/Purification Buffer, 5 ml 75 mM immidazole in 
Exosome/Purification Buffer, and then eluted using a gradient of 50-500 mM 
immidazole over 10 ml followed by 5 ml of 500 mM immidazole in Exosome/Purification 
Buffer. 1 ml fractions of both the wash step and elution stage were collected, snap 
frozen in liquid nitrogen and stored at -80 oC. The absorbance of fractions at 280 nm 
was followed on the ÄKTA with peaks indicating elution of proteins which was 
confirmed by SDS-PAGE. 
 
2.2.3 Thioredoxin-/ His- tagged proteins 
Recombinant NOP56 and NOP58 were expressed from the pBAD/Thio 
constructs in BL21 Codon Plus cells grown at 37 oC and cooled to 18 oC at an O.D.600 ≈ 
0.3-0.4 and expression induced by addition of 0.02 % arabinose for 16 h. Cells were 
harvested, sonicated and the proteins purified using HiTrap Ni Sepharose columns as 
described for His-tagged proteins.  
 
2.2.4 Desalting 
To remove the immidazole or glutathione used to elute proteins during their 
purification which would interfere with in vitro protein function, protein fractions were 
desalted using HiTrap Desalting columns (GE Healthcare). A desalting column was 
equilibrated with 25 ml of the appropriate protein purification or assay buffer and 
samples were applied to the column using the ÄKTA via an injecting loop. Samples 
were eluted in 500 µl fractions from the column over 10 ml with proteins and salt being 
eluted in different fractions. Protein elution was followed using an A280 trace and 
fractions corresponding to peaks were checked for the presence of protein using SDS-
PAGE. Protein samples were aliquoted, snap frozen and stored at -80 oC.  
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2.2.5 PreScission protease cleavage 
Proteins expressed from pGEX vectors are produced as GST fusions but 
contain a PreScission Protease site between the protein of interest and the GST-tag. 
PreScission Protease was expressed and purified via its own GST-tag as described 
above. Desalted protein was produced at a concentration of 1.8 mg/ml and 0.5 µl of 
this was used to cleave GST-tags off 100 µg protein at 4 oC for 1 h. PreScission 
Protease and cleaved GST-tags were then removed from the protein sample using 
50 µl of Glutathione Sepharose Fast Flow beads. 
 
2.3 Protein analysis methods 
2.3.1 SDS-PAGE and Western Blot transfer 
Protein samples were prepared by adding the necessary amount of Protein 
Loading Buffer (final concentrations; 74 mM Tris-HCl pH6.8, 1.25 mM EDTA, 20 % 
glycerol, 2.5 % SDS, 0.125 % bromophenol blue, 50 mM DTT). Protein samples were 
boiled at 95 oC for 2 min and vortexed prior to gel loading. Denaturing SDS 
polyacrylamide gels (SDS-PAGE) consisting of a 10 % or 13 % acrylamide resolving 
gel and a 4 % acrylamide stacking gel were used for large (≥ 70kDa) and small 
(<70kDa) proteins respectively. Electrophoresis was carried out on these gels at 200 V 
in 1 x Protein Running Buffer (25 mM Tris-HCl pH8.3, 250 mM glycine, 0.1 % SDS 
(w/v)). Proteins were visualised by incubation with Coomassie Blue Stain (0.1 % 
Coomassie Blue (w/v), 40 % methanol (v/v) and 10 % acetic acid (v/v)) for 1-16 h with 
gentle agitation. Gels were then de-stained by serial washes in 40 % methanol (v/v) 
with 10 % acetic acid (v/v) for as long as necessary. 
 
2.3.2 Determination of protein concentration 
The concentration of a protein sample was determined using a Nanodrop 
(Thermo Scientific). 1 µl of the protein sample was applied to the machine and the 
absorbance at 280 nm is used to determine the concentration.  
 
2.3.3 Western blotting 
Western blot analysis was used to detect specific proteins or protein tags in 
samples that had been separated by SDS-PAGE. Proteins were transferred from the 
polyacrylamide gel onto a nitrocellulose membrane (Protran, GE Healthcare) in  
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Transfer Buffer (25 mM Tris-HCl pH 8.3, 150 mM glycine, 10 % methanol) using a 
BioRad Western blotting transfer tank for 2 h at 60 V. Membranes were stained with 
Ponseau S Solution (Sigma) to verify the presence of proteins on the membrane. 
Membranes were then incubated in Blocking Buffer (PBS, 0.05 % Triton X-100 (v/v), 
2 % Marvel skimmed milk power (w/v)) for 1 h at room temperature or overnight 4 oC to 
minimise non-specific binding of antibodies to the membrane. Primary antibodies were 
diluted to their optimal concentration in Blocking Buffer. A list of antibodies used in this 
study is given in Table 2.5. Membranes were incubated with the primary antibody for 
1 h at room temperature before washing 3 x 5 min and 1 x 15 min with PBS, 0.05 % 
Triton-X100 (v/v). Secondary antibodies which were conjugated to horseradish 
Table 2.5 Antibodies used in Western Blotting 
Antibody Raised in Source/Reference 
RRP46 Rabbit G Pruijn  
CSL4 Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein – this study 
RRP6 Rabbit G Pruijn 
C1D Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein – this study 
MPP6 Rabbit G Pruijn 
DIS3 Mouse Abnova 
MTR4 Rabbit Eurogentec (N Watkins/J Brown) Raised against peptide 
fragments: GDQKGRKGGTKGPSNV and TDEPIFGKKPRIEES 
XRN2 Rabbit Bethyl A301-103A 
PNO1 Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein 
NOB1 Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein 
RIO2 Goat Santa Cruz E-14 
ENP1 Mouse Santa Cruz C-19 
PRP43-C Rabbit Bethyl A300-390A 
PRP43-N Rabbit R. Luhrmann 
NOP56 Rabbit Bethyl A302-720A 
NOP58 Rabbit Eurogentec (Watkins) 
Fibrillarin Rabbit Sigma Aldrich H140 
UTP24 Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein 
RCL1 Rabbit Eurogentec (Watkins) Raised against full length recombinant 
protein 
BMS1 Rabbit A.Turner (Turner et al., 2009) 
RPS19 Rabbit P. Mason (Idol et al., 2007) 
RRP5 Rabbit A.Turner (Turner et al., 2009) 
mBOP1 Rabbit D. Pestov (Strezoska et al. 2000) 
RBM28 Rabbit Santa Cruz Z-22 (sc-102075) 
POP1 Rabbit G. Pruijn/S. Altman (Mattijssen et al., 2010) 
RRP40 Rabbit G. Pruijn/S. Altman (Mattijssen et al., 2010) 
Viperin Mouse G. Pruijn/P.Cresswell (Mattijssen et al., 2010) 
Poly-HIS Mouse Santa Cruz H-3 
GST Goat Santa Cruz B14 
Thioredoxin Mouse Sigma-Aldrich T0803 
FLAG Mouse Sigma Aldrich F1804 
FLAG Rabbit Sigma Aldrich F7425 
Rabbit IgG-HRP Donkey Santa Cruz sc-25397 
Mouse IgG-HRP Donkey Santa Cruz sc-358914 
Goat IgG-HRP Donkey Santa Cruz sc-2020 
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peroxidise (HRP) were diluted in Blocking Buffer to the appropriate concentration and 
applied to membranes for 1 h at room temperature. Washes were then repeated as 
previously. Proteins were then developed by enhanced chemiluminescence (ECL) 
detection (Pierce) and exposure of hyperfilm (GE Healthcare) according to the 
manufacturer’s instructions. 
 
2.3.4 Creation of custom antibodies 
1mg of purified His-CSL4 and GST-C1D (Figure 2.1A) were sent to Eurogentec 
for production of polyclonal antibodies in rabbits. For each protein, two rabbits were 
immunised and serial bleeds taken (pre-Immume, PPI; small bleed, PP; large bleed, 
GP; final bleed, SAB). The crude serum antibodies were tested in preliminary Western 
blotting experiments on HeLa cell extract and the results of the preferred antibodies for 
each protein are shown in Figure 2.1B.  
 
2.3.4 Proteomics 
Protein reactions to be analysed by proteomics were mixed with NuPAGE LDS 
Sample Buffer (26 mM Tris-HCl pH 8.5, 35 mM Tris Base, 0.5 % LDS (v/v), 2.5 % 
glycerol (v/v), 0.1275 mM EDTA, 0.05 mM SERVA Blue H250, 0.04 mM Phenol Red) 
and separated on 4-12 % NuPAGE Novex® Pre-cast Bis Tris Mini Gels in MOPS 
Running Buffer (2.5 mM MOPS, 2.5 mM Tris Base, 0.005 % SDS (w/v), 0.05 mM EDTA 
pH 7.7). Gels were then stained with fresh Coomassie Blue Stain overnight. After 
destaining in 50 % methanol, 10 % acetic acid, gels were stored in 5 % acetic acid. 
Proteomic analysis was carried out by Dr Henning Urlaub, (Max-Planck Institute for 
Biophysical Chemistry, Gottingen, Germany.  
 
 
Figure 2.1 CSL4 and C1D antibodies A) Recombinant CSL4 and C1D were purified using 
their His- and GST-tags respectively. Proteins were separated by SDS-PAGE and visualised by 
Coomassie staining. 1mg of bovine serum albumin (BSA) indicates the relative concentrations 
of each protein. B) Mouse nuclear extract was separated by SDS-PAGE and transferred for 
Western blotting. Crude serum received from Eurogentec, pre-immune (PPI), small bleed (PP), 
large bleed (GP) and final bleed (SAB) were diluted 1:1000 (CSL4) or 1:250 (C1D) and used in 
Western blotting. The positions of marker proteins are indicated to the left of the panel and 
bands identified as CSL4 and C1D detected are indicated to the right of the panel. 
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2.4 RNA analysis methods 
2.4.1 RNA extraction 
2.4.1.1 Phenol:chloroform extraction 
The RNA was extracted from HeLa cell pellets (1 x 106 cells) by resuspending 
in 500 µl RNA extraction buffer as described above and heating to 95 °C for 2 min. An 
equal volume of phenol:chloroform:isoamylalcohol (25:24:1) was added and samples 
shaken vigorously for 5 min before centrifugation at 13,000 rpm in a benchtop 
microfuge. The upper aqueous layer containing RNA was removed to a clean 
microfuge tube and a second phenol:chloroform extraction performed in the same way. 
To remove traces of phenol in the sample 500 µl chloroform:isoamylalcohol (24:1) was 
added and mixing and centrifugation repeated as previously. To the final supernatant 
NaOAc pH 5.3 was added to a final concentration of 150 mM along with 1 ml ethanol. 
Samples were cooled either at -80 °C for 30 min or overnight at -20 °C prior to 
centrifugation at 13,000 rpm in a microfuge to pellet the RNA. The supernatant was 
removed, the pellet air dried at 37 °C and thoroughly resuspended in an appropriate 
volume of Nanopure water. 
A similar method was employed for RNA extraction during in vitro assays such 
as immunoprecipitations and glycerol gradients. In these cases a single 
phenol:chloroform:isoamylalcohol (25:24:1) step was used and the 
chloroform:isoamylalcohol step was omitted. 1 µg of tRNA was also included into each 
sample during ethanol precipitation to act as a carrier to aid precipitation of the RNA of 
interest.  
 
2.4.1.2 TRI reagent 
RNA was extracted from cell pellets of HEK293 and TC7 cells using TRI 
Reagent (Sigma) which is a guanidine thiocyanate and phenol based solution. Cell 
pellets were resuspended in 500 µl TRI reagent and incubated at room temperature for 
5 min to allow cell lysis. After addition of 100 µl chloroform, samples were vortexed and 
allowed to stand at room temperature for 15 min before centrifugation at 12,000 x g for 
15 min. The top aqueous layer containing RNA was then removed and to this, 250 µl 
isopropanol was added. Samples were mixed and allowed to stand at room 
temperature for 10 min before centrifugation at 12000 x g for 10 min. The supernatant 
was then removed to leave a white pellet. The pellet was washed in 75 % ethanol, air 
dried and resuspended in an appropriate volume of water shaking at 55 oC for 5 min. 
Corresponding protein samples were also obtained from the lower layers; DNA was 
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removed from the interface and pelleted by addition of 150 µl ethanol and 
centrifugation at 8000 x g for 5 min, proteins were then precipitated by addition of 
750 µl isopropanol, incubation at room temperature for 10 min and centrifugation at 
12000 x g for 10 min. The protein pellet was then washed three times in 0.3 M 
guanidine hydrochloride in 95 % ethanol, dried and resuspended as required.  
 
2.4.1.3 Determination of RNA concentration 
The concentration of RNA samples was determined using a Nanodrop (Thermo 
Scientific). The absorbance at 260 nm of 1 µl of the RNA sample was used to 
determine the concentration. The ratio of absorbance at 260 nm relative to 280 nm 
gave an indication of the purity of the sample. 
 
2.4.2 Northern blotting  
2.4.2.1 Acrylamide gel electrophoresis for small RNAs  
RNA samples were mixed with 2 x RNA Loading Dye (80 % formamide, 10 mM 
EDTA pH 8.0, 1 mg/ml xylene cyanol FF, 1 mg/ml bromophenol blue) and denatured at 
95 °C for 2 min. RNA was separated by electrophoresis on an 8-12 % acrylamide/ 7 M 
urea gel in 1 x TBE buffer, at 350 V for 1-2 h depending on the required separation of 
RNA species. RNAs were then transferred onto Hybond N membrane (Amersham 
Biosciences) using a Trans-Blot Cell (BIO-RAD) in 0.5 x TBE buffer at 60 V for 2 h. 
RNA was cross-linked to the membrane using a Stratalinker UV Crosslinker 
(Stratagene). 
 
2.4.2.2 Agarose-glyoxal gel electrophoresis for pre-rRNAs 
Agarose-glyoxal gels were used for the analysis of long pre-rRNA molecules. 3-
6 µg of total RNA was mixed in a 1:5 ratio of RNA:Glyoxal Loading Buffer (61.2 % 
DMSO (v/v), 20.4 % glyoxal (v/v), 12.2 % 1 x BPTE buffer (28.7 mM Bis-Tris, 9.9 mM 
PIPES, 1 mM EDTA) (v/v), 4.8 % glycerol (v/v), and 0.02 mg/ml ethidium bromide) and 
heated to 55 °C for 1 h. The electrophoresis gel system was used and thoroughly 
cleaned with RNAse Zap (Ambion) to remove RNases prior to use. Samples were 
separated by electrophoresis on a 1.2 % agarose / 1 x BPTE (30 mM Bis-Tris free acid 
pH 7.0, 10 mM PIPES free acid, 1 mM EDTA) gel run in 1 x BPTE buffer at 165 V for 
4 h. RNA in the gel could then be detected using UV light. The gel was washed in 
75 mM NaOH for 20 min, twice in Tris-Salt buffer (0.5 mM Tris-HCl pH 6.4, 1.5 M NaCl) 
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for 15 min each and finally in 6 x SSC (1 M NaCl, 0.1 M Na3C6H5O7) for 20 min. RNA 
was then transferred to a Hybond N membrane (Amersham Biosciences) overnight 
using capillary action in 6 x SSC buffer and RNA was cross-linked to the membrane as 
described in section 2.4.2.1.  
 
2.4.3 Radio-labelled probes and Northern Blot hybridisation 
2.4.3.1 Random Prime labelling 
Probes for the detection of sno/snRNAs, pre-rRNA 5’ETS fragments, and SRP 
RNA were produced by random prime labelling using a PCR product amplified from a 
plasmid template containing the full length RNA sequence, details are given in Table 
2.6.  
25-50 ng DNA template was mixed with nanopure water to a volume of 9 µl and 
incubated at 95 oC for 5 min to denature the DNA. 3 µl of random hexamer mix, 
(250 mM Tris pH 7.5, 50 mM MgCl2, 5 mM DTT, 500 μM dATP, 500 μM dGTP, 500 μM 
TTP) was then added along with 2 μl of 32P labelled dCTP and 1 μl of Klenow 
polymerase and the labelling reaction incubated at 37 oC for 30 min. The volume of the 
reaction was made up to 50 µl with water and it was passed through a G-50 spin 
column (GE Healthcare) by centrifugation at 2000 rpm to remove any unincorporated 
nucleotides. Probes were denatured by heating to 95 °C for 5 min and then added 
directly to 10 ml Hybridisation Buffer (25 mM NaPO4  pH 6.5, 6 x SSC, 5 x Denhardts, 
0.5 % SDS (w/v), 50 % deionised formamide, 100 μg/ml denatured salmon sperm 
DNA). 
 
Table 2.6 Random-prime labelled probes 
Probe 
Target 
Vector 
Amplification 
Primers 
Sequence 
U3 U3 pBS+SP6  
U3 Forward TAATACGACTCACTATAGGG 
U3 Reverse ATTAACCCTCACTAAAGGGA 
U1 U1 pUC18 
U1 Forward GGGGAAAGCGCGAACGCAG 
U1 Reverse TACTTACCTGGCAGGGGAG 
ETS1 5.8S pUC19 
ETS1_fwd GCTGACACGCTGTCCTCTGGCGA 
ETS1_rev CGGACAACCCCGCGGAGACGAGA 
ETS2 5.8S pUC19 
ETS2_altup CCGCCTTCGCTTCGCGGGTGCG 
ETS2_dw GGAAGCGGAGGAGGGTCCTCTGCG 
ETS3 5.8S pUC19 
ETS3_fwd TCGTGTCTGTGGCGGTGGGAT 
ETS3_rev TTCGGAAGAGCGGGCCGGGAGAA 
U14 
U14 pGEMT 
easy 
T7 TAATACGACTCACTATAGGG 
SP6 CATTTAGGTGACACTATAG 
7SL (S 
domain 
7SL pUC19 
7SL_fwd CTATGCCGATCGGGTGTCCGC 
7SL_rev CAGCACGGGAGTTTTGACCTGC 
MRP 
MRP pGEMT 
easy 
T7 TAATACGACTCACTATAGGG 
SP6 CATTTAGGTGACACTATAG 
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2.4.3.2 Transcription 
To detect U8, U13 and U15 snoRNAs, probes were made by T7 RNA 
polymerase transcription using a radio-labelled nucleotide and a PCR template 
containing the full length snoRNA sequence (Table 2.7). Transcription reactions were 
carried out by combining 50 ng of PCR product with 1 x Transcription Buffer (40 mM 
Tris-HCl pH 7.9, 6 mM MgCl2, 10 mM NaCl, 10 mM DTT, 2 mM Spermidine), 1 mM 
ATP, 1 mM GTP, 1 mM CTP, 0.1 mM UTP, 0.5 µl RNasin (Ambion), 1 µl T7 RNA 
Polymerase (NEB) and 2 µl α-32P UTP (1.32 µM, 1.48 MBq, PerkinElmer) in a total 
volume of 10 µl. Reactions were incubated at 37 oC for 2 h before addition of 1 µl Turbo 
DNase (Ambion) for a further 30 min at 37 oC to degrade the template DNA. The 
reaction volume was increased to 50 µl and centrifuged serially through two G50 Spin 
Columns (GE Healthcare) to remove any unincorporated nucleotides. Probes were 
denatured and resuspended in Hybridisation Buffer as above. 
 
2.4.3.3 Kinase labelled oligonucleotide probes 
Oligonucleotide probes were designed using the reverse complementary 
sequence of specific regions of pre-rRNAs and are shown in Table 2.8. 
Oligonucleotides, 19-40 bases long, were radiolabelled at the 5’ end by the addition of 
a 32P labelled phosphate group using T4 polynucleotide kinase (PNK). 10 pmol 
oligonucleotide was added to 1 x T4 PNK Buffer (Promega), 10 U T4 PNK (Promega) 
and 5 μl 32P-ATP in a 10 μl reaction which was incubated at 37 oC for 1 h. The reaction 
volume was increased to 50 µl with water and the probe passed through a G-50 spin 
column (GE Healthcare). Oligonucleotide probes were denatured at 95 oC for 2 min 
and added to 10 ml of SES1 (0.5 M sodium phosphate pH 7.2, 7 % SDS (w/v), 1 mM 
EDTA) for hybridisation. 
Table 2.7 Probes made by transcription 
Probe 
Target 
Vector 
Amplification 
Primers 
Sequence 
U8 U8 pBS+SP6 
T7 Forward TAATACGACTCACTATAGGG 
T3 Reverse ATTAACCCTCACTAAAGGGA 
U13 
U13 
pGem9Zf 
T7 Forward CATTTAGGTGACACTATAG 
SP6 Reverse CATTTAGGTGACACTATAG 
U15 
U15a 
pGEMTeasy 
T7 Forward TAATACGACTCACTATAGGG 
SP6 Reverse CATTTAGGTGACACTATAG 
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2.4.3.4 Hybridisation 
Membranes to be treated with random prime or transcription labelled probes 
were pre-hybridised for 1 h at 42 °C in Hybridisation Buffer (25 mM NaPO4 pH 6.5, 6 x 
SSC (0.9 M NaCl, 90 mM Na3C6H5O7 pH 7.0), 5 x Denhardts, 0.5 % SDS (w/v), 50 % 
deionised formamide, 100 μg/ml denatured salmon sperm DNA). Hybridisation was 
performed overnight at 42 °C. The membrane was washed twice for 5 min in 2 x SSC, 
0.5 % SDS (w/v) at room temperature, following by two washes in 2 x SSC, 0.1 % SDS 
(w/v) and then a final wash in 2 x SSC, 0.1 % SDS (w/v) at 50 °C for 30 min.  
Membranes to be probed with oligonucleotide probes were pre-hybridised for 
30 min at 37 °C in SES1 (0.5 M sodium phosphate pH 7.2, 7 % SDS (w/v), 1 mM 
EDTA). Hybridisation was carried out overnight at 37 °C following which membranes 
were washed twice in 1 x SSC, 0.1 % SDS (w/v). 
All membranes were dried and exposed to a phosphorimager screen. Signals 
were then detected using a Typhoon Scanner and analysed using ImageQuant 
software (GE Healthcare). 
 
2.4.5 RNaseH cleavage of pre-rRNA  
 Total RNA was extracted from RNAi treated, metabolically labelled HeLa cells 
(see section 2.6.4). 4 µg RNA was mixed with 0.35 nmol of DNA primer 
Table 2.8 Oligonucleotide probe sequences 
Probe Pre-rRNA  Sequence 
18S 18S GGGCGGTGGCTCGCCTCGCG 
5520 (5’ITS1) ITS1 CCTCGCCCTCCGGGCTCCGTTAATGATC 
5633 ITS1 GAACGAACGGGCACGC 
5687 ITS1 TCTCCCTCCCGAGTTCTCGGCTCT 
5958 ITS1 AATCCGGCCGGCCCCGAAGA 
6112 ITS1 CGCGCTAGGTACCTGGACGGC 
6121 (ITS1) ITS1 AGGGGTCTTTAAACCTCCGCGCCGGAACGCGCTAGGTAC 
6248 ITS1 GAGTCCGCGGTGGAG 
6318 ITS1 GCGACGGCCGCCGGGTAAAG 
6396 ITS1 GACACCACCCCACAGG 
6448 ITS1 GGTCGGAAGGTTTCACACCAC 
6508 ITS1 GGTTGCCTCAGGCCG 
6603 ITS1 AGGTCGATTTGGCGAG 
6773 ITS2 ATTGATCGGCAAGCGAC 
3’ITS1 ITS1 CGAGGTCGATTTGGCGAGGGC 
5.8S 5.8S CAATGTGTCCTGCAATTCAC 
5’ITS2 ITS2 CCGGGGCGATTGATCGGCAAGCGAC 
ITS ITS2 GCGCGACGGCGGACGACACCGCGGCGTC 
3’ITS2 ITS2 GCTCGGCGGACGGACGGACGGAATC 
28S-2 28S TGGTCCGTGTTTCAAGACGGGT 
28S-3 28S CAAGACCTCTAATCATTCGCTT 
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(GCTTATGACCCGCACTTACTCG) complementary to 18S rRNA. The primer was 
annealed to the RNA by heating to 95 oC for 3 min and cooling slowly to room 
temperature for 10 min. RNA with annealed primer was divided equally into two 
reactions, one to be treated with RNaseH and a control in which the enzyme is omitted. 
RNaseH Buffer (20 mM Tris-HCl pH 7.5, 20 mM KCl, 20 mM MgCl2, 0.1 mM EDTA, 
0.1 mM DTT, 0.8 U/ml RNasin) was added to a give a final volume of 20 µl and 
RNaseH added to one sample. RNaseH was prepared in the laboratory by Dr Rob van 
Nues and the amount of enzyme added to obtain optimal cleavage was empirically 
determined. Reactions were incubated at 37 oC for 30 min and then reactions 
terminated by addition of 80 µl of 0.3 M NaOAc, 2 mM EDTA and 100 µl 
phenol:chloroform. Samples were vortexed vigorously for 5 min and centrifuged at 
13,000 rpm in a benchtop centrifuge. The upper aqueous layer was removed and 2.5 
volumes of 100 % ethanol added. Samples were incubated at -80 oC for 1 h before the 
RNA was pelleted by centrifugation at 13,000 rpm in a microfuge. The supernatant was 
removed and the pellet dried. RNA pellets were resuspended directly in 10 µl Glyoxal 
Loading Buffer and analysed by agarose-glyoxal gel electrophoresis and Northern 
blotting as described above. 
 
2.4.6 Mapping RNA 3’ ends 
RNA was extracted from either control HeLa cells or from HeLa cells in which 
exonuclease components had been depleted (see section 2.6.2). 2 µg RNA was 
DNase treated with 1 µl/2U Turbo DNase (Ambion) in 1 x Turbo Buffer (Ambion) at 37 
oC for 1 h to remove any DNA contamination in the samples and then the enzyme was 
inactivated by denaturing at 80 oC for 5 min. An adaptor ddC oligonucleotide (12 µM) 
(5’ AGATCTAGAGGATGGATATGGTGTTCAGGC 3’) was ligated to all the RNA 
molecules in the samples using 1 µl T4 RNA Ligase (New England Biolabs) in 1 x T4 
RNA Ligase Buffer (New England Biolabs) for 16 h at 4 oC, after which the enzyme was 
deactivated by incubation of samples at 65 oC for 10 min. A reverse transcription was 
then performed using a reverse primer that anneals the sequence of the adaptor oligo 
(pJETrev 5’ GCCTGAACACCATATCCATCC 3’) and SuperScript III Reverse 
Transcriptase (Invitrogen). 2 µl pJETrev primer was added to the reaction and heated 
to 95 oC for 10 min to anneal the primer to the template. Reactions were divided into 
two and the following steps carried out in the presence or absence of SuperScript 
reverse transcriptase to verify that products detected in later steps are derived 
specifically from the RNA template. 1 x 1st Strand Buffer (Invitrogen), 0.05 M DTT, 
0.5 mM dNTP, 20 U Superasin (Ambion) and 100 U SuperScript III RT was added to 
the sample which was incubated at 50 oC for 30 min then 55 oC for a further 30 min to 
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generate cDNAs. PCR reactions were then carried out using GoTaq polymerase 
(Promega) and the pJETrev primer. Forward PCR primers depended on the specific 
RNA that was to be mapped. The preU3 primer overlaps 2 nucleotides into the 
precursor sequence, so will amplify only the U3 precursors and not mature U3.  
PCR products were in the size range 61-250 bp and were analysed on an 8 % 
non-denaturing acrylamide gel (acrylamide:bisacrylamide 19:1 in 1 x TBE). The gel 
was stained by washing with SYBER Safe DNA stain (1:50,000) for 10 min before 
visualisation of DNA by UV light. Sections of the gel containing PCR fragments of 
interest were excised from the gel and immersed in 1 x TBE + 0.1 %SDS with agitation 
for 16 h to elute the DNA from the gel slices. Ethanol precipitation as previously 
described was then used to purify and concentrate the DNA. Pellets were thoroughly 
washed in cold 70 % ethanol to remove traces of EDTA from the TBE that would inhibit 
later ligation steps. One-third of the generated material was ligated into the 
pGEMTeasy vector (section 2.1.5) and colonies containing vectors with inserted 
fragments selected by blue:white screening using interruption of the β-galactosidase 
gene on selective plates containing XGal as a marker.  
For sequencing of preU3 in control HeLa cells, DNA was extracted from 100 
white colonies using the Spin Column Plasmid Miniprep Kit (NBS Biologicals) following 
the manufacturer’s instructions. A sample of 20 clones was manually sequenced by 
chain termination sequencing using USB Sequense Version 2.0 DNA Polymerase. 
Plasmid DNA was first denatured and purified by treatment with 0.4 M NaOH for 20 min 
at 37 oC, neutralisation by addition of 0.5 M NaOAc pH 5.2 and ethanol precipitation. 
DNA was resuspended in 7 µl water and to this Sequenase Reaction Buffer (USB) was 
added to a 1 x concentration along with 1 pmol of 5’ 32P labelled T7 primer 
(5’ TAATACGACTCACTATAGGG 3’). Reactions were incubated at 37 oC for 30 min 
and slowly cooled to room temperature to anneal the labelled primer. Primer extension 
using limiting amount of dNTPS (75 nM of dATP, dTTP, dCTP and dGTP), 6 mM DTT 
and 2 U Sequenase Polymerase (USB) was carried out for 4 min at room temperature. 
Termination Mixes were prepared to contain 80 µM non-terminating dNTP and 8 µM 
terminal ddNTP and 50 mM NaCl for each of the four nucleotides. The 2’, 3’ –
 dideoxynucleoside-5’-triphosphates lack the 3’-OH group necessary for DNA chain 
elongation. Tubes were set up containing 3.5 µl of one of the four Termination Mixes 
and the labelling reaction was divided equally between the tubes (2.5 µl each). 
Reactions were continued at 37 oC for 5 min during which DNA synthesis continues 
until a ddNTP is incorporated so the final reaction contains a mixed population of 
chains terminated at a specific base along the sequence. Reactions were stopped after 
5 minutes by addition of RNA Loading Dye (80 % formamide, 10 mM EDTA pH 8.0, 
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1 mg/ml xylene cyanol FF,1 mg/ml bromophenol blue) and separated on a denaturing 
6 % acrylamide/7 M urea sequencing gel. The gel was fixed in 50 % methanol, 10 % 
acetic acid for 10 min, dried and results visualised by X-ray film exposure overnight. 
Once the U3 precursor sequence had been determined, this method was then refined 
to track only the Ts in the sequence and the pattern used to extrapolate the preU3 
sequence in the remaining 80 pGEMTeasy clones.  
The analysis of the 3’ end of U3 precursors in cells in which exosome 
components have been depleted by RNAi was carried out using the same methodology 
and pGEMTeasy clones were sequenced from positive colonies by GATC Biotech.  
 
2.5 In vitro assays 
2.5.1 Protein-Protein Interaction  
2.5.1.1 Glutathione sepharose-GST precipitation 
Equal amounts (approximately 50 ng) of each of the proteins of interest were 
mixed in a final volume of 200 µl of the buffer in which they were purified (Exosome or 
Purification Buffer). Samples were mixed at 4 oC on a rotary incubator for 1 h to allow 
formation of protein complexes. 40 µl of Glutathione Sepharose 4 Fast Flow Beads (GE 
Healthcare) (50 % in ethanol) were washed three times in the buffer pelleting in 
between washes by centrifugation at 3000 rpm in a benchtop centrifuge. Beads were 
added to each reaction and reactions were mixed for a further 2 h on a rotary incubator 
to allow GST tagged proteins and their complexes to bind. The beads were then 
pelletted by centrifuging at 3000 rpm for 1 min in a benchtop microcentrifuge. The 
beads were then washed three times in buffer as above and an additional wash step in 
which the beads were transferred to a clean microcentrifuge tube was included. Beads 
with bound proteins were then resuspended in 50 µl Protein Loading Buffer (74 mM 
Tris-HCl pH6.8, 1.25 mM EDTA, 20 % glycerol, 2.5 % SDS, 0.125 % bromophenol 
blue, 50 mM DTT) before analysis by SDS-PAGE and/or Western blotting. 
2.5.1.2 Immunoprecipitation 
A method similar to that described in section 2.5.1.1 was used for investigating 
protein-protein interactions between the thioredoxin tagged proteins, NOP56 and 
NOP58 and HIS- or GST-tagged exosome proteins. Protein A Sepharose CL-4B beads 
(GE Healthcare) were washed three times in Exosome Buffer. Anti-thioredoxin antibody 
was added (1:80 dilution) to the beads and mixed on a rotary incubator at 4 oC 
overnight. The wash steps were then repeated to remove any unbound antibody. 
Proteins were mixed and interactions determined as for pull-downs with Glutathione 
Sepharose 4 Fast Flow Beads. 
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 2.5.2 Protein-RNA interactions 
Regions of 18S rRNA and ITS1 that have been shown to bind pre-40S complex 
proteins by CRAC in yeast (Granneman et al, 2010) are predicted to bind human 
proteins in vitro. The sequence of 18S and ITS1 is highly conserved between mouse 
and human and these fragments were amplified by PCR using HotStar Taq polymerase 
using the primers shown in Table 2.9. Figure 2.2 shows where each of these primers 
binds on a secondary structural model of the 18S rRNA. For each substrate the forward 
primer in the PCR reaction contains a T7 promoter to enable the product to be 
radioactively labelled by in vitro transcription. 
 
 
 
 
 
 
 
 
Transcription reactions were carried out by combining 50 ng of gel recovered 
PCR product with 1 x Transcription Buffer (40 mM Tris-HCl pH 7.9, 6 mM MgCl2, 
10 mM NaCl, 10 mM DTT, 2 mM Spermidine), 1 mM ATP, 1 mM GTP, 1 mM CTP, 
0.1 mM UTP, 0.5 µl RNasin (Ambion), 1 µl T7 RNA Polymerase (kindly provided by N. 
Zenkin) and 2 µl α-32P UTP (1.32 µM, 1.48 MBq, PerkinElmer) in a total volume of 
10 µl. Reactions were incubated at 37 oC for 2 h before addition of 1 µl Turbo DNase 
(Ambion) for a further 30 min at 37 oC to degrade the template DNA. The reaction 
volume was increased to 50 µl and centrifuged serially through two G50 Spin Columns 
(GE Healthcare) to remove any unincorporated nucleotides. The activity of each RNA 
transcripts was determined using a scintillation counter and samples were diluted to 
5000 cpm/µl. Approximately 50 ng of GST-tagged protein (or combination of GST- and 
His-tagged proteins) was diluted in Binding Buffer (20 mM HEPES pH 7.4, 150 mM 
KCl, 1.5 mM MgCl2, 0.1 % Triton X-100 (v/v), 10 % glycerol (v/v) to a final reaction 
volume of 200 µl. When two proteins were mixed, reactions were incubated at 4 oC for 
Table 2.9 Primers for amplification of 18S rRNA substrates 
Primer Direction Sequence 
3761_T7 Forward 
GCCGAATTCTAATACGACTCACTATAGGGTCAGTTATGGTTCCTTT
GGTC 
4980_T7 Forward 
GCCGAATTCTAATACGACTCACTATAGGGTGGTGGTGCATGGCCG
TTC 
4882_T7 Forward 
GCCGAATTCTAATACGACTCACTATAGGGTGGAGCCTGCGGCTTA
ATTTG 
5318_T7 Forward 
GCCGAATTCTAATACGACTCACTATAGGGTCATAAGCTTGCGTTG
ATTAAGTCC 
5357_T7 Forward 
GCCGAATTCTAATACGACTCACTATAGGGACCGCCCGTCGCTACT
ACCGA 
4012 Reverse GCCGGATCCGCAGACGTTCGAATGGGTCG 
5176 Reverse GCCGGATCCCAGCCCCGGACATCTAAGGGC 
5188 Reverse GACGGATCCGTAGCGCGCGTGCAGCCCCG 
5527 Reverse GCCGGATCCTAATGATCCTTCCGCAGGTTC 
5927 Reverse ACACACAAGACGGGGAGAGCG 
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1 h on a rotary wheel to enable complex formation. 20 µl per reaction of Glutathione 
Sepharose 4 Fast Flow (GE Healthcare) bead slurry in ethanol was washed three times 
in Binding Buffer precipitating beads in between washes at 3000 rpm in a microfuge. 
Beads were then added to each reaction and proteins bound to the beads for 1 h at 
4 oC for 1 h on a rotary incubator. 1 µl (5000 cpm) of each labelled RNA transcript was 
then added to the sample and reactions incubated at 4 oC for a further 30 min. Beads 
with bound protein and RNA were then precipitated by centrifugation at 3000 rpm in a 
microfuge and washed 4 x in Binding Buffer with the beads being transferred to a clean 
microfuge tube on the final wash step. RNA was eluted from the beads by addition of 
160 µl of RNA Extraction Buffer (1 % SDS (w/v), 50 mM Tris pH 7.5, 50 mM NaCl, 
0.5 mM EDTA). To this 200 µl phenol:chloroform:isoamylalcohol (25:24:1) was added 
and shaken vigorously for 3 min. Samples were then centrifuged at 13,000 rpm in a 
microfuge for 5 min. The upper aqueous layer containing the RNA was removed and 
150 mM NaOAc, tRNA (50 µg/ml) and 600 µl ethanol added. Reactions were cooled at 
-20 oC for 2-16 h then centrifuged at 13,000 rpm in a benchtop centrifuge for 20 min to 
pellet RNA. The supernatant was removed and the pellets dried in a speed vac. 
Samples were resuspended in 10 µl RNA Loading Dye (40 % formamide, 0.5 mM 
EDTA, 50 µg/ml bromophenol blue, 50 µg/ml xylene cyanol). Samples were denatured 
at 95 oC for 2 min, cooled on ice and separated on an 8 % polyacrylamide, 7 M urea 
gel. Gels were fixed for 10 min in 50 % methanol, 10 % acetic acid and dried onto 
Whatman Paper (VWR International). Results were visualised by exposure to a 
phosphorimager screen and detected using a Typhoon imager and then analysed with 
ImageQuant software (GE HealthCare). 
 
73 
 
 
 
2.5.3 Kinase/phosphorylation assay 
RIO2 is a protein kinase and an assay was developed to assess both its ability 
to autophosphorylate and to detect phosphorylated substrates. 10 ng GST-RIO2 or 
GST-RIO2kd was incubated either alone (autophosphorylation) or with an equivalent 
amount of potential substrate proteins in a 10µl reaction in Purification Buffer (20 mM 
Tris-HCl pH 8.0, 300 mM KCl, 5 mM MgCl2, 0.1 % Tween 20 (v/v) and 10 % glycerol 
(v/v). A further reaction was set up in which HIS-NOB1 and GST-PNO1 had been pre-
incubated at 4 oC on a rotary wheel for 1 h to allow interaction between these proteins 
before addition of GST-RIO2 or GST-RIO2kd. 32P-ATP was added to a final activity of 
1 µCi in both the presence and absence of unlabelled ATP. Unlabelled ATP was added 
to provide sufficient phosphate to drive the kinase reaction (autphosphorylation 
 
Figure 2.2 Binding sites for primers used to amplify 
fragments of 18S RNA Outline of the secondary 
structure of human 18S RNA (adapted from 
http://www.rna.ccbb.utexas.edu/). Positions of primers 
used in PCR amplification are shown in red (forward 
primers) and blue (reverse primers). 
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reactions 0-1 mM, substrate phosphorylation 0.01 mM). Reactions were incubated at 
37 oC for 30 min and stopped by addition of Protein Loading Dye (74 mM Tris-HCl 
pH 6.8, 1.25 mM EDTA, 20 % glycerol, 2.5 % SDS, 0.125 % bromophenol blue, 50 mM 
DTT) to denature the proteins. Samples were heated to 95 oC for 2 min and loaded 
onto a 10 % denaturing polyacrylamide gel and separated by elecrophoresis. The gel 
was fixed for 10 min in 50 % methanol, 10% acetic acid before being dried onto 
Whatman paper (VWR International). Phosphoimager screen detection revealed 
proteins which had been phosphorylated as they had become labelled by incorporation 
of γ-P32-ATP. 
  
2.5.4 Ribonuclease assays 
Ribonuclease assays were used to assess the 3’-5’ exonuclease activity of 
various proteins (human RRP6, C1D, MPP6 and ENP1 and yeast RRP6). Two different 
substrates were used: a poly(A) substrate 30 nucleotides long (kindly provided by Dr 
Claudia Schneider, University of Edinburgh) and a fragment of the U14 snoRNA which 
forms a stem-loop structure, 5’ UCGCUGUGAUGAUUUAUUCUGAGCGAA 3’ 
(Eurgoentec). 10 pmol of each substrate was radio-labelled at the 5’ end using 32P-ATP 
which generates a monophosphate end. Reactions were carried out as for the labelling 
of oligo-probes using T4 PNK. To purify substrates, RNA extraction buffer was added 
to a volume of 50 µl and an equal volume of phenol:chloroform;isoamylalcohol 
(25:24:1) added. Reactions were briefly vortexed and centrifuged at 13,000 rpm in 
microcentrifuge. The upper aqueous layer was removed and passed through a G50 
spin column to removed unincorporated nucleotides. To this, NaCl was added to a final 
concentration of 250 mM along with 1 µl glycerol and 150 µl ethanol to precipitate RNA. 
Samples were incubated at -20 oC for > 2 h then centrifuged at 13,000 rpm to pellet the 
RNA which was then washed in 70 % ethanol. The pellet was resuspended in water to 
a concentration of 100 fmol/µl. Concentrations of proteins were determined by 
nanodrop as described above and 200 fmol was used per 10 µl reaction. Proteins were 
diluted in ExoMg Buffer (10 mM Tris–HCl pH 7.6, 75 mM NaCl, 2 mM DTT, 100 mg/ml 
BSA, 0.8 U/ml RNasin, 4.5 % glycerol, 0.05 % Triton X-100, 0.5 mM MgCl2) and 
incubated at 37 oC for 10 min. The each 10 µl reaction 10 fmol of labelled RNA 
substrate was added. Reactions were incubated at 37 oC for the desired duration and 
reactions stopped by addition of one volume of RNA Loading Dye (80 % formamide, 
10 mM EDTA pH 8.0, 1 mg/ml xylene cyanol FF, 1 mg/ml bromophenol blue). Samples 
were denatured either for 2 min at 95 oC for unstructured substrates or at 65 oC for 
stem loop RNAs before separation on a denaturing 12 % acrylamide, 8 M urea 
sequencing gel. Products were visualised using a phosphorimager.  
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2.6 Cell Culture and in vivo assays 
2.6.1 Cell culture  
Human HeLa SS6 (cervical carcinoma) cells were routinely cultured in 
Dulbecco’s Modified Eagles Medium (DMEM) containing 4500 mg/L glucose, L-
glutamine and sodium bicarbonate, without pyruvate (Sigma Aldrich) supplemented 
with 10 % (v/v) foetal bovine serum (FBS), 100 units/m penicillin and 100 µg/ml 
streptomycin. Cells were grown in a monolayer in a 5 % CO2 humidified incubator at 
37 oC. When at 80 % confluent, cells were released by treatment with 1 x trypsin EDTA 
(Sigma Aldrich) in sterile phosphate buffered saline (PBS, Sigma Aldrich) for 5 min at 
37 oC, resuspended in DMEM and reseeding of an appropriate percentage.  
A strain of HEK293 (human embryonic kidney) cells, Flp-In™ T-REX™-293 
(Invitrogen) were cultured using the same methods as for HeLa cells. These HEK293 
cells contain a stably integrated pFRT/lacZeo vector derived from S. cerevisiae to 
provide a specific Flp Recombinase site. They also contain an integrated pcDNA6/TR 
vector allowing constitutive expression of the Tet-repressor under the control of the 
human CMV promoter and a sequence conferring blasticidin S resistance. This 
enabled these cells to be used for generating tetracycline-inducible stable cell lines. To 
maintain selection of cells containing plasmids for expression of FLAG-tagged proteins 
of interest, cells were cultured in the presence of 100 µg/ml hygromycin and treated 
with 10 µg/ml blasticidin at each third passage. 
TC7 cells are a derivative of CaCo-2 (colon cancer) cells that are well 
characterised as a model for differentiation. TC7 cells were cultured in DMEM 
supplemented with non-essential amino acids (glycine 7.5 mg/L, L-alanine 8.9 mg/L, L-
asparagine 1.32 mg/L, L-aspartic acid 1.33.0 mg/L, L-glutamic acid 1.47 mg/L, L-
proline 1.15 mg/L, L-serine 1.05 mg/L and 0.1 mM glutamine). When passaging cells, 
they were grown to 80 % confluency, trypsinised using 4 ml 1 x trypsin in sterile PBS at 
37 oC for 10-15 min. Cells often formed clumps which were allowed to settle prior to 
reseeding the flask. To achieve differentiation, cells were seeded into a flask as normal 
and allowed to grow for 22 days during which time the culture media was regularly 
changed. After this time, differentiated cells were harvested as normal.  
HeLa, HEK293 and TC7 cells were all harvested by pelleting cells using a 
swing bucket centrifuge at 800 rpm for 5 min. Media were removed and pellets used 
directly or snap frozen in liquid nitrogen and stored at -80 oC. Stocks of all cell lines 
were prepared by resuspending approximately 5 x 106 cells in 1 ml Freezing Medium 
(DMEM, 20 % FBS, 10 % DMSO) and slowly cooling to -80 oC before storing in liquid 
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nitrogen. Cell stocks were revived by rapid thawing at 37 oC, washing the cells in 2 x 
10 ml culture medium followed by normal growth in a T175 flask.  
 
2.6.2 RNA interference (RNAi) 
2.6.2.1 RNAi in HeLa cells 
Specific target proteins in human cells were selectively depleted using siRNA 
targeting specific mRNA sequences (Table 2.10). A control siRNA that targeted firefly 
luciferase mRNA (GL2) was used in each experiment. This gene is not present in HeLa 
cells and has previously been demonstrated to have no effect on cell growth or RNA 
levels in HeLa SS6 cells (Elbashir et al, 2002). siRNAs purchased from Eurogentec 
need to be pre-annealed into a duplex prior to use. Sense and anti-sense strands were 
combined to a final concentration of 20 µM in 1 x Annealing Buffer (100 mM KOAc, 
2 mM MgOAc, 30 mM HEPES-KOH (4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic 
acid pH 7.4), heated to 90 °C for 1 min and incubated at 37 °C for 1 h before use. 
siRNAs purchased from MWG Eurofins are pre-annealed and were resuspended in 1 x 
Universal siRNA Buffer (MWG Eurofins) to a final concentration of 20 µM. SMARTPool 
siRNAs (Dharmacon) were also resuspended to 20 µM in 1 x Annealing Buffer prior to 
use. 
Transfection of siRNA duplexes into HeLa cells was done by chemical reverse 
transfection using Lipofectamine™ RNAiMAX reagent (Invitrogen). Knock-downs were 
generally carried out in six-well plates but could be scaled up or down depending on 
the amount of material required; the following protocol is for a six-well plate. 
Complexes were prepared in the well by combining 150 pmol siRNA(s) with 500 µl 
Opti-MEM I Reduced serum medium with L-glutamine (Invitrogen) and addition of 4 µl 
RNAiMAX reagent for 15-20 min at room temperature. HeLa cells were harvested by 
trypsinising as previously described and resuspending in DMEM media containing no 
antibiotics. Cells were counted using a CASY cell counter (Innovatis AG) and diluted in 
media without antibiotics to a concentration of 7.5 x 104 cells/ml. 2 ml of cell solution 
was then added to each well containing siRNAs. Penicillin and Strepotmycin were 
added to each well 6 h after transfection to the concentrations normally used for growth 
of HeLa cells. Cells were grown for 60-72 hours in the presence of the siRNA and then 
harvested from the wells by trypsinisation as described above. Cells were split into 
pellets containing approx 7.5 x 105 cells and either snap frozen in liquid nitrogen for 
storage at -80 °C or disrupted directly for RNA extraction. 
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Table 2.11 siRNA duplexes used to deplete specific mRNAs in human cells 
Target 
Gene  
Target sequence Source Reference 
GL2 CGTACGCGGAATACTTCGATT Eurogentec Elbashir et al., 2001 
RRP46 
GGAGCUCACAUUUAUGGAATT 
Eurogentec Watkins et al., 2004 ACAAGGCCACACUCGAAGUTT 
ACAUUCAAAGGAGCUCACATT 
RRP6 
GAAGGCAGCUGAGCAAACATT 
Eurogentec N/A UGAGCAGAGUAAUGCAGUATT 
AGAUGAAAGUUACGGAUAUTT 
C1D GUUGGAUCCACUUGAACAATT MWG Schilders et al., 2007 
MPP6 
GAGCACUGGUACUUGGAUUTT 
MWG Schilders et al., 2005 CAGUAGAGCUUGAUGUGUCTT 
GAUAUGAGACCUUGGUGGGTT 
MTR4 
GACAGCAGCUUGCCAAAUUTT 
Eurogentec N/A CUGGUGAUGUUACUAUUAATT 
GGCUUUACAUUCCUAAAGATT 
DIS3 AGGUAGAGUUGUAGGAAUATT MWG Staals et al., 2010 
XRN2 
AAGAGUACAGAUGAUCAUGTT 
MWG West et al., 2004 
GGGAAGAAAUAUUGGCAAATT 
NOP58 CAAGCATGCAGCTTCTACCGTT MWG Watkins et al., 2004 
NOP56 CAAUAUGAUCAUCCAGUCCATT Eurogentec Watkins et al., 2004 
Fibrillarin 
CAGTCGAGTTCTCCCACCGCTT 
MWG Watkins et al., 2004 
GATGTGTGTTGATACTGTTGCAC 
RPS19 GAUGGCGGCCGCAAACUGATT MWG  
POP1  GAAUUUAACCGUAGACAAATT MWG Mattijssen et al., 2010 
RPP38 GCUAUUGGACUUCAGAAGATT MWG Cohen A, et al., 2003 
RPP40 CCUUAAACUUGGAUUCUAATT MWG Mattijssen et al., 2010 
BOP1 AUGGCAUGGUGUACAAUGATT MWG Rohrmoser et al.,  2007 
RBM28 
CGAGAAGGCUUGAUUCGUG 
Dharmacon 
SMARTPOOL 
N/A 
GAAAUUACCCUCUGAUGUG 
ACUCAAAUAUGUCCGCAUU 
CAAAGGCUGUAGAUGACAA 
RRP5 UGAAGGUUGUCGUAUUGAATT MWG Sweet et al., 2007 
UTP24 
UGAAAAGAAGAAUCCGUAA 
Dharmacon 
SMARTPOOL 
N/A 
CAAGGAAGUAUGCGACCAU 
GAAGGAUCCCAGCGCAUUA 
UCCAAGAUUUGAACGAUUA 
RCL1 
ACGAAUGGUUCUCGAAUUG 
Dharmacon 
SMARTPOOL 
N/A 
CUACAGGGGUGGAUGCGUA 
CUGGGAAGUCUCCGGGCUU 
GAACAUGACUGUAGCGUCC 
BMS1 
UCAAAGAGGAAGAAGAUUA 
Dharmacon 
SMARTPOOL 
N/A 
CAAAAGAAGCGCUGUUUAA 
GGGAUUUAGAGGAGGUUAU 
GGGCAUCAAACGACGGAAA 
RIO2 GGAUCUUGGAUAUGUUUAATT MWG Zemp et al., 2009 
ENP1 
CGAAAUCAGGCGUGAGCUU 
MWG Carron et al., 2010 
GAUGUUCAUGAACAAGAATT 
DIM1 
GAUUCAACGCAGAAGGUAUUU 
Dharmacon 
SMARTPOOL 
N/A 
GAUGGUCUAGUAAGGAUAAUU 
CUUAAGACCAACUGAUGUAUU 
ACCAGAAGAUUUCAGCAUAUU 
NOB1 
UCACCGAGGAUCAGCGCUUUU Dharmacon 
SMARTPOOL 
N/A 
GCAAAUUGGAUGGGCGUCUUU 
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2.6.2.2 RNAi depletion and rescue in HEK293 cells 
  HEK293 stable cell lines for RNAi resistant expression of tagged proteins of 
interest were induced using tetracycline at the appropriate concentration (Table 2.11) 
to obtain 1:1 expression of tagged:endogenous proteins for 24 h. Transfection of siRNA 
duplexes to deplete the endogenous protein of interest in the induced HEK293 cells 
was carried out as for HeLa cells but using 5µl RNAiMAX reagent. Transfected cells 
continued to be induced with tetracycline and were harvested 48 h after siRNA 
treatment as described above. 
 
2.6.3 Creation of HEK293 Stable Cell Lines 
 Genes of interest were cloned into a modified pcDNA5/FRT/TO vector 
containing 2x FLAG tags, a tetracycline-regulated hybrid human CMV/TetO2 promoter, 
and a hygromycin B resistance gene with a FRT site in the 5’ coding region. When Flp-
In T-Rex HEK293 cells are transfected with both this pcDNA5 vector and pOG44, a 
plasmid constitutively expressing Flp recombinase, homologous recombination 
between the FRT sites is enabled. This brings about integration of the tagged gene of 
interest and the hygromycin resistance gene in frame with their respective promoters. 
Cells in which the gene of interest has been integrated can then be selected for by 
culturing in the presence of hygromycin B (Figure 2.3). 
 To generate such stable cell lines, Flp In T-Rex HEK293 cells were grown in 
six-well plates to 60 % confluency. 9 µl/well of FuGene HD (Roche Applied Sciences) 
was mixed with 91 µl of Opti-MEM I (Invitrogen) and incubated at room temperature for 
5 min. To this, 1.8 µg pOG44 and 0.6 µg pcDNA5 per well were added and allowed to 
Table 2.11 siRNA duplexes used to deplete specific mRNAs in human cells - continued 
 
 
 
 
Target 
Gene  
Target sequence Source Reference 
NOB1 
UCACCGAGGAUCAGCGCUUUU 
Dharmacon 
SMARTPOOL 
N/A 
GCAAAUUGGAUGGGCGUCUUU 
ACAGAAAAGAUGACAGCGAUU 
AGAAAGUGUCCGUGACCGUUU 
PNO1 
GCUAACAGAUACACACCAUUU 
Dharmacon 
SMARTPOOL 
N/A 
GGACUUCAGAUACGCUUUAUU 
AGAGAAUGUGACACGGACAUU 
CUUAAAAGGGCUCCGAACAUU 
PRP43 
UGAAAGUAGUUCUAUAUAUTT 
MWG N/A 
UAAGACUAAAGUAUUUAAUTT 
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incubate for a further 15 min before the mixture was added to the cells in a drop wise 
manner.  
 
Chemically transfected cells were incubated for 48 h under normal culture conditions. 
Selection of positive integrants was then initiated by addition of 100 µg/ml hygromycin 
B and 10 µg/ml blasticidin S. Colonies of selected cells were allowed to form for up to 
two weeks and resupended. Expression of tagged protein was induced by addition of 
0-1 mg/ml tetracycline for at least 36 h. The concentrations of tetracycline required to 
induce 1:1 expression of endogenous and tagged-protein in each cell line used in this 
study this given in Table 2.11. 
 
Figure 2.3 Schematic representation of pcDNA5 homologous recombination into Flp-In 
T-Rex HEK293 cells Homologous recombination (dotted line) is shown between the pcDNA5-
FLAG vector and the Flp Recombination sites (FRT) in the modified HEK293 cell genome. This 
is aided by the Flp Recombinase encoded within pOG44. Shown are; SV40 promoter (PSV40); 
start codon (ATG); Flp Recombination sites (FRT); hygromycin resistance gene (hygromycin); 
pUC origin (for propagation in E. coli); Ampicillin resistance gene (Amp.); CMV promoter 
(pCMV); Tetracycline operator sequences (2 x Tet O2); 2 x FLAG Precission Protease 6 x His 
Tag (Tag); Gene of interest (GOI); BGH polyadenylation signal (BGH pA, required for efficient 
termination and polyadenylation of mRNA); and lacZ fusion with the zeocin resistance gene 
(lacZ-Zeocin). Based on a figure from Invitrogen. 
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2.6.4 Metabolic RNA labelling 
 HeLa cells were cultured in six-well plates and RNAi depletion of factors of 
interest carried out as required. 48 h after transfection of siRNA duplexes, the culture 
media were changed for phosphate-free DMEM. This media was prepared according to 
a Sigma high-glucose DMEM (D5671) formulation without NaHPO3 supplemented with 
10 % dialysed FCS. Cells were depleted of phosphate for 1 h. Culture media was then 
exchanged for phosphate-free DMEM containing 15 µCi/ml 32P labelled inorganic 
phosphate at 37 oC for 1 h. Labelled media was then removed and cells were washed 
with 2 ml normal DMEM supplemented with 10 % FCS. Wells were harvested as 
required (time points, 0, 15, 30, 60, 120 min) by trypsinisation. RNA was extracted from 
labelled cells using TRI-reagent and analysed by agarose-glyoxal gel electrophoresis 
or PAGE as appropriate. PAGE gels were dried and RNAs visualised using a 
phosphorimager. RNA separated on agarose-glyoxal gels was transferred to Hybond-N 
membranes by capillary action and RNAs visualised as for PAGE. 
 
2.6.5 Treatment of HeLa cells with leptomycin B 
Human cells were treated with 30 nM leptomycin B for 2 h (Muro et al, 2008; 
Rouquette et al, 2005) before being harvested for RNA extraction or being fixed for 
immunofluorescence. 
 
2.6.6 Immunofluorescence 
HEK293 cells were grown on 10 mm round coverslips in 24-well plates in 500 µl 
media to 80 % confluence in the presence of tetracycline if required. Cover-slips were 
washed 3 x in PBS and fixed using 4 % paraformaldehyde (w/v) in PBS pH 7.4 for 
20 min. Cover-slips were then washed 3 x in PBS, incubated in PBS, 0.1 % Triton-
X100 for 15 min at room temperature, washed 3 x in PBS and blocked for 1 h at room 
Table 2.11 Tetracycline concentrations used to induce stably transfected HEK293 cells 
HEK293 
cell line 
Concentration of 
tetracycline  (ng/ml) 
RRP6  100 
RRP6exo 100 
DIM1 5 
NOB1 1 
PNO1 2 
RIO2 1 
RIO2kd 1 
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temperature in PBS, 10 % FBS (v/v), 0.1 % Triton-X100. Primary antibodies (Table 
2.12) were then applied using an appropriate dilution of antibody in 50 µl of 10 %FBS 
(v/v), PBS pH7.4 for 1 h at room temperature. Cover-slips were then washed 3 x briefly 
and 3 x 10 minutes in PBS before applying 50 µl of appropriate secondary antibody in 
10 % FBS (v/v), PBS pH7.4 for 1 h at room temperature. Cover-slips were again 
washed 3 x briefly and 3 x 10 minutes in PBS with the addition of DAPI (0.1 µg/ml, 
Sigma Aldrich) in the penultimate wash. Finally, coverslips were briefly immersed in 
water and ethanol, dried and mounted, inverted onto glass slides using 3.5 µl Moviol. 
Cells were then examined using a Zeiss Axiovert 200M inverted microscope with a 
Plan-Apochromat, 100 x / 1.40 oil, ∞ / 0.17 objective (Zeiss). The Zeiss filter sets used 
were: 02 (DAPI); 20 (Cy3); 26 (Cy5). 
 
 2.6.7 Preparation of whole cell extract 
Human cells were cultured as described above, harvested and snap frozen in 
pellets containing approximately 5 x 106 cells. To prepare extracts for gradient analysis 
or immunoprecipitation a pellet was thawed on ice and resuspended in 500 µl Gradient 
Buffer (10 % glycerol, 20 mM HEPES-NaOH pH7.9, 150 mM KCl, 0.5 mM EDTA, 1 mM 
DTT) and disrupted by sonication using a Bandelin Sonopuls HD2070 ultrasonic 
homogeniser with a 2mm MS72 titanium microtip for 15 s at minimum power. Triton-
X100 (0.2 % (v/v)) and 1.5 mM MgCl2 (in the case of immunoprecipitations) were added 
and insoluble material pelleted by centrifugation at 13,000 rpm in a microfuge at 4 oC 
for 10 min. The cleared supernatant could then be used as required. 
 
2.6.8 Immunoprecipitation 
10 µl of Protein G Sepharose beads (GE Healthcare) per immunoprecipitation 
(IP) were washed in 3 x 1 ml PBS+ 0.1 % Triton-X100 with centrifugation at 3,000 rpm 
in a microfuge for 1 min at 4 oC between steps. After the final wash step, beads were 
resuspended in 1 ml IP buffer (20 mM HEPES pH 8.0, 150 mM NaCl, 3 mM MgCl2, 
0.5 mM DTT, 10 % glycerol (v/v), 0.1 % Triton-X100 (v/v)) with 5 µl of mouse α-FLAG 
Table 2.12 Antibodies used in immunofluorescence 
Antibody Raised in  Source Dilution 
FLAG (polyclonal) Rabbit Sigma F7425 1:500 
Fibrillarin 72B9 Mouse Michael Pollard/Ger Pruijn 1:500 
Mouse IgG Alexa Fluor 555 
conjugate 
Donkey Invitrogen A31570 1:500 
Rabbit IgG Alexa Fluor 647 
conjugate 
Donkey Invitrogen A31573 1:500 
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antibody per IP reaction or no antibody as a negative control, and incubated on a rotary 
incubator overnight at 4 oC. Sepharose beads were then washed 3 x in IP Buffer as 
described above and aliquoted per IP reaction. Cell extract from either HEK293 or 
HeLa cells was prepared as described in Section 2.6.6 and this was added to the 
prepared sepharose beads which were rotated for 2 h at 4 oC. 10 % of the extract was 
retained for downstream RNA and protein extraction to give a relative measure of input. 
Immunoprecipitation reactions were washed 3 x in IP buffer as previously, 
resuspended in 1 ml IP buffer, transferred to a new microcentrifuge tube and pelleted 
at 3,000 rpm for 1 min. RNA and protein were then extracted from samples as 
described in Section 2.4.1.1 for analysis by Northern and Western blotting, 
respectively.  
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Chapter Three 
The roles of human exonucleases in RNA processing 
and degradation in the nucleus 
 
3.1 Introduction 
Exoribonucleases play major roles in both prokaryotic and eukaryotic cells in 
the processing and degradation of a variety of RNAs. Cells produce large quantities of 
both coding (mRNAs) and non-coding RNAs (rRNAs, snoRNAs and snRNAs) (Warner, 
1999). The majority of eukaryotic transcripts are produced as precursors and undergo 
controlled processing to form mature, functional RNAs. RNA degradation is also 
important both for maintaining steady-state RNA levels within the cells and as part of 
quality control mechanisms that target aberrant RNAs for degradation.  
RNA can be processed and degraded from either the 5’ or 3’ end. XRN2 (Rat1 
in yeast) and XRN1 provide the majority of 5’-3’ exonuclease activity in the nucleus and 
cytoplasm, respectively, but other 5’-3’ exonucleases such as NOL12 (Rrp17 in yeast) 
have also been identified (Johnson, 2001; Long & McNally, 2003; Oeffinger et al, 
2009). The exosome provides the majority of the 3’-5’ exonuclease activity in the cell 
although other 3’-5’ exonucleases, such as the REX proteins also play important roles 
(Allmang et al, 1999b; Mitchell et al, 1997).  
 
 
 
Figure 3.1 Structure of the eukaryotic exosome Schematic representations of the core 
eukaryotic exosome and active subunits shown for the top, bottom and side. Dark blue and 
mid-blue ovals represent PH domain proteins homologous to archaeal RRP41 and RRP42 
respectively. Pale blue circles correspond to the trimeric cap formed by RNA-binding domain 
proteins which containing KH and S1 domains which stabilises the interactions of the 
hexameric ring. RNase D-like RRP6, shown in red, is probably located in the proximity of the 
trimeric cap while the exo-/endonuclease, DIS3 (yellow) is anchored to the lower face of the 
core exosome via its PIN domain (small yellow shape).    
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The exosome is an evolutionarily conserved multi-protein complex which in 
eukaryotes is formed around an inactive core that consists of nine individual subunits 
arranged as a hexamaeric ring of PH domain proteins, RRP41, RRP45, RRP42, MTR3, 
RRP43 and RRP46, stabilised by a trimeric cap composed of KH/S1 domain containing 
RNA binding proteins, RRP4, RRP40 and CLS4 (Figure 3.1) (Liu et al, 2006). In yeast, 
the exosome is constitutively associated with Rrp44, a protein which possesses both 
exonuclease and endonuclease activity (Lebreton et al, 2008; Mitchell et al, 1997; 
Schneider et al, 2007; Schneider et al, 2009). A second exonuclease, Rrp6, is also a 
component of the nuclear exosome (Mitchell et al, 2003). In higher eukaryotes, two 
exosome-associated Rrp44 homologues have been identified, DIS3 (in the nucleus) 
and DIS3L (in the cytoplasm) although it is not clear if these are as closely associated 
with the exosome as their yeast counterpart is (Staals et al, 2010; Tomecki et al, 
2010b). The human exosome is also associated with the RNase D-like exonuclease, 
RRP6, predominantly in the nucleolus but also in the nucleus and possibly in the 
cytoplasm (Tomecki et al, 2010b). Rrp44 is anchored to the lower face (opposite the 
cap) of the core exosome through its PIN domain and it is proposed that unstructured 
RNA substrates recognised by the RNA binding proteins in the cap pass through the 
central channel of the hexameric ring and are degraded by Rrp44 as they exit 
(Bonneau et al, 2009; Lorentzen et al, 2008; Schneider et al, 2007; Wang et al, 2007). 
Structured RNA substrates are, however, thought to be directly cleaved by the 
endonuclease activity of the PIN domain of Rrp44 and are degraded without passing 
though the core exosome. It is less certain how Rrp6 interacts with the core exosome 
and different models have been proposed that place Rrp6 either close to the trimeric 
cap or on the opposite face (Cristodero et al, 2008; Lehner & Sanderson, 2004). The 
activity of the exosome in both yeast and humans is regulated by a range of different 
cofactors and in the nucleus, RRP6 interacts with two cofactors, C1D (Rrp47 in yeast) 
and MPP6, which are thought to recruit the exosome to particular substrates (Milligan 
et al, 2008; Mitchell et al, 2003; Schilders et al, 2005; Schilders et al, 2007). Another 
mechanism of exosome recruitment in the nucleus is through the polyadenylation of 
target substrates by the TRAMP complex which makes them more favourable 
substrates (Houseley et al, 2006; Kadaba et al, 2004; Kadaba et al, 2006; LaCava et 
al, 2005; Vanacova et al, 2005). The TRAMP helicase, MTR4 is, however, particularly 
associated with the nuclear exosome and acts as a TRAMP-independent exosome 
cofactor in functions such as processing of 5.8S rRNA (Lubas et al, 2011; Schilders et 
al, 2007). 
 Many substrates of the yeast exosome in both the nucleus and cytoplasm have 
been identified and some of the nuclear substrates are shown in Figure 3.2 (Houseley 
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et al, 2006; Kiss & Andrulis, 2011; Lykke-Andersen et al, 2009; Schmid & Jensen, 
2008a; Tomecki et al, 2010a; Vanacova & Stefl, 2007). The yeast exosome is involved 
in processing of precursors of sn/snoRNAs and was initially characterised through its 
role in the formation of the mature 3’ end of 5.8S rRNA (Allmang et al, 1999a; Mitchell 
et al, 1997; Mitchell et al, 1996). Degradation functions of the exosome include 
turnover of fragments of pre-rRNAs released during processing and unstable 
transcripts such as CUTs and PROMPTs in the nucleus (Chekanova et al, 2007; 
Milligan et al, 2008; Neil et al, 2009; Preker et al, 2008). Exosome functions in RNA 
surveillance came to light through its participation in the degradation of defective non-
coding RNAs (sn/sno/t/rRNAs) and incorrectly spliced mRNAs in the nucleus. 
Cofactors of the exosome which also participate in specific exosome functions have 
been identified. It is not yet clear how these exonucleases determine whether a 
substrate should be targeted for degradation or whether only processing to generate a 
specific mature end is required.  
 
Much less is known about the composition and roles of the human exosome 
than the yeast exosome. The only example of the human exosome stably associated 
with a substrate is with U3 and U8 pre-snoRNAs making snoRNA biogenesis an ideal 
system for investigating human exosome processing in the nucleus (Watkins et al, 
2004; Watkins et al, 2007). In yeast, the 3’ ends of snoRNAs are processed by the 
exosome (Allmang et al, 1999a; Mitchell et al, 2003). snoRNPs are required for 
ribosome biogenesis as they not only carry out important post-transcriptional 
modifications but because some, such as U3, U14 and U8 are also essential for 
 
Figure 3.2 Diverse functions of the exosome in the nucleus Schematic representation of 
the core yeast exosome and some of its nuclear substrates. The cofactors linked to each 
exosome function are given along the relevant arrow. The role of the human exosome in 
processing and degradation of the substrates highlighted with black circles will be investigated 
in this study. 
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specific cleavage steps in pre-rRNA processing (Henras et al, 2008; Watkins & 
Bohnsack, 2011). Many snoRNAs in vertebrates are encoded within introns of protein 
coding genes and are released from the pre-mRNA either by splicing of the intron lariat 
or by endonucleolytic cleavages in regions flanking the snoRNA (Dieci et al, 2009). 
This is followed by 5’ and 3’ end processing to produce the mature snoRNA (Allmang 
et al, 1999a; Petfalski et al, 1998).  
Other snoRNAs, such as U3 and U8, are independently transcribed by RNA 
polymerase II and precursors contain a 5’ m7G cap and a 3’ extension. The mature 
snoRNA is produced by hypermethylation of the cap and removal of the 3’ extension by 
exonuclease processing (Filipowicz & Pogacic, 2002; Mouaikel et al, 2002; Weinstein & 
Steitz, 1999). In yeast, most snoRNAs are independently transcribed and contain both 
5’ and 3’ extended sequences. It has been shown that the 5’ extensions are removed 
by Rat1 and Xrn1, whereas the 3’ extensions are first cleaved by the endonuclease, 
Rnt1 (Chanfreau et al, 1998b; Kufel et al, 2003) and are then processed by the 
exosome (Allmang et al, 1999a). snoRNA processing occurs concurrently with the 
assembly of proteins to form the snoRNP complex. Mature box C/D snoRNPs contain 
four core proteins which are assembled hierarchically; 15.5K first binds a conserved 
stem in the box C/D motif and this in turn recruits NOP56, NOP58 and fibrillarin 
(Watkins et al, 2002; Watkins et al, 2000). In human cells, biogenesis of the U3 
snoRNP complex is achieved by a large multi-protein pre-snoRNP complex (Watkins et 
al, 2004). Proteins linked to snoRNP assembly include biogenesis factors NUFIP, 
BCD1, NOP17 and the ATPases, TIP48 and TIP49 (McKeegan et al, 2007).  
The yeast exosome not only participates in the 3’ end formation of 5.8S, but is 
also involved in other stages of ribosome biogenesis. Three of the four ribosomal 
RNAs, 18S, 5.8S and 28S are co-transcribed as a single precursor by RNA polymerase 
I. This precursor includes external transcribed spacer regions (5’ETS and 3’ETS) and 
two internal transcribed regions (ITS1 and ITS2) which are removed by an ordered 
series of endonucleolytic cleavages and exonucleolytic processing to release the 
mature rRNAs (Henras et al, 2008). The 5’ external spacer (5’ETS) is removed in a 
step-wise manner by endonucleolytic cleavages at A0 and A1 in yeast and in higher 
eukaryotes, at an additional cleavage site, A’. In mouse cells, both XRN2 and the 
exosome are required for turnover of specific fragments released by these cleavages 
(Kent et al, 2009; Wang & Pestov, 2011). In yeast, both 5’-3’ exonucleases including 
Rat1 (XRN2) and the 3’-5’ exonuclease complex, the exosome, are involved in the 
formation of the mature ends of both 5.8S and 28S rRNAs (Mitchell et al, 1996). The 
role of the exosome and some of its cofactors in the formation of the 3’ end of 5.8S is 
conserved in human cells (Schilders et al, 2005; Schilders et al, 2007). In both plant 
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and mouse cells, a role for XRN2 in pre-rRNA processing which does not appear to be 
directly related to its exonuclease activity has also been demonstrated (Wang & 
Pestov, 2011; Zakrzewska-Placzek et al, 2010). Further, in yeast the exosome plays an 
important role in quality control pathways which ensure the production of functional 
ribosomes by degradation of defective pre-rRNAs (Houseley et al, 2006). These 
aberrant precursors are polyadenylated by the TRAMP complex targeting them for 
degradation by the exosome. Polyadenylated pre-rRNAs have been identified in higher 
eukaryotes implying that this mechanism may be conserved. 
 The majority of our knowledge about the many functions of exonucleases, 
particularly the exosome, is derived from studies carried out in S. cerevisiae. Although 
evidence suggests that some of these functions are conserved in human cells, it is 
likely that exonucleases also have additional or different roles in RNA processing in 
higher eukaryotes. We therefore aimed to characterise the interactions and activity of 
the human nuclear exosome in vitro and study its function on two substrates with which 
the human exosome has been shown to be associated, pre-snoRNAs and ribosomal 
RNAs. 
 
3.2 Results 
3.2.1 Purification and interactions of recombinant exonuclease proteins and their 
cofactors  
A crystal structure of the core human exosome composed of nine subunits has 
been published (schematic in Figure 3.1) but it was not clear how the active subunits 
and cofactors interacted with this core (Liu et al, 2006). In yeast, Rrp44 provides the 
majority of the activity of the exosome but DIS3, the nuclear homologue in human cells, 
is less stably associated with core exosome (Staals et al, 2010; Tomecki et al, 2010b). 
This suggests that human RRP6 and its cofactors may play a more prevalent role in 
processing of exosome substrates in human cells. It was therefore decided to 
investigate how human RRP6 and its cofactors, C1D and MPP6, interact with proteins 
of the nine-membered core exosome.  
His-tagged forms of the nine core exosome proteins; RRP4, RRP40, CSL4, 
RRP43, RRP46, RRP41, RRP45, RRP42 and MTR3 were over-expressed in E.coli and 
purified by nickel-affinity. GST-tagged RRP6, C1D, MPP6 and GST-alone were 
similarly over-expressed in E.coli and purified using their GST-tags (Figure 3.3A). 
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His-RRP45 was very unstable and did not remain in solution at usable 
concentrations so this protein was excluded from subsequent interaction studies. In 
preliminary experiments, His-RRP41 co-purified with a large number of other proteins 
(exosome cofactors and snoRNP proteins). The data generated were not reproducible 
and the large number of potential interactions observed suggested that these 
interactions were non-specific. For this reason RRP41 was also not included in further 
protein-protein interaction studies. 
Recombinant His-tagged core exosome proteins were incubated with either 
GST-alone, GST-RRP6, GST-C1D or GST-MPP6 and any complexes formed were 
purified using glutathione sepharose. Bound proteins were then separated by SDS-
PAGE, followed by Western blotting using an α-His antibody. This detected core 
exosome proteins that had been co-purified with the sepharose bound GST, GST-
 
Figure 3.3 Protein-protein interactions between the core exosome, RRP6 and its cofactors 
A) Proteins of interest were expressed in E. coli, purified by either their His- or GST-tags, 
separated by SDS-PAGE and visualised by Coomassie staining. Positions of marker proteins are 
indicated to the left of the panel. B) Recombinant GST or GST-tagged RRP6, C1D7 or MPP6 was 
bound to glutathione sepharose and incubated with each of the His-tagged core exosome 
proteins. Co-purified complexes were separated by SDS-PAGE and analysed by Western blotting 
using an α-His antibody. A) represents 10X input of each protein. Co-purified proteins are 
indicated to the right of relevant panels C) Reactions were carried out as in B) using glutathione 
sepharose bound to either GST-alone, GST-C1D or GST-MPP6 and untagged-RRP6 was added 
as indicated above the panel. In each panel, the first three lanes show 10% input (10% In). Co-
purified complexes were separated by SDS-PAGE and visualised by Coomassie staining. D) 
Schematic diagram of protein-protein interactions between the core human exosome, RRP6 and 
it’s cofactors. PH domain proteins which form the hexameric ring are shown in dark and mid- 
blue. RNA binding (KH/S1) domain proteins of the cap are shown in pale blue. RRP6 and its 
cofactors are shown in red and pink. Strong interactions are indicated by thick black lines and 
weak interactions are indicated with dashed lines. 
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RRP6, GST-C1D or GST-MPP6 and are therefore able to interact with the GST-tagged 
proteins (Figure 3.3B). None of the core exosome proteins interacted with the GST-tag 
alone showing that interactions observed with exosome proteins were specific to the 
coding regions of the proteins. RRP6 was able to co-purify RRP40 efficiently 
suggesting a strong interaction, while weaker interactions were also observed with 
RRP4, CSL4, MTR3, RRP43 and RRP42. As RRP6 interacts with all the KH/S1 
domain proteins, this suggests that RRP6 is associated with the “cap” face of the core 
exosome. Weak protein-protein interactions were also observed between C1D and 
RRP40, CSL4 and MTR3. As C1D is a cofactor of RRP6 it is logical that interactions 
are seen with RRP6-interacting proteins and suggests C1D also interacts with the cap-
side of the exosome. All the interactions of C1D are weaker than those observed for 
RRP6 implying that C1D is less closely associated with the core exosome than RRP6 
is. No protein-protein interactions were observed between the core exosome and 
MPP6.  
It was next decided to determine if human RRP6 interacts with C1D and MPP6 
as the yeast proteins do. GST-RRP6 was expressed from the pGEX6P1 plasmid, 
which encodes a PreScission protease cleavage site between the protein coding region 
and the GST-tag. Purified GST-RRP6 was treated with PreScission protease to 
produce untagged protein. GST-alone and GST-C1D were incubated with untagged 
RRP6 and complexes formed were co-purified using glutathione sepharose. Proteins 
were then analysed by SDS-PAGE and proteins visualised by Coomassie staining 
(Figure 3.3C, left panel). RRP6 did not co-purify with the GST-alone showing no 
interaction had taken place, whereas a robust interaction was detected between RRP6 
and C1D. 10% protein inputs were also separated by SDS-PAGE and by comparison 
>10% of RRP6 is co-precipitated by C1D. A similar experiment was carried out using 
GST-MPP6 and an equally robust interaction with RRP6 was observed (Figure 3.3C, 
right panel). As MPP6 was not observed to interact the with core exosome proteins, 
this suggests that RRP6 mediates association of these proteins with the core exosome 
in vivo. Based on these data, a protein-protein interaction network has been outlined 
(Figure 3.3D). 
 
3.2.2 Ribonuclease activity of the exosome 
In yeast, RRP6 has been characterised as having distributive 3’-5’ exonuclease 
activity but, at the time of carrying out these experiments, the exonuclease activity of 
the human protein had not been investigated. Characterising the in vitro activity of 
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RRP6 is important as this sheds light on which substrates the protein may be able to 
process in vivo and how this processing might take place. 
 
3.2.2.1 Recombinant human RRP6 has distributive 3’-5’ exonuclease activity in 
vitro  
In vitro exonuclease assays were carried out using purified recombinant human 
RRP6 (hRRP6) and S. cerevisae RRP6 (yRRP6) proteins (Figure 3.4A). RNase D-like 
nucleases, such as RRP6, contain conserved DEDD motifs in their catalytic sites. 
These four key amino acid residues are essential for the exonuclease activity of the 
proteins (Januszyk et al, 2011). A sequence alignment of yeast and mammalian RRP6 
identified the human RRP6 DEDD motif and the first amino acid in this as aspartate 
313. For the expression of a catalytically inactive enzyme, hRRP6exo, a point mutation 
was introduced into the plasmid from which the protein was expressed so that D313 
would be substituted by alanine. Time course nuclease assays using a 5’-end labelled 
poly (A) RNA substrate were performed, with samples taken at various time points over 
two hours. Both human and yeast RRP6 exhibited 3’-5’ exonuclease activity under 
these conditions (Figure 3.4B). In contrast, the hRRP6exo protein showed no nuclease 
activity confirming that the activity observed for hRRP6 and yRRP6 can be attributed to 
the protein itself and that D313 is a key amino acid for the catalytic activity of hRRP6 
(Figure 3.4B). When hRRP6 was included, the full length labelled RNA was totally 
converted to shorter products within 10 min. Accumulation of progressively shorter 
fragments increased during the time course and after 120 min all the labelled RNA had 
been converted to fragments of 10 nt or less. The total amount of labelled RNA present 
after 120 minutes was significantly lower than the input suggesting that much of the 
RNA had been completely degraded to single nucleotides. Similarly, yRRP6 converted 
the full length RNA substrate to short products within the first 10 min of the assay. The 
range of fragments detected at each point during the time course was slightly longer 
than those detected for hRRP6 by approximately 5 nt. After 120 min in the presence of 
yRRP6 the labelled RNA had all been converted to products 10-17 nt in length. Taken 
together, the data suggest that the human recombinant protein purified for this 
experiment had slightly higher 3’-5’ exonuclease activity than the yeast protein.  
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Figure 3.4 In vitro exonuclease activity of human RRP6 A) Human RRP6 (hRRP6), human 
RRP6 D313A (hRRP6exo) and yeast RRP6 (yRRP6) were expressed in E. coli and purified by 
their GST-tags. Purified proteins were then separated by SDS-PAGE and visualised by 
Coomassie staining. The positions of the marker proteins are indicated to the left of the panel. B) 
200 fmol of recombinant protein (hRRP6, RRP6exo or yRRP6) and 10 fmol of 5’ end labelled 30-
mer-polyadenosine (A30) RNA substrate (shown in (C)) were incubated for 120 min at 30 
o
C with 
samples of equal volume being taken at the time points shown above the panel. Reactions were 
separated on a 12 % polyacrylamide/8 M urea gel and visualised using a phosphorimager. The 
asterisk marks a labelled contaminant in the substrate which should be disregarded. D) 
Schematic outline of the U14 stem loop substrate. A red asterisk marks the labelled 5’ end. E) 
Exonuclease assays using the 5’ end U14 RNA substrate and hRRP6, hRRP6exo and yRRP6 
were carried out and results visualised as in A). F) Exonuclease assays using human RRP6 were 
carried out in the presence and absence of the exosome cofactors, GST-C1D and GST-MPP6 
(see previous figure). 
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3.2.2.2 Human RRP6 is able to degrade RNA with secondary structure  
 The poly (A) substrate used in the previous section is not representative of RNA 
substrates that the exosome is likely to encounter in the cell as it does not form any 
secondary structures. We therefore investigated the exonuclease activity of both yeast 
and human RRP6 in the degradation of an RNA substrate containing a stem-loop. A 27 
nt fragment of the U14 snoRNA which forms a stem-loop structure with 10 nt involved 
in base-pairing interactions, 17 nt forming the loop and a single nucleotide overhang at 
the 3’ end was radio-labelled at the 5’ end (Figure 3.4C). Neither hRRP6exo or yRRP6 
were able to degrade this substrate in vitro (Figure 3.4D). Purified hRRP6 did, 
however, degrade the stem-loop RNA with a ladder of shorter RNAs becoming 
detectable over time (Figure 3.4D). The activity of hRRP6 on this structured substrate 
is notably lower than on poly (A) RNA with only approximately 10 nt being removed 
within two hours and a significant proportion of full length RNA remaining intact for the 
duration of the time course.  
 
3.2.2.3 The 3’-5’ exonuclease activity of RRP6 is stimulated by C1D and inhibited 
by MPP6 
In the nucleus, RRP6 is associated with cofactor proteins, C1D and MPP6, and 
although these cofactors are required for many of the functions carried out by the 
RRP6-exosome, for example in 5.8S rRNA processing, it is not clear what role they 
play (Schilders et al, 2005; Schilders et al, 2007). We have been able to demonstrate 
protein-protein interactions between RRP6 and its cofactors, C1D and MPP6, so next 
investigated whether these cofactors influenced the exonuclease activity of RRP6.  
Recombinant C1D, MPP6 and RRP6 were incubated individually or in various 
combinations with the 5’ end-labelled U14 stem-loop labelled RNA substrate and 
samples taken over a time course. No exonuclease activity was observed for either 
C1D or MPP6 alone. RRP6 displayed 3’-5’ exonuclease activity with the appearance of 
a ladder of truncated 5’ labelled substrates after 5 min (Figure 3.4E). When RRP6 was 
combined with C1D, the exonuclease activity was enhanced as a more significant 
increase in the accumulation of short RNA species of 16-18 nt was detected (Figure 
3.4E). Even after 30 min incubation, these short fragments were barely detectable 
when RRP6 was mixed with MPP6, indicating that the exonuclease activity of RRP6 
was inhibited (Figure 3.4E). Further, the RNA substrate was rapidly degraded, in 5 min 
to a 22 nt species by RRP6 alone, whereas when MPP6 was also present this 
fragment was only detectable to a comparable level after 15 minutes. When RRP6 was 
combined with both C1D and MPP6, the exonuclease activity observed was 
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comparable to that of RRP6 alone. Taken together, these data suggest that C1D 
promotes the in vitro exonuclease activity of RRP6 while MPP6 regulates or inhibits 
this activity.  
 
3.2.3 Protein-protein interactions between exosome and snoRNP 
proteins/biogenesis factors 
 Association of the human exosome with pre-snoRNAs has been demonstrated 
in vivo by immunoprecipitation of pre-U3 and pre-U8 with antbodies raised against the 
exosome component, RRP46 (Watkins et al, 2004; Watkins et al, 2007). It was, 
therefore, decided to investigate if direct protein-protein interactions between exosome 
subunits and both core snoRNP proteins and snoRNP biogenesis factors could also be 
detected in vitro. Core snoRNP proteins fibrillarin and 15.5K and the snoRNP 
biogenesis factors TIP48, TIP49, BCD1, NUFIP and NOP17 were expressed with N-
terminal GST-tags in E. coli and purified using their tags (Figure 3.5A, left panel). The 
core snoRNP proteins, NOP56 (residues 1-458) and NOP58 (residues 1-435) were 
expressed with N-terminal thrioredoxin (TRX) and C-terminal His tags in E. coli and 
were purified using their His-tags (Figure 3.5A, right panel). These truncated versions 
of NOP56 and NOP58 have been shown to function normally in snoRNP complexes 
(Gautier et al, 1997; Lafontaine & Tollervey, 2000). These recombinant snoRNP 
proteins were incubated with the His-tagged core exosome proteins described in 
section 3.2.1 (Figure 3.5B) and any complexes formed were purified using glutathione 
sepharose (GST-tagged proteins) or anti-thioredoxin bound protein G sepharose 
(NOP56 and NOP58). Reactions containing the ATPases, TIP48 and TIP49, were 
supplemented with 1 mM ATP to reflect the ATP-bound state of these proteins during 
snoRNP biogenesis. Complexes formed were analysed by SDS-PAGE followed by 
Western blotting to detect the His-tagged exosome proteins (Figure 3.5C). None of the 
exosome proteins were observed to co-purify with the GST or TRX-tags implying that 
no interactions were taking place and verifying that any exosome proteins co-purified 
with the snoRNP proteins were detected due to interactions with the proteins 
themselves. No interactions were detected between exosome proteins and the mature 
snoRNP proteins, fibrillarin, 15.5K, NOP56 or NOP58. A robust interaction was 
detected between the snoRNP biogenesis factor, BCD1, and the exosome protein, 
MTR3. Weaker, but repeatable, interactions were detected between the ATPases, 
TIP48 and TIP49, and the S1/KH domain exosome proteins, RRP40 and CSL4. No 
interactions were detected between the exosome proteins and proteins found in the 
mature snoRNP. These data imply that the exosome is associated with pre-snoRNPs 
but may suggest that it dissociates when the mature snoRNP is formed.  
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Figure 3.5 Protein-protein interactions between exosome proteins and snoRNP proteins A) 
GST- or His/Thioredoxin (TRX)-tagged core snoRNP proteins and GST-tagged snoRNP 
biogenesis factors were over-expressed in E. coli and purified through their GST or His tags. 
Purified proteins were separated by SDS-PAGE and transferred for Western blotting using 
antibodies to detect the GST tag (left panel) or the His tag (right panel). Red asterisks mark the 
full length proteins. Protein loading represents 10% input for interaction experiments (C) except 
for NOP58 where the amount of protein was increased two fold. B) His-tagged core exosome 
proteins were over-expressed in E. coli and purified using their His-tags. Purified proteins were 
separated by SDS-PAGE and analysed by Western blotting using an antibody which detects the 
His-tags. Protein loading represents 10% input for the interaction experiments shown in (C). C) 
Recombinant GST, GST-tagged snoRNP proteins, TRX or His/TRX snoRNP proteins were bound 
to either glutathione sepharose or anti-thioredoxin bound protein G sepharose and incubated with 
each of the His-tagged core exosome proteins. Co-purified complexes were separated by SDS-
PAGE and analysed by Western blotting using an antibody which detects the His-tags.  
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3.2.4 Sequencing of precursor snoRNAs  
 To understand how the exosome may be involved in snoRNA processing we 
first wanted to investigate the nature of box C/D snoRNA precursor sequences and the 
pathways by which they are removed in normal cells. The human exosome has been 
shown to be associated with two box C/D pre-snoRNAs, U3 and U8 making these pre-
snoRNAs appropriate candidates for investigation (Watkins et al, 2004; Watkins et al, 
2007). The mechanisms by which these two pre-snoRNAs are thought to be processed 
are, however, different. U8 snoRNA has a 25 nt precursor sequence that is removed in 
a multi-step pathway with four distinct precursors identifiable by Northern blotting 
(Watkins et al, 2007), while the U3 snoRNA has a shorter precursor that, it is proposed, 
is removed in a single processing step. Although human pre-U3 processing has not 
been thoroughly investigated, in rat, two different U3 precursors have been detected 
(Stroke & Weiner, 1985; Watkins et al, 2004). We therefore, determined the distribution 
of 3’ end of pre-U3 in wild-type human cells. 
 Total RNA was extracted from HeLa cells and an oligonucleotide adaptor 
ligated to the 3’ ends of all RNA molecules. Reverse transcription from a primer 
annealing to the adaptor oligonucleotide generated cDNAs representing all the RNAs 
to which the adaptor had been ligated. PCR amplifications were then carried out using 
a forward primer specific for the 3’ end of U3. As pre-U3 is much less abundant than 
mature U3, this primer was designed to extend from the 3’ end of the mature sequence 
2 nt into the precursor sequence so that pre-snoRNAs would be specifically amplified 
(Figure 3.6A). PCR products were separated on a non-denaturing polyacrylamide gel 
(Figure 3.6B) and the band corresponding to pre-U3 excised. PCR products were 
extracted from the gel and cloned into pGEMTeasy. DNA was extracted from 85 
colonies and sequenced. 15 plasmids were sequenced using reactions terminating at 
each of the four bases and the remainder were sequenced using only reactions 
terminating at thymine bases (Figure 3.6C). A graphical representation of the number 
of U3 precursors found terminating at each nucleotide in the precursor sequence is 
given in Figure 3.6D.  
 Sequencing data showed that the longest precursor sequences were 13 nt long 
and could be defined as 5’-TTTTCCTTCTTGA-3’. This sequence differs from the 
published precursor sequence of U3 (5’-TTTTCCTTCATT-3’) which had been defined 
based on data from Northern blot analysis and comparison to database sequences 
(Watkins et al, 2004). The approach described here, however, assesses the 3’ ends of 
human pre-U3 directly. 
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Figure 3.6 U3 precursor sequencing A) Outline of the method used for pre-snoRNA sequencing. 
Black lines indicate mature snoRNA sequence, red indicates precursor sequence, blue indicates 
adaptor oilgonucleotide and grey indicates cDNA/PCR products. Reaction steps are named adjacent 
to flow diagram arrows. B) Total RNA was extracted from HeLa cells and an adaptor oligonucleotide 
ligated to 3’ ends from which reverse transcription (+ or- enzyme as indicated) was followed by PCR 
using a preU3-specific primer. PCR products were separated on a 6 % non-denaturing 
polyacrylamide gel and visualised with UV. The positions of DNA markers is shown to the left. The 
pre-U3 specific band which was excised is indicated. C) PCR products shown in B were extracted 
from the acrylamide gel and cloned into pGEMTeasy vector. DNA was extracted from positive clones 
and sequenced. A full-length precursor sequence terminating at each of the bases is shown to the 
left. Samples were separated on a denaturing 12 % polyacrylamide/7 M urea gel and products 
visualised by autoradiography. D) Bar chart showing number cloned pre-U3 sequences terminating 
at each nucleotide in the precursor sequence. E) Alignment of U3 precursors from human, mouse 
and rat adapted from Watkins et al. Cell 2004. Sequences are aligned with respect to the mature 
snoRNA sequence and the position of the 3’ box (Neuman de Vegvar et al., 1986; Hernandez and 
Weiner, 1986; Neuman de Vagvar and Dahlberg, 1990). 3’ ends of intermediate precursors 
processing steps are indicated with red arrows for rat (Stroke and Weiner, 1985), below and for 
human sequences, above. 
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Our data demonstrate that the majority of U3 precursors terminate at one of 
three different nucleotides indicated by the upper red arrows in Figure 3.6E. This 
suggests that, like U8 precursors (Watkins et al, 2007), human U3 precursors are 
heterogeneous and are also processed in a step-wise manner. As the U3 precursors 
only differ in length by 2-3 nt they can only be distinguished by direct sequencing 
methods as applied here. Previously published data (Stroke & Weiner, 1985) have 
shown that pre-U3 in rat is processed via two intermediates also indicated in Figure 
3.6E. As we find that both U3 and U8 pre-snoRNAs are processed using a similar 
multistep mechanism, this may indicate a common pathway for pre-snoRNA 
processing. 
 A similar approach was used to try to define the precursor sequence of U8. 
Although the majority of plasmids from the colonies screened did not contain U8 
sequences, sequencing data from the U8-containing clones obtained, identified several 
pre-snoRNAs terminated 4, 13, 17 and 23 nt from the 3’ end of the mature sequence. 
These correspond with the published precursor intermediates (Watkins et al, 2007). 
The number of pre-U8 clones was, however, insufficient for any conclusions to be 
drawn about the relative ratios of each of these precursors. 
 
3.2.5 RNAi depletion of key exosome subunits does not significantly affect pre-
snoRNA or mature snoRNA levels 
 To determine if the exosome is involved in the 3’ processing of snoRNAs, the 
levels of pre-snoRNAs in cells depleted of exosome subunits and cofactors were 
investigated. If the activity of the exosome is required for converting pre-snoRNAs into 
mature snoRNAs, decreasing exosome levels is likely to inhibit processing causing pre-
snoRNAs to accumulate with a concomitant decrease in mature snoRNA levels. 
Consistent with this hypothesis, deletion of either Rrp6 or Rrp47 from yeast cells 
causes the accumulation of 3’ extended snoRNAs (e.g. snR38, snR50, snR52) and 
snRNAs such as U6 (Mitchell et al, 2003). 
siRNA duplexes targeting the nuclear exosome subunits, RRP46, RRP6 and 
DIS3 and the cofactors, C1D, MPP6 and MTR4, were chemically transfected into HeLa 
cells. A siRNA duplex targeting the mRNA of firefly luciferase, a gene not expressed in 
HeLa cells, was also used as a negative control. 60 hours after transfection, cells were 
harvested. Western blot analysis of proteins from RNAi treated cells using antibodies 
specifically detecting each protein of interest showed that each of the exosome 
proteins had been depleted to <10% of normal levels while the levels of the 
cytoskeletal protein, actin, were unaffected (Figure 3.7A). Each siRNA duplex 
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specifically depleted its target protein and none were observed to affect the levels of 
any other exosome proteins. 
 
To determine if exosome depletion affected pre-snoRNA levels, RNA was 
extracted from RNAi treated cells and analysed on a denaturing polyacrylamide gel 
followed by Northern blotting using a probe hybridising to U8. This snoRNA was 
chosen as it has a long precursor sequence meaning pre-snoRNAs are readily 
distinguishable from mature snoRNAs using this method. This showed that no 
significant increase in the levels of any of the four U8 precursors could be observed 
after depletion of any of the exosome subunits (Figure 3.7B). It was not possible to 
perform a similar analysis of U3 precursors in cells depleted of exosome proteins using 
Northern blotting as the U3 precursor sequence is short and the mature U3 snoRNA is 
relatively so abundant that the precursor cannot easily be distinguished by Northern 
blotting. 
 
Figure 3.7 Depletion of exosome subunits by RNAi does not lead to changes in precursor or 
mature snoRNA levels A) HeLa cells were chemically transfected with siRNA duplexes to deplete 
firefly luciferase (control), RRP46, RRP6, C1D, MPP6, MTR4 or DIS3. Protein was extracted from 
RNAi depleted cells after 60 hours and analysed by SDS-PAGE followed by Western blotting. 
Proteins of interest were detected by antibodies specific to each protein, indicated to the left of 
each panel B) RNA was extracted from siRNA treated cells, separated on an 8% acrylamide/7M 
urea gel, transferred to a nylon membrane and hybridised with an oligonucleotide probe targeting 
mature U8 snoRNA. C) RNA was also analysed by Northern blotting using probes hybridising to the 
sn/snoRNAs; U1, U3, U8, U13, U14 and U15. D) Quantification of sn/snoRNA levels shown in C) 
were carried out using ImageQuant software. snoRNA levels were normalised to U1 and are given 
as a percentage compared to snoRNA levels in cells treated with the control siRNA.  
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We further examined the levels of a range of different mature snoRNAs in cells 
depleted of specific exosome proteins. HeLa cells were transfected with siRNAs 
targeting exosome proteins and cofactors as above. RNA was analysed by PAGE 
followed by Northern blotting using probes hybridising to the independently transcribed 
snoRNAs (U3, U8 and U13), snoRNAs derived from introns (U14 and U15) and the 
snRNA, U1. RNAs were visualised using a phosphorimager and quantified. U1 was 
used as a loading control and the levels of all the snoRNAs were normalised to U1 
levels (Figure 3.6C, D). No significant differences in the levels of any of these snoRNAs 
could be observed by Northern blot analysis. Quantitation showed that the levels of all 
these snoRNAs in each of the exosome knockdowns varied by <10 % compared to 
control cells and no consistent trends were observed for any particular exosome 
protein on either class of snoRNA. It was concluded that RNAi depletion of exosome 
proteins and cofactors did not significantly affect snoRNA levels. 
 
3.2.6 Exonucleases are required for turnover of snoRNAs 
 Another possible function of the exosome is the degradation, rather than the 
processing, of snoRNAs. As part of other work presented in Chapter 4, POP1, a core 
protein of the RNase MRP snoRNP, was depleted both individually and in combination 
with the 5’-3’ exonuclease, XRN2. Western blot analysis of proteins from siRNA treated 
cells showed that the targeted proteins were significantly depleted (Figure 3.8A). RNA 
from siRNA treated HeLa cells was analysed by PAGE followed by Northern blotting 
using a probe hybridising to the RNA component of RNase MRP. This revealed that 
depletion of POP1 caused the levels of MRP RNA to decrease to 37 % of those in cells 
treated with a control siRNA (Figure 3.8B). Interestingly, depletion of XRN2 caused 
MRP RNA levels to increase almost two-fold and when XRN2 was co-depleted with 
POP1, MRP RNA levels were 90 % of those in control cells (Figure 3.8B). This 
increase in the levels of a mature RNA following depletion of an exonuclease indicated 
that XRN2 was important for the turnover of MRP RNA and raised the possibility that 
this method could be used to identify whether the exosome also played a role in 
degradation of either MRP RNA or box C/D snoRNAs. 
 Co-depletion of either of the active subunits of the exosome, RRP6 or DIS3, 
with POP1 did not rescue MRP RNA levels as XRN2 did, indicating that the exosome is 
not required for turnover of MRP RNA (Figure 3.8C). Depletion of any of the core box 
C/D snoRNP proteins causes a decrease in snoRNA levels (Newton et al, 2003) and 
(Watkins lab, unpublished data). HeLa cells were transfected with siRNA duplexes 
targeting NOP58, RRP6, DIS3, XRN2 or combinations of NOP58 with one of the  
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exonucleases. Western blot analysis of proteins from siRNA treated cells showed that 
NOP58 was significantly depleted (Figure 3.8D). RNA was analysed by PAGE followed 
by Northern blotting using probes hybridising to the independently transcribed 
snoRNAs, U3 and U8, the intronic snoRNA, U14, and the RNA component of the signal 
recognition particle (SRP), 7SL. The levels of 7SL were used as a loading control and 
the levels of all the snoRNAs were normalised to this. Depletion of NOP58 caused the 
levels of U3, U8 and U14 to be decreased approximately three fold (Figure 3.8E, F). 
Co-depletion of DIS3 with NOP58 did not significantly restore the levels of any of the 
snoRNAs suggesting that DIS3 is not involved in snoRNA turnover (Figure 3.8E, F). In 
contrast, depletion of either RRP6 or XRN2 with NOP58 rescued U8 levels by 15%, 
U14 levels by approximately 10% and U3 levels by 15 and 22% respectively (Figure 
3.8E, F). These results were reproducible and from this we concluded that both RRP6 
 
Figure 3.8 Exonucleases are important for turnover of snoRNAs A) HeLa cells were transfected 
with a control siRNA or siRNA duplexes targeting POP1, XRN2 or both proteins. After 60 hours cells 
were harvested and protein levels were analysed by Western blotting. Due to lack of anti-POP1 
antibody, the membrane carrying control and POP1 samples was probed in the laboratory of G. 
Pruijn. B) RNA was separated on an 8 %polyacrylamide/7M urea gel by electrophoresis and 
transferred to a nylon membrane. Northern blot hybridisation was carried out using probes 
recognising MRP or U1 snRNA. + indicates that POP1 is present and – represents depletion of 
POP1. RNA was visualised using a phosphorimager and quantified using ImageQuant software. C) 
A similar experiment to that described in (A) was performed but instead of XRN2, cells were 
depleted of the active exosome subunits, RRP6 or DIS3. D and E) HeLa cells were depleted of the 
exonuclease proteins shown above the panel individually (+) or in combination with NOP58 (-). 
Western blot analysis of proteins from cells in which NOP58 had been depeleted was carried out. 
Northern blot hybridisation was performed using probes to detect U3, U8 and U14 snoRNAs and the 
RNA component of the signal recognition particle, 7SL. F) Results shown in (E) were quantified 
using ImageQuant software and loading was normalised to 7SL levels. Relative levels of each 
snoRNA were then calculated by comparison to their levels in control cells. 
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and XRN2 are involved in the turnover of both independently transcribed and intronic 
snoRNAs. 
 
3.2.7 Formation of the 3’ end of 5.8S rRNA involves the exosome in human cells 
 We next decided to investigate roles of the exosome in pre-rRNA processing in 
human cells. One of the best characterised roles of the yeast exosome is in 3’ 
processing of 5.8S pre-rRNA and this function has been shown to be conserved in 
human cells (Mitchell et al, 1996; Schilders et al, 2005; Schilders et al, 2007; Tomecki 
et al, 2010b). HeLa cells were transfected with siRNA duplexes targeting RRP46, 
RRP6, C1D, MPP6, MTR4 or DIS3 and cells were harvested after 60 h. RNA was 
extracted from RNAi treated cells and analysed by PAGE followed by Northern blotting 
and hybridisation using probes targeting the mature 5.8S sequence and the 5’ end of 
ITS2. Following depletion of each of the exosome proteins and cofactors two extended 
precursor forms of 5.8S (Pre-I and Pre-II), which were not found in control cells, were 
detected (Figure 3.9). These precursors contained sequences at 5’ end of ITS2 
demonstrating that they are 3’ extended precursors of 5.8S. Depletion of different 
exosome subunits leads to variation in the relative extent to which each of the 
precursors accumulates. When RRP46 or the helicase, MTR4, were depleted 
predominantly the longer, Pre-II form was detected. Conversely, in the absence of 
MPP6, Pre-I is seen to accumulate to a much greater extent than Pre-II. Pre-I and Pre-
II accumulate to a similar extent upon depletion of either RRP6, its cofactor, C1D, or 
DIS3.  
 
 
3.2.8 Exonucleases are required for the degradation of pre-rRNA fragments 
In yeast, another key role of exonucleases in the nucleus is the degradation of 
pre-rRNA fragments that have been released by endonucleolytic cleavages during 
processing (Lebreton et al, 2008; Petfalski et al, 1998; Schaeffer et al, 2009; Schneider 
et al, 2009). This has subsequently also been shown to be the case in mouse cells 
 
Figure 3.9 The exosome and its cofactors are 
required for 3’ processing of 5.8S rRNA HeLa 
cells were transfected with a control siRNA or 
siRNA duplexes targeting the core exosome 
(RRP46), the active exosome subunits, RRP6 or 
DIS3, or the nuclear cofactors, C1D, MPP6 or 
MTR4. Cells were harvested after 60 hours and 
RNA was extracted. RNA was analysed on an 8% 
polyacrylamide/7M urea gel followed by Northern 
blotting using probes hybridising to the mature 
5.8S pre-rRNA or the 5’ end of ITS2.  
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(Wang & Pestov, 2011). The 5’ETS is removed from the pre-rRNA transcript in a 
stepwise manner via three cleavage sites, A’, A0 and A1, in higher eukaryotes. It was, 
therefore, of interest to see if any 5’ETS fragments accumulated in the absence of 
either RRP6 or XRN2 in HeLa cells.  
 RNAi was used to deplete RRP6 or XRN2 from HeLa cells as previously 
described. RNA was extracted and analysed by agarose-glyoxal gel electrophoresis 
followed by Northern blotting using probes hybridising to regions of the 5’ETS: 5’ to A’ 
(ETS1), between A’ and A0 (ETS2) or between A0 and the 5’ end of 18S (ETS3) (Figure 
3.10A). In control cells, none of these 5’ETS fragments were detected but after 
depletion of XRN2, the ETS1 and ETS3 fragments were seen to accumulate 
suggesting that XRN2 participates in their turnover (Figure 3.10B). The probe 
hybridising to the ETS3 region shows significant cross-hybridisation with 18S but the 
ETS3 fragment, which is approximately 200 nt longer, can be seen to accumulate 
above 18S after XRN2 depletion. Significantly less of the ETS3 fragment was seen to 
accumulate than either ETS1 or ETS2. Depletion of RRP6 did not lead to accumulation 
of either of these fragments but did lead to accumulation of the ETS2 fragment (Figure 
3.10B). Two differently sized ETS2 fragments were observed suggesting that turnover 
of this fragment occurs in multiple stages.  
When detected by Northern blotting following agarose-glyoxal gel 
electrophoresis, the ETS1 fragment appeared as a diffuse band suggesting it is 
composed of a heterogeneous population of RNAs. To investigate this, RNA from cells 
depleted of XRN2 was analysed using a 4 % polyacrylamide gel followed by Northern 
blotting using the probe hybridising to ETS1. The ETS1 fragment accumulated after 
XRN2 depletion migrated as two bands and comparison to a labelled size markers 
shows that this fragment is approximately 400 nt in length (Figure 3.10C). These 
observations are consistent with this fragment being generated by endonucleolytic 
cleavage at the A’ site and XRN2 being the primary exonuclease involved in its 
degradation.  
When RRP6 was depleted, accumulation of a novel intermediate, 37S*, was 
also detected using both the ETS2 and ETS3 probes but not the ETS1 probe (Figure 
3.10B). This indicates that the transcripts from which 37S* are derived have undergone  
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A’ cleavage but not downstream processing. Assuming that the 5’ end of 37S* maps to 
the A’ cleavage site, the size of this intermediate implied that the 3’ end would 
terminate either at the 3’ end of ITS2 or within 28S. Northern blot mapping of 37S* in 
cells depleted of RRP6, using probes spanning this region, was carried out to address 
this question. 37S* was detected using probes hybridising 1300 nt into 28S but not 
when using a probe hybridising 1700 nt from the 5’ end of 28S (Figure 3.10D). This 
demonstrated that the 3’ end of 37S* lies between 1300-1700 nt downstream of the 5’ 
end of 28S. This suggests it is not an rRNA processing intermediate but that instead, it 
is a degradation product normally turned over by the exosome. A very weak signal was 
 
Figure 3.10 Exonucleases in degradation of pre-rRNA fragments A) Schematic outline of 
human pre-rRNA showing the relative positions of important cleavages and probes using in 
Northern blot hybridisation. B) RNAi using siRNAs targeting either firefly luciferase (Control), 
RRP6 or XRN2 mRNAs was carried out in HeLa cells. Cells were harvested and RNA extracted 60 
hours after transfection. RNA was analysed on a 1.2 % agarose-glyoxal gel which was then 
transferred to a nylon membrane. The membrane was stained using methylene blue to visualise 
28S and 18S mature rRNAs. Northern blot hybridisation was carried out using probes targeting 
either the 5’-A’ (ETS1), A’-A0 (ETS2) or A0-A1 (ETS3) fragments of pre-rRNA shown in A. RNAs 
were visualised using a phosphorimager. Pre-rRNA intermediates detected by each probe are 
shown to the right of each panel and the asterisk marks cross-reactivity of the ETS3 probe with 
18S. C) RNA was also separated on a 4 % polyacrylamide/7 M urea gel, transferred to a nylon 
membrane and hybridised using the ETS1 probe. A 5’ end labelled 100 bp DNA ladder was run 
alongside RNA samples. Results were visualised using a phosphorimager. D) RNA from HeLa 
cells treated with either a control siRNA or depleted of RRP6 was analysed on a 1.2 % agarose-
glyoxal gel and transferred to a nylon membrane. Northern blotting was carried out using probes 
hybridising to ETS1, ETS2 and two regions of 28S. RNA was visualised using a phosphorimager. 
Red asterisk marks accumulation of 37S*. 
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detected for 37S* in control cells suggesting this is a naturally occurring fragment that 
accumulates much more significantly when the exosome is depleted.  
Similarly, depletion of XRN2 lead to the accumulation of a novel intermediate, 
41S*, that can be detected with all of the 5’ETS probes (Figure 3.10B). 47S is at least 5 
fold less abundant than 45S and following XRN2 depletion, 41S* accumulated to a 
level comparable with 47S suggesting that it is a minor product. Based on the size of 
this intermediate, the 3’ end of 41S* is predicted to lie within the mature 28S sequence 
indicating that it is a degradation intermediate that is normally turned over from the 5’ 
end by XRN2.  
In addition, after RNAi depletion of XRN2, Northern blot hybridisation with the 
ETS1 probe revealed accumulation of another aberrant processing intermediate, 
30SL5’, (Figure 3.10B) which will be discussed in more detail in Section 3.2.11. 
 
3.2.9 The exonuclease activity of RRP6 is required for degradation of the ETS2 
fragment 
 By depletion of RRP6 we have shown that this exonuclease is required for 
degradation of the ETS2 fragment. This does not, however, demonstrate that the 
enzymatic activity of RRP6 is responsible for this. To confirm whether the exonuclease 
activity of RRP6 is required for turnover of the ETS2 fragment, stably transfected 
HEK293 cell lines were generated in which endogenous RRP6 could be depleted by 
RNAi and expression of FLAG- tagged wild-type, inactive protein (RRP6exo) or the 
FLAG-tag alone (pcDNA5) could be induced by addition of tetracycline. 
The RRP6exo expressed in these cells incorporates the D313A modification 
shown to inhibit the in vitro activity of RRP6 (Figure 3.4). Expression of tagged proteins 
in these cell lines utilises the normal cellular expression mechanisms and will be 
targeted by RNAi pathways as for endogenous proteins. In order to express the tagged 
protein during knockdowns, five individual base changes within the target sequence of 
each siRNA that did not alter the amino acid sequence of the open reading frame but 
would prevent siRNA annealing were introduced (Figure 3.11A).  
To enable the tagged proteins to be expressed to the same level as the 
endogenous protein, the concentration of tetracycline required to induce 1:1 expression 
was determined. Expression of FLAG-tagged protein was tested over a range of 
tetracycline concentrations (0-1 µg/ml) by treating cells for 48 hours before harvesting 
and analysis by Western blotting (Figure 3.11B). In each cell line, increasing the 
tetracycline concentration led to increased expression of FLAG-tagged proteins 
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corresponding to the correct sizes while levels of the SSU processome protein, PNO1, 
did not vary. Western blotting using an antibody against RRP6 showed the presence of 
both the endogenous and tagged forms of each protein. It was determined that the 
concentration of tetracycline required to mimic endogenous protein levels was 100 
ng/ml for RRP6. It should be noted that it was not possible to over-express RRP6 even 
at the maximum possible tetracycline concentration of 1 µg/ml. Further, increasing 
expression of the tagged form of RRP6 suppressed endogenous protein.  
The sub-cellular localisations of the FLAG-tagged, mutant forms of RRP6 were 
determined and compared to that of the wild-type FLAG-tagged protein by 
immunofluorescence since such modifications can lead to protein mislocalisation 
preventing induced proteins from carrying out the functions of the endogenous protein 
(Watkins lab, unpublished data). Cells expressing the FLAG-tag only, FLAG-tagged 
wild-type RRP6 or the RNAi resistant forms of FLAG-RRP6 or RRP6exo were induced 
with the optimial concentration of tetracycline on cover-slips for 48 hours prior to fixing. 
Antibodies specifically recognising the FLAG-tag or the core snoRNP protein, fibrillarin, 
were used in immunofluorescence and DAPI was used to visualise nuclear material. 
DAPI binds most strongly to DNA in the nucleoplasm and nucleoli appear as “holes” 
within the nucleus. Immunofluorescence showed that in all cell lines fibrillarin was 
localised exclusively to the nucleolus and is found both diffused and in concentrated 
speckles as expected (Puvion-Dutilleul et al, 1991) (Figure 3.11C). Consistent with 
previous immunofluorescence studies in which RRP6-specific antibodies were used 
(Tomecki et al, 2010b), here, RRP6 was found throughout the nucleus but significantly 
concentrated in the nucleolus and some weak RRP6-staining could be observed in the 
cytoplasm (Figure 3.11C). 
Cells expressing the FLAG-tag (pcDNA5) or RNAi-resistent FLAG-RRP6 or -
RRP6exo were transfected with siRNA duplexes targeting the mRNAs of either firefly 
luciferase (C) or RRP6 (Δ6) and after 48 hours, the expression of RRP6 was analysed 
by Western blotting. Following the control knockdown in pcDNA5 cells, the endogenous 
protein was still present whereas in cells expressing either FLAG-RRP6 or -RRP6exo 
treated with RRP6 siRNAs, only the larger, FLAG-tagged forms of RRP6 could be 
detected (Figure 3.11 D). RNA extracted from these cells was analysed by Northern 
blotting using a probe hybridising to ETS2. The levels of 47/45S and 30S were 
unaffected and the ETS2 fragment did not accumulate in either control cells or in those 
where the endogenous protein had been replaced by FLAG-tagged RRP6 (Figure 
3.11E). When the endogenous protein was replaced with FLAG-RRP6exo, however, 
significant accumulation of the ETS2 fragment was observed demonstrating that the 
activity of RRP6 is indeed required for the degradation of this fragment (Figure 3.11E). 
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It is interesting to note that 37S* was not detected in HEK293 cells during RNAi-
depletion and rescue experiments suggesting that this intermediate may be specific to 
HeLa cells.  
A similar approach was attempted to determine if the exonuclease activity of 
XRN2 was required for degradation of the ETS1 and ETS3 fragments but this was not 
successful. HEK293 cell lines for the expression of RNAi-resistant FLAG-tagged XRN2 
and inactive XRN2 were produced but it was not possible to induce expression of the 
tagged proteins to the same level as the endogenous protein. 
 
 
 
 
Figure 3.11 The exonuclease activity of RRP6 is required for degradation of the ETS2 
fragment A) Outline of siRNA target sites in RRP6. Point mutations are shown in red. B) Cells 
from RNAi resistant FLAG-RRP6 (RRP6) or FLAG-RRP6exo (RRP6exo) HEK293 stable cell lines 
were cultured in the presence of tetracycline at different concentrations (given above the panel) for 
36 hours before harvesting. Proteins were extracted and analysed by SDS-PAGE followed by 
Western blotting using the antibodies shown to the left of the panel. Tagged (F6) and endogenous 
(6) proteins are identified. C) Cells expressing only the FLAG tag (pcDNA5), FLAG-RRP6 
(RRP6wt), RNAi resistant FLAG-RRP6 (RRP6) and RNAi resistant FLAG-RRP6exo (RRP6exo) 
were grown on coverslips and induced with 100 ng tetracycline for 36 hours, fixed and assayed by 
immunofluorescence using α-Fibrillarin (green), α-FLAG (red) and DAPI (blue). D) pcDNA5, RRP6 
and RRP6exo cells were induced with tetracycline for 24hours then treated with siRNAs targeting 
either firefly luciferase (C) or RRP6 (Δ6) for a further 48 hours before harvesting. Proteins were 
extracted and analysed by SDS-PAGE followed by Western blotting using antibodies against 
RRP6 or NOP56. FLAG-tagged and endogenous proteins are identified to the right of the panel. E) 
RNA extracted from these cells was analysed by agarose-glyoxal gel electrophoresis followed by 
transfer to a nylon membrane. Methylene blue staining shows the levels of mature 28S and 18S 
rRNAs. Northern blotting using a probe hybridising to ETS2 detected pre-rRNA species identified 
to the right of the panel. 
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3.2.10 The role of DIS3 and exosome cofactors in degradation of the ETS2 
fragment and 37S* 
We have established that RRP6 is required for degradation of both the ETS2 
fragment and 37S* in HeLa cells. To investigate if the other active subunit of the 
exosome in the nucleus, DIS3, or any of the nuclear cofactors of the exosome were 
also required for these functions, HeLa cells were transfected with siRNAs targeting 
RRP46, RRP6, C1D, MPP6, MTR4 or DIS3 and pre-rRNA was analysed by agarose-
glyoxal gel electrophoresis followed by Northern blotting using the ETS2 probe. 37S* 
was seen to accumulate following depletion of the core exosome and each of the 
cofactors tested, demonstrating that they are all required for degradation of this 
intermediate (Figure 3.12). However, 37S* was not accumulated above background 
levels following depletion of DIS3, implying that this protein did not participate in 
degradation of this aberrant pre-rRNA. The ETS2 fragments were accumulated after 
depletion of RRP46, RRP6, MPP6 or MTR4, but not when C1D or DIS3 were depleted 
(Figure 3.12). Interestingly, these data imply that the exosome requires specific 
activities and cofactors depending on which RNA substrate is degraded, with C1D 
being important for degradation of 37S* but not the ETS2 fragment and RRP6, rather 
than DIS3, required for both of these functions. Further, the longer and shorter forms of 
the ETS2 fragment accumulated to different extents depending on which exosome 
component was depleted, although this varied between experiments. Here, depletion of 
RRP46 lead to significant accumulation of comparable amounts of both forms of the 
ETS2 fragment whereas depletion of RRP6, MPP6 or MTR4 cause the longer ETS2 
fragment to be accumulated to a much higher level than the shorter form. This may 
suggest that different exosome cofactors are required at different stages of the turnover 
of this fragment.  
 
 
Figure 3.12 The role of DIS3 and 
the exosome cofactors in the 
degradation of the ETS2 fragment 
and 37S* HeLa cells were 
transfected with siRNA duplexes 
targeting the core exosome 
(RRP46), RRP6, C1D, MPP6, 
MTR4, DIS3 or a control siRNA. 
After 60 hours, cells were harvested 
and RNA was extracted. RNA was 
analysed by agarose-glyoxal gel 
electrophoresis followed by 
Northern blotting using a probe 
hybridising between the A’ and A0 
sites (ETS2). 28S and 18S rRNA 
was visualised by methylene blue 
staining.  
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3.2.11 XRN2 and MTR4 are required for A’ cleavage in HeLa cells  
  Depletion of XRN2 from HeLa cells caused accumulation of 30SL5’ (Figure 
3.10A, 3.13A). This intermediate is detectable with the ETS1 probe indicating that it is a 
5’ extended form of 30S in which A’ cleavage has not taken place (Figure 3.13A). This 
implies that XRN2 is required for A’ cleavage in HeLa cells as its homologues are in 
mouse and plant cells (Wang & Pestov, 2011; Zakrzewska-Placzek et al, 2010). 
Depletion of the exosome and TRAMP helicase, MTR4, also lead to accumulation of 
30SL5’ suggesting that this protein plays a hitherto unidentified role in A’ cleavage in 
HeLa cells (Figure 3.13B). Consistent with roles in A’ cleavage, depletion of either of 
these proteins caused accumulation of 47S. Hybridisation with the ETS2 probe which 
also detects the normal, 30S pre-rRNA processing intermediate, showed that 30SL5’ 
does not accumulate as significantly following MTR4 depletion as after depletion of 
XRN2 although both proteins were depleted to similar extents, suggesting that XRN2 
plays a more important role in this cleavage step (Figure 3.13A, B).  
 
 
Figure 3.13 XRN2 and MTR4 are required for A’ cleavage A) HeLa cells were transfected with 
siRNAs to deplete either XRN2, RRP6 or combinations of these proteins or a control siRNA. + 
indicates cells in which XRN2 levels are normal and – denotes cells in which XRN2 has been 
depelted 60 hours later, RNA was extracted, separated on a 1.2% agarose-glyoxal gel and 
transferred to a nylon membrane which was stained with methylene blue to visualise 28S and 
18S rRNAs. Northern blotting using probes hybridising to ETS1 and ETS2 was carried out and 
RNAs visualised using a phosphoimager. Pre-rRNA intermediates identified are given to the right 
of the panel. B) Experiments were carried out as in A) using siRNAs to depleted XRN2, MTR4, 
both these proteins or a control siRNA. 
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Northern blotting of RNA from cells depleted of XRN2 using the ETS1 probe 
detected both the ETS1 fragment and also an additional, longer 5’ETS fragment 
extending from the 5’ end of the transcript to the A0 cleavage site (5’-A0) (Figure 
3.13A). This implies that when XRN2 is depleted, A’ cleavage can be bypassed and 
removal of the 5’ETS can occur through the A0 site instead. Indeed, when XRN2 and 
RRP6 were co-depleted, the ETS1 fragment was barely detectable and the 5’-A0 
fragment was observed to accumulate more significantly than when only XRN2 was 
depleted (Figure 3.13A). Our data would suggest, therefore, that the 3’ end of the 
majority of the ETS1 fragment accumulated after XRN2 depletion is not generated by 
A’ cleavage but instead is produced by 3’-5’ exonucleolytic processing by RRP6. This 
is consistent with the fact that RRP6 is normally responsible for the degradation of this 
pre-rRNA sequence as part of the ETS2 fragment. Northern blot analysis using the 
ETS2 probe also revealed that when RRP6 and XRN2 are co-depleted, the ETS2 
fragments are accumulated to levels far exceeding those observed when only RRP6 is 
depleted (Figure 3.13A). In different experiments, the accumulation of the ETS2 
fragment was not always as strong as presented in this figure but always exceeded the 
levels observed when RRP6 was depleted individually. This suggests that although the 
ETS2 fragment is not accumulated when XRN2 is depleted individually, that XRN2 
does participate in its turnover. The significant accumulation of the ETS2 fragment 
when both RRP6 and XRN2 are depleted may also imply that, as above, the 5’-A0 
arising from bypassing A’ cleavage, is processed to the 5’ side of the A’ cleavage site 
by 5’-3’ exonucleases other than XRN2. Depletion of MTR4 did not cause accumulation 
of the 5’-A0 fragment (Figure 3.13B). When MTR4 and XRN2 are co-depleted this 
fragment accumulates much more significantly than when only XRN2 is depleted and 
accumulation of the ETS1 fragment was notably reduced (Figure 3.13B). It may be 
interesting to note that the ratio of the longer and short ETS2 fragments is shifted 
towards the shorter product by co-depletion of XRN2 with either of the exosome 
proteins, MTR4 or RRP6. 
 
3.2.12 Core box C/D snoRNP proteins are essential for complete removal of the 
5’ETS but not for A’ cleavage 
 To assess how significant the roles of XRN2 and MTR4 in A’ cleavage are, it 
was decided to deplete other factors that are known to be required for this processing 
step and compare the severity of defects observed. The U3 snoRNP is required for 
efficient A’ cleavage in both yeast and humans and depletion of the U3-specific protein, 
hU3-55K, causes some accumulation of 30SL5’ (Prieto & McStay, 2007). The U3 
snoRNP, and other snoRNPs involved in pre-rRNA processing also contain the 
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common core snoRNP proteins, NOP56, NOP58 and fibrillarin. The effect of depleting 
these proteins on pre-rRNA processing, particularly on A’ cleavage, have not been 
investigated in human cells.  
Each of these U3 snoRNP proteins was, therefore, depleted from HeLa cells 
using RNAi. Western blot analysis of proteins from siRNA treated cells showed that the 
levels of NOP56, NOP58, fibrillarin and hU3-55K were all depleted to <10% of that in 
control cells while the levels of the cytoskeletal protein, actin, or the core exosome 
protein, CSL4, were unaffected (Figure 3.14A). 
  
Pre-rRNA from RNAi treated cells was analysed by agarose-glyoxal gel 
electrophoresis followed by Northern blotting using probes hybridising to the 5’ end of 
the pre-rRNA transcript (ETS1) or the 5’ end of ITS1. Depletion of NOP56, NOP58 or 
fibrillarin caused an increase in 47S levels indicating that A’ cleavage is impaired in 
these cells (Figure 3.14B). Also observed when levels of the snoRNP proteins were 
decreased was the accumulation of 30SL5’, a 5’ extended form of 30S in which A’ 
cleavage has not occurred (Figure 3.14B, C). This implies that when any of the core 
snoRNP proteins are depleted, A’ cleavage is inefficient. However, after snoRNP 
 
Figure 3.14 Depletion of snoRNP proteins affects A’ cleavage but completely inhibits 5’ETS 
removal HeLa cells were transfected with siRNA duplexes targeting the core snoRNP proteins, 
NOP56, NOP58 and fibrillarin, the U3-specific protein, hU3-55K, or control siRNAs. A) 60 hours 
after transfection, cells were harvested and both RNA and proteins extracted. Proteins were 
separated by SDS-PAGE and analysed by Western blotting using antibodies against the targeted 
proteins and either actin or CSL4 as loading controls. B and C) RNA was analysed using agarose-
glyoxal gel electrophoresis followed by Northern blotting using a probe hybridising near the 5’ end 
of the pre-rRNA transcript (ETS1) (B) or the 5’ end of ITS1 (C). Mature 28S and 18S rRNAs were 
visualised by methylene blue staining. The positions of the pre- and mature rRNAs are given to the 
right of the panel. D) 48 hours after siRNA transfection, cells were depleted of phosphate, pulse-
labelled with 
32
P orthophosphate and grown in normal media for 3 hours before harvesting. RNA 
was extracted and analysed by agarose-glyoxal gel electrophoresis and visualised using a 
phosphorimager. Total RNA was visualised using ethidium bromide staining (UV). 
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protein depletion, both 45S and 30S were still detected, with 30S being more abundant 
than 30SL5’, implying that in the majority of transcripts, A’ cleavage occurs normally. In 
contrast, accumulation of both 21S and 18SE, the downstream processing products of 
30S were dramatically decreased when the snoRNP proteins were depleted (Figure 
3.14C). This indicates that while the core snoRNP proteins are important for efficient 
A’, they are essential for complete removal of the 5’ETS. The requirement for the core 
snoRNP proteins for A’ cleavage appears comparable to that for MTR4 or XRN2 as 
47S and 30SL5’ are observed to accumulate to similar extents, although it must be 
noted that the proteins were depleted to slightly different extents. 
 In addition to U3, other snoRNPs are required for pre-rRNA processing and of 
particular interest is U8 as this snoRNP is only found in higher eukaryotes. In Xenopus 
laevis, U8 is required for biogenesis of the large subunit rRNAs so it was decided to 
investigate the role of NOP56, NOP58, fibrillain and hU3-55K in biogenesis of both 18S 
and 28S rRNA using metabolic labelling experiments. HeLa cells were treated with 
siRNAs targeting the mRNAs of each of the snoRNP proteins. Cells were then 
metabolically labelled using 32P orthophosphate which was chased with media 
containing unlabelled phosphate. Cells were harvested after 3 h and pre-rRNA was 
separated by agarose-glyoxal gel electrophoresis, transferred to a nylon membrane 
and analysed using a phosphorimager. In cells transfected with a control siRNA, 
47/45S, 28S, 18S and the 28S precursor, 32S, were all detected (Figure 3.14D). 
Depletion of NOP56, NOP58 or fibrillarin caused significant decreases in the levels of 
28S rRNA and almost abolished production of 18S rRNA (Figure 3.14D). In contrast, 
depletion of the U3-specific protein, hU3-55K, lead only to a decrease in 18S levels 
and did not affect 28S accumulation (Figure 3.14D). Taken together, this indicates that 
the U3 snoRNP is only required for cleavages affecting small subunit rRNA biogenesis 
while the proteins found in all box C/D snoRNPs are also necessary for biogenesis of 
the large subunit rRNAs, potentially as part of the U8 snoRNP.  
 
3.3 Discussion 
We have investigated the roles of the human exosome in processing of two 
different substrates, pre-rRNA and snoRNAs. Extending previous observations 
showing that the human exosome is associated with pre-snoRNAs (Watkins et al, 
2004; Watkins et al, 2007), we have demonstrated in vitro interactions between 
snoRNP biogenesis factors and exosome proteins. Our data question whether the 
exosome is directly involved in the processing of snoRNA precursors but demonstrate 
a role for the exosome in turnover and quality control of snoRNAs. We have also 
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shown that in HeLa cells the exosome and XRN2 have important degradation functions 
in the recycling of excised pre-rRNA spacer fragments and in the removal of aberrant 
or excess rRNA precursors. XRN2 and the TRAMP helicase, MTR4, have additional 
roles in processing of the 5’ETS as they are both required for A’ cleavage and XRN2 is 
clearly important for this step as loss of XRN2 can lead to A’ cleavage being bypassed. 
A’ cleavage is similarly inefficient in cells depleted of the core box C/D snoRNP 
proteins but surprisingly, the major role of these proteins is in 5’ETS processing steps 
downstream of A’ cleavage.  
 
The role of exonucleases in degradation of cleaved 5’ spacer fragments is 
conserved from mouse (Wang & Pestov, 2011) to human cells. XRN2 is responsible for 
the 5’-3’ degradation of the fragments extending from the 5’ end of the transcript to the 
A’ cleavage site (ETS1) and also from the A0 to A1 sites (ETS3). The fragment between 
the A’ and A0 (ETS2) is, by contrast, primarily degraded from the 3’ end by the 
exosome (Figure 3.15). The main exonuclease responsible for turnover of this fragment 
is RRP6 and DIS3 does not seem to be involved. Interestingly, the RRP6 cofactors, 
MPP6 and MTR4 also participate in this processing but C1D does not. Taken together, 
these data imply that while the A0 provides an entry point for exonucleolytic processing, 
that exonucleases are impeded from initiating degradation of these fragments from the 
site of A’ cleavage. Many proteins are required for A’ cleavage and the U3 snoRNP 
 
Figure 3.15 Factors required for removal of the 5’ETS in HeLa cells Schematic representation 
of the 5’ external transcribed spacer region (black line) of the pre-rRNA transcript from human cells. 
Endonuclease cleavage sites are marked above the transcript and the fragments released by these 
cleavages are shown below. The proteins activities required for degradation of these fragments; 
exosome (red) and XRN2 (green) are shown with the direction of processing indicated.  
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interacts with this region of the pre-rRNA (Borovjagin & Gerbi, 2001; Gerbi et al, 2003) 
so it is possible that this processing machinery remains associated with either the 3’ 
end of the ETS1 fragment or the 5’ end of the ETS2 fragment after cleavage, thereby 
protecting these ends from the action of the exonucleases. Indeed, in yeast, it has 
been shown that both the U3 snoRNP and several U3-associated proteins (UTPs) 
proteins are still associated with the 5’ETS fragments after the 5’ETS cleavages have 
occurred (Billy et al, 2000; Granneman et al, 2003; Hoang et al, 2005; Krogan et al, 
2004; Peng et al, 2004; Wegierski et al, 2001). The two 5’ETS fragments which 
accumulated when XRN2 was depleted (ETS1 and ETS3) appear to accumulate to 
different extents. It is not possible to predict how much of these fragments is generated 
by pre-rRNA processing as they are not normally visible but when both XRN2 and 
RRP6 were co-depleted, the accumulation of the ETS2 fragment far exceeded the 
amount of any fragment accumulated when a single exonuclease was depleted. This 
implies that the accumulation of 5’ETS fragments detected when either XRN2 or RRP6 
was depleted individually only represents a small fraction of the total amount of these 
fragments produced. This suggests that there is redundancy between the 
exonucleases involved with the Rrp17 homologue, NOL12, being a likely candidate for 
carrying out the same functions as XRN2 and the REX proteins potentially involved in 
ETS2 degradation.  
The ETS2 and ETS1 fragments detected when the exonucleases RRP6 or 
XRN2 are depleted both appear as doublets when resolved on agarose-glyoxal and 
acrylamide gels, respectively, suggesting that they are degraded in multistep pathways. 
This is supported by the observation that depletion of different subunits and cofactors 
of the exosome caused variation in the ratio of the longer and shorter forms of the 
ETS2 fragment detected. Furthermore, co-depletion of either RRP6 or MTR4 with 
XRN2 also increased accumulation of the shorter form of the ETS2 fragment relative to 
the longer form, suggesting that different processing activities are required at different 
stages of turnover of these fragments.  
XRN2 is required for A’ cleavage in HeLa cells as it is in both mouse and plant 
cells (Wang & Pestov, 2011; Zakrzewska-Placzek et al, 2010). It has been suggested 
that XRN2 is not directly involved in this cleavage step but instead, that failure to 
degrade the ETS1 fragment which also requires XRN2 prevents other factors required 
for A’ cleavage from being recycled (Wang & Pestov, 2011). In Arabadopsis thalina, 
XRN2 has been shown to degrade the 5’ end of the full length transcript which exposes 
the A’ site enabling cleavage to take place (Zakrzewska-Placzek et al, 2010). In HeLa 
cells, depletion of XRN2 caused the accumulation of 30SL5’, an aberrant form of the 
30S precursor which accumulates if A’ cleavage is affected. However, both 30S and 
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the ETS1 fragment were also detected showing that XRN2 is not essential for this 
cleavage. It is interesting to note that depletion of XRN2 decreased 45S production 
significantly while 30S levels were only marginally affected. This suggests that when 
XRN2 is depleted, A’ cleavage is not always the first processing step to occur on the 
47S pre-rRNA but can occur after cleavage in ITS1 and convert 30SL5’ into 30S. Also 
observed following XRN2 depletion was a weak accumulation of a fragment extending 
from the 5’ end of the transcript to A0. This indicates that depletion of XRN2 can result 
in A’ cleavage being bypassed. Co-depletion of XRN2 with RRP6 caused a much more 
significant accumulation of this fragment and loss of the ETS1 fragment normally 
detected when XRN2 is depleted. This may suggest that a proportion of the ETS1 
fragment detected when XRN2 was depleted individually could actually be derived from 
the 5’-A0 fragment undergoing 3’-5’ processing by the exosome to a site upstream of 
A’. Although MTR4 is also required for A’ cleavage, the 5’-A0 fragment was not 
detected perhaps suggesting that MTR4 is less critical for A’ cleavage than XRN2. 
Taken together these observations suggest that depletion of XRN2 changes the order 
of cleavage steps required to produce 18S rRNA and promotes cleavage at the A0 site. 
It is not, however, clear what role XRN2 or MTR4 perform in A’ cleavage. Both XRN2 
and MTR4 are involved in the quality control of pre-rRNA processing and in yeast, 
XRN2 is associated with the rDNA. It is possible therefore, that as part of the 
surveillance machinery, these proteins function to ensure the correct order of cleavage 
events. Depletion of the core exosome or RRP6 does not affect A’ cleavage so the role 
of MTR4 in A’ processing seems to be an exosome-independent function. It is also 
possible that the helicase activity of MTR4 may be required to modify the RNA 
secondary structure of the A’ cleavage site to enable the endonuclease to gain access. 
This would be comparable to how the helicase, Prp43, is proposed to facilitate access 
of Nob1 to its cleavage site at the 3’ end of 18S in yeast (Pertschy et al, 2009). 
Association of the U3 snoRNP with pre-rRNA at the A’ cleavage site is a key 
step in formation of pre-ribosomal complexes so it was assumed that the core proteins 
of the snoRNP would be essential for A’ cleavage. While depletion of hU3-55K (Prieto 
& McStay, 2007) fibrillarin, NOP56 or NOP58 did cause defects in A’ cleavage, this 
processing step was still able to occur, albeit inefficiently. However, cleavages at A0 or 
A1 were completely blocked by depletion of the core snoRNP proteins implying that 
although the U3 snoRNP binds near the A’ cleavage site, that its major function is in 
fact in the downstream removal of the 5’ETS. 
Depletion of exonucleases from HeLa cells also revealed roles for the exosome 
and XRN2 in pre-rRNA quality control. 37S* and 41S* both appear to be aberrant 
intermediates normally degraded by the exosome and XRN2, respectively. It is 
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possible that 37S* is produced by premature termination of transcription within 28S 
with the partial transcripts then targeted for degradation by the exosome. Alternatively 
and more likely, the exosome is involved in degradation of excess or aberrant full-
length transcripts that need to be removed as part of the cell’s RNA surveillance 
mechanisms. 37S* has undergone A’ cleavage which suggests that the normal pre-
rRNA processing pathway is initiated before the transcript is targeted for degradation. 
37S* is detectable at very low levels in control cells suggesting that the 3’ end of this 
fragment may represent a natural stalling point of the exosome. This could be due to a 
particular sequence or structure that it is difficult for the exosome to degrade. Since 
37S* is probably derived from a full length transcript, other exonucleases such as the 
REX proteins must be able to initiate degradation but are unable to proceed beyond the 
3’ end of 37S*. Interestingly, the RRP6 cofactor, C1D, is needed for degradation of 
37S* while it is not required for turnover of the ETS2 fragment. This possibly indicates 
that when the exosome is carrying out recycling functions it does not need C1D but this 
protein is more important for targeting the exosome to aberrant substrates which are to 
be degraded as part of the quality control pathways. However, DIS3 does not 
participate in turnover of 37S* as RRP6 does, suggesting that this fragment is 
degraded in the nucleolus from which DIS3 is excluded in human cells. However, DIS3 
along with RRP6 does function in processing the 3’ end of 5.8S pre-rRNA which is 
likely to occur in the nucleoplasm. 
In yeast, deletion of key proteins of the exosome, Rrp6 and Rrp47, causes 
accumulation of 3’ extended precursors of both snoRNAs and snRNAs implying that 
the exosome is required for the maturation of these small RNAs (Allmang et al, 1999a; 
Costello et al, 2011). The human exosome is present within the same large complexes 
as the U3 and U8 pre-snoRNPs (Watkins et al, 2004; Watkins et al, 2007) so it was 
postulated that the function of the exosome in pre-snoRNA processing is conserved in 
higher eukaryotes. Protein-protein interactions were detected in vitro between exosome 
proteins (MTR3, CSL4 and RRP40) and snoRNP biogenesis factors (BCD1, TIP48 and 
TIP49) while no interactions were detected with proteins found in mature snoRNPs. 
The significance of the individual interactions detected has not been investigated 
further but they support the observation that the human exosome is stably associated 
with pre-snoRNP complexes. It is possible that more interactions would be detected 
between exosome proteins and snoRNP biogenesis factors when these proteins are 
assembled into the exosome and the pre-snoRNP respectively. Depletion of key 
activities of the human exosome by RNAi did not, however, cause a significant 
accumulation of precursors of the U8 snoRNA raising doubts about whether the human 
exosome is required for pre-snoRNA processing as its yeast counterpart is. It was 
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difficult to determine whether this was also the case for precursors of the U3 snoRNA 
since the 3’ extension is small and precursors cannot readily be distinguished from the 
mature snoRNA. The levels of mature snoRNAs transcribed independently (U3, U8) or 
those that are released from introns by splicing (U14, U15) were also not significantly 
affected by depletion of exosome factors. It is, however, possible that the human 
exosome plays a non-essential role in processing of pre-snoRNAs with other 3’-5’ 
exonucleases such as the REX proteins potentially also able to perform this function. 
However, the exosome subunit, RRP6, and XRN2 are both clearly required for the 
turnover of other non-coding RNAs, box C/D snoRNAs and the unique snoRNA, RNase 
MRP RNA. Depletion of NOP58 causes a significant decrease in snoRNA levels 
because pre-snoRNPs which are not associated with this core protein are detected as 
aberrant and are therefore degraded. Co-depletion of either RRP6 or XRN2 with 
NOP58 partially restores snoRNA levels implying that the exosome and XRN2 are 
involved in this quality controlled degradation. It is likely that this also reflects an 
involvement of RRP6 and XRN2 in the normal turnover of snoRNAs. The U3 snoRNA 
is produced in excess (Knox et al, 2011) and it is probable that this is also the case for 
other snoRNAs meaning unnecessary snoRNAs may need to recycled. DIS3 was not 
found to participate in snoRNA degradation possibly because in human cells, DIS3 is 
found predominantly in the nucleoplasm unlike RRP6, which is concentrated in nucleoli 
where snoRNA turnover occurs. 
A model of RNA processing by the yeast exosome is proposed in which the 
activities of Rrp44 and Rrp6 are coordinated such that the dual endonuclease and 
processive exonuclease activity of Rrp44 is responsible for removing long, structured 
RNA sequences and this is followed by fine trimming to a defined specific 3’ end using 
the distributive activity of Rrp6. At the time of carrying out our experiments the in vitro 
activity of human RRP6 had not been investigated although data on this have recently 
been published (Januszyk et al, 2011). Human and yeast RRP6 both possess similar 
distributive 3’-5’ exonuclease activity. We conclude that the activity was distributive 
rather than processive as a ladder of partially processed fragments was detected over 
the course of 2 h whereas previously published data for the processive exosome 
enzyme, Rrp44, show complete degradation of the same substrate in 60 min 
(Schneider et al, 2009). It appears that human RRP6 is able to degrade poly (A) RNA 
at a slightly faster rate than yeast Rrp6 but the difference is subtle.  
Specific structured RNA substrates accumulate when yeast Rrp6 is mutated 
(Allmang et al, 1999a) and concordantly, our data showed that yeast Rrp6 is unable to 
process RNA with secondary structure in vitro. In contrast, human RRP6 is able to 
degrade structured RNA substrates in vitro. An explanation for this difference between 
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the activities of yeast and human RRP6 can be derived from the recently published 
crystal structure of a fragment of human RRP6 (Januszyk et al, 2011). This showed 
that the orientation of the catalytic amino acids of RRP6 (the DEDD box) is well 
conserved between yeast and humans but that a linker between the exonuclease 
domain and the HRDC domain, which forms one face of the active cleft, is in a more 
open conformation in the human protein, thereby allowing double stranded RNAs 
access to the catalytic site. This raises the possibility that human RRP6 is able to 
degrade RNAs that the yeast protein cannot and therefore may have additional 
functions in vivo. It is proposed that the decision between degradation and site specific 
processing could be determined by RNA secondary structures causing exonucleases 
to stall. It is possible that these would not be sufficient to stop the action of human 
RRP6 implying that alternative mechanisms, such as proteins bound to RNA 3’ ends, 
may be required to halt the activity of RRP6.  
A crystal structure of the nine-membered core human exosome is available but 
little is known about how RRP6 or nuclear cofactors associate with this core. Our data 
show that RRP6 interacts with all three RNA binding proteins of the exosome cap 
suggesting that RRP6 binds to the upper face of the exosome possibly at the opening 
to the central channel through which RNA substrates are proposed to pass. This is 
consistent with cryo-electron microscopy studies of the Leishmania tarentole exosome 
that show RRP6 binding to this side of the exosome (Cristodero et al, 2008). In 
contrast, yeast two-hybrid data demonstrate that human RRP6 interacts with proteins 
of the hexameric ring (Lehner & Sanderson, 2004) and here weak in vitro interactions 
were also detected between RRP6 and RRP43, RRP42 and MTR3. In yeast, Rrp6 and 
Rrp44 are both associated with nuclear exosomes and since they are both large 
proteins, it is possible that the anchoring of Rrp44 to the lower face of the exosome by 
its PIN domain (Schneider et al, 2009), dictates that RRP6 interacts with the cap-face 
of the complex. In human cells, RRP6 is predominantly found in the nucleolus while 
DIS3 is localised to the nucleoplasm (Tomecki et al, 2010b) suggesting that complexes 
containing RRP6 but not DIS3 are formed and it is possible that in these cases, RRP6 
does not interact with the exosome in the same way. However, in vivo each of the core 
exosome proteins, used individually in this assay, would be part of the multi-protein 
complex so we cannot rule out the possibility that the interactions identified here are 
not fully representative of all the contacts RRP6 may make with the assembled core 
exosome.  
RRP6 appeared to bridge interactions between the core exosome and the 
cofactors, C1D and MPP6, since neither of these proteins was seen to interact 
significantly with the core exosome but both displayed robust interactions with RRP6. 
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C1D and MPP6 are RNA binding proteins and their yeast homologues are important for 
recognition of particular RNA features, such as double stranded RNA or pyrimidine rich 
sequences, so could target the exosome to particular substrates. This may suggest 
that these factors could stimulate processing by the exosome by recruiting the complex 
to its substrates (Milligan et al, 2008; Schilders et al, 2005; Stead et al, 2007). 
However, we have shown that their human counterparts are also able to directly 
modulate the activity of RRP6 in vitro. C1D stimulated the exonuclease activity of 
RRP6 during the degradation of a structured RNA substrate while MPP6 inhibited it, 
suggesting that these different cofactors may associate at different times during 
processing of a substrate, altering the activity of RRP6 as appropriate. It is interesting 
to note that RRP6, but not the processive DIS3 exonuclease, is required for 
degradation of several long substrates such as 37S* and the ETS2 fragment but the in 
vitro activity of RRP6 remains distributive even when stimulated by C1D. This implies 
that in the context of the cell, the exonuclease activity of RRP6 is significantly 
enhanced compared to recombinant protein in vitro. Further, DIS3 is required for 
processing of 5.8S precursors, but not degradation of 37S* or turnover of the ETS2 
fragment and C1D only participates in 3’ end processing of 5.8S. Degradation of 37S* 
and the ETS2 fragments is likely to occur in the nucleolus, from which DIS3 is 
excluded, but although C1D localises predominantly to nucleoli, this exosome protein is 
also not required for their turnover. It is clear therefore, that specific exosome activities 
and cofactors are required for degradation of different substrates. 
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Chapter Four 
Major and minor pre-rRNA processing pathways for 
internal transcribed spacer 1 in humans  
4.1 Introduction 
Three of the four ribosomal RNAs (rRNAs), 18S, 5.8S and 28S (25S in yeast), 
are co-transcribed as a single precursor (pre-rRNA) by RNA Polymerase I (RNA pol I) 
in the nucleolus (Venema & Tollervey, 1995). This primary transcript contains the 
mature rRNA sequences along with two external transcribed spacer regions (5’ETS 
and 3’ETS) as well as two internal transcribed spacer regions (ITS1 and ITS2) (Figure 
4.1A). This precursor undergoes both modification and a series of endonucleolytic 
cleavages and exonucleolytic processing to remove the spacer regions and release the 
mature rRNAs which are assembled into the large (LSU) and small (SSU) ribosomal 
subunits (Figure 4.1B) (Henras et al, 2008).  
S. cerevisiae has been extensively used as a model for studying pre-rRNA 
processing and almost all our understanding of the pathways is derived from these 
studies. Many of the cleavage sites have been mapped and several of the nucleases 
responsible for particular steps have been identified but others remain elusive (Henras 
et al, 2008). One of the key steps in pre-rRNA processing is the separation of the small 
(18S) and large (5.8S and 28S) subunit rRNAs which is achieved by cleavages at A2 
and A3 in ITS1. Cleavage at A2 is linked to removal of the 5’ETS and is reported to be 
carried out by Rcl1 (Horn et al, 2011). These steps are mediated by the small subunit 
processome complex which is recruited to the pre-rRNA co-transcriptionally and is 
primarily composed of the subcomplexes: t-UTP, b-UTP, c-UTP, MPP10 and U3 
snoRNP (Kos & Tollervey, 2010; Phipps et al, 2011). Following A2 cleavage, the 
mature 3’ end of 18S is generated by another endonucleolytic cleavage at site D 
carried out by Nob1 (Lamanna & Karbstein, 2009; Pertschy et al, 2009). A protein of 
the SSU processome, Rrp5, provides a link between the two ITS1 cleavages as it is 
required for processing at both A2 and A3 (Venema & Tollervey, 1996). Endonucleolytic 
cleavage at the A3 site is mediated by the RNA-protein complex, RNase MRP (Lygerou 
et al, 1996). A3 cleavage also requires Nop4 (RBM28 in humans) and is followed by 5’-
3’ exonucleolytic processing by Rat1 (XRN2 in humans) and Rrp17 to generate the 
mature 5’ end of 5.8S rRNA (Berges et al, 1994; Oeffinger et al, 2009; Petfalski et al, 
1998; Sun & Woolford, 1994). A number of proteins, termed the A3 cluster proteins, 
which includes Erb1 (BOP1 in humans), are required for this processing after A3 
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cleavage (Granneman et al, 2011; Rohrmoser et al, 2007; Sahasranaman et al, 2011; 
Strezoska et al, 2000).  
Relatively little is known about pre-rRNA processing in human cells and none of 
the cleavage sites have been mapped nor have any of the nucleases responsible for 
mediating these processing steps been identified. Homologues of many of the trans-
acting ribosome biogenesis factors identified in yeast, including the nucleases, can be 
found in human cells although it is not yet clear whether their functions are conserved. 
Site 2 appears to be the initial cleavage in mammalian ITS1 that separates the SSU 
and LSU rRNA(s). In higher eukaryotes, pre-rRNA processing appears to be more 
complex than in yeast and includes both an extra cleavage in the 5’ETS at the A’ site 
and an additional ITS1 processing step that converts 21S into 18SE (Rouquette et al, 
2005) (Figure 4.1A, B). It is not understood how this additional ITS1 processing step 
occurs and two different models have been proposed (Figure 4.1A). One model is 
based on data showing that the depletion of a late-acting SSU component, ENP1, 
causes accumulation of a partially processed intermediate smaller than 21S. The 
heterogeneity of the 3’ end of this intermediate led to the suggestion that site 2 
cleavage is followed by 3’-5’ exonucleolytic processing (Carron et al, 2011). In contrast 
to this, data from mouse cells provide evidence of an endonucleolytic cleavage at the 
2a site near the 3’ end of 18S which is stimulated by depletion of the 5’-3’ exonuclease, 
XRN2 (Rat1 in yeast) (Wang & Pestov, 2011). Although in yeast, A2 is the primary 
cleavage that separates the LSU and SSU rRNAs, it has been speculated that 
cleavage at site 2a which generates 18SE, rather than the major site 2 in human pre-
rRNA, is equivalent to A2. This raises the possibility that site 2 is therefore analogous to 
the yeast A3 site, which is cleaved by the RNA-protein complex, RNase MRP, but it is 
not yet clear if this is indeed the case. Depletion of Dicer, the endonuclease linked to 
miRNA and siRNA production, appears to influence cleavages close to the predicted 
site 2 cleavage as various differently 5’ extended forms of 5.8S rRNA were weakly 
accumulated (Liang & Crooke, 2011). The significance of this observation is not fully 
understood and the defects observed were not severe enough to suggest that Dicer is 
the main endonuclease involved in site 2 processing. 
Key questions remain, therefore, about the pathway of mammalian ITS1 
processing. Although, similar to yeast, two endonuclease cleavage sites have been 
identified, it is not clear whether these sites are analogous to the yeast ITS1 cleavages 
both in terms of the nucleases involved and the manner in which they contribute to 
processing of ITS1. How ITS1 is processed is of particular interest as this separates 
the large subunit rRNAs from the small subunit rRNA. As there is an additional ITS1 
processing step in higher eukaryotes that is not conserved from yeast, understanding 
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human ITS1 processing may highlight important differences between the processing 
pathways used in these different organisms. This is of particular interest as several 
genetic diseases, such as the ANE and CHH syndromes and Diamond Blackfan 
anaemia are linked to defects in ribosome production (Freed et al, 2010; Mattijssen et 
al, 2010b; Narla et al, 2010; Nousbeck et al, 2008). Furthermore, ribosome production 
is up-regulated in cancer and several ribosome biogenesis factors, such as BOP1 and 
ENP1, are associated with specific cancers (Chung et al, 2011; Killian et al, 2006; 
Wang et al, 2009).  
We therefore performed a systematic analysis of human homologues of yeast 
factors linked to ITS1 processing in human cells and characterized the order and 
nature of the processing events involved. 
 
 
Figure 4.1 pre-rRNA processing pathways in 
human cells A) Alternative pre-rRNA 
processing pathways in human cells are shown 
with the numbers corresponding to the 
intermediates shown in (B) and arrows indicating 
the direction of processing. The major pathway 
is shown in black and minor pathways are 
shown in grey. B) Schematic representations of 
the initial pre-rRNA transcript containing the 
mature rRNAs, 18S (blue), 5.8S (orange) and 
28S (yellow), the internal transcribed spacer 
regions (ITS1 and ITS2) and the external 
transcribed spacers (5’ETS and 3’ETS). The 
major cleavage sites are marked above the 
transcript. Normal processing intermediates 
corresponding to (A) are shown below 47S and 
three aberrant pre-rRNA fragments described in 
this chapter are shown at the bottom of this 
panel. 
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4.2 Results 
4.2.1 Northern blot mapping of ITS1 cleavage site in human pre-rRNA 
 The two alternative models of how the additional ITS1 processing step is 
mediated (Carron et al, 2011; Rouquette et al, 2005; Wang & Pestov, 2011) raise 
questions about the processing sites that exist in human ITS1 and how the ends of the 
pre-rRNA intermediates resulting from ITS1 cleavages are generated. A Northern blot 
mapping approach was, therefore, undertaken to determine which ITS1 regions were 
present in different pre-rRNAs and to define the cleavage sites. RNA was extracted 
from HeLa cells and separated by agarose-glyoxal gel electrophoresis, transferred to a 
nylon membrane and analysed by Northern blotting. A series of probes spanning the 
internal transcribed spacer regions (ITS1 and ITS2) were used for hybridisation. The 
sequences chosen included the extreme 5’ and 3’ end of each spacer region and the 
positions of the internal probes were often dictated by the extreme GC content of 
human ITS1 sequences. Similar experiments have previously been undertaken by 
David Tollervey, University of Edinburgh (unpublished data) and the results of these 
investigations are combined in this dataset (Figure 4.2A, B). The abundance of short 
pre-rRNAs (30S, 32S, 21S and 12S) relative to 47/45S was calculated as a ratio for 
each probe and results are given as a bar chart in Figure 4.2B. Several of the probes 
used significantly cross-hybridised to either 28S or 18S mature rRNAs and in particular 
instances, this affected the signals detected for 47/45S, 32S and 30S. This only 
influenced the pre-rRNA of interest in the case of the 6773 probe and here, the fraction 
that this bias represented was calculated by comparison to Northern blot data 
generated using a probe directly targeting 28S and was subtracted.  
All of the probes used recognised 47/45S but three probes, 6396, 6448 and 
6508, only detected 47/45S pre-rRNA and none of the smaller pre-rRNAs, indicating 
the region spanned by these probes is not associated with either the small or large 
subunit pre-rRNAs (Figure 4.2A, B). This implies that the cleavage which separates the 
LSU and SSU pre-rRNAs (site 2) occurs within this region but does not rule out the 
possibility that more than one cleavage site is used. In addition to 47/45S, the 18S 
precursors, 30S and 21S, were detected by probes hybridising in the region from the 5’ 
end of ITS1 (5520) to position 6318. Compared to probes hybridising to the 5’ end of 
ITS1, progressively weaker 30S and 21S signals were detected by probes between 
positions 6121 and 6318. This suggests that the 3’ ends of these pre-rRNAs are not 
homogeneous but instead range between positions 6121 and 6318 implying that 
following site 2 cleavage, the 3’ ends of 30S and 21S are generated by exonucleolytic 
processing. The large subunit precursors, 32S and 12S, were readily detectable using 
probes hybridising to ITS2 sequences but a probe at the 3’ end of ITS1 only weakly 
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detected 32S and 12S was not recognised, indicating that all of 12S and the majority of 
32S does not contain ITS1 sequences (Figure 4.2A, B). Depletion of the 5’-3’ 
exonuclease, XRN2, increased the amount of 32S containing 3’ITS1 sequences 
implying that XRN2 is involved in exonucleolytic processing to remove ITS1 sequences 
from 32S and potentially also 12S (data not shown). 
 
 
Figure 4.2 Mapping ITS1 cleavages in HeLa cells A) Total RNA was extracted from HeLa cells and 
separated by agarose-glyoxal gel electrophoresis. RNA was transferred to a nylon membrane and 
Northern blotting carried out using probes hybridising across ITS1 and ITS2. The number given 
represents the 5’ end nucleotide of the target of each probe within the pre-rRNA sequence. Pre-rRNA 
intermediates detected are indicated to the left and right of the panel. Red asterisk marks significant 
probe cross-hybridisation to 28S. ). Northern blot data was generated by Katherine Sloan (5520, 5687, 
5958, 6112, 6121, 6318, 6448, 7564, 6603, 6773 and 7564) or by David Tollervey (5633, 6248, 6396, 
6508, 6603, 6773, 6833). B) Levels of 47/45S, 30S, 32S, 21S and 12S pre-rRNA were quantified 
using Image Quant software and ratios of 30S or 21S and 32S or 12S to 47/45S were calculated. 
These ratios are given as a bar chart with a schematic outline of ITS1 and ITS2 showing the relative 
positions of each of the probes. C) HeLa cells were transfected with siRNA duplexes to deplete XRN2 
or a control siRNA. After 60 h, cells were harvested, RNA was extracted and separated on a 4% 
acrylamide/7M urea gel alongside a 5’end radiolabelled ladder. RNA was transferred to a nylon 
membrane and Northern blot hybridisation performed using a probe hybridising to the middle of ITS1 
(6121). RNA was visualised using a phosphorimager. 
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In yeast, fragments of pre-rRNA spacer regions that are released by sequential 
endonucleolytic cleavages are commonly degraded by exonucleases including the 
exosome and Rat1 (XRN2). To determine if multiple endonucleolytic cleavages occur 
in human ITS1, we investigated if fragments of ITS1 are released and accumulate 
when exonucleases are depleted. HeLa cells were transfected with siRNA duplexes 
targeting the mRNAs of either XRN2 or the exosome subunit, RRP6. As a negative 
control, a siRNA duplex targeting firefly luciferase mRNA, which is not expressed in 
HeLa cells, was also used. RNA was extracted 60 h after siRNA transfection and was 
separated on a 4% acrylamide denaturing polyacrylamide gel, followed by Northern 
blotting using probes hybridising to ITS1. Depletion of XRN2 caused accumulation of a 
fragment of ITS1 that was approximately 800 nt in length (Figure 4.2C). This fragment 
was not detected in cells transfected with the control siRNA, with those targeting RRP6 
or when using a probe hybridising to the very 5’ end of ITS1. It was, therefore, 
concluded that this fragment is generated by endonucleolytic cleavages at site 2 
between nucleotides 6396 and 6508, and at site 2a. No other fragments of ITS1 were 
detected when either XRN2 or RRP6 was depleted suggesting that there is only a 
single cleavage between nucleotides 6396 and 6508.  
Our data indicate that site 2 cleavage is rapidly followed by 5’-3’ exonucleolytic 
processing to generate the 5’ end of 5.8S, analogous to the situation in yeast. As the 3’ 
ends of the 18S precursors, 21S and 30S, appear to be heterogeneous, we conclude 
that these precursors are similarly generated by 3’-5’ exonucleolytic processing 
following site 2 cleavage. This may explain why neither LSU nor SSU precursors could 
be detected in a region of approximately 160 nt although our data imply that there is 
only a single cleavage in this region. It appears, therefore, that dual endonuclease 
cleavages at sites 2 and 2a can occur releasing a fragment of ITS1 which is degraded 
by XRN2. 
 
4.2.2 RNAi depletion of RRP6, XRN2 or ENP1 leads to altered 18S RNA 
processing 
Detection of the 800 nt ITS1 fragment in HeLa cells after depletion of XRN2 
indicates that the 18SE precursor can be generated by an endonucleolytic cleavage at 
site 2a. Previously published data, however, shows that depletion of the ribosome 
biogenesis factor, ENP1, causes accumulation of 21SC, suggesting that 18SE could 
instead be generated by exonucleolytic processing of 21S (Carron et al, 2011). The 
majority of the 3’-5’ exonuclease activity in the nucleolus is derived from RRP6, one of 
the active subunits of the exosome, making this a likely candidate for carrying out this 
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processing step. We therefore used RNAi to deplete XRN2, ENP1 or RRP6 from HeLa 
cells. Proteins were extracted from siRNA treated cells and Western blot analysis 
showed that each protein was specifically and significantly depleted by the siRNA 
treatment (Figure 4.3A). The levels of rRNA processing intermediates in these cells 
were then analysed by agarose-glyoxal gel electrophoresis followed by Northern 
blotting using probes hybridising to the 5’ end (5520) or the middle of ITS1 (6121) 
(Figure 4.3C, D).  
 
 
 
Figure 4.3 RRP6 and ENP1 are required for ITS1 processing A) Schematic outline of a section of 
the human pre-rRNA transcript with the positions of the probes used in Northern blot hybridisation, 
5’ITS1 (5520) and ITS1 (6121) indicated relative to the mature rRNAs. B) HeLa cells were transfected 
with siRNA duplexes to deplete RRP6, XRN2, ENP1 or with a control siRNA targeting firefly luciferase 
mRNA. Cells were harvested after 60 h and proteins were extracted, separated by SDS-PAGE, 
followed by Western blotting using antibodies raised against the target proteins and the core snoRNP 
protein, fibrillarin, or the cytoskeletal protein, actin. The red asterisk indicates residual signal from 
previous probing of the membrane with an antibody against RRP6, which migrates slightly faster than 
XRN2. C) and D) RNA was extracted from siRNA treated cells and analysed by agarose-glyoxal gel 
electrophoresis where 28S and 18S mature rRNAs were visualised by ethidium bromide staining (UV). 
RNA was transferred to a nylon membrane and Northern blotting using indicated in (A). Pre-rRNAs 
were visualised using a phosphorimager and the positions of various pre-rRNA intermediates are 
indicated between the panels. + indicates RRP6 is present at normal levels while – denotes depletion 
of RRP6. E) The relative levels of pre-rRNAs from the lower portion of panel (D) were quantified using 
ImageQuant software and are shown as line graphs depicting intensity in arbitrary units (a.u.) 
compared to the distance migrated through the gel. Levels were normalised to 28S rRNA. The identity 
of each peak is indicated. 
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Compared to control cells, depletion of XRN2 led to an increase in 47S levels 
and the appearance of 30SL5’, a 5’ extended form of 30S, both of which indicate that 
XRN2 is required for efficient A’ cleavage as discussed in section 3.11 (Figure 4.3C). 
Depletion of XRN2 also caused an increase in the levels of 26S, only detected in some 
experiments (see Figure 5.9), implying that the order of cleavage steps during 5’ETS 
removal is altered by XRN2 depletion as suggested in the previous chapter. Also 
observed after XRN2 depletion were significant accumulations of 36S and the 800nt 
ITS1 fragment, implying that an increased proportion of pre-rRNA is cleaved at site 2a 
prior to site 2 processing. Interestingly, 36S is barely detectable in control cells 
suggesting endonucleolytic processing at site 2a does not normally occur before site 2 
cleavage. However, despite variations in the levels of several pre-rRNA species, the 
level of the final 18S precursor, 18SE, was not affected by XRN2 depletion suggesting 
that the order of cleavages is altered without changing the overall kinetics of 
processing.  
Consistent with published data (Carron et al, 2011), depletion of ENP1 did not 
affect the levels of longer pre-rRNAs (47S, 45S or 30S) but led to a large increase in 
21S levels, the appearance of 21SC, a 3’ shortened form of 21S and a decrease in 
18SE levels (Figure 4.3D, E). Similarly, depletion of RRP6 did not affect the early pre-
rRNA processing steps but did cause an even more significant decrease in 18SE levels 
and the accumulation of 21SC. The appearance of this partially processed form of 21S 
was accompanied by a range of intermediate products seen as a smear between 21S 
and 18SE. This implies that loss of RRP6 causes inefficient exonucleolytic processing 
of 21S. Co-depletion of both ENP1 and RRP6 caused cumulative defects with a 
stronger accumulation of 21SC, a greater reduction of 21S levels and a significantly 
stronger decrease in the amount of 18SE than observed in either of the single 
knockdowns (Figure 4.3C).  
Taken together, these data support the notion that 21S is converted to 18SE by 
exonucleolytic processing and show that the exosome component, RRP6, is required 
for this step. This pathway is a major route for 18SE production as depletion of RRP6 
decreases 18SE levels significantly. Although depletion of XRN2 appears to promote 
an alternative endonucleolytic processing pathway, this does not change the overall 
rate of 18SE production, implying that the cell does not normally rely on this alternative 
endonculeolytic pathway to remove ITS1 sequence. 
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4.2.3 Metabolic labelling of rRNA shows that RRP6 is required for 18S production 
Northern blot analysis (Figure 4.3C, D) clearly demonstrates that depletion of 
RRP6 inhibits formation of 18SE while although depletion of XRN2 changes the 
balance of cleavages used to generate 18SE, it does not affect the overall levels of 
18SE. Our data therefore suggest that a major pathway by which 18S rRNA is 
produced requires RRP6. To determine if this is the case, metabolic labelling 
experiments were carried out. Metabolic labelling of cells following RNAi mediated 
depletion of a protein of interest enables RNA formed de novo to be analysed 
specifically making any defects caused by loss of the protein more readily detectable 
than by Northern blotting. HeLa cells were transfected with either a control siRNA 
duplex or those targeting RRP6 or XRN2 mRNAs. Cells were metabolically labelled 
using 32P orthophosphate then grown in media containing unlabelled phosphate and 
harvested over a timecourse of 4 h following removal of the labelled media. Total RNA 
was separated by agarose-glyoxal or by denaturing polyacrylamide gel electrophoresis, 
transferred to a nylon membrane and RNA visualised using a phosphorimager (Figure 
4.4). 
In control cells, at the start of the chase (time 0) only 47/45S was detectable 
with the first significant appearance of the 32S intermediate after 60 min. The 28S and 
18S mature rRNAs then accumulated at later time points. 41S, 30S and 21S were just 
detectable but due to their relatively low abundance were difficult to follow in these 
experiments. In cells depleted of either RRP6 or XRN2, after 3 h incubation with 
unlabelled media, 32S and 28S were accumulated to approximately 80% of the level 
detected in control cells. In cells depleted of XRN2 the levels of 18S rRNA was also 
approximately 80% of those found in control cells but in contrast, 18S rRNA levels in 
cells depleted of RRP6 were decreased to approximately 30% of normal levels (Figure 
4.4). This suggests that the levels of 18S and 28S mature rRNAs is affected by 
depletion of RRP6 or XRN2 (see below for explanation) but that that RRP6 is 
specifically required for the efficient production of 18S in human cells. We conclude 
that the majority of the SSU rRNA is produced by exonucleolytic processing of ITS1 
following site 2 cleavage. 
128 
 
 
Depletion of XRN2 caused a parallel decrease in the levels of both 18S and 
28S mature rRNAs and depleting RRP6 affected 28S levels to a similar extent. While it 
is possible that this represents an equal requirement for these exonucleases in 28S 
and 18S production, it also raises the possibility that depletion of any essential protein, 
not only those directly involved in ribosome biogenesis, would affect the growth rate of 
the HeLa cells and therefore slow the accumulation of mature rRNAs. To test this, 
RNAi was used to deplete a protein which is known to be essential for cell viability but 
 
Figure 4.4 RRP6 is required for 18S production HeLa cells were transfected with siRNA 
duplexes to deplete RRP6 or XRN2 or with control siRNAs. 48 h after transfection, the cells 
were depleted of phosphate and pulse labelled with 
32
P orthophosphate. The labelled media 
was then replaced with normal media for varying lengths of time (indicated above each lane). 
Cells were harvested and RNA was extracted. This was separated using agarose-gloxal gel 
electrophoresis (upper panel) or on an 8 % acrylamide/7 M urea gel (lower panel) and RNAs 
were visualised using a phosphorimager. The total RNA loaded on the agarose-glyoxal gel was 
visualised by ethidium bromide staining (UV) and the acrylamide gel loaded correspondingly. 
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that does not participate in formation of ribosomes. The signal recognition particle 
(SRP) is an RNA-protein complex which is important during translation but is not 
associated with pre-ribosomes (Grudnik et al, 2009). One of the core subunits of this 
complex, SRP14, was depleted from HeLa cells (Figure 4.5A) before metabolic 
labelling and RNA analysis as described above. After depletion of SRP14, the mature 
rRNAs accumulated at a slower rate than in control cells and after 3 h, 28S and 18S 
levels were ~80% of those observed in control cells (Figure 4.5B). This implies that 
depletion of non-ribosome biogenesis factors which have other essential functions in 
the cell, decreases the rate of pre-rRNA processing by approximately 20%. For a 
protein factor to be considered critical for the biogenesis of either subunit, depletion of 
the protein must therefore, cause a greater than 20% decrease in mature rRNA levels 
or alter the ratio between 28S and 18S levels as is the case when RRP6 is depleted. 
As the SRP complex is involved in translation, it is possible that the decreased rate of 
ribosome biogenesis reflects negative feedback from translation inhibition, but this is 
unlikely. 
In these experiments it also appeared that 18S accumulated earlier than 28S 
with 18S first detectable after 60 min incubation with unlabelled media and 28S not 
detectable until 3 h after the change of media. This was surprising as the rate of 
production of both subunits was expected to be the same. The immediate precursor of 
18S, 18SE, only extends beyond the 3’ end of 18S by approximately 25 nt and cannot 
be resolved separately from 18S on the agarose glyoxal gel used. It was therefore 
likely that the 18S signal detected after 60 and 120 min incubation with unlabelled 
media actually represented 18SE precursor rRNA. To test this possibility, an antisense 
oligonucleotide primer recognising the sequence 200 nt upstream of the 3’ end of 18S 
was annealed to labelled RNA from control cells and samples were treated with 
RNaseH to cleave the pre-rRNA specifically at the site of the annealed primer. This 
generated an approximately 200 nt fragment corresponding to the 3’ end of 18S and an 
~225 nt RNA derived from the 18SE precursor. RNA was separated on an 8% 
denaturing acylamide gel that was dried and labelled RNA was visualised using a 
phosphorimager (Figure 4.5C). 30 and 60 min after addition of unlabelled media, the 
longer fragment corresponding to18SE was detectable at 2-3 fold higher levels than the 
short fragments derived from 18S, but after 120 min, levels of the shorter fragment 
exceeded those of the longer. This shows that, when analysing full length pre-rRNAs 
by agarose-glyoxal gel electrophoresis, the majority of the signal detected 30 and 60 
min after incubating with unlabelled media is 18SE, but at later time points (120-240 
min) the majority of the signal is derived from accumulated 18S (Figure 4.6D). 
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4.2.4 The exonuclease activity of RRP6 is required for processing of 21S to 18SE 
Since RRP6 is important for processing to form 18SE and overall 18S 
production we next wanted to verify whether the exonuclease activity of RRP6 was 
responsible for the conversion of 21S into 18SE. To determine if the exonuclease 
activity of RRP6 was required for 18SE production, stably transfected HEK293 cell 
lines in which endogenous RRP6 could be replaced with either FLAG-tagged wild-type 
RRP6 or an inactive form of RRP6 (RRP6exo) were used as described in Section 
3.2.9, Figure 3.11. Mutation of an amino acid, D313 in the catalytic site abolishes the 
exonuclease activity of RRP6. Additional mutations were introduced into the open 
 
Figure 4.5 Depletion of essential proteins not involved in ribosome biogenesis 
decreases the rate of mature rRNA synthesis A) HeLa cells were transfected with siRNA 
duplexes targeting the mRNA of the SRP complex protein, SRP14, or with control siRNAs. 
After 48 hours cells were harvested and proteins analysed by SDS-PAGE followed by Western 
blotting using antibodies detecting SRP14 or the snoRNP protein, fibrillarin (FIB.). B) Cells 
were depleted of SRP14 as in (A) and after 48 h, cells were depleted of phosphate, labelled 
with 
32
P orthophosphate and then grown in normal media. Cells were harvested at the time 
points shown above the panel Total RNA was extracted and analysed by agarose-glyoxal gel 
electrophoresis, transferred to a nylon membrane and visualised using a phosphorimager. C 
and D) HeLa cells were pulse labelled as in (B) but cells were harvested at various time points 
after addition of normal media (shown above the panel). RNA was extracted and a primer 
annealing approximately 200 nt upstream of the 3’ end of 18S was annealed. Equal amounts of 
RNA were treated with RNase H and separated on an 8 % polyacrylamide/7 M urea gel. RNA 
was visualised using a phosphorimager and the levels of the fragments corresponding to 18S 
and 18SE in RNase H treated samples were quantified using ImageQuant software.  
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reading frame (ORF) of both the wild-type and the inactive proteins to enable RNAi 
resistant expression of these proteins without changing the coding potential 
 
Cells expressing FLAG-RRP6, FLAG-RRP6exo or just the FLAG-tag (pcDNA5) 
were chemically transfected with siRNA duplexes to deplete RRP6 (Δ6) or a control 
siRNA targeting firefly luciferase mRNA (C). After 48 h, cells were harvested and 
protein levels were analysed by Western blotting. In cells expressing FLAG-tagged 
forms of RRP6, the endogenous protein was no longer detectable after siRNA 
treatment while the longer, tagged forms of the protein were present at the same levels 
as the endogenous protein in the control cells (Figure 4.6A). RNA was extracted from 
these cells and was analysed by agarose-glyoxal gel electrophoresis followed by 
Northern blotting using a probe hybridising to the 5’ end of ITS1 (Figure 4.6B). In 
control cells and those expressing FLAG-tagged wild-type RRP6, the levels of all the 
 
Figure 4.6 The exonuclease activity of RRP6 is required for 18SE production A) HEK293 
cells stably transfected with plasmids expressing FLAG-tagged RRP6, RRP6 with a mutation 
changing D313A in its active site (RRP6exo) or just the FLAG-tag were transfected with either 
a control siRNA duplex (C) or siRNAs to deplete the endogenous RRP6. The open reading 
frames of RRP6 in the plasmids had been altered so expression of the tagged forms of RRP6 
was resistant to the siRNA treatment. The levels of endogenous and FLAG-tagged proteins 
were monitored by Western blotting using antibodies against RRP6 or the core snoRNP protein 
NOP56 as a loading control. B) Pre-rRNA was analysed by agarose-glyoxal gel electrophoresis 
followed by Northern blotting using a probe hybridising to the 5’ end of ITS1. The levels of 
mature rRNAs, 28S and 18S were visualised by methylene blue staining (lower panels). The 
positions of intermediates detected are given to the left of the panel. C) The levels of pre-
rRNAs from (B) were quantified using ImageQuant software and are given as a line graph 
showing the intensity in arbitrary units (a.u.) relative to migration through the gel. The identity of 
each peak is indicated. 
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pre-rRNA intermediates detected were comparable to those in control cells. However, 
when endogenous RRP6 was replaced with inactive RRP6, both 21S and 21SC 
accumulated and the level of 18SE was significantly reduced compared to control cells. 
These findings clearly demonstrate that the exonuclease activity of RRP6 is the major 
activity required for processing of 21S to produce 18SE. 
 
4.2.5 The core exosome and exosome cofactors are required for 18SE production 
RRP6 usually functions as a component of a multi-protein complex, the 
exosome. We therefore investigated the roles of the core exosome component, 
RRP46, the other active subunit of the nuclear exosome, DIS3, and the RRP6 
cofactors, C1D, MPP6 and MTR4, in the production of 18SE. Each protein was 
depleted from HeLa cells using RNAi as described in the previous chapter (Figure 3.7). 
The effects of these depletions on pre-rRNA processing were analysed by agarose-
glyoxal gel electrophoresis, followed by Northern blotting using a probe hybridising to 
the 5’ end of ITS1. Here we focus on the levels of 21S, 21SC and 18SE, as the only 
significant effect on the longer pre-rRNAs was an accumulation of 30SL5’ following 
MTR4 depletion, which has been discussed in the previous chapter (section 3.11). 
Depletion of the core exosome subunit, RRP46, or the TRAMP component, 
MTR4, led to a decrease in 18SE levels and a strong smear of intermediate products 
between 21S and 18SE (Figure 4.7A, B). The intensity of this smear of intermediates 
was significantly higher in these knockdowns than when RRP6 was depleted, but 21SC 
did not specifically accumulate above this background. Depletion of the RRP6 cofactor, 
MPP6, led to increased 21S levels and a weak accumulation of 21SC but no overall 
decrease in 18SE levels suggesting that while MPP6 is important for efficient 18SE 
production, it is not absolutely required (Figure 4.7A, B). Depletion of C1D or DIS3 had 
no noticeable effect on 21S, 21SC or 18SE levels implying that these proteins are not 
required for this step (Figure 4.7A, B). Conversion of 21S into 18SE is likely to occur in 
the nucleolus and since DIS3 is excluded from this compartment in human cells, it is 
not surprising that this nuclease does not participate in the production of 18SE. In the 
previous chapter we demonstrated that both DIS3 and C1D are required for 5.8S 
processing and C1D functions in the degradation of 37S* confirming that the decreases 
in protein levels caused by RNAi treatment are sufficient to induce pre-rRNA 
processing defects. These data therefore show that the core exosome, RRP6, MTR4 
and to a lesser extent, MPP6, but not DIS3 or C1D are important for 18SE production. 
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4.2.6 The 3’ end of 21SC maps to the base of a long stem-loop structure 
The heterogeneous 3’ ends of 21SC accumulated in cells depleted of ENP1 
have been mapped by 3’ RACE and terminate between nucleotides 6162-6177 of the 
human pre-rRNA sequence (Carron et al, 2011). When RRP6 was depleted, the 
partially processed intermediate, 21SC, accumulated and Northern blot mapping of the 
3’ end of this intermediate corresponded with the 3’ end mapped by Carron et al. 
(2010) following ENP1 depletion (data not shown). The appearance of a partially 
processed intermediate when RRP6 is depleted may imply that other 3’-5’ 
exonucleases are also able to initiate ITS1 processing following site 2 cleavage but the 
decrease in 18SE formation suggests that only the exosome is able to process 
efficiently beyond the 3’ end of 21SC. As 21SC can also be detected at very low levels 
in control cells, this suggests that the 3’ end of 21SC may represent a natural stalling 
point for the exosome. To investigate what may interrupt exonucleolytic processing at 
this particular site, the secondary structure of ITS1 was modelled using software 
available at http://swissmodel.expasy.org and is shown in Figure 4.8. In this model, the 
 
Figure 4.7 The core exosome, MTR4 and MPP6 are required for 18SE production A) HeLa 
cells were transfected with siRNA duplexes targeting the mRNAs of the core exosome subunit, 
RRP46, the active nuclear exosome subunits, RRP6 or DIS3 and the cofactors, MPP6, C1D or 
MTR4. After 60 h, cells were harvested and RNA was extracted. RNA was analysed by agarose-
glyoxal gel electrophoresis followed by Northern blotting using a probe hybridising to the 5’ end 
of ITS1. Mature rRNAs were visualised by methylene blue staining and are indicated to the left of 
the panels. B) The levels of the pre-rRNA intermediates shown in (A) were quantified using 
ImageQuant software and were normalised to 28S mature rRNA levels. For each protein 
depletion, this is shown as line diagrams depicting intensity in arbitrary units (a.u.) versus the 
distance migrated through the gel. Black lines correspond to pre-rRNAs from control cells and 
grey lines indicate the levels of pre-rRNAs in cells depleted of the named exosome protein. 
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3’ end of 21SC is found at the bottom of a long stem-loop structure. Although we have 
shown that human RRP6 is able to degrade an RNA with a 5 bp terminal stem in vitro 
(section 3.2.2.2), a stem-loop of this magnitude is still likely to represent a considerable 
challenge for the exosome. The secondary structure of ITS1 in this region is, therefore, 
probably responsible for interrupting exonucleolytic processing leading to formation of 
21SC.  
 
 
4.2.7 Endonucleolytic cleavage at site 2a provides an exosome independent 
mechanism for 18SE production 
The major pathway for 18SE production involves exonucleolytic processing of 
21S by the exosome and RRP6. Depletion of XRN2, however, revealed that 18SE can 
also be produced by an endonucleolytic cleavage at 2a. In cells depleted of different 
exosome components, we did not see increased evidence of endonucleolytic cleavage 
at 2a, characterised by accumulation of 36S and the ITS1 fragment, implying that these 
pathways are not naturally redundant (Figure 4.9A). However, we investigated whether 
stimulating endonucleolytic cleavage at 2a by depleting XRN2 could bypass the 
requirement for the exosome and MTR4 in 18SE production. The effect of depleting 
RRP46 or MTR4 individually or in combination with XRN2 on 18SE levels was 
assessed using Northern blotting (Figure 4.9A). The accumulation of 30SL5’ following 
depletion of MTR4 has been discussed in the previous chapter. As described above, 
18SE levels were not affected by XRN2 depletion whereas depletion of either RRP46 
or MTR4 led to a significant decrease in 18SE levels. However, 18SE levels in cells 
 
Figure 4.8 The 3’ end of 21SC is a the base of the 
long stem structure in ITS1 A secondary structure 
model of ITS1 was generated using software available 
at http://swissmodel.expasy.org and the positions of 
the 3’ ends of ITS1, 21S and 21SC are highlighted. 
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depleted of either RRP46 or MTR4 could be restored to within 10 % of normal levels by 
co-depletion of XRN2 (Figure 4.9B). This underlines the observation that the majority of 
18SE is normally produced by exonucleolytic processing by the exosome but this 
dependence on the exosome can be bypassed by depletion of XRN2 which stimulates 
an alternative pathway through endonucleolytic cleavage at 2a. 
 
4.2.8 Site 2a in human pre-rRNA is analogous to A2 in yeast  
Our data identify two endonuclease cleavage sites in ITS1; a primary cleavage 
site at 2 which separates the LSU and SSU rRNAs and a secondary cleavage site at 
2a. In yeast, cleavages at A2 and A3 separate the LSU and SSU rRNAs but A3 
cleavage is a non-essential step. It has, however, been proposed that site 2a in human 
pre-rRNA is analogous to the yeast A2 site. This raises the possibility that this cleavage, 
equivalent to yeast A2, only plays a minor or possibly redundant role in human pre-
rRNA processing. In yeast, cleavage at A2 is dependent on many components of the 
SSU processome and has been suggested to be carried out by the Rcl1 endonuclease 
 
Figure 4.9 Exosome independent production of 
18SE A) HeLa cells were transfected with siRNAs 
duplexes to deplete RRP46, DIS3 or MTR4 either 
alone or together with XRN2 or with control 
siRNAs. + denotes pre-rRNA from cells in which 
XRN2 is present at normal levels and – indicates 
depletion of XRN2. After 60 h, RNA was extracted 
and analysed by agarose-glyoxal gel 
electrophoresis followed by Northern blotting using 
probes hybridising to the middle of ITS1 (top 
panel) or the 5’ end of ITS1 (middle panel) and 
mature rRNAs (28S and 18S) were visualised 
using methylene blue staining. Mature and pre-
rRNA intermediates detected are indicated to the 
left of the panel. B) 21S and 18SE levels detected 
with the 5’ITS1 probe were quantified using 
ImageQuant software. Levels were normalised to 
mature 28S levels and are shown relative to levels 
in control cells as a bar chart.  
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(Horn et al, 2011). We therefore used RNAi to deplete key SSU processome proteins 
and 18S processing factors, fibrillarin (core snoRNP), UTP24 (putative endonuclease), 
RCL1 (A2 endonuclease in yeast), BMS1 (GTPase), RRP5 (required for A2 and A3 in 
yeast), NOB1 (site D endonuclease in yeast), ENP1 and the r-protein, RPS19 (involved 
in ITS1 exonucleolytic processing), from HeLa cells. This was followed by Northern 
blotting or metabolic labelling to determine whether these factors were required for 
either of the cleavages in ITS1. It is difficult to identify factors required for the 2a 
endonucleolytic cleavage since 36S is the only intermediate specifically generated by 
this cleavage and it is barely detectable in human cells. However, depletion of XRN2 
stimulates the 2a endonucleolytic pathway so each knockdown was carried out both 
individually and in combination with XRN2 to enable cleavage at 2a to be monitored.  
Western blot analysis of proteins from siRNA treated cells showed that each 
protein of interest had been depleted significantly compared to control cells while levels 
of other proteins (CSL4, RIO2 or actin) were unaffected by the RNAi treatment (Figure 
4.10A). RNA was extracted from siRNA treated cells and analysed by agarose-glyoxal 
gel electrophoresis followed by Northern blotting using probes hybridising to either the 
5’ end of ITS1 or the middle of ITS1. Depletion of fibrillarin, UTP24 or BMS1 led to 
increased accumulation of 30S compared to control cells and depletion of fibrillarin also 
caused accumulation of 30SL5’, a 5’ extended form of 30S that occurs when A’ 
cleavage is impaired (as discussed in Chapter 3). In all of these knockdowns, 41S, 21S 
and 18SE precursors could not be detected. This indicates that these core SSU 
processome proteins are all required for complete removal of the 5’ETS, but since 30S 
was detected, implies that they are not required for ITS1 cleavage at site 2. Co-
depletion of XRN2 with either fibrillarin, UTP24 or BMS1 resulted in the complete 
absence of 36S and the ITS1 fragment indicating that these proteins are essential for 
endonucleolytic cleavage at site 2a (Figure 4.10B). Depeletion of RCL1 resulted in 
increased levels of 26S and 30S implying that RCL1 is required for cleavage at site A1 
in the 5’ETS but is not needed for site 2 cleavage. However, depletion of RCL1 caused 
a significant decrease in 18SE levels suggesting that it is important for exonucleolytic 
processing following site 2 cleavage (Figure 4.10B). Similarly, depletion of either ENP1 
or RPS19 caused a significant decrease in 18SE levels and in these cases, the levels 
of 21S and 21SC were dramatically increased. Following depletion of RPS19, 30SL5’ 
was detectable suggesting this protein is also required for A’ cleavage (Figure 4.10B 
and Figure 4.11). Co-depletion of RPS19 with XRN2 abolished accumulation of both 
36S and the ITS1 fragment whereas co-depletion of either ENP1 or RCL1 with XRN2 
merely decreased the levels of these pre-rRNAs (Figure 4.10B) suggesting all three of 
these proteins are required for cleavage at site 2a. It is not valid to compare the relative 
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Figure 4.10 SSU processome components are required for endonuclease cleavage at site 2a 
A) and B) HeLa cells were transfected with siRNA duplexes targeting the mRNAs of various 
ribosome biogenesis factors (indicated above the panels) either individually or in combination with 
those targeting XRN2. + denotes cells in which XRN2 is present at normal levels and – indicates 
cells in which XRN2 has been depleted. After 60 h cells were harvested and RNA and proteins 
were extracted. A) Protein samples from individual knockdowns were analysed by Western blotting 
using antibodies against the targeted proteins and CSL4, RIO2, fibrillarin or actin as loading 
controls. B) RNA was separated by agarose-glyoxal electrophoresis followed by Northern blotting 
using probes hybridising to the middle of ITS1 (top and second panel), the 5’ end of ITS1 (third 
panel). Mature rRNAs 28S and 18S were visualised using methylene blue staining. Mature and pre-
rRNAs are indicated to the right and left of the panel and fine lines link the identical pre-rRNAs on 
the middle sections. C) HeLa cells depleted of ribosome biogenesis factors for 48 h were depleted 
of phosphate and pulse labelled with 
32
P orthophosphate. Cells were then incubated with normal 
media for 3 h before harvesting. RNA was extracted and separated using agarose-glyoxal gel 
electrophoresis and visualised using a phosphorimager. The total RNA was visualised by ehtidium 
bromide staining (UV) 
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dependence of 2a on each of these proteins as they were depleted to different extents. 
Depletion of NOB1 caused no changes to the levels of longer pre-rRNAs either 
individually or when co-depleted with XRN2 but did result in increased accumulation of 
18SE. This suggest that its role as the endonuclease responsible for cleavage at the 3’ 
end of 18S is conserved from yeast to humans and that it is not required for cleavage 
at either 2 or 2a (Figure 4.10B). Consistent with these data, metabolic labelling 
experiments showed that depletion of fibrillarin, UTP24, NOB1, BMS1, RCL1, ENP1 or 
RPS19 resulted in a decrease or the complete loss of 18S rRNA. The increases in 30S 
levels following depletion of fibrillarin, UTP24, RCL1 and BMS1 and those of 21S 
following depletion of either ENP1 or RPS19 observed by Northern blotting were also 
detectable (Figure 4.10C). Depletion of fibrillarin also caused a decrease in 28S levels 
as previously discussed (Section 3.2.12). 
 
 In yeast, deletion of Rrp5 impairs pre-rRNA processing at sites A0, A1, A2 and A3 
implicating Rrp5 in rRNA processing steps required for formation of both the small and 
large subunit rRNAs (Venema et al. 1996). Metabolic labelling showed that when cells 
were depleted of RRP5, 45S levels were radically increased and that production of 
both 18S and 28S mature rRNAs was significantly inhibited (Figure 4.10C). Northern 
blot analysis of RNA from cells depleted of RRP5 also showed a major increase in 45S 
levels and a decrease in the accumulation of 30S and 18SE (Figure 4.10A and Figure 
4.12). The decrease in 18SE levels observed was not mirrored by a decrease in 21S 
levels implying that RRP5 functions in exonucleolytic processing from site 2 to 2a. 
Northern blotting analysis also revealed accumulation of novel fragments above 30S 
and 21S which have been termed 30SL3’ and 21SL3’ respectively. Using agarose-
glyoxal gel electrophoresis, the 30SL3’ intermediate appears the same size as both 
30SL5’, the 5’ extended form of 30S which accumulates when A’ cleavage is affected, 
and the LSU rRNA precursor, 32S. 30SL3’ does not, however, contain the 5’ end of the 
5’ETS implying that it is a 3’ extended form of 30S but this could not be confirmed by 
Northern blotting because of the overlap with 32S. 21SL3’ was also detectable using 
probes hybridising to the 3’ end of ITS1 and 5.8S but not the 5’ end of ITS2 (Figure 
 
Figure 4.11 RPS19 is required for efficient A’ 
cleavage RNA from cells depleted of RPS19 and 
control cells was analysed using agarose-glyoxal 
gel electrophoresis followed by Northern blotting 
using probes hybridising upstream (ETS1) and 
downstream (ETS2) of the A’ cleavage site in the 
5’ETS. Methylene blue staining was used to 
visualise mature 28S and 18S rRNAs and the 
positions of both mature rRNAs and pre-rRNAs are 
indicated to the left and right of the panels. 
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4.12). By comparison, we infer that the 3’ end of 30SL3’ was also likely to contain 
3’ITS1 and 5.8S sequence. It was concluded that depletion of RRP5 caused 
accumulation of some pre-rRNAs in which site 2 cleavage had been bypassed and 
processing instead occurred in ITS2. It is not clear where the cleavage site in ITS2 is 
and it is likely that it is followed by 3’-5’ exonuclease processing to degrade the 
aberrant precursors. Co-depletion of RRP5 with XRN2 inhibited production of both 36S 
and the ITS1 fragment indicating RRP5 is also required for 2a cleavage. 
  Taken together these data imply that the 2a site in human pre-rRNA is 
analogous to yeast A2 since cleavage at this site is dependent on several proteins of 
the SSU processome, including the yeast A2 endonuclease, Rcl1. Similar to yeast, 
where Rrp5 is required for cleavage at A2 and A3, depletion of RRP5 inhibited both 
ITS1 cleavages (2 and 2a). This raises the possibility that site 2 in human pre-rRNA 
may be equivalent to the A3 cleavage in yeast.  
 
 
Figure 4.12 Mapping 30SL3’ and 21SL3’ accumulated after RRP5 depletion A) Schematic 
outline of partial pre-rRNA transcript showing the relative positions of the probes used in 
Northern blot hybridisation in green. B) RNA from control cells and those depleted of RRP5 was 
separated using agarose-glyoxal gel electrophoresis. Northern blotting was carried out using 
probes hybridising to the pre-rRNA regions shown in (A). pre-rRNA intermediates detected are 
indicated to both the left and right of the panel. Northern blot membranes were stained with 
methylene blue (MB) to visual mature 28S and 18S rRNAs.  
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4.2.9 Depletion of BOP1 and to some extent RBM28 impairs site 2 cleavage 
 In yeast, Nop4, which is homologous to human RBM28, is essential for efficient 
A3 cleavage. Following A3 cleavage in yeast, exonucleolytic processing is used to 
generate the mature 5’ end of 5.8S processing and this requires a cluster of A3 factors 
including Erb1 (BOP1 in higher eukaryotes). BOP1 and RBM28 were depleted from 
HeLa cells, either individually or in combination with XRN2, and the effects of pre-rRNA 
processing were examined using Northern blotting (Figure 4.13A-C) and metabolic 
labelling (Figure 4.13E, F). Depletion of BOP1 resulted in a significant decrease in 28S 
levels and accumulation of 47/45S and 41S without affecting 18S levels (Figure 4.13F). 
Also observed was a defect in 5.8S accumulation with loss of the normally major, short 
form of 5.8SS and an increased accumulation of 5.8SL (Figure 4.13E) implying that the 
pathways used to produce 5.8S following site 2 cleavage are analogous to those used 
in yeast after A3 cleavage. Northern blotting of RNA from cells depleted of BOP1 
showed increased levels of 47/45S and 41S as well as a significant accumulation 36S 
and a novel 5’ shortened form of 36S, 36SC (Figure 4.13A, B and Figure 4.14). The 
levels of 32S, 30S, 21S and 12S were notably reduced while 18SE levels remained 
largely unaffected (Figure 4.14A, B). These data imply that loss of BOP1 impairs site 2 
cleavage and co-depletion of BOP1 with XRN2 decreases the amount of the ITS1 
fragment accumulated, reflecting this block in site 2 cleavage (Figure 4.13 A, C). 
Although depletion of BOP1 impairs site 2 cleavage, the levels of 18SE were not 
altered because an increased proportion of pre-rRNA was cleaved at 2a in the 
endonucleolytic processing pathway. The appearance of 36SC implies that pre-rRNA 
cleaved at 2a rather than site 2, can undergo 5’-3’ exonucleolytic processing to 
generate 32S. Co-depletion of BOP1 with XRN2 causes a greater accumulation of 36S 
but does not change the level of 36SC implying that XRN2 is one of the 5’-3’ 
exonucleases involved in generating this intermediate.  
 In contrast, depletion of RBM28 caused mild defects in the levels of 28S and 
5.8S but the ratio of 5.8SS to 5.8SL and 18S levels were not altered. Metabolic labelling 
experiments revealed a significant increase in 47/45S levels which was also detectable 
using Northern blotting implying that all the pre-rRNA processing steps downstream of 
A’ cleavage are slowed when RBM28 is depleted. Also observed using Northern 
blotting were increases in 41S, 36S and 36SC levels while 32S and 12S levels were 
slightly decreased. When RBM28 was co-depleted with XRN2, 36S was accumulated 
to a much greater extent than when XRN2 alone was depleted. These data show that 
when RBM28, the homologue of Nop4 which is essential for A3 cleavage, is depleted, 
ITS1 processing is slowed and an increased proportion of pre-rRNA is cleaved at 2a 
before cleavage site 2. We therefore conclude that site 2 in human ITS1 is analogous 
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to yeast A3 cleavage. This cleavage, however, plays a more important role in pre-rRNA 
processing in humans than in yeast as it is the endonuclease cleavage that separates 
the large and small subunit rRNA and our data also suggest that the relative 
importance of protein factors such as RBM28 (Nop4) in site 2 and A3 cleavages may 
differ. 
 
 
 
 
 
Figure 4.13 BOP1 and RBM28 are required for site 2 cleavage in ITS1 A and B) HeLa cells were depleted 
of RRP5, BOP1, RBM28 or XRN2 and after 48 h the cells were pulse labelled with 
32
P orthophosphate then 
grown in normal media for 3 h. RNA was extracted and separated using agarose glyoxal (A) or 8 % 
polyacrylamide/7 M urea gel electrophoresis (B) and was visualised using a phosphorimager. Total RNA was 
visualised using ethidium bromide staining (UV). C-F) HeLa cells were transfected with siRNA duplexes to 
depleted BOP1 or RBM28 either individually or in combination with XRN2 or with control siRNAs. – indicates 
depletion of XRN2 and + indicates normal XRN2 levels. After 60 h RNA and proteins were extracted. C) 
Proteins were separated by SDS-PAGE and analysed by Western blotting using antibodies raised against 
mouse BOP1, RBM28 or those recognising CSL4 or fibrillarin (FIB.) as loading controls D) RNA was analysed 
by agarose-glyoxal gel electrophoresis followed by Northern blotting using probes hybridising to the 5’ end of 
ITS1, middle of ITS1 or ITS2, as indicated to the left of the panel. Mature 28S and 18S rRNAs were visualised 
by methylene blue staining of membranes. E-F) Levels of pre-rRNA intermediates were determined using 
ImageQuant software, normalised to mature 18S levels, compared to either control cells (F) or those depleted 
of only XRN2 (E) and are shown as bar charts.  
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4.2.10 Human RNase MRP is not required for site 2 cleavage 
In yeast, endonucleolytic cleavage at A3  is a non-essential step that is carried 
out by the RNP, RNase MRP. The only pre-rRNA processing defect detected when 
RNase MRP, the enzyme responsible for carrying out this cleavage, is deleted, is a 
change in the ratio of the long and short forms of 5.8S rRNA. Since the A3-like 
cleavage at site 2 in human pre-rRNA is the primary ITS1 cleavage which separates 
the LSU and SSU rRNAs, RNase MRP would be predicted to be critical for formation of 
21S and 32S pre-rRNAs. RNase MRP is a snoRNP consisting of a single RNA and 7-
10 proteins including the core components, POP1 and RPP40. In yeast, Pop1 is 
essential for RNase MRP accumulation and function (Lygerou et al, 1994). Using RNAi, 
POP1 or RPP40 was depleted from HeLa cells and POP1 was co-depleted with XRN2. 
Proteins were analysed by Western blotting (probing was carried out in the laboratory 
of Dr Ger Pruijn due to a lack of available antibodies) which showed that both POP1 
and RPP40 had been specifically depleted by the siRNA treatment (Figure 4.14A). 
Depletion of these proteins using identical siRNA duplexes has previously been shown 
to inhibit RNase MRP cleavage of the viperin mRNA leading to increased viperin 
protein levels (Mattijssen et al, 2010a). RNA was analysed on a denaturing 
polyacrylamide gel followed by Northern blotting using probes hybridising to the RNA 
component of RNase MRP and the SRP RNA component, 7SL. This showed that in 
cells treated with each of these siRNAs, the levels of RNase MRP RNA were 
decreased between four and six fold (Figure 4.14B).  
Pre-rRNAs from cells depleted of either POP1 or RPP40 were also analysed by 
agarose-glyoxal electrophoresis followed by Northern blotting using different probes 
spanning ITS1, 5.8S and ITS2. No rRNA processing defects were observed in these 
cells compared to rRNA extracted from control cells (Figure 4.14C, D). The levels of 
21S, 30S and 32S, which would be expected to decrease if RNase MRP was required 
for site 2 cleavage, were not altered, suggesting that although site 2 is to some extent 
analogous to yeast A3, RNase MRP does not appear to be the endonuclease 
responsible for this cleavage. Depletion of these proteins in combination also did not 
cause any pre-rRNA processing defects. This result was also obtained by an 
independent group of collaborators (Dr Sandy Mattijssen and Dr Ger Pruijn, 
unpublished data). POP1 was also co-depleted with XRN2 to determine whether 
RNase MRP plays any role in the alternative ITS1 cleavage at 2a. However, the levels 
of 36S and the ITS1 fragment detected when these proteins were co-depleted were the 
same as those observed when XRN2 was depleted alone ruling out his possibility 
(Figure 4.14C).  
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To confirm whether any role in ribosome biogenesis for RNase MRP/P could be 
detected, metabolic labelling experiments were carried out on cells depleted of either 
POP1 or RPP40. Total RNA was analysed using both agarose-glyoxal gel 
electrophoresis and polyacrylamide gel electrophoresis (Figure 4.14E). The ratio of 
28S to18S rRNAs was not altered compared to control cells and although a slight 
decrease in the rate of rRNA processing was detected, this was no more significant 
 
Figure 4.14 Site 2 cleavage does not depend on RNase MRP A) HeLa cells were transfected 
with siRNA duplexes to deplete the RNase MRP subunits; POP1 or RRP40 or with control siRNAs. 
After 60 hours RNA and proteins were extracted. Proteins were separated by SDS-PAGE and 
analysed by Western blotting using antibodies raised against the RNAi targeted proteins or γ 
tubulin. B) RNA from siRNA treated cells was separated on an 8% polyacrylamide/7M urea gel and 
transferred for Northern blotting using probes hybridising to either the RNA component of RNase 
MRP or the RNA component of the signal recognition particle (7SL). RNA levels were quantified 
using ImageQuant software and normalised to 7SL, then compared to levels in control cells. C) 
RNA from cells depleted of POP1, XRN2 or both proteins was analysed by agarose-glyoxal gel 
electrophoresis followed by Northern blotting using probes hybridising to the 5’ end of ITS1, the 
middle of ITS1 or the middle of ITS2. Mature rRNAs were visualised by methylene blue staining. D) 
RNA from cells depleted of RPP40 or POP1 was analysed as in (C). E) HeLa cells were transfected 
with siRNAs to deplete POP1, RPP40 or control siRNAs. After 48 hours cells were pulse labelled 
with 
32
P orthophosphate, then grown in normal media with cells harvested at the time points 
indicated above the panel. RNA was extracted and analysed by both agarose-glyoxal gel 
electrophoresis and on an 8% denaturing polyacrylamide gel. RNA was then visualised using a 
phosphoimage. The RNA species detected are indicated to either side of the panel. 
144 
 
than was observed when the essential, non-ribosome biogenesis factor, SRP14, was 
depleted. No defects in the ratio of long to short forms of 5.8S rRNA were detected as 
were observed in yeast. Taken together these data strongly suggest that although 
RNase MRP has other important functions in human cells, that it is not essential for 
ribosome biogenesis and questions whether site 2 is completely analogous to yeast A3.  
 
4.2.11 pre-rRNA intermediates in human cell lines and after differentiation 
 We have identified that two alternative mechanisms exist for the production of 
18SE; a major pathway involving exosome processing following site 2 cleavage and a 
minor pathway involving endonucleolytic cleavage of site 2a. It appears that blocking 
site 2 cleavage by depleting BOP1 or RBM28 stimulates the alternative cleavage at 2a 
but inhibiting exonucleolytic processing following site 2 does not, implying these 
pathways are not redundant. It was, therefore, of interest to investigate whether there is 
a physiological relevance of conserving two alternative pathways for 18SE production 
and to determine if there are circumstances when the pathway involving 
endonucleolytic cleavage at 2a plays a more dominant role. Ribosome biogenesis has 
been shown to be down-regulated during differentiation when the growth rate of cells is 
decreased. We therefore speculated that the exonucleolytic processing pathway could 
represent the most efficient method of 18SE production for rapidly growing cells but 
when the growth rate is decreased during differentiation, the alternative pathway may 
be used more. Further, much of the published data describing 36S as the product of 
endonucleolytic cleavage at 2a was derived from studies carried out in mouse cells and 
the relative accumulation of 36S to other pre-rRNAs seems greater than in HeLa cells. 
This raises the possibility that the relative use of these alternative pathways is 
dependent on cell type. To investigate this hypothesis, the levels of key pre-rRNA 
intermediates and proteins playing important roles in ITS1 processing were determined 
in three different cell lines, HeLa, HEK293 and TC7. The TC7 cell line is a derivative of 
the CaCo-2 cell line (colon cancer cells) and has been used as a model for studying 
differentiation (Meinl et al, 2008). Cells are grown to confluence and then maintained 
for a further 22 days during which they undergo differentiation. Pre-rRNA levels were 
determined in both undifferentiated and differentiated TC7 cells to characterise 
changes that may occur as ribosome biogenesis is slowed.  
 HeLa, HEK293 and TC7 cells were grown to 70% confluence and TC7 cells 
were allowed to differentiate before harvesting. When CaCo-2 undergo differentiation, 
the levels of the core snoRNP protein, fibrillarin, are unchanged but the levels of many 
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SSU processome factors including PNO1 are decreased (Knox et al, 2011). To verify 
that the TC7 cells had undergone differentiation, Western blot analysis was carried out  
 
using antibodies raised against these two proteins. Fibrillarin levels were observed to 
be uniform across all cell lines and after differentiation, indicating even loading across 
the gel, whereas a significant decrease in PNO1 levels was observed in the TC7 cells 
grown for 22 days, confirming that these TC7 cells had differentiated (Figure 4.15A). 
RNA was extracted from all these cells and analysed by agarose-glyoxal gel 
electrophoresis. Northern blotting was carried out using probes hybridising upstream 
 
Figure 4.15 The use of alternative ITS1 processing pathways is not altered during 
differentiation A) HeLa, HEK293 and TC7 cells were cultured. RNA was extracted from HeLa, 
HEK293 and TC7 cells both before (UnDiff) and after differentiation (Diff). Protein was extracted 
from cells and separated by SDS-PAGE followed by Western blotting using the antibodies 
indicated to the left of the panel. B) RNA was separated by agarose-glyoxal gel electrophoresis 
followed by Northern blotting. Membranes were stained with methylene blue (MB) to visualise 
mature rRNAs. Hybridisation was carried out using radiolabelled probes shown below the panel. 
Pre-rRNA intermediates observed are indicated using each probe is indicated to the left of each 
panel. C) Quantification was performed using ImageQuant TL software and pre-rRNA levels were 
normalised to 28S rRNA. Results are summarised in the bar graph. When a pre-rRNA is detected 
using more than one probe the data shown in the bar graph is as follows: 47S (ETS1), 47/45S 
(ETS2), 41S (ITS1), 36S (ITS1), 30S (ETS2), 26S (ITS1), 21S (ITS1) and 18SE (18SE) although 
numbers are representative of data generated with all probes. 
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(ETS1) and downstream (ETS2) of the A’ cleavage site in the 5’ETS, at the 5’ end of 
ITS1 and in the middle of ITS1 (Figure 4.15B). The levels of pre-rRNA intermediates 
detected by each of the probes were determined and compared to levels found in HeLa 
cells. The results are shown as a bar chart in Figure 4.15C. The levels of 36S, which is 
generated by endonucleolytic cleavage at the 2a site, were not significantly varied 
across the cell lines used or after differentiation. It would, therefore, appear that the 
balance between the alternative processing pathways to produce 18SE is not affected 
by long-term changes in cell growth rate. It is interesting to note, however, that after 
differentiation, the levels of 47S are significantly increased compared to those in 
undifferentiated cells, while the levels of all other pre-rRNA intermediates are 
decreased after differentiation (Figure 4.15B, C). This demonstrates that as cellular 
growth rate is reduced and the rate of ribosome biogenesis slows, the rate of rRNA 
processing is also decreased. Another notable difference is that the level of 18SE is 
considerably higher in HEK293 cells than in either HeLa or TC7 cells (Figure 4.15B, C).  
 
4.3 Discussion 
 Here we have characterised two alternative processing pathways for the 
removal of ITS1 in human cells. The major pathway involves a single endonucleolytic 
cleavage at site 2, which is to some extent analogous to yeast A3. As in yeast, this is 
followed by 5’ exonucleolytic processing to produce the mature 5’ end of 18S but in 
contrast to yeast, is also followed by 3’ exonucleolytic processing by the exosome to 
site 2a. This generates 18SE, a precursor of 18S, which extends approximately 25 nt 
beyond the 3’ end of 18S. We also provide evidence that 18SE can be produced by an 
endonucleolytic cleavage at site 2a, which is equivalent to yeast A2, but in humans, this 
cleavage is inefficient and plays a minor role in pre-rRNA processing. Although 
inhibiting site 2 cleavage stimulates 2a cleavage, this minor pathway cannot 
compensate for a block in exonucleolytic processing following site 2 cleavage to 
produce 18SE unless stimulated to do so by co-depletion of XRN2.  
Following site 2 cleavage, RRP6, the 3’-5’ exonuclease component of the 
nucleolar exosome, processes to site 2a to remove the majority of ITS1 sequence from 
the 3’ end of 18S. The core exosome, the TRAMP helicase, MTR4, and to a lesser 
extent, the RRP6 cofactor, MPP6, are required for this processing. Depletion of RRP6 
caused a significant decrease, but not an absolute block, in 18SE accumulation and 
the appearance of a partially processed intermediate, 21SC, suggesting other proteins, 
such as the REX exonucleases, are also able to inititate and in some cases complete 
21S processing to 2a. In contrast, depletion of either the core exosome or MTR4 
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caused a smear of intermediates perhaps implying that these proteins are required to 
recruit the exosome to the pre-rRNA or to enhance the activity of RRP6 to enable it to 
degrade this substrate. The region of ITS1 that is removed is approximately 800 nt 
long, 82% GC rich and is highly structured, possibly explaining the requirement for the 
helicase, MTR4, and making it likely that the activity of human RRP6 is significantly 
increased in the context of the cell compared to that observed in vitro (see section 
3.2.2). DIS3 was not required for this exonucleolytic processing step and as DIS3 is 
excluded from nucleoli in human cells, it is likely that ITS1 processing by the exosome 
predominantly occurs in the nucleolus. The nucleolar RRP6 cofactor, C1D, was also 
not required for ITS1 processing although we have previously shown that it does 
function in the turnover of the 37S* and in 5.8S processing (Figure 3.9 and Figure 
3.12). We further observed that the SSU biogenesis factors, RPS19, ENP1, RRP5 and 
RCL1, were required for this processing linking the exosome to the SSU processome. 
 
 
Figure 4.16 Alternative ITS1 processing 
pathways in yeast and human cells 
Schematic representation of the yeast, 
human major and minor ITS1 processing 
pathways are shown. Exonuclease and 
endonuclease processing steps are shown in 
red, SSU processome components in green, 
yeast A3 cluster proteins in yellow and RRP5 
which is required for both ITS1 cleavages in 
purple. 
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Although we have identified alternative ITS1 processing pathways, 
exonucleolytic processing following site 2 cleavage is clearly the major route since we 
see little evidence of pre-rRNAs cleaved at 2a prior to site 2 and inhibiting exosome 
processing of ITS1 severely decreases both 18SE and 18S levels. This is supported by 
the observation that stimulating 2a cleavage by depletion of XRN2 is able to rescue 
18SE production in the absence of the core exosome or MTR4. Exonucleolytic 
processing between sites 2 and 2a in human cells is somewhat comparable to yeast 
where modifications in the A2 site, which block cleavage, result in the exosome 
processing back to A2 following A3 cleavage to enable normal 18S production (Allmang 
et al, 2000). However, this alternative pathway has evolved to be the major processing 
mechanism in humans.  
We found that multiple components of the SSU processome are required for 2a 
cleavage, making this cleavage analogous to A2 cleavage in yeast. In contrast to yeast, 
cleavage at site 2a is part of a minor pre-rRNA processing pathway in human cells. The 
only precursor which is specific to this pathway, 36S, is barely detectable in a variety of 
human cells lines (HeLa, HEK293, TC7) implying that only a small fraction of pre-rRNA 
is normally processed via this pathway but it is not possible to quantifiy this. When 
cleavage at site 2a is stimulated, either by blocking site 2 cleavage or by depletion of 
XRN2, no precursors were detected that had been processed at site 2a but still 
contained any 5’ETS sequence. This implies that, as in yeast (Venema & Tollervey, 
1995), cleavage at 2a (A2) occurs simultaneously with, or following, removal of the 
5’ETS.  
There are several reasons why 2a cleavage may be inefficient and these 
include, the proximity of the cleavage site to the 3’ end of 18S, possible inhibition by 
protein factors or, if removal of the 5’ETS precedes 2a cleavage, that this causes 
dissociation of the necessary 2a processing machinery. In yeast, early pre-rRNA 
processing steps, including A2 cleavage, can occur co-transcriptionally whereas in 
humans, A’ cleavage is the only step thought to occur during transcription. It is possible, 
therefore, that the efficiency of 2a (A2) is determined by the timing of processing 
relative to transcription. Alternatively, depletion of proteins required for site 2 cleavage 
stimulated 2a processing, possibly indicating that they also inhibit 2a cleavage. This 
may represent a regulatory mechanism by which the optimal pre-rRNA pathway is 
favoured while maintaining an alternative method of processing. It is not entirely clear 
why depletion of XRN2 stimulates 2a cleavage but as mentioned in the previous 
chapter, XRN2 appears to coordinate the optimal order of pre-rRNA cleavages. It is not, 
however, entirely clear why there are two alternative pathways for 18SE production that 
are not fully redundant. We speculated that when cells underwent differentiation, the 
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decreased growth rate may alter the balance between these pathways but this was not 
the case. However, similar alternative pathways have also been described in X. laevis 
oocytes suggesting that this is a common feature of pre-rRNA processing in higher 
eukaryotes (Savino & Gerbi, 1990). 
In yeast, a cluster of seven proteins, including Erb1, Nop7 and Ytm1, are co-
recruited to the A3 cleavage site and these proteins are required for processing to form 
the mature 5’ end of 5.8SS, recruitment of large subunit ribosomal proteins and 
regulating pre-rRNA folding in ITS2 (Granneman et al, 2011; Sahasranaman et al, 
2011). The homologue of Erb1, BOP1, is also found in a complex with homologues of 
Nop7, PES1, and Ytm1, WDR12, (Holzel et al, 2005; Lapik et al, 2004) making it likely 
that this complex is functionally homologous to the yeast A3 cluster. In yeast, an 
additional protein associated with the A3 cluster is Nop4, but unlike the others, this 
protein is essential for A3 cleavage. Our data show that cleavage at site 2 in human 
pre-rRNA is inhibited by depletion of RRP5 or BOP1 but loss of RBM28 (Nop4) only 
slowed the rate of cleavage at this site. The involvement of these factors in site 2 
cleavage implies that it is analogous to yeast A3 cleavage but the precise roles of the 
homolgous proteins do not seem to be conserved. Depletion of RRP5, BOP1 or 
RBM28 caused a delay in pre-rRNA processing following A’ cleavage implying that both 
ITS1 cleavages were slowed. Depletion of RRP5 specifically blocked cleavage at 2a 
and this effect was sufficient to cause ITS1 cleavages to be bypassed, forcing 
processing to occur in ITS2. In yeast, blocking A3 cleavage or the downstream 
processing inhibits formation of the major, short form of 5.8S, 5.8SS, and causes 
accumulation of 5.8SL. Depletion of BOP1 from HeLa cells caused a similar phenotype 
implying that this step of processing is conserved from yeast to humans.  
Although site 2 appeared to be analogous to yeast A3, depletion of RNase MRP 
proteins did not affect site 2 cleavage or the subsequent processing to produce 5.8S. 
RNAi depletion of the RNase MRP/RNase P proteins using identical siRNAs has, 
however, been shown to inhibit cleavage of the viperin mRNA (Mattijssen et al, 2011). 
Consistent with this, knockdown of the RNase MRP/P subunit, RPP38, was previously 
shown to block tRNA processing but only have a minimal effect on 5.8S rRNA 
processing (Cohen et al, 2003). It therefore, appears that RNase MRP is not the 
primary endonuclease responsible for site 2 cleavage in humans, although we cannot 
rule out the possibility that it plays a redundant role in this processing. This suggests 
that an additional endonuclease, possibly one specific to higher eukaryotes, is required 
for ITS1 cleavage to separate the LSU and SSU rRNAs.  
Characterisation of the specific functions of RBM28, RNase MRP and BOP1 in 
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human pre-rRNA processing is important as these proteins are linked to ANE and CHH 
syndromes and colorectal cancer, respectively (Chung et al, 2011; Glazov et al, 2011; 
Killian et al, 2006; Nousbeck et al, 2008; Ridanpaa et al, 2001; Spiegel et al, 2010). 
This will be discussed in more detail in section 6.4.  
151 
 
Chapter Five 
Analysis of factors involved in formation of the 3’ end 
of 18S rRNA 
5.1 Introduction 
 The small subunit rRNA, 18S, is co-transcribed with the large subunit rRNAs, 
5.8S and 28S (25S in yeast). 18S rRNA is separated from the large subunit rRNAs by 
cleavage in ITS1 at site 2 in human pre-rRNA or at sites A2 and A3 in yeast (Figure 5.1). 
Many proteins required for formation of the small subunit form a multiprotein complex 
called the SSU processome and five major sub-complexes, U3 snoRNP, MPP10 
complex, tUTP, bUTP and cUTP, have been identified (Henras et al, 2008). The SSU 
processome is recruited to the pre-rRNA co-transcriptionally and is responsible for 
many steps in the biogenesis of the small subunit including removal of the 5’ETS, 18S 
pre-rRNA processing and assembly of early pre-ribosomal complexes. 
 
In yeast, a number of additional proteins are required for the final stages of 
formation of the mature 3’ end of 18S which occur as the pre-40S complex is exported 
from the nucleus into the cytoplasm. Some of these factors, such as Dim1, Nob1, 
Pno1, Prp43, Enp1, Ltv1 and Tsr1, become associated with early complexes but 
perform their main functions during or after export into the cytoplasm. Others, such as 
Rio2, are predominantly localised in the cytoplasm and are only associated with pre-
 
Figure 5.1 pre-rRNA processing to produce 18S rRNA Schematic outlines of the pre-rRNA 
intermediates in the pathway for 18S production in human cells. Cleavage sites are shown 
above the full length transcript and 18S (blue), 5.8S (orange) and 28S (yellow) mature rRNAs 
are shown. The lengths of intermediates is given to the left in Svedburg units (S) and C 
denotes a 3’ shortened form of an intermediate and EXO (red) indicates this is processed by 
the exosome. 
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40S complexes during the final maturation steps. This set of factors includes some 
proteins whose functions in yeast are known, while the roles of others remain elusive. 
Nob1 is the endonuclease responsible for cleavage at site D to remove all ITS1 
sequence from the 3’ end of 18S and Pno1 is proposed to be a cofactor of Nob1 
(Lamanna & Karbstein, 2011; Vanrobays et al, 2004). Prp43, is also necessary for this 
processing step (Pertschy et al, 2009). Since Prp43 is a helicase, it is suggested that 
structural rearrangement of the pre-rRNA around site D is required for Nob1 cleavage. 
The dimethyltransferase, Dim1, catalyses the methylation of two conserved adenosine 
residues at the 3’ end of 18S and failure to do this causes formation of non-functional 
ribosomes (Lafontaine et al, 1998b). Enp1 is a protein which, along with Ltv1, is 
released from pre-40S complexes when it is phosphorylated by Hrr25 causing a major 
structural rearrangement of the beak region of the small subunit. Regulation of this step 
is critical for enabling export of the pre-40S complex into the cytoplasm (Schafer et al, 
2006). Much less is known about SSU biogenesis factors in human cells but late pre-
40S complexes have been purified through RIO2 and all these proteins, except DIM1, 
were co-purified, suggesting that the composition of these complexes is relatively well 
conserved (Zemp et al, 2009). 
 
 In yeast, it has been demonstrated, using an in vivo cross linking method 
(CRAC), that many of these late-acting SSU biogenesis factors are directly associated 
with 18S rRNA and binding sites near the 3’ end of 18S have been defined 
(Granneman et al, 2010). A crystal structure of the eukaryotic 40S small subunit in 
complex with Initiation factor I from Tetrahymena thermophilia (Rabl et al, 2010) shows 
the three dimensional structure of 18S and the relative positions of the proteins found 
in the mature ribosome. A structure of a pre-40S complex from S. cerevisiae containing 
most of the late-acting SSU biogenesis factors discussed here has also been 
generated using cryo-electron microscopy (Figure 5.2) (Strunk et al, 2011). Taken 
together, these studies enable a clearer understanding of the final structures of the 3’ 
end of 18S and the possible interactions, rearrangements and regulation of the late 
acting biogenesis factors. 
 
Figure 5.2 Structure of a late pre-40S 
complex from S. cerevisiae Model of late 
pre-40S complex from S. cerevisiae based 
on a cryo electron microscopy showing the 
positions of late small subunit transacting 
factors modelled onto a crystal structure of 
the T. thermophilia small ribosomal 
subunit. Adapted from Strunk et al. 2011 
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 In the previous chapter, we have shown that the pre-rRNA processing pathway 
used to form the 3’ end of 18S in human cells is considerably different to that used in 
yeast. In yeast, removal of ITS1 occurs by sequential endonucleolytic cleavages at A2 
or A3 then at site D. In contrast, in human cells, cleavage at site 2, which is in some 
ways analogous to the yeast A3 cleavage, is followed by exonucleolytic processing by 
the exosome to the 2a site which removes the majority of ITS1 sequence (Figure 5.1). 
Since this additional ITS1 processing step is not found in yeast but the composition of 
late pre-40S particles seems well conserved (Zemp et al, 2009), it is likely that factors 
involved in formation of the 3’ end of 18S have evolved additional or different functions 
in human cells to enable this increased complexity in processing to occur. Formation of 
the mature end of 18S appears to be carried out by NOB1 endonucleolytic cleavage as 
in yeast (section 4.2.8). The immediate precursor of 18S, 18SE, is only extended from 
the 3’ end of 18S by approximately 25 nt and is predominantly generated by 
exonucleolytic processing rather than endonucleolytic cleavage. This raises several 
questions, such as why and how exonucleolytic processing is halted close to, but not 
directly at, the mature end of 18S. Exonucleolytic processing of ITS1 by the exosome 
also involves the small subunit protein, RPS19, the SSU biogenesis factors, ENP1 and 
to some extent RCL1. This implies that ITS1 processing is coordinated with other 
important events in formation of the mature 3’ end of 18S and raises the possibility that 
the proteins involved in these other steps are required for exonucleolytic processing of 
ITS1 to 2a. Since these late-acting SSU biogenesis factors bind to the 3’ end of 18S in 
yeast, it is possible that they are responsible for terminating exonucleolytic processing 
at 2a. It is further possible that other factors involved in formation of the 3’ end of 18S 
are involved in mechanisms by which ITS1 processing is regulated. As phosphorylation 
often provides a control mechanism, the kinase activity of RIO2 is of particular interest. 
Although all the proteins identified in yeast as performing the final 18S maturation steps 
have human homologues, little is known about whether their functions are conserved 
and what additional roles they may play. 
 
5.2 Results 
5.2.1 RNAi depletion of late-acting SSU biogenesis factors 
In the previous chapter, we showed that the immediate precursor of 18S, 18SE, 
is produced by exonucleolytic processing by the exosome. This processing requires the 
small subunit protein, RPS19, the late acting small subunit (SSU) biogenesis factor, 
ENP1 and to some extent the SSU processome component, RCL1. We aimed, 
therefore, to identify other proteins that may be required for efficient exosome 
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processing of ITS1 to produce 18SE. In yeast, several proteins have been shown to be 
important for formation of the 3’ end of 18S with defects in conversion of 20S into 18S 
being characteristic of depleting these proteins, making the human homologues likely 
candidates for involvement in exosome processing of ITS1.  
HeLa cells were chemically transfected with siRNAs targeting the mRNAs of 
ENP1, NOB1, PNO1, RIO2, DIM1 or PRP43. A duplex targeting the firefly luciferase 
mRNA, which is not expressed in HeLa cells, was used as a negative control. 60 h 
after transfection, cells were harvested. Proteins were extracted and analysed by SDS-
PAGE followed by Western blotting. Antibodies against ENP1, NOB1, PNO1, RIO2 and 
PRP43 were used and showed that the levels of each of the targeted proteins were 
specifically decreased compared to control cells while levels of the cytoskeletal protein, 
actin, or the core snoRNP protein, fibrillarin, were not affected (Figure 5.3A). For DIM1, 
a usable antibody against the endogenous protein could not be sourced, so it was not 
possible to confirm whether protein levels had been successfully decreased in HeLa 
cells. However, to confirm that the siRNA duplexes used were able to specifically 
decrease DIM1 levels, their effectiveness was tested in stably transfected HEK293 
cells expressing FLAG-tagged DIM1. Such cells were transfected with either control 
siRNAs or those targeting DIM1 and DIM1 levels were monitored by Western blotting 
using an antibody which detects the FLAG-tag. This showed that FLAG-DIM1 levels 
were significantly reduced by the siRNA treatment while actin levels remained 
unchanged (Figure 5.3A). 
RNA was also extracted from siRNA treated cells and pre-rRNAs analysed by 
agarose-glyoxal gel electrophoresis followed by Northern blotting using a probe 
hybridising to the 5’ end of ITS1 (Figure 5.3B). Results were visualised using a 
phosphorimager and quantification of the levels of each pre-rRNA intermediate 
compared to control cells is given as a line diagram (Figure 5.3C). As described in the 
previous chapter, depletion of ENP1 led to an increase in 21S, the appearance of 
21SC and a decrease in 18SE levels. Depletion of PNO1 did not affect the levels of 
47/45S or 30S but caused a significant increase in the 26S pre-rRNA intermediate. 26S 
corresponds to a precursor extending from the A0 cleavage site in the 5’ETS to site 2 in 
ITS1 and is generated when cleavage at A1 is impaired. An increase in 21S levels and 
a decrease in 18SE levels were also observed and smears of 26SC and 21SC were 
detectable below 26S and 21S respectively implying PNO1 may play a role in 
processing to form 18SE (Figure 5.3 B, C). This will be discussed in more detail in 
Section 5.2.5. When either RIO2 or NOB1 were depleted from HeLa cells, a significant 
increase in 18SE levels was observed while the levels of the other pre-rRNA species 
did not vary relative to cells transfected with the control siRNA (Figure 5.3 B, C). This  
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implies that, as in yeast, these proteins are only required for the final maturation step in 
18S production. 
Depletion of DIM1 leads to a small increase in the amounts of 26S and 21S 
accumulated and a subtle decrease in 18SE levels suggesting that DIM1 may be 
indirectly involved in exonucleolytic processing of 21S. More strikingly, novel pre-rRNA 
intermediates smaller than 18S and 41S, here termed, 16S* and 38S*, respectively, 
were also detected (Figure 5.3B, C, Figure 5.4A, B). 38S* was not always detectable 
and was only accumulated to significant levels in some knockdown experiments. The 
sizes of these fragments imply that they are not generated by an alternative processing 
 Figure 5.3 Late-acting pre-40S biogenesis factors are required at different stages of pre-rRNA 
processing A) HeLa cells were chemically transfected with siRNA duplexes specifically targeting 
firefly luciferase (control), ENP1, NOB1, PNO1, RIO2, DIM1 or PRP43. Protein was extracted from 
RNAi depleted cells after 60 h and analysed by SDS-PAGE followed by Western blotting. Proteins of 
interest (except DIM1) were detected by antibodies specific to each protein, indicated to the left of 
each panel. HEK293 cells expressing FLAG-DIM1 at the same level as the endogenous protein were 
also transfected with siRNA duplexes to deplete DIM1 or control siRNAs. Proteins were analysed by 
SDS-PAGE followed by Western blotting using an antibody which detected the FLAG-tag. B) RNA 
was extracted from siRNA treated cells, separated by electrophoresis on a 1.2 % agarose-glyoxal gel 
and transferred to a nylon membrane. Methylene blue (MB) staining was used to visualise 28S and 
18S mature rRNAs and Northern blot hybridisation was performed using a probe detecting the 5’ end 
of ITS1 C) The levels of pre-rRNA intermediate detected by Northern blotting in cells depleted of each 
protein are shown as lane profiles graphs, generated using ImageQuant software. Levels were 
normalised to 28S levels and each graph depicts intensity in arbitrary units (a.u.) relative to the 
distance migrated though the gel. pre-rRNA levels in cells depleted of a protein of interest (colour) 
relative to levels detected in cells transfected with the control siRNA (black) are shown. 
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pathway, but instead suggest that they are aberrant fragments of pre-RNA undergoing 
degradation. To map these fragments, RNA extracted from DIM1 depleted cells was 
analysed by Northern blotting using probes hybridising to the 3’ end of the 5’ETS 
(ETS3) and the middle of ITS1 (ITS1). Both fragments were detected using the ITS1 
probe but neither was detected by the ETS3 probe (Figure 5.4A). It was, therefore, 
concluded that 16S* and 38* are generated from 21S or 18SE and 41S being degraded 
from the 5’ end. This implies that non-DIM1 associated pre-rRNAs are detected as 
aberrant and are targeted for degradation by 5’-3’ exonucleases (Figure 5.4B).  
 
 
5.2.2 PRP43 is not required for 18S production in HeLa cells  
It was expected that the human homologue of yeast Prp43 would have a similar 
role in ribosome biogenesis to its yeast counterpart and cause an accumulation of the 
immediate precursor of 18S, but depletion of PRP43 from HeLa cells did not alter the 
levels of any of the precursors of 18S rRNA (Figure 5.3B, C). This suggests that the 
function of this protein in cleavage at the 3’ end of 18S may not be conserved from 
yeast to humans. It was, however, possible that the kinetics of 18S production were 
affected by depletion of PRP43 and Northern blotting may not be a sensitive enough 
 
Figure 5.4 21S and 41S are degraded from the 5’ 
end when DIM1 is depleted A) HeLa cells were 
chemically transfected with siRNA duplexes targeting 
firefly luciferase (control) or DIM1. Cells were 
harvested 60 h after transfection and RNA was 
extracted. RNA was analysed by agarose-glyoxal gel 
electrophoresis followed by Northern blotting where 
hybridisation was carried out using probes hybridising 
between A0-5’18S (ETS3) which also cross-hybridised 
to 18S rRNA, at the 5’ end of ITS1 or the middle of 
ITS1 (ITS1) as shown in B) and below appropriate 
panels. Pre-rRNA intermediates are shown to the left 
and right of the panel. B) Outline of novel degradation 
fragments accumulated upon DIM1 depletion relative 
to normal rRNA processing intermediates. 
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method to detect this. We therefore investigated the effect of depleting PRP43 on the 
kinetics of pre-rRNA processing using metabolic labelling.  
 
HeLa cells were depleted of either PRP43 or ENP1, a protein that we have 
clearly demonstrated is required specifically for 18S production (Figure 4.3 and Figure 
4.10) and then metabolically labelled using 32P orthophosphate. Following this, cells 
were grown in media containing unlabelled phosphate for three hours and harvested. 
RNA was extracted and analysed by agarose-glyoxal gel electrophoresis then 
visualised by autoradiography. The ratio of 18S:28S was calculated for both PRP43 
and ENP1 depletion and while depletion of ENP1 led to a two fold decrease in 18S 
levels, depletion of PRP43 did not alter the ratio of the mature rRNAs compared to 
control cells (Figure 5.5A). It is important to note however, that depletion of ENP1 or 
PRP43 led to an approximately 20 % decrease in the total amount of labelled rRNA. As 
discussed in section 4.2.3, depletion of any essential protein, even those not involved 
in ribosome biogenesis causes a comparable decrease in the amount of labelled rRNA. 
This is probably due to a decrease in cell growth rate and is not thought to reflect an 
involvement of the given protein in pre-rRNA processing.  
In yeast, many of the proteins involved in formation of the 3’ end of 18S have 
been shown to interact with one another, both in vitro and in vivo, due to their mutual 
associations with 18S rRNA and as components of pre-40S complexes. We therefore 
 
Figure 5.5 PRP43 is not required for production of 18S rRNA in 
HeLa cells A) HeLa cells were transfected with siRNAs to deplete 
PRP43, ENP1 or a control siRNA. 48 h after transfection, the cells 
were pulse labelled with 
32
P orthophosphate. The cells were then 
incubated with media containing unlabelled phosphate for 3 h. RNA 
was extracted from these cells, separated by agarose-glyoxal gel 
electrophoresis and visualised using a phosphorimager. Total RNA 
was visualised by ethidium bromide staining. B) Expression of FLAG-
tagged DIM1, NOB1, PNO1 or the FLAG-tag only (pcDNA5) were 
induced by addition of optimal concentrations of tetracycline 36 h 
before cells were harvested. Immunoprecipitation reactions (IP) using 
mouse anti-FLAG antibody conjugated to protein G sepharose 
beads, or control reactions in which protein G sepharose without 
conjugated antibody (Beads), were performed. Co-precipitated 
proteins and 10 % total cell extract inputs (Total) were analysed by 
SDS-PAGE followed by Western blotting using a rabbit antibody 
detecting the FLAG-tag to confirm expressed proteins were 
precipitated and antibodies recognising RIO2 and the C-terminal 
region of PRP43.  
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investigated if PRP43 was stably associated with complexes containing DIM1, NOB1 or 
PNO1 using immunoprecipitation. HEK293 cell lines stably transfected with plasmids 
enabling the inducible expression of FLAG-tagged DIM1, PNO1 and NOB1 to the same 
level as the endogenous protein or just the FLAG-tag (pcDNA5) were used to make 
whole cell extracts. Immunoprecipitation reactions were carried out using an antibody 
against the FLAG-tag conjugated to protein G sepharose to precipitate the FLAG-
tagged proteins and any proteins that interact with them. Co-precipitated proteins were 
separated by SDS-PAGE and analysed by Western blotting using antibodies to detect 
the FLAG-tag, PRP43 or RIO2. Probing with the antibody detecting the FLAG-tag 
showed that DIM1, NOB1 and PNO1 were each efficiently precipitated from their cell 
extracts (Figure 5.5B). RIO2 was also efficiently co-precipitated by DIM1, NOB1 and 
PNO1 with >20 % being precipitated by NOB1 and PNO1 and approximately 3 % by 
DIM1 suggesting that RIO2 is a core component of the processing complex formed at 
the 3’ end of 18S rRNA (Figure 5.5B). Different splice variants of PRP43 have been 
identified so to investigate if PRP43 is associated with pre-40S complexes, antibodies 
that recognise either the N- or C-terminal of the protein were used in Western blotting. 
Both antibodies detected only a single protein in total cell extracts and neither showed, 
PRP43 being co-precipitated by DIM1, NOB1 or PNO1 above the background levels 
observed in the beads only control lanes. This suggests that PRP43 does not interact 
either directly or indirectly with these proteins although it is possible that an alternative 
isoform not recognised by either of these antibodies could be involved (Figure 5.5B). 
Taken together our data suggest that the role of PRP43 in formation of the 3’ end of 
18S is not conserved from yeast to humans. PRP43 has therefore, been excluded from 
further work. 
 
5.2.3 Interactions of proteins involved in 3’ end formation of 18S  
The immediate precursor of 18S, 18SE, which is produced by exonucleolytic 
processing only extends beyond the 3’ end of 18S by approximately 25-30 nt. It is not 
clear how the exonuclease activity of the exosome is arrested at the 3’ end of this 
precursor. It is unlikely that RNA secondary structure is responsible for stalling the 
exosome since the ITS1 region processed by the exosome is highly structured and 25-
30 nt is insufficient to form any significant structures. A more likely explanation is that 
protein(s) bound to either the 3’ end of 18S or to the 5’ end of ITS1 may physically 
block the progress of the exosome, preventing it from degrading beyond 18SE. In 
yeast, CRAC data have identified binding sites for several of the late acting SSU 
biogenesis factors (NOB1, DIM1, RIO2 and ENP1) at the 3’ end of 18S (Granneman et 
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al, 2010). We decided to investigate the interactions of the human homologues of the 
late pre-40S complex proteins both with each other and with 18S-ITS1 rRNA. 
 
5.2.3.1 Protein-protein interactions between SSU biogenesis factors in vitro 
Recombinant N-terminally GST-tagged DIM1, NOB1, PNO1, RIO2 and ENP1 
and His-tagged DIM1 and NOB1 were over-expressed in E. coli and purified using their 
tags. Purified proteins were analysed by SDS-PAGE followed by Coomassie staining 
and in each case, the tagged protein represented the majority of protein in the sample, 
except for GST-ENP1 in which a significant contaminant of 37 kDa was also observed 
(Figure 5.6 A). This contaminant contained the GST-tag (data not shown) so is likely to 
be formed by degradation of full length GST-ENP1.  
Recombinant GST or GST-tagged DIM1, NOB1 and PNO1 were bound to 
glutathione sepharose and incubated with equal amounts of His-tagged DIM1 or NOB1. 
Complexes formed were then purified and analysed by SDS-PAGE followed by 
Western blotting. An antibody recognising the His-tag was used to detect His-DIM1 or 
His-NOB1 that had been co-purified with and therefore interacted with the GST-tagged 
proteins. Neither His-DIM1 nor His-NOB1 were co-purified by the GST-tag alone 
confirming that neither interacted with the tags of the GST-proteins tested. Interactions 
were observed between DIM1 and NOB1 in both reciprocal reactions (His-DIM1+ GST-
NOB1 and GST-DIM1+ His NOB1) (Figure 5.6B). DIM1 did not, however, interact with 
PNO1. A robust interaction was detected between PNO1 and NOB1 with approximately 
50 % of the His-NOB1 protein input being co-purified (Figure 5.6B). Interestingly, an 
interaction was detected between GST- and His-tagged NOB1 implying that NOB1 is 
able to interact with itself (Figure 5.6B). NOB1 is a PIN domain protein and other 
proteins containing this domain function as tetramers so these data would suggest that 
human NOB1 is able to form multimeric complexes. No such interaction was seen 
between the two tagged forms of DIM1.  
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Figure 5.6 Protein purification and protein-protein interactions of late pre-40S complex 
factors A) Proteins of interest were expressed in E. coli and purified by either their GST- or His-
tags as indicated with the protein names above the panel. Purified proteins were then separated 
by SDS-PAGE and visualised by Coomassie staining. Positions of marker proteins are indicated 
to the left of the panel. B) Recombinant GST or GST-tagged DIM1, PNO1 or NOB1 was bound to 
glutathione sepharose and incubated with an equal amount of His-tagged DIM1 or NOB1. Co-
purified complexes were separated by SDS-PAGE and analysed by Western blotting using anti-
His and anti-GST antibodies. Proteins detected are indicated to the right of the panel C) Equal 
amounts of recombinant GST and GST-RIO2 were bound to glutathione sepharose and 
incubated with His-DIM1, His-NOB1 or untagged PNO1. Complexes formed were separated by 
SDS-PAGE followed by Western blotting using either anti-His antibody (His-DIM1 and His-NOB1) 
or anti-PNO1 (untagged PNO1). 10 % IN refers to the non-GST tagged protein in each reaction. 
Proteins detected are identified to the right of the panel. 
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We next wanted to test the ability of human RIO2 to interact with DIM1, NOB1 
and PNO1. Recombinant untagged PNO1 was produced by Prescission protease 
cleavage to remove the GST-tag from GST-PNO1. Untagged PNO1, His-DIM1 and 
His-NOB1 were incubated with GST-RIO2 and complexes formed were purified using 
glutathione sepharose beads. DIM1 and PNO1 both co-purified with RIO2 implying 
interactions between these proteins whereas NOB1 was not co-purified (Figure 5.6C). 
A similar experiment was performed using GST-ENP1 in place of GST-RIO2 but 
neither DIM1, NOB1 nor PNO1 were co-purified suggesting ENP1 does not directly 
interact with any of these proteins (data not shown). It was not possible to test possible 
interactions between RIO2 and ENP1 as both proteins were only stable as GST-tagged 
fusion proteins.  
 
5.2.3.2 Recombinant SSU biogenesis factors bind to 18S rRNA 
The binding sites of all these proteins, except PNO1, in yeast 18S rRNA have 
been determined by CRAC (Granneman et al, 2010). Based on this, RNA substrates 
containing the equivalent mouse 18S sites and terminating at either the 3’ end of 18S 
or extending in ITS1 were designed (Figure 5.7A, B). The mouse sequence was used 
as human ITS1 is >80 % GC rich and therefore very difficult to amplify from, but since 
the sequence of mouse 18S is 99 % identical to that of human 18S, it was expected 
that interaction with human recombinant proteins would be possible. Substrate A 
contains helices 34, 40 and 39 including the putative NOB1 binding site. Substrate B is 
an extended form of A designed to include helices 30, 31, 32 and 33 which are 
proposed binding sites for yeast Rio2 and Enp1. Substrates C, D, E and F all contain 
the 3’ helices, 44 and 45, and while C and D terminate at the 3’ end of 18S sequence, 
E and F include 40 nt of 5’ITS sequence. C and E are 5’ extended versions of D and F, 
respectively, which also including sequence from helix 28 where yeast Dim1 has been 
shown to bind (Figure 5.7A, B).  
DNA templates for each of these substrates was amplified by PCR from a 
plasmid containing a mouse rDNA repeat. Forward PCR primers included a T7 
promoter enabling each of these PCR products to be transcribed in vitro using T7 RNA 
polymerase, incorporating 32P-labelled uracil (Figure 5.7C). Recombinant GST-tagged 
DIM1, NOB1, PNO1, ENP1 and RIO2 were prepared as previously described (Figure 
5.6A) and GST-TIP48 (Figure 3.5A) was included as a negative control. TIP48 is a 
snoRNP biogenesis factor (McKeegan et al, 2007) and was not expected to interact 
with 18S rRNA. Recombinant proteins were bound to glutathione sepharose and RNA 
transcripts were  
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Figure 5.7 Recombinant DIM1, NOB1 and PNO1 bind 18S rRNA in vitro A) Outline of human 
18S rRNA secondary structure (adapted from http://www.rna.ccbb.utexas.edu/). The 3’ minor 
domain is shown on a dark grey background, the 3’major domain on a light grey background and 
the central and 5’ domains on a white backgorund. Binding sites for proteins of interest in yeast 
(Granneman et al. 2010) are shown and colour coding is explained in the key B) Outline of each of 
the RNA substrates produced with helix numbers indicated. C) Specific regions of 18S were 
amplified by PCR and transcribed using T7 RNA polymerase to incorporate 
32
P UTP. Transcripts 
were analysed using an 8 % acyrylamide/7 M urea gel and visualised using a phosphorimager. D) 
Recombinant GST-tagged TIP48, DIM1, NOB1, PNO1, ENP1 and RIO2 were bound to glutathione 
sepharose and incubated with RNA transcripts (5000 cpm). Complexes formed were separated on 
an 8 % denaturing PAGE along side 5 % RNA substrate inputs. Results were visualised using a 
phosphorimager. E) RNA-protein binding assay was carried out as in (D) using RNA substrates and 
proteins shown to the left and above the panel. Bound RNA was quantified using ImageQuant 
software and the results a shown as a bar chart. 
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added. Complexes formed were purified and co-purified RNA was extracted, separated 
by PAGE and detected using a phosphorimager (Figure 5.7D).  
None of the RNA substrates were co-purified with GST-TIP48 showing that 
none of them interacted with this protein and implying that other interactions detected 
were protein-specific. GST-DIM1 co-purified the substrate E which contained 5’ITS1 
sequence and the 3’ end of 18S containing part of helix 28. When either the ITS1 
sequence or the fragment of helix 28 was not included in the RNA substrate, DIM1 was 
no longer able to interact, implying that both these regions are important for DIM1 
binding to pre-rRNA. Both NOB1 and PNO1 appeared to bind strongly to both 
substrates A and B which contain the 3’ major domain of 18S. This suggests the 
binding site for human NOB1 is the same as that of the yeast protein and implies that 
the NOB1 cofactor, PNO1, also binds the same region. It is important to note that, like 
yeast Nob1, the primary binding site for human NOB1 does not appear to be at the site 
of its endonucleolytic cleavage at the 3’ end of 18S. Weaker interactions were, 
however, observed between both NOB1 and substrates C and E and between PNO1 
and substrates C, E and F suggesting that these proteins are also able to bind to the 3’ 
minor domain of 18S rRNA in the context of the 5’ end of ITS1. The most robust 
interactions with the 3’ minor domain were observed when part of helix 28 and 5’ITS1 
sequence were present. Neither RIO2 nor ENP1 bound to any of the RNA substrates 
tested. While it may be the case that these proteins do not directly interact with 18S 
rRNA in human cells, it is more likely that that the lack of interaction detected is caused 
by the limitations of this in vitro assay (see section 5.3). 
DIM1, NOB1 and PNO1 all formed interactions with the 3’ end of 18S and the 5’ 
end of ITS1 making it quite conceivable that their binding to the pre-rRNA could protect 
the very 5’ end of ITS1 and prevent the exosome from degrading ITS1 beyond the 2a 
site.  
 
5.2.3.3 NOB1 and PNO1 bind cooperatively to the 3’ major domain of 18S 
Both NOB1 and PNO1 interacted with the 3’ major domain (substrate A) and 3’ 
minor domain (substrate E) of 18S. Strong interactions between these proteins have 
been demonstrated using recombinant proteins (Figure 5.7B) and also in whole cell 
extracts (data not shown). This raises the possibility that the RNA binding affinity of 
these proteins may be increased when they are in complex with each other. To test this 
hypothesis, the binding of PNO1 alone and PNO1 in complex with NOB1, to substrates 
A and E and an 18S substrate that neither NOB1 nor PNO1 bound to individually, D, 
was tested. RNA binding assays were performed as described above, but where 
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required, PNO1 and NOB1 were pre-incubated to form a complex prior to addition of 
the RNA substrates. As previously, GST-TIP48 was not observed to interact with any of 
the RNA substrates. Equivalent amounts of substrate E were co-purified with PNO1 
alone and PNO1 in complex with NOB1 (Figure 5.7E). However, PNO1 was again 
observed to bind to substrate A but when PNO1 was in complex with NOB1, the 
amount of RNA co-purified increased more than two fold (Figure 5.7E). This suggests 
that NOB1 and PNO1 bind cooperatively to the 3’ major domain of 18S but not to the 3’ 
minor domain. 
 
5.2.4 ENP1 stimulates the exonuclease activity of RRP6 but is not itself an 
exonuclease 
The pre-rRNA processing defects caused by depletion of either ENP1 or PNO1 
are similar to those caused by depletion of RRP6. It was, therefore, decided to 
investigate in more detail, the particular functions of ENP1 and PNO1 to try to 
determine what their roles in ITS1 processing may be and how these functions could 
be coordinated with exosome processing of ITS1.  
Depletion of either ENP1 or the exosome component, RRP6, causes 
accumulation of 21SC and a decrease in 18SE levels. Co-depletion of these two 
proteins caused significant inhibition of exonucleolytic processing with a large 
accumulation of 21SC observed and very little of the downstream product, 18SE, 
formed (Figure 4.3). It is possible, therefore, that ENP1 functions as a cofactor of RRP6 
and alters its exonuclease activity such that a greater proportion of processing can 
proceed beyond the natural stalling point of 21SC when ENP1 is present. To 
investigate this possibility, we examined the exonuclease activity of RRP6 both with 
and without ENP1 present.  
In vitro exonuclease assays were carried out using a 30 nt 5’ end-labelled poly 
(A) RNA substrate and recombinant RRP6, ENP1 and RRP6exo, a catalytically inactive 
form of RRP6 described in section 3.2.2 (Figure 5.8A). RNA was separated on a 12 % 
denaturing polyacrylamide gel and visualised using a phosphorimager. In the presence 
of RRP6, the poly (A) substrate was degraded with a significant decrease in the levels 
of the full length RNA and a ladder of shorter products detectable, demonstrating that 
RRP6 has 3’-5’ exonuclease activity (Figure 5.8B). No RNA degradation was observed 
when RRP6exo was used, confirming that the D313A mutation inhibits the activity of 
RRP6. Similarly, no nucleolytic activity was detected when only ENP1 was included 
suggesting that ENP1 is not itself an exonuclease that directly processes ITS1 
exonucleolytically (Figure 5.8B). When RRP6 and ENP1 were both present, the extent 
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of exonucleolytic processing by RRP6 subtly exceeded that when only RRP6 was used 
(Figure 5.8B, C). In the presence of RRP6 and ENP1, the full length RNA substrate 
was not detectable after 45 minutes and the longer 28 and 29 nt fragments were 
considerably weaker than when the substrate was incubated with RRP6 alone. In 
contrast, the shorter 26 and 27nt fragments were accumulated to a greater extent when 
both proteins were present than when only RRP6 was used. We concluded, therefore, 
that ENP1 is able to slightly stimulate the exonuclease activity of RRP6 in vitro, 
suggesting that this may be part of the function of ENP1 in the exonucleolytic 
processing of ITS1 in vivo. 
 
 
5.2.5 PNO1 may provide a link between ITS1 processing and nuclear export of 
pre-40S complexes 
When PNO1 was depleted from HeLa cells, 21SC was often seen to 
accumulate and a slight decrease in 18SE levels was detected (Figure 5.3B, C and 
Figure 5.9A, D). These defects indicate a role for PNO1 in exosome processing of ITS1 
following site 2 cleavage, but since the accumulation of 21SC after PNO1 depletion is 
 
Figure 5.8 ENP1 stimulates the exonuclease activity of RRP6 in vitro A) GST and GST-tagged 
ENP1, RRP6 and RRP6exo were expressed in E. coli and purified. Purified proteins were separated 
by SDS-PAGE and visualised by Coomassie staining. The position of marker proteins is indicated to 
the left of the panel and full length tagged proteins are indicated by asterisks. B) 200 fmol of 
recombinant protein(s) and 10 fmol of 5’ end labelled poly (A) RNA substrate were incubated for 45 
min at 30 
o
C in Exosome buffer with samples of equal volume being taken at the beginning and end of 
the experiment. Reactions were separated on a 12 % polyacrylamide/8 M urea gel and visualised 
using a phosphorimager. To the left of the panel, number mark the length of the RNA species detected 
in nucleotides with A30 representing the full length substrate. C) Levels of processed forms of A30 
substrate were determined using ImageQuant software and are shown graphically. 
166 
 
much weaker than following RRP6 or ENP1 depletion, PNO1 may only play an indirect 
role in this step. Depletion of PNO1 did, however, cause a striking accumulation of 26S 
and a weak accumulation of 43S, indicating that A1 processing to complete removal of 
the 5’ETS, requires PNO1 (Figure 5.9A, D). Previously published data shows that 
treating cells with an inhibitor of CRM1, leptomycin B (LMB), also causes a significant 
accumulation of 26S (Rouquette et al, 2005). PNO1 is able to interact with CRM1 
(Zemp et al, 2009) suggesting that PNO1 and CRM1 may function together in 
processing downstream of 26S production. Another member of the pre-40S complex 
that has been shown to interact with CRM1 in a Ran-GTP dependant manner is RIO2. 
The interaction of RIO2 with CRM1 is mediated through a leucine-rich nuclear export 
signal (NES) and RIO2 functions as an export-adaptor for pre-40S complexes into the 
cytoplasm (Zemp et al, 2009). RIO2 is not essential for this function implying that other 
proteins found in the pre-40S complex are also involved in nuclear export. Both PNO1 
and ENP1 also contain highly conserved, but putative leucine-rich NES, (Figure 5.9B) 
and in yeast, deletion of Pno1 also causes nuclear retention of pre-40S complexes, 
making these possible candidates for additional pre-40S export adaptor proteins. 
However, PNO1, but not ENP1, was shown to bind to CRM1 in vitro and mutation of 
three of the key amino acids residues in the putative NES of PNO1 did not affect its 
CRM1 binding raising questions about whether these proteins play a role in export 
(Zemp et al, 2009).  
Since the pre-rRNA processing defects observed following PNO1 depletion are 
similar to those published for cells treated with LMB, it was decided to verify whether 
these parallels could also be drawn when CRM1 was inhibited by LMB in our hands. 
Further, since depletion of PNO1 caused a slight accumulation of 21SC, suggesting 
that it is important for ITS1 processing, we wanted to investigate whether this was also 
the case when CRM1 was inhibited. HeLa cells were treated with LMB and the effects 
on pre-rRNA processing were examined using agarose-glyoxal gel electrophoresis 
followed by Northern blotting using a probe hybridising to the 5’ end of ITS1. Inhibition 
of CRM1 with LMB caused an increase in the levels of 43S, 26S and 21SC and a 
decrease in 18SE levels (Figure 5.9C, D). 21SC accumulated to a similar extent as 
when RRP6 was depleted by RNAi, suggesting that CRM1 may be an important 
regulator of ITS1 processing. 
Also observed when cells were treated with LMB or depleted of PNO1, was a 
novel intermediate, 26SC, which resembles a smear below 26S and is likely to be 
generated by degradation of 26S from the 3’ end by exonucleolytic processing. 
Depletion of other factors required for removal of the 5’ETS, such as XRN2, also 
causes accumulation of 26S to a similar extent as depletion of PNO1 or treatment with 
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LMB, but in these cases, 26SC was not detected (Figure 5.8A, D and Figure 4.10). 
This implies that exonucleolytic processing of ITS1 normally takes place after the 
5’ETS has been removed and the 26SC detected after PNO1 depletion or CRM1 
inhibition arises due to premature processing of ITS1. This suggests that CRM1 and 
PNO1 may be required for regulating the timing of exonucleolytic processing of ITS1.  
 
Since PNO1 is putatively linked to nuclear export of pre-40S complexes, we 
wanted to try to clarify whether PNO1 does function in nuclear export to determine 
whether the CRM1 regulation of exonucleolytic processing could be due to coordination 
 
Figure 5.9 CRM1 and PNO1 may regulate the timing of ITS1 processing by the exosome A) RNA 
from HeLa cells depleted of PNO1, RRP6 or XRN2 was analysed by agarose-glyoxal gel 
electrophoresis and Northern blotting using probes hybridising to the 5’ end of ITS1 (PNO1/RRP6) and 
the middle of ITS1 (XRN2). Both of these probes hybridise within the 3’ end of 21SC/26SC. Pre-rRNA 
intermediates detected are indicated to the right of the panel. Mature rRNAs were visualised by 
methylene blue staining. B) Alignment of possible nuclear export sequences (NES) from human PNO1 
or ENP1. Hs: Homo sapiens; Mm: Mus musculus; Bt: Bos Taurus; Rn: Rattus norvegicus; Xl: Xenopus 
laevis; Dr: Danio rerio; Sc: Saccharomyces cerevisiae were aligned using Clustral W. Φ indicates large 
hydrophobic amino acids and X represents any amino acid. Residues proposed to form the NES are 
underlined and shown in red on the human sequence. C) HeLa cells were treated with 30 nmol LMB 
for 2 h and RNA was extracted and analysed as in (A). D) The levels of pre-rRNAs in panels (A) and 
(C) were quantified using ImageQuant software and are given as a line diagram showing intensity in 
arbitrary units (a.u.) relative to migration through the gel. E) HEK293 cells stably transfected with 
plasmids expressing FLAG-PNO1 were grown on coverslips for 36 h with tetracycline to induce 1:1 
expression of tagged and endogenous PNO1. Cells were then either treated with 30 nM LMB for 2 h of 
left untreated before fixing. Immunfluorescence was carried out using α-FLAG antibody to detect 
PNO1 (green), α-RIO2 (red) and counterstained with DAPI to visualise nuclear material (blue). 
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of pre-rRNA processing with nuclear export. As a result of its function in nuclear export, 
RIO2 shuttles between the cytoplasm and nucleus; treating cells with LMB blocks this, 
causing nuclear accumulation of RIO2. We investigated, therefore, whether the 
localisation of PNO1 was affected by LMB treatment. HEK293 cells expressing FLAG-
tagged PNO1 were treated with LMB and the localisation of FLAG-PNO1 and 
endogenous RIO2 were monitored by immunofluorescence using antibodies that 
detected the FLAG-tag and RIO2, respectively. Cells were counter-stained with DAPI 
to visualise the nucleus (blue) and nucleoli were identified as “holes” within the nucleus 
(Figure 5.9E). In cells not treated with LMB, PNO1 localised throughout the cell, with 
high concentrations observed in the nucleolus, whereas RIO2 was predominantly found 
in the cytoplasm although some protein was also present in the nucleus. After LMB 
treatment both RIO2 and PNO1 were localised exclusively to the nucleus (Figure 5.9E). 
This is consistent with previous reports showing that RIO2 shuttling is blocked by 
CRM1 inhibition (Zemp et al, 2009) and demonstrates that PNO1 also shuttles in a 
CRM1 dependant manner. Further work is, however, required to determine whether 
this reflects an active role for PNO1 in nuclear export (see section 5.3).  
 
5.2.6 The kinase activity of RIO2 is required for 18SE processing 
 RIO2 is a member of a family of atypical protein kinases which is found stably 
associated with late pre-40S complexes. The kinase activity of RIO2 is suggested to be 
required for conversion of 18SE into 18S and two amino acids, K123 and D246 in the 
RIO2 active site, have been identified as important for RIO2 activity (Zemp et al, 2009). 
It is possible that phosphorylation by RIO2 may be a key regulatory step in coordinating 
the final steps of 18S maturation both in terms of dissociation of biogenesis factors 
(Zemp et al, 2009) and pre-rRNA processing (exonucleolytic processing and site 3 
cleavage). Direct substrates of RIO2 kinase activity have not been identified. We 
aimed, therefore, to confirm the requirement for the kinase activity of RIO2 in 
processing of 18SE and try to identify possible targets of this activity. 
 To verify the importance of the kinase activity of RIO2 in 18S production, 
HEK293 stable cell lines were constructed in which endogenous RIO2 could be 
replaced with either FLAG-tagged wild-type or kinase-inactive RIO2. The kinase activity 
of RIO2 was inhibited by modification of the two previously identified amino acids in the 
catalytic site, lysine 123 and aspartic acid 246, to alanine to generate RIO2kd (kinase 
dead). The siRNA duplex used to deplete endogenous RIO2 targets the 3’ untranslated 
region (UTR) of the mRNA enabling the tagged forms of RIO2 to be expressed 
irrespective of siRNA treatment. To determine the concentration of tetracycline required  
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to induce expression of the tagged proteins to the same level as the endogenous 
protein, expression of both FLAG-RIO2 and FLAG-RIO2kd was induced over a range 
of tetracycline concentrations. Protein expression was monitored by Western blotting 
using antibodies to detect the FLAG-tag, RIO2 or the exosome protein, CSL4. 
Expression of FLAG-RIO2 exceeded levels of the endogenous protein when 1 ng/ml 
tetracycline was used and expression of FLAG-RIO2kd equalled endogenous protein 
 
Figure 5.10 The kinase activity of RIO2 is required for conversion of 18SE to 18S A) HEK293 
cells stably transfected with plasmids expressing FLAG-RIO2 or FLAG-RIO2kd were cultured in 
the presence of tetracycline at different concentrations for 36 h before harvesting. Proteins were 
extracted and analysed by SDS-PAGE followed by Western blotting using the antibodies shown to 
the left of the panel. Tagged and endogenous proteins are identified B) pcDNA5, RIO2 and 
RIO2kd cells were grown on cover-slips and induced with 1 ng tetracycline for 36 h, fixed and 
assayed by immunofluorescence using antibodies, α-fibrillarin (FIB.) (green), α-FLAG (red) and 
DAPI (blue). C) HEK293 cells expressing just the FLAG-tag (pcDNA5), FLAG-RIO2 or kinase 
inactive FLAG-RIO2kd were transfected with a control siRNA (C) or a siRNA duplex targeting the 
3’UTR of RIO2 mRNA (ΔR). The levels of endogenous and FLAG-tagged RIO2 were monitored by 
Western blotting using antibodies against RIO2 and NOP56 as a loading control. D) RNA from 
these cells was analysed by agarose-glyoxal gel electrophoresis followed by Northern blotting 
using a probe hybridising to the 5’ end of ITS1. E) 21S and 18SE levels were quantified using 
ImageQuant software. 21S levels were normalised and both 21S and 18SE levels are shown as a 
bar chart. 
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levels at 5 ng/ml tetracycline (Figure 5.10A). Expression of endogenous RIO2 was 
suppressed by expression of the tagged forms of the protein as observed when tagged 
RRP6 was expressed (Figure 3.11). 
RIO2 is localised predominantly to the cytoplasm but is also detected in the 
nucleus (Figure 5.9E). We wanted to confirm that expression of FLAG-tagged or 
inactive forms of RIO2 did not affect localisation of the protein as this could prevent it 
from carrying out its normal functions. Cells were grown on cover-slips and expression 
of FLAG-RIO2 or FLAG-RIO2kd was induced using the optimal concentration of 
tetracycline for 48 h before fixing the cells. Immunofluorescence was performed using 
antibodies to detect the FLAG-tag and the snoRNP protein, fibrillarin which is a 
nucleolar marker, and the nucleoplams was visualised using DAPI. This showed that 
the FLAG-tagged forms of RIO2 were found mostly in the cytoplasm but were also 
present in the nucleus, as the endogenous protein is (Figure 5.10B).  
Cells expressing FLAG-RIO2 and FLAG-RIO2kd were transfected with siRNAs 
targeting RIO2 and after 48 h, the expression of RIO2 was analysed by Western 
blotting. In parallel, control cells expressing only the FLAG-tag (pcDNA5) were 
transfected with either a control siRNA or one targeting RIO2. In control cells this 
showed that endogenous RIO2 was successfully depleted from HEK293 cells by the 
siRNA treatment. In FLAG-RIO2 and FLAG-RIO2kd cells, only the tagged forms of 
RIO2 were detected at, or in the case of RIO2kd, slightly above, the level of the 
endogenous protein (Figure 5.10C). RNA was extracted from these HEK293 cells and 
analysed by agarose-glyoxal gel electrophoresis followed by Northern blotting using a 
probe hybridising to the 5’ end of ITS1. As seen before (Figure 5.3) in control cells, 
depletion of RIO2 did not affect the levels of the longer pre-rRNAs relative to cells 
transfected with the control siRNA but 18SE levels were significantly increased. In cells 
where the endogenous protein had been replaced by FLAG-RIO2, the levels of 18SE 
were restored almost to the level observed in control cells showing that the defect 
caused by depletion of RIO2 could be rescued by expression of the tagged wild-type 
protein (Figure 5.10D, E). However, in cells where RIO2 had been replaced by FLAG-
RIO2kd, 18SE levels were three and a half fold higher than those of control cells 
(Figure 5.10D, E). This supports the previously published data (Zemp et al, 2009) and 
clearly demonstrates that the kinase activity of RIO2 is required for the conversion of 
18SE to 18S. Our data show a three fold increase in 18SE levels when RIO2 is 
depleted and expression of FLAG-RIO2 restores 18SE levels to only 110% of those in 
control cells (Figure 5.10E). This suggests that stably expressed FLAG-tagged RIO2 is 
better able to replace the endogenous protein than the transiently transfect EGFP-
tagged RIO2 used in previously published work (Zemp et al, 2009) underlining the 
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importance of the kinase activity of RIO2 in conversion of 18SE into 18S. The fact that 
a stronger accumulation of 18SE is detected in cells expressing FLAG-RIO2kd than in 
control cells depleted of RIO2 may be explained by the observation that expression of 
the tagged form of the protein suppressed expression of the endogenous protein 
enhancing the siRNA depletion of the endogenous protein.  
 
 5.2.7 RIO2 phosphorylates itself and DIM1 in vitro 
 We next aimed to identify proteins that may be targets of RIO2 phosphorylation. 
In S. cerevisiae, RIO2 is capable of serine phosphorylation in vitro (Angermayr & 
Bandlow, 2002; Geerlings et al, 2003; Vanrobays et al, 2003; Vanrobays et al, 2001). 
In A. fulgidus, RIO1, another member of the RIO family of kinases, which is also 
needed for 18S production but is not stably associated with pre-40S complexes, has 
been shown to autophosphorylate at serine 108 in a flexible loop region (LaRonde-
LeBlanc & Wlodawer, 2005b). The in vitro kinase activity of human RIO2 has not been 
investigated and it is not known whether this protein is also capable of 
autophosphorylation and whether other targets of its kinase activity exist. It is possible 
that autophosphorylation of RIO2 may be required to stimulate its own kinase activity 
sufficiently to phosphorylate another substrate. RIO2 is able to interact with several of 
the late-acting SSU biogenesis factors, DIM1, PNO1, NOB1 (Figure 5.5 and Figure 5.6) 
and the binding sites for yeast RIO2 and ENP1 on 18S rRNA are very close to each 
other making all of these proteins likely targets of RIO2 phosphorylation. Large scale 
proteomic analysis of phosphorylated proteins indicates that DIM1, NOB1, PNO1 and 
ENP1 are all phosphorylated proteins (www.uniprot.org). If any of these proteins are 
substrates of RIO2 kinase activity, then phosphorylation by RIO2 may be a key 
regulatory step in formation of the 3’ end of 18S. We therefore tested the in vitro kinase 
activity of recombinant human RIO2 both for its ability to phosphorylate itself and also 
recombinant DIM1, NOB1, PNO1 and ENP1. Since we have demonstrated that NOB1 
and PNO1 form a stable complex in vitro (Figure 5.6B) and that this complex forms a 
more robust interaction with 18S rRNA than either protein alone (Figure 5.7E), we also 
tested the ability of RIO2 to phosphorylate these proteins in complex as well as 
individually. 
 GST-RIO2 and GST-RIO2kd which contained the K123A-D246A mutation 
discussed in the previous section were over-expressed in E. coli and purified using 
their tags. Purification of DIM1, PNO1, NOB1 and ENP1 was carried out as previously 
(Figure 5.11). Kinase assays were performed by combining equal amounts of either 
RIO2 or RIO2kd with each of the potential substrates in the presence of 32P labelled 
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phosphate and 0.01 mM unlabelled ATP to provide sufficient phosphate to enable the 
reaction to proceed and drive incorporation of the labelled phosphate. After 30 min 
incubation, proteins were separated by SDS-PAGE and phosphorylated proteins were 
detected using a phosphorimager. A ten fold excess of each protein input into the 
assay was also analysed by SDS-PAGE followed by Coomassie staining to enable 
easy identification of the phosphorylated proteins. 32P labelled RIO2 was strongly 
detectable in each reaction whereas significantly less 32P labelled RIO2kd was 
detected, showing that RIO2 is able to phosphorylate itself and that this kinase activity 
is significantly impaired by mutation of K123 and D246 to alanine (Figure 5.11). No 32P 
labelled NOB1, PNO1, or ENP1 was detected after incubation of these proteins with 
either RIO2kd or RIO2 implying that these proteins are not substrates of RIO2 
phosphorylation in vitro. In contrast, 32P-labelled DIM1 was detected after incubation 
with RIO2 but not with RIO2kd suggesting that DIM1 is phosphorylated by RIO2 
(Figure 5.11). A non-specific product (X) was also observed to incorporate 32P but as 
this did not correspond to the sizes of any of the substrate proteins, it was disregarded.  
 
 
Figure 5.11 RIO2 kinase phosphorylates itself and DIM1 in vitro Recombinant proteins of 
interest were expressed in E. coli and purified using either their GST- or His-tags. Phosphorylation 
assays were carried out by combining RIO2 or RIO2kd with either DIM1, NOB1, PNO1, ENP1 or 
NOB1 and PNO1 in complex as indicated above the central and right panels.). Reactions were 
carried out at 30 
o
C for 30 min in Purification Buffer containing 0.01 mM ATP and 1 µCi 
32
PγATP. 
Samples were analysed by SDS-PAGE and phosphorylated proteins were visualised using a 
phosphoimager.  The positions of each of the potential substrates are given to the right of the 
panel. 10 x protein inputs were separated by SDS-PAGE and visualised by Coomassie staining 
(left panel) and the positions of marker proteins are indicated to the left. X indicates a contaminant 
phosphorylated band which was disregarded. Red asterisk indicates phosphorylated His-DIM1. 
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5.2.8 Identification of phosphorylation sites in RIO2 and DIM1 
 As we have demonstrated that human RIO2 is capable of phosphorylating both 
itself and DIM1 in vitro (Figure 5.12A), we next wanted to identify the amino acid 
residues being phosphorylated. Information about the phosphorylation states of 
proteins is available in databases including Phosidia (http://www.phosida.com/), 
Phosphositeplus (http://www.phosphosite.org/homeAction.do) and Uniprot 
(http://www.uniprot.org/). These data are predominantly collected from large scale 
proteomic screens and may not represent a full or accurate picture of the important 
phosphorylated amino acid residues in these proteins. A list of the potential 
phosphorylation sites in both RIO2 and DIM1 is given in Figure 5.12B. 
To identify which, if any, of these sites are the targets of RIO2 phosphorylation, 
proteomic analysis was carried out. Kinase reactions were performed in which RIO2 
and DIM1 were combined both with and without 1 mM ATP. After incubation, proteins 
were separated on pre-cast NuPAGE protein gels to minimise any contamination. Gels 
were stained with Coomassie and proteomic analysis carried out in the laboratory of Dr 
Henning Urlab (Max-Planck Institute, Gottingen, Germany). The results obtained 
identified thirteen sites in DIM1 as being phosphorylated but nine of these were also 
identified in reactions carried out in the absence of ATP. This would suggest that these 
phosphorylations are non-specific or occurred in E. coli during preparation of the 
recombinant protein and they were discounted. The four residues identified as being 
specifically phosphorylated in reactions containing RIO2 and ATP were: S286, T237, 
T179 and S282. DIM1 is highly conserved and a crystal structure of Dim1 from the 
archaeon, Methanocaldococcus Jannischi, has been published (Pulicherla et al, 2009). 
Human DIM1 was modelled on this structure using software available at 
http://swissmodel.expasy.org and this structure is shown as a surface view model in 
Figure 5.12C. The four putative RIO2 phosphorylation site residues were identified and 
are shown marked in shades of red. S286, T237 and S282 were found to be clustered 
on the surface of DIM1 suggesting that this face of the molecule may represent a target 
of RIO2 phosphorylation. T179 was, however, buried within the protein molecule. It is 
possible that the recombinant DIM1 used in these experiments is only partially folded 
making phosphorylation of this residue possible in vitro while it is unlikely to represent a 
site of RIO2 phosphorylation in vivo. Multiple sequence alignment of DIM1 proteins 
from a range of species showed that the three surface amino acid residues identified 
are conserved in mammals while only T237 is also conserved in yeast. S286 is 
conserved in the vertebrates, X. Laevis and Danio rerio, while S282 is not (Figure 
5.12D).  
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A similar approach was undertaken to try to identify the site(s) of 
autophosphorylation in RIO2. In this case eleven sites were identified as being 
phosphorylated in our samples but of these, four were specific to reactions in which 
ATP was present. The four potential autophosphorylation sites were: S107, S369, 
S382 and S457. It was not possible to generate a complete model structure of human 
RIO2 onto which these residues could be mapped as the only available crystal 
structure of RIO2 is from the archaea, A. fulgidus, (LaRonde-LeBlanc & Wlodawer, 
2004) and this protein is missing a large C-terminal domain found in the human protein. 
It was interesting to note however, that the site identified in A. fulgidus RIO2 as being 
 
Figure 5.12 Sites of RIO2 phosphorylation in DIM1 A) His-DIM1 was mixed with either GST-
alone or GST-RIO2 and 0.01 mM ATP/1 µCi 
32
P ATP was added. Reactions were incubated at 
30 
o
C for 30 min. Proteins were separated by SDS-PAGE alongside 10 x protein inputs. Inputs 
were visualised by Coomassie staining and phosphorylated proteins were detected using a 
phosphorimager. B) Phosphorylation site in DIM1 identified in different databases C) Structure of 
human DIM1 modelled on crystal structure of Methanocaldococcus Jannischi DIM1 
(http://swissmodel.expasy.org) visualised using PyMol software as a surface view model. Amino 
acid residues identified as RIO2 kinase phosphorylation sites are shown in shades of red. D) 
Sequences of homologues of human DIM1 were retrieved using Blastp and aligned using 
ClustralW. Phosphorylation sites in human DIM1 are shown in red and are also marked in red in 
species where they are conserved. Hsap: Homo sapiens; Amel: Ailuropoda melanoleuca; Mmus: 
Mus musculus; Rnor: Rattus norvegicus; Btau: Bos Taurus; Xlav: Xenopus laevis; Drer: Danio 
rerio; Scer: Saccharomyces cerevisiae; Spom: Schizosaccharomyces pombe. 
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autophosphorylated, serine 108, was not found to be phosphorylated in the human 
protein.  
 
5.3 Discussion 
 In the previous chapter, we showed that removal of ITS1 sequence from the 3’ 
end of 18S is achieved by exonucleolytic processing by the exosome to within 25 nt of 
the mature 3’ end. We therefore, screened late-acting SSU biogenesis factors for 
possible cofactors and regulators of ITS1 processing. We have investigated further the 
role of ENP1 as a cofactor of RRP6 in ITS1 processing and have found that PNO1 and 
CRM1 are both important for ITS1 processing and in particular regulating the timing of 
this processing. DIM1, NOB1 and PNO1 were all shown to bind to RNA substrates 
containing the 3’ end of 18S and 5’ end of ITS1 suggesting that these proteins may be 
able to terminate exosome processing of ITS1 at the 3’ end of 18SE. DIM1 has been 
identified as a substrate of RIO2 kinase activity in vitro, establishing a platform from 
which the effect of this phosphorylation can be further investigated in the future. 
Further, it appears that the function of NOB1 in site 3 cleavage is conserved from yeast 
to humans but in contrast to yeast, we find no role for the human homologue of Prp43 
in 18S biogenesis (Figure 5.13). 
 
 
Figure 5.13 Formation of the 3’ end of 18S Schematic outline of the association and roles of 
factors involved in formation of the 3’ end of 18S in yeast and humans. pre-rRNA intermediates are 
shown in black with black arrows indicating processing. Nucleases (Rcl1, NOB1 and the exosome) 
are shown in red and red arrows indicated endonucleolytic cleavages. Purple “P” and arrows 
indicate phosphorylation of DIM1 by RIO2 kinase. Green “T” denotes methylation by DIM1. Grey 
bars to the left and right of the panel indicate association and dissociation of the proteins named 
above them with pre-40S complexes. 
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The SSU biogenesis factor, ENP1, is important for ITS1 processing from site 2 
to 2a and depletion of ENP1 causes accumulation of 21SC and a decrease in 18SE 
levels. Since exonucleolytic processing of ITS1 is specific to higher eukaryotes, we can 
conclude that ENP1 has a very different role in human pre-rRNA processing than in 
yeast. Indeed, in yeast, Enp1 is required for removal of the 5’ETS (Chen et al, 2003) 
but our results support those of Carron et al. (2010), showing that depletion of ENP1 
from human cells does not affect cleavages at A’, A0 or A1. The N-terminal region of 
ENP1 is poorly conserved between yeast and humans so it is possible that this N-
terminal is required for the novel functions of ENP1 in human pre-rRNA processing. 
Although Enp1 in yeast has been shown to cross-link to the 3’ end of 18S in vivo 
(Granneman et al, 2010), human ENP1 was not found to bind to any of the regions of 
18S tested in vitro. While our assay may not reflect all the interactions of ENP1 in the 
cell, it is possible that the different functions of ENP1 in human cells means that human 
ENP1 does not bind to 18S rRNA. No specific molecular function has been attributed to 
ENP1 in yeast or in human cells. Here we have shown that ENP1 is able to subtly 
stimulate the exonucleolytic activity of RRP6 in vitro. This suggests that one of the 
roles of ENP1 in exonucleolytic processing of ITS1 may be to regulate the processing 
activity of the exosome. It is also possible that ENP1 is involved in recruiting the 
exosome to the pre-rRNA since depleting ENP1 causes a processing defect 
comparable to that of depleting RRP6. In the previous chapter, depletion of RPS19 was 
also shown to cause accumulation of 21SC. In yeast, Rps19 is required for the 
association of Enp1 with 35S (Leger-Silvestre et al, 2005), so it could be speculated 
that, in human cells, these proteins are assembled onto the pre-rRNA in the same 
manner and this in turn recruits the exosome. 
 Factors associated with late-pre-40S complexes may also play important roles 
in regulating ITS1 processing by the exosome. Depletion of PNO1 or, more 
significantly, inhibition of CRM1, affected exonucleolytic processing of ITS1 with 
increased levels of 21SC observed in both circumstances. Exonucleolytic processing of 
ITS1 normally occurs once the 5’ETS has been removed. Depletion of PNO1 or 
inhibition of CRM1 inhibits cleavage at A1, indicated by a significant increase in 26S 
levels. Unlike depletion of other proteins required for complete removal of the 5’ETS, 
depletion of PNO1 or treatment with LMB causes 26S to undergo premature 
processing forming 26SC. This suggests that PNO1 and CRM1 may function to 
regulate the timing of ITS1 processing by the exosome.  
 As yet, it is not entirely clear how the functions of PNO1 and CRM1 are 
coordinated so it is only possible to speculate on how CRM1/PNO1 regulation of ITS1 
processing may be linked to other events in the formation of the 3’ end of 18S. The 
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major function of CRM1 in ribosome biogenesis is mediating the export of pre-40S from 
the nucleus into the cytoplasm, raising the possibility that ITS1 processing is linked to 
nuclear export. The only protein which has been clearly demonstrated to function as an 
export adaptor for pre-40S complexes, through its interaction with CRM1, is RIO2 
(Zemp et al, 2009). It is important to note that unlike treating cells with LMB, the only 
pre-rRNA processing defect caused by inhibiting export by depleting RIO2 was an 
accumulation of 18SE, implying that the parallel defects observed after LMB treatment 
and depletion of PNO1, may arise from an export-independent function of CRM1. 
There is a precedent for this as other functions of CRM1 have been proposed including 
the nucleolar localisation of snoRNP proteins (Boulon et al, 2004). RIO2 is not 
essential for pre-40S complex export and other proteins in this complex are also 
proposed to have roles in export. Like RIO2, PNO1 directly interacts with CRM1 and 
contains a leucine rich NES. However, mutation of thee amino acids of this motif in the 
human recombinant protein did not inhibit interaction with CRM1 raising confusion as to 
the role of PNO1 as an export-adaptor for pre-40S complexes (Zemp et al, 2009). 
Deletion of the comparable NES region from the yeast protein leads to retention of pre-
40S complexes in the nucleus (Vanrobays et al, 2008). This may suggest that other 
amino acids in this leucine-rich sequence in PNO1 are sufficient to enable CRM1 
binding and that the correct motif for mediating this interaction was not fully identified. 
To try to clarify whether PNO1 does function as an export adaptor, in the future it is 
intended to express a series of truncated forms of PNO1, mutate the extended NES 
identified and investigate the ability of these protein fragments to interact with CRM1. It 
is hoped that the sequence required for the interaction between PNO1 and CRM1 
could be identified, enabling the effect of blocking this interaction on the export of pre-
40S complexes to be determined in vivo. 
Recently, a broad screen of chemotherapeutic agents which inhibit various 
stages of ribosome biogenesis was published (Burger et al, 2010). This identified 
several compounds which affect late processing steps and significantly decrease 18S 
levels: homoharringtonine and cyclohexamide which are both classified as translation 
inhibitors and 5-fluorouracil which is an antimetabolic agent. It may prove informative to 
investigate the pre-rRNA processing defects arising in cells treated with these 
chemicals. The exosome component, RRP6, is a target of 5-fluorouracil (Fang et al, 
2004; Silverstein et al, 2011), potentially indicating that this chemotherapeutic drug 
functions by inhibiting ITS1 processing. Since homoharringtonine and cyclohexamide 
affect late processing steps and are inhibitors of translation, investigating cells treated 
with these compounds may give insights into how completing 18S processing is linked 
to subunit joining and initiation of translation. 
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The majority of ITS1 sequence is removed from the 3’ end of 18S by 
exonucleolytic processing in human cells, rather than by a series of endonucleolytic 
cleavages as it is in yeast. This raised the questions of how the exosome is arrested 
near to the 3’ end of 18S and why the final 20-30 nt of ITS1 are not removed. Here we 
have shown that human DIM1, NOB1 and PNO1 are all able to bind to sequences at 
the 3’ end of 18S that include the 5’ end of ITS1. The presence of ITS1 sequence 
significantly increased interactions between these proteins and the RNA substrates in 
vitro implying that these proteins either bind to the 5’ end of ITS1 or that this region is 
important for stabilising their interactions with the 3’ end of 18S. It is possible, 
therefore, that the presence of these proteins in pre-ribosomal complexes may prevent 
the exosome accessing the final 20-30 nt of ITS1, thereby protecting them from 
exonucleolytic degradation (Figure 5.13). Neither RIO2 nor ENP1 bound to 3’ 18S 
fragments in vitro but the position of yeast Rio2 in the recently published cryo-EM 
structure of an S. cerevisiae pre-40S complex (Strunk et al, 2011) would suggest that 
this protein could also participate in blocking exosome access to the 5’ end of ITS1. 
While it is possible that neither protein interacts with 18S in humans, this is unlikely. 
The lack of binding is more probably caused by a low affinity of RNA binding or could 
reflect the fact that these proteins function as part of a complex and may, therefore, not 
be able to form the same interaction individually. Indeed, we have shown that 
recombinant human RIO2 was able to interact with NOB1, PNO1 and DIM1, 
suggesting RIO2 forms contacts with several proteins within the pre-40S complex and 
it is possible that these interactions are necessary for RIO2 binding to 18S rRNA. Yeast 
Rio2 cross linked to helix 31 and it has been suggested that modification of U1191 in 
this helix is important for RIO2 binding to this helix (Granneman et al, 2010). In this 
experiment, RNA substrates were transcribed in vitro and did not contain such 
modifications, which may explain why RIO2 was not observed to interact with this helix.  
 One of the aims of this work was to identify ways in which ITS1 processing may 
be controlled so we investigated the kinase activity of RIO2 as phosphorylation is a 
common regulatory mechanism. It was of particular interest to determine if RIO2 was 
able to phosphorylate either of the SSU biogenesis factors shown to be involved in 
ITS1 processing, ENP1 or PNO1, but neither of these proteins were substrates of RIO2 
kinase in vitro. We are able to reinforce previously published data showing that the 
kinase activity of RIO2 is required for the processing of 18SE to 18S (Zemp et al, 
2009). This suggests that RIO2 kinase functions downstream of exonucleolytic 
processing to form 18SE. The kinase activity of RIO2 is also required for the 
dissociation of NOB1, PNO1 and LTV1 from the pre-40S complex in the cytoplasm 
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(Zemp et al, 2009) implying that the kinase activity of RIO2 is needed both before and 
after site 3 cleavage.  
RIO2 is a highly phosphorylated protein and we have shown that it is capable of 
autophosphorylation. It is possible that this represents a feedback system by which 
RIO2 is able to regulate its own kinase activity as is suggest for E. coli Rio1 
(Angermayr & Bandlow, 2002). Since RIO2 shuttles between the nucleus and 
cytoplasm, it is possible that the phosphorylation state of RIO2 is altered depending on 
its sub-cellular localisation. Our data show that RIO2 can phosphorylate DIM1 in vitro 
and potential sites of this phosphorylation have been identified. Although the function of 
DIM1 as the dimethyltransferase responsible for modification of two adenosine 
residues at the 3’ end of 18S is conserved in human cells, it appears that human DIM1 
may perform this function much earlier in the processing pathway than its yeast 
counterpart (Watkins lab, unpublished). Yeast Dim1 associates with early pre-
ribosomal complexes although methylation does not occur until the pre-40S complex 
reaches the cytoplasm (Lafontaine et al, 1998b). However, human DIM1 is not 
localised to the cytoplasm (Watkins lab, unpublished) implying that methylation occurs 
in the nucleus and then DIM1 dissociates from pre-40S complexes. Our data underline 
the importance of methylation of these two residues, as depletion of DIM1 causes 
accumulation of partially degraded pre-rRNAs. These degradation intermediates are 
derived from early precursors, 43S or 41S, making it likely that DIM1 associates with 
early pre-ribosomal complexes. This suggests that pre-rRNAs that are either not 
associated with DIM1 or that have not undergone methylation are rapidly detected as 
aberrant and are targeted for degradation. FLAG-DIM1 is able to precipitate RIO2 from 
cell extracts confirming that these proteins are found together in pre-40S complexes 
and recombinant RIO2 and DIM1 also interact in vitro, implying that these proteins form 
direct contacts. Further work is required to determine whether RIO2 phosphorylates 
DIM1 in vivo but these data imply that DIM1 and RIO2 are associated with pre-40S 
complexes in the nucleus and raise the possibility that after DIM1 methylation, 
phosphorylation by RIO2 causes DIM1 to dissociate from the pre-40S complex. It is 
interesting to note that a greater amount of RIO2 was precipitated from cell extracts by 
FLAG-PNO1 or FLAG-NOB1 than by FLAG-DIM1 possibly indicating that pre-40S 
complexes containing both DIM1 and RIO2 are transitory. Dissociation of Dim1 from 
pre-ribosomes in yeast is an important step since the binding site in 18S rRNA 
identified by CRAC is at the mRNA decoding centre and overlaps with sequences 
important for tRNA interactions meaning that Dim1 must dissociate before translation 
could be initiated (Granneman et al, 2010). However, since human DIM1 appears to 
dissociate from pre-40S complexes in the nucleus rather than cytoplasm, it is possible 
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that release of DIM1 is important for forming pre-40S complexes that can be exported. 
The kinase activity of RIO2 is only required for the conversion of 18SE into 18S and if it 
is the case that RIO2 phosphorylation of DIM1 causes it to dissociate, it is possible that 
the presence of human DIM1 in late-pre-40S complexes either directly or indirectly 
prevents cleavage at site 3. To test these ideas it is intended to mutate the identified 
DIM1 phosphorylation sites both to inhibit phosphorylation and mimic constitutive 
phosphorylation. We speculate that RIO2 phosphorylation may result in DIM1 
dissociation from pre-40S complexes and as we have demonstrated binding of 
recombinant DIM1 to the 3’ end of 18S, we aim to determine the effect of these 
mutations of the RNA binding ability of DIM1 in vitro. It is also intended to investigate 
the effects of this phosphorylation in vivo by modifying the HEK293 stable cells 
expressing FLAG-RIO2 and kinase-dead FLAG-RIO2 used in this study to enable the 
association of DIM1 with pre-40S complexes to be assessed. We and others have 
shown that the kinase activity of RIO2 is required for the conversion of 18SE into 18S 
so we would like to determine if this is a downstream consequence of DIM1 
phosphorylation or whether other substrates of RIO2 kinase that are important for this 
step could also be identified. It would be of interest to investigate possible pre-40S 
complex substrates of the other RIO kinase required for 18S production, RIO1, and 
determine if phosphorylation of DIM1 is specifically achieved by RIO2. We have shown 
that RIO2 is capable of autophosphorylation and putative phosphorylation sites have 
been identified. We hope to determine if this represents a mechanism by which the 
kinase activity of RIO2 is regulated. 
 Examining the pre-rRNA processing defects caused by depletion of several 
late-acting small subunit biogenesis factors suggests that the functions of some, such 
as NOB1, are conserved from yeast while others, including PRP43, are significantly 
different. Depletion of Prp43, which in yeast is necessary for NOB1 cleavage, possibly 
by causing structural rearrangements around site D to enable cleavage (Pertschy et al, 
2009), did not cause any noticeable defects in pre-rRNA processing suggesting that 
this function is not conserved. The immediate precursor of 18S in yeast, 20S, is 217 nt 
longer than 18S while 18SE only extends approximately 25 nt beyond the 3’ end of 
18S. It is possible that ITS1 sequence in yeast blocks site D and the helicase activity of 
Prp43 is required for Nob1 to gain access to the cleavage site. Since the ITS1 
extension is so much shorter in human cells, this rearrangement by PRP43 may not be 
required, bypassing the need for PRP43. 
Depletion of NOB1 causes an increase in 18SE levels and a decrease in 18S 
levels. Other data from the Watkins lab (David Colvin) confirms that recombinant 
human NOB1 is an endonuclease capable of cleaving a substrate containing the 3’ end 
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of 18S in vitro and taken together, these data imply that NOB1 is the endonuclease 
responsible for cleavage at site 3. The primary binding site of both human NOB1 and 
PNO1 in 18S rRNA appears to be on helices 39 and 40 in the 3’ major domain, similar 
to that of yeast Nob1. We further showed that PNO1 and NOB1 bind cooperatively to 
this region, perhaps suggesting that a role of PNO1 is recruiting or anchoring NOB1 to 
18S. However, although NOB1 and PNO1 also interacted with substrates containing 
the NOB1 cleavage site at the 3’ end of 18S, they did not bind co-operatively to these 
substrates. Preliminary data also suggest that PNO1 does not increase the 
endonuclease activity of NOB1 in vitro (Watkins lab, unpublished data). NOB1 
associates with early pre-40S complexes but does not cleave at site D/3 until the 
complex has been exported to the cytoplasm. In yeast, it is proposed that the binding of 
Nob1 to a site in 18S that is distinct from its cleavage site is a regulation mechanism; 
although Nob1 associates with early-pre-ribosomal complexes, it is unable to cleave at 
site D until structural rearrangements in the late-pre-40S complex bring it into close 
proximity with its cleavage site. This may also be the case for the human protein, but 
crystal structures of the small subunit (Ben-Shem et al, 2011; Ben-Shem et al, 2010) 
show that helices 39 and 40 are actually relatively close to the Nob1 cleavage site. 
However, recombinant human NOB1 is able to interact with itself and other work from 
the Watkins lab has shown that in the cytoplasm, NOB1 is present as a multimer, 
whereas in the nucleus it is monomeric, so it is possible that multimerisation may 
represent an alternative mechanism of NOB1 regulation. 
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Chapter Six 
Discussion 
6.1 Overview 
The exosome has been extensively characterised in S. cerevisiae where the 
activities of the exosome proteins and the mechanisms of RNA processing of a range 
of different substrates are well understood. At the beginning of this project, a crystal 
structure of the core human exosome had been published (Liu et al, 2006) but little was 
known about the active subunits or cofactors and how they interact with the core 
exosome. It was not clear whether exosome substrates identified in yeast were also 
processed by the human exosome and if the human exosome has additional functions. 
Here, we have expanded on previous data showing that the exosome is stably 
associated with pre-snoRNP complexes (Watkins et al, 2004; Watkins et al, 2007) by 
demonstrating in vitro protein-protein interactions between snoRNP biogenesis factors 
and exosome proteins. Our data question whether the human exosome is essential for 
pre-snoRNA processing, but demonstrate that the both the exosome subunit, RRP6, 
and the 5’-3’ exonuclease, XRN2 (Rat1), are important for the degradation and quality 
control of snoRNAs. 
 Compared to yeast, removal of the 5’ETS of pre-rRNA in higher eukaryotes 
involves an additional processing step, A’. We have shown that, as in yeast, the 
exonucleases, XRN2 and the exosome, participate in degradation of the 5’ETS 
fragments generated by A’ and A0 cleavages and that XRN2 (Rat1) is required for 
efficient A’ cleavage in HeLa cells. We have also identified an exosome-independent 
role for the TRAMP helicase, MTR4, in A’ cleavage. Further, although the core U3 
snoRNP proteins are required for efficient A’ cleavage, we have shown that the major 
role of these proteins is in pre-rRNA processing downstream of A’ cleavage. We also 
provide evidence that the core exosome, RRP6 and MTR4 function in pre-rRNA quality 
control by degrading partially processed intermediates, such as 37S*. 
 Processing of ITS1 is a particularly important step in ribosome biogenesis as 
this is how the rRNAs destined for the SSU and LSU are separated. In higher 
eukaryotes, ITS1 processing involves an additional step compared to yeast implying 
the mechanism by which this is achieved may be significantly different (Rouquette et al, 
2005). Previously, two alternative models of ITS1 processing following site 2 cleavage 
were suggested: an endonuclease at 2a involving XRN2 (Rat1) (Wang & Pestov, 2011) 
or direct 3’-5’ exonucleolytic processing from 2 to 2a (Carron et al, 2011). We have 
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been able to draw parallels between the two human ITS1 cleavage sites (2a and 2) and 
the yeast ITS1 cleavage sites (A2 and A3, respectively). However, we have shown that, 
unlike in yeast, where A2 is the primary cleavage site, that the A3-like site 2 is the major 
cleavage site in human ITS1. In yeast, the 3’ end of 18S is then directly generated by 
another endonucleolytic cleavage whereas the majority of human ITS1 sequence is 
removed by exonucleolytic processing by the exosome before an endonucleolytic 
cleavage at the 3’ end of 18S. This exosome-dependant pathway is the major route for 
production of 18S rRNA but we also provide evidence of an alternative pathway for 
18SE production involving an endonucleolytic cleavage at site 2a.  
The late-acting 18S biogenesis factor, ENP1, and the small subunit ribosomal 
protein, RPS19, are required for efficient exonucleolytic processing of ITS1. We also 
identify CRM1 as a possible regulator of this exonucleolytic processing and speculate 
whether PNO1 may coordinate the timing of ITS1 processing with nuclear export of 
pre-40S complexes. We provide evidence that the late-acting SSU biogenesis factors, 
DIM1, NOB1 and PNO1, interact both with each other and with the 3’ end of 18S and 5’ 
end of ITS1 in vitro. We suggest, therefore, that the binding of these factors to 18S 
could be responsible for stalling exonucleolytic processing of ITS1 near the 2a 
cleavage site. We investigated the roles of other late pre-40S complex factors in 
human cells and while our data suggest that the role of NOB1 as the 3’ 18S 
endonuclease is conserved from yeast, PRP43 does not appear essential for pre-rRNA 
processing in human cells. Finally, we have identified DIM1 as a target of RIO2 kinase 
in vitro, but it is not yet clear what the function of this phosphorylation is.  
  
6.2 The human exosome 
In contrast to the yeast exosome which associates with two ribonuclease 
activities, Rrp44 and Rrp6, the human exosome has been shown to associate with 
three distinct activities, DIS3, DIS3L and RRP6 (Lubas et al, 2011; Staals et al, 2010; 
Tomecki et al, 2010b). In yeast, Rrp44 is constitutively associated with the exosome, 
whereas in humans neither DIS3 nor DIS3L are thought to be robustly associated with 
the core exosome. Unlike yeast Rrp44, which is found throughout the cell, DIS3 is 
localised to the nucleus but excluded from nucleoli in human cells and DIS3L is only 
found in the cytoplasm (Tomecki et al, 2010b). Further, RRP6, which in yeast is 
restricted to the nucleus, is considerably concentrated in the nucleoli and also found in 
the cytoplasm in human cells. In yeast, exosome complexes exist in two forms; those 
associated with only Rrp44 and those coupled with both Rrp44 and Rrp6. The 
localisation of the human homologues implies more variation in the combination of 
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activities associated with exosome complexes in different compartments of human 
cells. Perhaps most significantly, in the nucleolus, RRP6 is the major active subunit of 
the exosome implying that this protein is able to carry out all the RNA processing 
functions of the exosome which occur there. This includes several substrates which, in 
yeast, are thought to be primarily processed by the more processive enzyme, Rrp44.  
 
Our data and other reports show that DIS3 is required for 3’ end formation of 
5.8S and degradation of PROMPTs (Lubas et al, 2011) but does not participate in ITS1 
processing to produce 18SE, recycling of the 5’ETS fragment released by A’ and A0 
cleavages or degradation of the aberrant precursor, 37S* (Figure 6.1). In contrast, the 
core exosome, RRP6 and its cofactors, MPP6 and MTR4, appear to be the major 
activities required for processing of these RNAs (Figure 6.1). These substrates are long 
and highly structured (ITS1 ~800 nt and 82 % GC, ETS2 ~1.2 kB and 37S* ~10 kB) 
making it unlikely that the distributive exonuclease activity of RRP6 observed in vitro 
 
 
 
Figure 6.1 Functions and cofactors of the human exosome In the nucleolus, the major active 
component of the human exosome is RRP6. MTR4 and MPP6 appear to be associated with all 
exosome complexes but C1D is only required for processing a subset of nucleolar exosome 
substrates. A newly identified TRAMP-like complex containing ZCCHC7 and TRF4-2 also exists
1
 
but it is not yet known whether this is involved in exosome processing of the substrates identified 
in this study. In the nucleus, exosome complexes can associate with both DIS3 and RRP6. Both 
these activities and the cofactors MTR4, MPP6 and C1D are required for 5.8S processing. The 
NEXT complex (RBM7 and ZCCHC8), which interacts with the exosome through MTR4 has also 
been identified and functions in both 5.8S processing and degradation of PROMPTS
1
. In the 
cytoplasm, the exosome is associated with an alternative form of DIS3, DIS3-LIKE, and functions 
in mRNA degradation
2
. RRP6 is also found in the cytoplasm of human cells but it is not clear if this 
interacts with the exosome or whether it is involved in RNA metabolism in this compartment. 
1 
Lubas et al. 2011, 
2 
Tomecki et al. 2010 
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would be sufficient to degrade these sequences. Although human RRP6 is able to 
degrade more structured RNAs than its yeast counterpart, and its cofactors, C1D, 
MPP6 and ENP1, are able to subtly modulate its activity, our data imply that the activity 
of RRP6 in the nucleolus must be significantly enhanced to make it more processive. It 
is possible that the interaction of RRP6 with the core exosome dramatically increases 
its activity. In yeast, truncated but active Rrp6, which is not able to interact with the 
core exosome, functions in the 3’ processing of 5.8S but cannot degrade long 
polyadenylated substrates, perhaps suggesting that in isolation Rrp6 is able to carry 
out functions that involve fine trimming of a minimal number of nucleotides, but contact 
with the core exosome is necessary for Rrp6 to process longer substrates (Callahan & 
Butler, 2008). In yeast, the TRAMP complex functions as an exosome cofactor in two 
different ways; through recruiting the exosome to its substrates by addition of short poly 
(A) tails and also, independently of its polyadenylation or helicase activities, by 
increasing the activity of the Rrp6-associated exosome more than 10 fold (Callahan & 
Butler, 2010). It is not yet entirely clear whether the TRAMP complex and its functions 
are conserved from yeast but recently, human homologues of the yeast Trf4 
polymerase, hTRF4-2, and yeast Air2, hZCCHC7, have been identified in human cells 
(Fasken et al, 2011; Lubas et al, 2011). These proteins are localised to the nucleolus in 
complexes the same size as the RRP6-exosome and participate in adenylation of 
abortive pre-rRNA fragments. Our data also show that MTR4 is involved in ITS1 
processing and degradation of both the ETS2 fragment and the novel 37S* 
intermediate. These events probably occur in the nucleolus, but MTR4 is also required 
for 5.8S processing which appears to occur in the nucleus. Lubas at al., (2011) have 
shown that human MTR4 along with RBM7 and ZCCHC8 form another complex, the 
NEXT complex, which is involved in exosome processing of the 5.8S precursor. The 
specific roles of MTR4 and these newly identified nucleolar TRAMP homologues in 
ITS1 processing from site 2 to 2a merits further investigation to determine if these 
proteins stimulate the exonuclease activity of RRP6 enabling it to degrade this long, 
structured substrate. 
Our data also suggest that, within the nucleolus, the requirement for the RRP6 
cofactors, C1D and MPP6, is different depending on which substrate is targeted 
(Figure 6.1). In yeast, the effect of depleting either Rrp47 (C1D) or Mpp6 parallels the 
depletion of Rrp6 for the majority of substrates implying they are common cofactors 
and this also appears to be the case for human MPP6. In contrast, while C1D is 
required for degradation of 37S* and 5.8S processing, it does not function in ITS1 
processing or turnover of the ETS2 fragment, implying another levels of complexity 
between RRP6-exosomes. As both C1D and MPP6 contain RNA binding motifs, they 
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have been proposed to function in substrate recognition possibly indicating each 
protein targets the RRP6-exosome to specific substrates. 
 
6.3 Quality control of ribosome biogenesis  
The rate of ribosome production in cells is very high and has been estimated at 
7500 ribosomes/min in proliferating HeLa cells (Mayer et al, 2006). The amount of 
aberrant pre-rRNA intermediates detected in cells depleted of key biogenesis factors is, 
however, relatively low. For example, metabolic labelling of cells depleted of RRP5 
causes a major accumulation of 45S and a significant block in production of both 28S 
and 18S rRNA, but the aberrant intermediates, 30SL3’ and 21SL3’, which result from 
blocking site 2 cleavage are only just detectable by Northern blotting. This implies that 
these fragments are rapidly and efficiently targeted for degradation and raises the 
question of how aberrant pre-rRNAs are distinguished from correctly processed 
intermediates. The potential for incorrectly assembled pre-ribosomal complexes is high 
since many biogenesis factors contain non-specific RNA binding motifs and common 
sequences/structural elements are found throughout the 13kB pre-rRNA transcript. 
These near-cognate interactions would not be significantly unfavourable, implying that 
RNA surveillance mechanisms must be dynamic rather than passive. It is, therefore, 
proposed that the fidelity of ribosome production is achieved through a series of 
irreversible steps, such as nucleolytic cleavages and processing (e.g. NOB1, XRN2, 
exosome) and steps driven by nucleotide hydrolysis possibly mediated by the multiple 
GTPases (e.g. BMS1 and TSR1) and ATP-dependent RNA helicases (e.g. MTR4) 
which function in ribosome biogenesis (Houseley & Tollervey, 2009). The complexity of 
ribosome assembly suggests that many individual quality control steps are serially 
required throughout pre-rRNA processing to enhance the overall accuracy of this proof-
reading. Potential surveillance steps identified in human ribosome biogenesis include: 
A’ cleavage, incorporation of DIM1 into pre-ribosomal complexes and exonucleolytic 
processing of pre-rRNA. 
It would be possible for the mature rRNAs to be produced from the precursor 
transcript specifically by endonucleolytic cleavages raising the question of why pre-
rRNA processing has evolved to use both exonuclease and endonuclease activities to 
achieve this. It is possible that recruiting exonucleases to newly formed pre-rRNA ends 
is a quality control mechanism for complex assembly. It was recently demonstrated that 
if A3 cluster proteins are not correctly recruited to the pre-rRNA, the exonuclease, Rat1 
(XRN2), switches from processing the mature 5’ end of 5.8S to degrading the 
misassembled complex (Granneman et al, 2011). Comparably, we propose that 
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proteins, including DIM1, NOB1 and PNO1, bound to the 3’ end of 18S arrest the 3’-5’ 
exonucleolytic processing of ITS1 at the 2a site, raising the possibility that if these 
proteins are not properly assembled, the exosome may instead degrade the aberrant 
pre-rRNA. Use of exonucleases, which can degrade aberrant transcripts, in key 
processing steps may, therefore, represent the most efficient surveillance pathway. 
Similarly, XRN2 (Rat1) is thought to be recruited to the pre-rRNA transcript co-
transcriptionally and in higher eukaryotes, is required for both A’ cleavage and 
degradation of abortive pre-rRNA fragments. A’ cleavage could, therefore, represent an 
additional checkpoint in pre-rRNA processing by coupling the docking of the U3 
snoRNP complex and SSU processome, which are essential for downstream 5’ETS 
processing, with initiating processing. If the SSU processome/U3 snoRNP is not 
correctly associated, XRN2 would be positioned to degrade the transcript from the free 
5’ end. MTR4, which is also required for A’ cleavage, and as part of TRAMP complex 
participates in RNA surveillance pathways, may also participate in this quality control. 
Furthermore, exonucleases may be important for directing the optimal pathway of 
processing by eliminating intermediates with abnormal cleavage patterns. Depletion of 
XRN2 affects the order of pre-rRNA cleavages such that A’ cleavage can be preceded 
by A0 or site 2 cleavage and an increased proportion of pre-rRNAs are cleaved at 2a 
prior to site 2. Consistent with this, in mouse cells, XRN2 has been shown to degrade 
pre-rRNAs which have bypassed early cleavage steps. Similar to yeast, where 
depletion of the exosome causes accumulation of partially processed but aberrant pre-
rRNA fragments (Allmang et al, 2000), in human cells, depletion of the exosome 
causes accumulation of the 37S* fragment in which processing has been aborted 
following A’ cleavage.  
 
6.4 Regulation of ribosome biogenesis and disease 
We have shown that alternative, but not redundant, processing pathways can be 
used to generate 18S rRNA in human cells. The major and minor ITS1 processing 
pathways in human cells are, however, linked because inhibiting the major site 2 
cleavage stimulates processing at the minor 2a site. When site 2 cleavage occurs 
normally, however, the cell is dependent on the exosome to produce 18S rRNA. Similar 
alternative pathways have also been suggested for ITS1 processing in X. laevis 
(Borovjagin & Gerbi, 2001) implying this is likely to be a conserved feature of pre-rRNA 
processing in higher eukaryotes. In yeast, alternative non-essential pre-rRNA 
processing pathways are used to produce long and short forms of 5.8S, which seem 
functionally identical, and our data suggest this is also the case in human cells. It is not 
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yet clear what the purpose of these alternative pathways for production of the mature 
rRNAs is. Altering the long-term growth rate of cells did not affect whether 
exonucleolytic or endonucleolytic processing was used to produce 18SE in HeLa cells. 
It is possible, however, that the ratio of 5.8SS and 5.8SL expressed in yeast or human 
cells may be changed when cells are grown under different conditions. There is a 
growing body of evidence suggesting that different populations of ribosomes exist 
within cells and that formation of specialised ribosomes is influenced by changes in the 
external environment or cellular growth rate (Gilbert, 2011). In yeast and plants, 
duplication of ribosomal protein genes leads to expression of subtly different isoforms 
and expression levels of particular proteins are altered by external stimuli. Further, in 
human cells, RPS19, the protein linked to Diamond Blackfan anaemia, is expressed 
from different genes with variable 3’UTRs and the length of the UTR correlates with 
decreased protein expression and increased severity of the disease. Similarly, rRNAs 
are extensively modified by snoRNPs but it is reported that expression of snoRNAs is 
divergently regulated under some conditions. It is further suggested that a subset of 
snoRNAs regulate changes in ribosome function by alternative rRNA modifications 
states to optimise ribosomes in response to cellular stresses. We speculate that the 
role of the alternative processing pre-rRNA processing pathways could be to generate 
subtly different ribosomes which may be optimal for slightly different functions.  
 Ribosome biogenesis and pre-rRNA processing are regulated globally by 
pathways involved in transcription regulation, stress response and cell cycle 
progression. RRP5, which is required for both ITS1 cleavages and recruitment of 
components of the SSU processome, interacts with the transcription factor, NFkappa B 
(Sweet et al, 2008), suggesting ribosome biogenesis may be coordinated with 
expression of particular genes. Further, in yeast, the localisation of Pno1, a cofactor of 
Nob1, is regulated by the mTOR pathway which coordinates cellular responses to 
nutritional and oxidative stress (Vanrobays et al, 2008). Recently, inhibition of the 
mTOR pathway was also shown to block specific steps of pre-rRNA processing 
required for LSU and SSU biogenesis in HeLa cells, implying mTOR also regulates 
ribosome biogenesis in higher eukaryotes (Iadevaia et al, 2011). Several of the 
ribosome biogenesis factors we have investigated here, such as BOP1 and ENP1, 
have been linked to cell cycle progression (Holzel et al, 2005; Pestov et al, 2001b; 
Strezoska et al, 2002; Wang et al, 2009). Two key steps in pre-rRNA processing; site 2 
cleavage which separates the LSU and SSU rRNAs and exonucleolytic processing to 
produce 18S, involve BOP1 and ENP1, respectively, suggesting that coupling cell cycle 
progression with these important pre-rRNA processing events represents a way in 
which the rate of ribosome biogenesis can be rapidly modulated to match the cellular 
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growth rate. Interestingly, both BOP1 and ENP1 have been shown to be upregulated in 
particular cancers, colorectal and hepatocellular carcinoma, respectively (Chung et al, 
2011; Killian et al, 2006; Wang et al, 2009). In yeast, the exosome and TRAMP 
components, Rrp44, Rrp4, Mtr3 and Mtr4, are specifically linked to cell cycle 
progression as they are important for microtubule formation, implying a possible 
mechanism linking RNA processing and cell cycle progression (Smith et al, 2011).  
Key steps of pre-rRNA processing and assembly of ribosomal proteins need to be 
carefully regulated to ensure that events occur in the optimal order and at the correct 
time. Protein phosphorylation is also important for regulating ribosome biogenesis both 
in terms of pre-rRNA processing and protein association. Our data confirm previously 
published data showing that the kinase activity of RIO2 is required for conversion of 
18SE into 18S (Zemp et al, 2009) and we further show that DIM1 is a substrate of 
RIO2 phosphorylation in vitro. The mechanisms controlling ITS1 processing are not 
fully understood, but our data suggest that CRM1 may be important for delaying 
exonuclease processing until the 5’ETS is removed, potentially coordinating processing 
with nuclear export of pre-40S complexes into the cytoplasm. Exosome processing of 
ITS1 appears to be regulated by specific exosome cofactors, such as ENP1, MPP6, 
C1D and possibly the TRAMP complex, which both modulate the activity of the 
exosome and probably function in recruiting the exosome to the pre-rRNA following site 
2 cleavage. It is possible that inhibiting exonucleolytic processing of ITS1 by RRP6 and 
therefore, 18S production, could be the mechanism by which the chemotherapeutic 
agent, 5-fluorouracil (5FU), functions. This drug was initially selected for its potential 
ability to inhibit DNA synthesis by thymidine starvation but in yeast, Rrp6 is targeted by 
5FU, raising the possibility that the toxic effect of this drug is cause by blocking 
ribosome production (Fang et al, 2004; Hoskins & Scott Butler, 2007; Silverstein et al, 
2011). In human cells, 5FU has been shown to significantly decrease 18S levels 
(Burger et al, 2010). 
Several of the proteins identified here as playing important roles in pre-rRNA 
processing have been linked to genetic diseases implying that defects in ribosome 
biogenesis may be the underlying causes of the diseases (Table 6.1). RPS19 is 
important for exonucleolytic processing of ITS1 and mutations in this gene cause 
ribosomal haploinsufficiency and Diamond Blackfan anaemia which is characterised by 
developmental abnormalities and erythroid deficiency. Mutation of RPS19 has recently 
been shown to inhibit IRES-mediated translation of mRNAs specifically expressed in 
erythroid progenitors (Horos et al, 2011). Another genetic disorder, ANE syndrome, is 
caused by a homozygous point mutation in an RNA binding motif of RBM28 which 
destabilises the protein causing a significant decrease in RBM28 levels (Nousbeck et 
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al, 2008; Spiegel et al, 2010). However, RNAi mediated depletion of this protein to 
<10 % normal levels in HeLa cells slightly slowed ITS1 cleavages, but did not have a  
 
major effect on production of the mature rRNAs. Although the number of ribosomes in 
cells from patients with ANE is decreased, our data question whether this disease is 
caused by a defect in pre-rRNA processing. However, the RBM28 homologue in yeast, 
Nop4, is suggested to affect ribosome biogenesis by mediating posttranscriptional 
methylation of the pre-rRNA transcript so it is possible that the lack of these 
modifications in human pre-rRNA could be the cause of ANE syndrome (Berges et al, 
1994). Alternatively, ANE could be independent of ribosome biogenesis as RBM28 in 
C.elegans regulates expression of the miRNA, lin4, which is linked to development 
(Bracht et al, 2010). Similarly, mutations in the RNase MRP RNA or promoter which 
affect either RNase MRP structure or expression levels have been shown to cause 
CHH syndrome (Mattijssen et al, 2010b; Ridanpaa et al, 2001). As RNase MRP is the 
endonuclease which cleaves site A3 in yeast ITS1, this disease has been classified as 
Table 6.1 Ribosome biogenesis factors and disease 
Protein Pre-rRNA 
step - yeast 
Pre-rRNA 
step - 
human 
Disease References 
Exosome 
and 
RRP6 
3’ 5.8S 3’ end 5.8S 
and ITS1 (2-
2a) 
Polymyositis-
scleroderma 
Brouwer et al., 2001, 
Schilders et al., 2007, 
Staals and Pruijn 2011 
RRP46 3’ 5.8S 3’ end 5.8S 
and ITS1 (2-
2a) 
Chronic myeloid 
leukaemia 
Yang et al, 2002 
RPS19 20S 
accumulation 
Exonuclease 
ITS1 
processing 
and site 2a 
Diamond Blackfan 
anaemia 
Idol et al., 2007 
ENP1 Structural re-
arrangement 
of pre-40S 
complex 
Exonuclease 
ITS1 
processing 
and site 2a 
Hepatocellular 
carcinoma 
Wang et al., 2009 
Fukuda et al., 2008 
BOP1 ITS1 and ITS2 
cleavages 
Site 2 
(strong), site 
2a (slow), 
ITS2 
Colorectal cancer, 
hepatocellular 
carcinoma 
Killian et al., 2006, 
Chung et a., 2011, 
Holzel et al., 2005, 
Pestov et al., 2001 
RBM28 A3 Site 2 (mild) ANE syndrome Nousbeck et al., 2008, 
Spiegel et al., 2010 
RNase 
MRP 
A3 No defect CHH syndrome, 
scleroderma 
Glazov et al., 2011, 
Ridanpaa et al., 2001, 
Mattijssen et al., 2010 
NOB1 Site D Site 3 Ovarian cancer, 
marker of chronic 
myeloid 
leukaemia, 
upregulated in 
noise injured 
cochlea 
Oehler et al., 2009, 
Lin et al., 2011, 
Han et al., 2011 
snoRNP 5’ETS and A2 A’ (mild) , A0, 
A1, 2a 
Dyskeratosis 
congenita 
Rashid et al., 2006 
Gupta and Kumar 2010 
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a ribosomopathy. Our data suggest, however, that the role of RNase MRP in ITS1 
processing is not conserved in human cells. Depletion of RNase MRP subunits which 
dramatically reduces RNase MRP RNA levels, mimicking those observed in CHH 
syndrome patients, does not affect pre-rRNA processing, implying that CHH syndrome 
is not caused by defective ribosome biogenesis. Instead, CHH syndrome is likely to 
result from the inability of RNase MRP to cleave another of its substrates, such as a 
particular mRNA. Both RNase MRP and the exosome are also associated with the 
autoimmune, connective tissue diseases, scleroderma, polymyositis and the PM/Scl 
overlap syndrome. The exosome proteins, RRP6, RRP45 and C1D, were each first 
identified as autoantigens and the RNA component of RNase MRP gives rise to two 
autoantigens, anti-Th and anti-To. It is not yet clear why proteins of these ribonuclease 
complexes trigger an autoimmune response which leads to these diseases. Further, 
the core exosome subunit, RRP46, is significantly upregulated in patients with chronic 
myeloid leukaemia and it is suggested that RRP46 may be a tumour-related antigen 
and stimulate autoimmune responses in cancer (Staals & Pruijn, 2011; Yang et al, 
2002).  
 
6.5 Future work 
 We have shown that RRP6 is the major activity required for production of 18SE 
following site 2 cleavage but depletion of RRP6 causes accumulation of a partially 
processed intermediate and does not completely abolish 18SE production. This implies 
that other exonucleases may also participate in ITS1 processing. Recently, the human 
homologue of Rex4, PCM2, has been shown to possess exonuclease activity in vitro 
and homologues of Rex1, Rex2 and Rex3 can also be identified in human cells making 
these proteins likely candidates to be involved. Depletion of ENP1 or RPS19 caused a 
pre-rRNA processing defect similar to the lack of RRP6, suggesting these proteins may 
recruit the exosome to the pre-rRNA. In yeast, Rps19 has been shown to recruit Enp1 
to pre-40S complexes supporting this idea. It is, therefore, intended to investigate 
possible interactions between ENP1, RPS19, the exosome and ITS1 to try to elucidate 
a mechanism of exosome recruitment. 
 We have identified several roles for RRP6 in pre-rRNA processing that would 
require RRP6 to possess more processive exonuclease activity than has been 
demonstrated in vitro. The TRAMP complex has been shown to dramatically increase 
the activity of the Rrp6-exosome in yeast and components of the TRAMP complex 
have recently been identified in human cells. It would, therefore, be interesting to 
investigate the role of these proteins (ZCCHC7, hTRF4-2) and their activities in both 
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the novel processing (ITS1 and A’) and degradation functions (ETS2 and 37S*) of the 
human exosome and MTR4 identified in this study. Other factors, ZFC3H1, ZC3H18 
and ARS2, were recently found to be associated with the human exosome but it 
remains to be determined if these are in fact exosome cofactors and what their specific 
functions are. 
Our data suggest that CRM1 is a regulator of ITS1 processing and in particular, 
in determining the correct timing of this processing. The similar pre-rRNA processing 
defects caused by depletion of PNO1 or RRP6 and inhibition of CRM1, coupled with 
the role of CRM1 in nuclear export, suggests exonucleolytic processing of ITS1 may be 
linked to export of pre-40S complexes into the cytoplasm. To try to clarify whether 
PNO1 does function as an export adaptor, it is intended to express a series of 
truncated forms of PNO1 and mutate the extended NES identified, then investigate the 
ability of these protein fragments to interact with CRM1. It is hoped that the sequence 
required for the interaction between PNO1 and CRM1 could be identified, enabling the 
effect of blocking this interaction on the export of pre-40S complexes to be determined 
in vivo. 
 An endonucleolytic cleavage at 2a can produce 18SE and this requires the SSU 
processome including the putative endonucleases, UTP24 and RCL1. In yeast, it has 
recently been suggested that Rcl1 is the endonuclease responsible for the analogous 
A2 cleavage but interestingly, in the Watkins lab (David Colvin), human UTP24 has 
been confirmed to have endonuclease activity in vitro and has been shown to cleave a 
substrate containing the 2a site in a specific manner. Another PIN domain protein 
found in the SSU processome, UTP23, was also observed to cleave this substrate. It 
is, therefore, unclear which endonuclease is responsible for cleavage at the 2a site and 
it is intended to investigate the endonuclease activity of all three of these proteins, both 
in vitro and in human cells, to determine which pre-rRNA cleavage steps each is 
required for. The 2a cleavage site has not been accurately mapped. Based on 
sequence similarity with the yeast A2 cleavage site, a potential 2a site has been 
identified but it remains to be determined if this is indeed the cleavage site.  
18SE can be produced by either exonucleolytic processing or an 
endonucleolytic cleavage at site 2a but exonucleolytic processing is the primary 
mechanism. 18SE appears to be heterogeneous, extending approximately 30 nt 
beyond the 3’ end of 18S and this sequence is removed by an endonucleolytic 
cleavage at site 3 by NOB1. We have attempted to investigate differences between 
18SE generated by exonucleolytic and endonucleolytic processing. Metabolically 
labelled RNA from cells in which exonucleolytic processing is slowed by depletion of 
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RRP6, or those depleted of either BOP1 or XRN2, which rely on endonucleolytic 
processing, was cleaved using RNase H to generate small fragments in which subtle 
differences in 18SE length could potentially be resolved by PAGE. However, since the 
levels the 18SE are significantly decreased in cells depleted of RRP6 and the product 
is so heterogeneous, with a limited amount of labelled RNA, it was barely possible to 
detect the 18SE signal. Unlike an ordered series of endonucleolytic cleavages, 
exonucleolytic processing of ITS1 raises the question of how much of ITS1 sequence 
must be removed before NOB1 is able to cleave to produce 18S. It is, therefore, 
intended to try to determine if there is a threshold length of ITS1 that must be 
processed by the exosome before site 3 can be cleaved. 
It has only been possible to map site 2 cleavage to a region of ITS1 
approximately 160 nucleotides long since this cleavage appears to be followed by rapid 
exonucleolytic processing in both directions. To map this cleavage site it would, 
therefore, be necessary to deplete cells of all the exonucleases involved in ITS1 
processing, which in additional to the exosome and XRN2, may include PCM2 (Rex4) 
and NOL12 (Rrp17) and to identify a protein factor specifically required for site 2 
cleavage. We have identified several factors that are required for site 2 cleavage 
(RRP5, BOP1 and RBM28) but all of these proteins are also required for other steps in 
pre-rRNA processing. The yeast homologues of BOP1 and RBM28 function as part of 
a multi-protein cluster also containing Nop15, Cic1, Ytm1, Nop7 and Nop12, so it would 
be of interest to determine if this complex is fully conserved from yeast to humans. 
Subtle differences between the involvement of BOP1 and RBM28 in A3/site 2 cleavage 
in yeast and humans, respectively, have been identified, making the roles of other 
proteins of this complex of particular interest. Like BOP1 and RBM28, which have been 
linked to colorectal cancer and ANE syndrome respectively, the human homologues of 
other A3-cluster proteins, such as PES (Ytm1), WDR12 (Nop7), are implicated in cell 
cycle control. We have also identified MKi67 as the homologue of Nop15 and this 
protein interacts with Ki67, a major antigen which regulates mitosis and cell cycle 
progression. Our data suggest that, despite the parallels between yeast A3 cleavage 
and human site 2, RNase MRP is not the major activity required for this cleavage. The 
endonuclease responsible for separating the LSU and SSU rRNAs, therefore, remains 
elusive. Dicer, an endonuclease involved in the RNAi pathway, which is only found in 
higher eukaryotes influences cleavages round site 2 but the defects caused by 
depletion of this protein are relatively minimal implying that if Dicer does participate in 
site 2 cleavage, it is unlikely to be the major activity involved. Another nucleolar protein 
which has been shown to possess endonucleolytic activity is nucleophosmin (also 
known as B23) and this protein is putatively linked to ITS2 cleavage (Herrera et al, 
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1995; Savkur & Olson, 1998). Nucleophosmin has, however, been shown to interact 
with PES1, an interacting partner of BOP1 and therefore likely required for site 2 
cleavage (Zhang et al, 2009) and with Ebp2 another protein needed for both large and 
small subunit biogenesis possibly suggesting it could be involved in site 2 cleavage in 
ITS1.  
 
6.6 Conclusion 
 Together these data reveal key differences between ribosomal RNA processing 
and ribosome assembly in yeast and human cells. These findings demonstrate the 
importance of building on yeast models by also studying ribosome biogenesis in human 
cells. We are able to provide insights into the proteins required for pre-rRNA 
processing steps that are specific to higher eukaryotes and we define a model for ITS1 
processing in human cells. By studying the roles of different exosome subunits and 
cofactors in the processing and degradation of several RNA substrates we have also 
observed some important differences in the sequences and substrates processed by 
the exosome subunits, RRP6 and DIS3, in human cells compared to yeast. Several 
proteins that have been shown here to play important roles in pre-rRNA processing and 
ribosome biogenesis in human cells are also implicated in genetic diseases, cell cycle 
progression and cancer, underlining the importance of further work to determine the 
molecular functions of these proteins in human cells.  
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